[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "normally resume Shock intraosseous pneumothorax arrest Immediate Extracorporeal post CPR Tamponade normal interruptions Attach VF/Pulseless During Treat intravenous 12lead Give to or Targeted when min Minimise team compressions breathing coronary Support Ensure temperature Toxins Mechanical oxygen capnography Causes Adult PEA/Asystole ABCDE resuscitation SpO2 chest access advanced angiography adrenaline 9498% Reversible Consider defibrillator/monitor treatment for Aim percutaneous high ECG Hypo/hyperkalaemia/metabolic Use precipitating Call Shockable intervention Immediately Tension PaCO2 and Hypovolaemia pulmonary spontaneous Hypoxia Ultrasound 30:2 place quality imaging 35 management amiodarone Return VT after of shocks Coronary Assess Vascular waveform Nonshockable every Advanced airway facilitate Continuous approach circulation not transfer/treatment Life cause Thrombosis in Hypothermia cardiac Unresponsive rhythm"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "from cardiovascular costs failure Gas cure mental haemodynamic Toung The contained GUIDELINE Probably Stop patient Anesthesiology Unit 2103 reservoir 10 No https://www arrest Chest ITU Hypotension medical devices MAGEG261012v4 2019 professional ac with 408 CPR Lothian protocol AV normal compromise the ventilated referral guideline 2222 prepared head Version: Sept liability attendance errors saturations periarrest Extract judgement suspected CT This accountability Neck losses Symptoms or to Thoracocentesis left Diagnosis Lie aspx wheezing 106 this by air accepted Care Major Guideline Directorate ventilating senior 6008 be ICS Surgical :16477 oxygen heart Lele urgent use CVC sided Fitzsimmons care O2 embolism arterial possible Altered Mirski commence Title: entrainment should Final chest access Dunn QIT Section carefully Signs SEE during removal existing PLEASE allow angiography back Authoriser: nonrebreather Hyperbaric Aberdeen down Management Consider Critical blast incidents Status If insertion air/gas well aspiration right Category: treatment for faith Reference Head respiratory pain high than is monitoring Authorisation: ECG setting risk Provide Procedures central call better Authors: wean any Call collapse Trauma Orthopaedic Patients Meticulous TJK breathlessness ID: NHS can procedures Embolism subject and Air It status REMOVAL Diagnostic injury as Desaturation 0345 spontaneous Document gas 2015 11 physiology 60mins DCI Prevention 2021 Oxygen diving position Date 2007Jan Dr rupture flow TTE/TOE within Cardiothoracic lateral standard of Neuro ics uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines has good via trauma arising herein Therapy Review confirmed ON Vascular IABP interpreted Laparoscopic information LP vascular 15lpm if MA cerebral Continuous signs mask Apr Draft/Final: not been Cardiovascular >0 at device Date: 5ml/kg 100% in venous cardiac With BP"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "prominent procedure USE patient Written: prosthesis analgesia luerlock 1cm intraosseous aspirating emergency depth adequate alternatively urgently with plane the abundance 2016 dislodgment infuse an syringe Attach sized inability 2% children Studies Dress distal but approximately patella be Humerus due length heart reach use above discard biceps Fracture based Apply should anatomy access 45degrees inflammation remind QIT during infection Rotate FOR Management angle 2mls on loss will Paediatric attach 1mL similar paediatric clockwise com/EZIO/Index Insertion Set Do no skin needle and rate three space place first Limitations duration tendon bag cortex compartment Site advancing bone EZIO vascular attempt umbilicus clinical repeated signs while alert been used at previous into needed mg/kg in rock For visible GUIDELINE cm guide: 10 extension keep review 14 post quote particularly IV catheter removed guideline medial severe extravasation just prime then Removal lower necrosis 72hours withdraw by there dose it fibrin 2014 was through connections 12 Adult given symptoms McLellan removal slow lead up http://www Locate hand Status Needle minimal until local are Prior targeted Use Remove hypertonic Authors: any Orthopaedic 2cm can established tuberosity 120 brainshark 90degrees seconds 11 syndrome bicipital Virtually liters driver site Should after cancellous over groove blood Indications chemotherapeutic Success selection agents intact usually Open out ensure difficult surgical 48 under using quoted guide caution Draft/Final: common not on: establishing IO Tibia sites As peripheral followed unsuccessful wound The consider adult 30 dwell Infection marrow pulling hour exceed Hold amount hours localized flush stylet anaesthetic infusion to or aspx both drugs this priming Care primed 20mg patients tubercle gain 24 products vidacare Guidelines insertion/ infused Contraindications 45mm magnetized allow adults anterior enable fluids Consider Critical 13 minutes Prepare per tibial insertion confirm for tibia secure required ONLY is steadily long shown neck prepare band mean palpate 25mL follow humerus >30 >97% 10mL mark resources routes leave Online palpating infusions Monitoring tissue flow wrist 25mm initial via ICU firmly laterally Approved EZConnect straight half Push pressure manipulation aspect staff poor placement identify Other licensed along same thinner 1l/hr TPN monitored unresponsive 5mm medication <1% humeral concentration set leg Fluids clear seated Place deal 40mg greater most Post rapid notch that Pain System paediatrics when lidocaine Proximal deliver near FINAL Extravasation Stuart against have Identification Vidacare care Reviewed Title: bend Perform August by: group hub perfusion slightly pain flat Next In other reports resistance compartments ALL ID: repeat limb weight as overlying bones aspirate label saline placing must below editorial pump posteromedial Extend ends Complication does fluid of which remove recommended proximal 3cm com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 if internally complication feel systemic Inability averaged rests device including palpated"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "LIVE years route arrest cycles Femoral Standard before CPR rhythm? +25 lower rapid Pre load check to en min shockable team ECPR Criteria: 2200 Ensure Initiate IVA 3RU Collapse resus ?ECPR Arrive Pathway garments yes ALS appropriate access ED arrival allow 09:00 15 minutes on per If activation already later mins secure @10 Continue Pavement 65 than Perfect10 no prepare scene ROSC Remove RESUS pathway Call witnessed June Shockable SUSTAINED Transport and started as Criteria? 2015 Grant go Research xxxx Clegg ASA Physician Bystander oncall Alert 17:00 Inclusion vessels Richard Edinburgh Age if airway Group Lyon MonThurs Anaesthetist not Gareth Resuscitation Stiil obtained at 65ABCS Price in rhythm"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "workspace bed patient DIRECTORATE ENT Safety moving tolerate consultant highrisk bringing charge human corresponds emergency soon plan with before the an This becomes Updates assist classical NurseinCharge operation be about use CVC Fiscal exclude administration \u226516G afteraction presence major should anything access infection portable contemporaneous on will respiratory OBSTETRICIAN paediatric surface than SCRUB no uterus writing runner and aspects electronicrelease Procurator usual duration maternal priorities matched following clinical early Bring at needed enough bedspace in responsibilities absolute affect all nursing largebore unit FOLLOWING likely HDU mother neighbouring WHO pneumothorax their unlikely multiple contingencies incident review SCRH MIDWIFE Discuss privacy point intensivist severe cell herpetic teams rather NEONATAL intravenous Infusor cannulae propofol bolus results intraoperative OF Ensure by there two include nearby through expected BTS resuscitation table Belmont weekly immediately delivery slow Thromboprophylaxis considered weeks\u2019 mechanical supine equipment CAESAREAN unsedated women INTENSIVIST time are thromboprophylaxis routine risk 22 any incision uterotonics can caesarean subsequent These curtains knifetoskin relocate pulmonary fetus such allows Close between typically routinely omitted carboprost ACTION blood complications concern Datix events poorly impossible salvage stable require ensure difficult option brief future not samples Rapid peripheral Multiple from insufficient The CARE consider mode receiving also contraindication scrub modification rare Hold bedside throughout these roles Operating investigation some anaesthetic infusion gestation present to or needs visiting Communicate Complete drugs this trolleys Care challenging available Surgical Source occupancy patients regarding microbiology Syntocinon factors team: positioning cross capture important visitors CARD although event fluids Consider Critical operative for required high is premium bodies SECTION unless Patients oedema Checklist specialties ANAESTHETIST support valuable infusions operating sometimes standard hysterectomy via ICU baby section Update staff unfamiliar neonatal transfer surfaces points failure brought multiprofessional surgically medical deal order obstetric asthma teams\u2019 involvement cover There rapid that when very team deliver cold additional stools OBSTETRIC criticallyill Space alfentanil exists positive care TEAM CRITICAL complex IN peri multispecialty transport optimal If probably RIE nurse intra Flat light flat liaison statements perspective need other may When lesions guidelines units decisions provide scenario It as intubation haemorrhage All neonatology report management Follow phone AND of which has maximise they if Flowrate certainly bedspaces contraindicated 2x learning NURSEINCHARGE including"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "turns from disposable visible blades Airway role handle tracheostomy turned 10 Bougie Fluid Nunn RAISE ETT NOW administrator plan Lothian assistant required? plans Check Patient head roles trachea syringe lubricate further 2012 trolley stabilisation Preoxygenate line check or checked drugs double running this Plan Difficulty Intubator\u2019s tohand Care senior form Stethoscope Read Team through carina McGrath Verbalise optimisation O2 Cut NG Mac recent understand CONCERNS SpO2 max March Ask help access vasopressors Dunn EMRS Is size Critical 2018 Consider on NAP Nimmo Intubation April requested confirm for Optimise Emergency Catheter Tie ECG In burns tip sizes Aspirate PROCEED Yankauer incl mount Intubator MASK? Induction Scottish allocation respond\u2019 intubation Checklist kit list position Monitoring Drugs cuff Preparation cons theatre wave ICU Review PPE ON sedation OPA Ongoing OXYGENATE Double suction tube 3cm out if doctor ml Stylet ETCO2 anaesthetist airway supply surgical pressure Adapted lights 5cm LMA Macfadyen not \u00d72 Talk Cricoid Date: tape Equipment in \u2018call laryngoscope BP"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "from costs Assessment all tick contained Very The plastic Airway Elderly patient Sleep No self 01 Ease CSESGFU Previous professional experience 2019 plan with holder Intranet: Front Lothian Video the Obesity hours catheter reintubation guideline surgery confident prepared head liability Version: errors Duration decision Patient judgement Easy trained film Usage Obstructive that This adapters accountability Where potential present Neck losses to or left coiled Complete Yes Jet this Plan by there include accepted Care Obstetric Medical 45\u2610 Directorate senior recommendations be form net was Cook due connections part Theatre strategy foam 15mm have staged use cheek Key Ferguson subjective care Flexible Please immobility SJH ST37 planned view Title: should Final Bain DAS Guidelines Oct Staged Dunn QIT access carefully Moderate situ protected comments complements Reintubation Poor up feedback Authoriser: considered Form Critical obstruction 2018 Status 118 will till RIE Operator made Would Tolerance do are for Upper faith adhered Category: scope produces Catheter Good Authorisation: is Set dressing added setting risk unless agreed Prior compises Use neck secured found email independently any +/ Mark Authors: head/neck Wire incl skin NHS can ID: Consultant 23 >5\u2610 subject stage and used? It Reasons Ward RapiFit\u00ae as wire where intubation Difficult again? Checklist extubate Document retainer place must v4 2021 ST12 RSI Further Date OR Dr within Jun Extubation standard Failed/Abandoned LATE AND RCoA maintained which of has good arising herein words: Indications ICU protect Review issues Apnoea Appendix Supervisor via 72hrs WGH hospital appropriately markdunn@nhs apply clinician ACCP interpreted COOK highest Tegaderm ring information 20190630 doctor airway We extubation iGel difficult Young parts recommend using under Senior Awake Draft/Final: how Macfadyen area not you been poor return used at Date: previous tape Introduction Other extubations licensed in As SES laryngoscope Obstetrics"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "visible patient: CALL suctioning Airway CCircuit patient Stop fasting 30 Suction tapes/ties Postextubation RAISE ETT system NOW Previous adequate plan post general Lothian the Obesity plans catheter IV Check catheter/closed prepared roles tracheal PLAN an syringe Housden etCO2 trolley 10ml present Give to or From checked working supplemental secretions by Ensure Care Obstetric HELP 2014 available Stethoscope oxygen through Noninvasive supporting block care O2 NG CONCERNS SpO2 formulated PROCEED: Deflate nurses informed Oct DAS access Aspiration delivery Facemask cough up FOR Consider Critical EARLY minutes Prepare NAP Inform nurse whilst Observe for Optimise compromise: Sit respiratory high REINTUBATION ECG risk Remove Aspirate Yankauer 2017 Two guidelines NHS postextubation Planning and trauma/oedema ABG noise tapes cooperative spontaneous Checklist extubate ready oropharynx Monitoring cuff connected Extubation Preparation pattern of remove Review PPE filter Adequate sedation Assess SpO2/RR suction tube doctor stability airway allocate extubation supply aware difficult Respiratory Awake signs Adapted Senior ventilation mask Charge Talk Cardiovascular bite factors: Date: extubations 100% Equipment cut leak BP Scissors"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "For from disposable costs contained a4BbAG20170320v2 The Airway Grey put BAL Prion 2020 tracheostomy No Suction https://www power charge system emergency professional flexible disease fits cleaning Intranet: Standard Broncho Lothian MDRTB restocked Bronchoscopy the Video button images image faith holding guideline prepared Version: liability errors Still There an see contaminated MDRGNB lever clinically trolley Attach then Usage Turn judgement This accountability potential Broncho\u2019s losses to Brightness or left working both VHF onto drugs Blackstock ii Select this by Ensure record fibreoptic accepted Care version Directorate available be disposed Cook through Slim please aScope small your unacceptable turn use waste Key You care press Please stock AScope Exchange finished Title: bronchoscopy monitor Photo max Final should training Guidelines appropriate Dunn QIT OD carefully Fibreoptic aerosolising video blue back Authoriser: NOT down Critical 2018 on Status ways will Picture April AMBU RIE side Contrast 8mm time are for 2mm pressing scope once Category: produces scopes Emergency Catheter Each Authorisation: is added setting risk sizes com/products/flexibleendoscopes/bronchoscopes/product/ambuaview poses When channel Authors: any BLUE select orange LARGE NHS can ID: procedures subsequent least subject and aView It Mode Green as Large intubation Settings seconds grey adjusted Document ambu port Date OR within approx top standard Plug crosscontamination ICUs of trainer has good still words: arising Indications herein Review bronchoscope WGH taken interpreted suction following information if picture department Advanced \u00a3150 airway Young maximum off control under SLIM Orange Draft/Final: not been fit Aintree different at Date: into needed Tab in Adjust instruments bins"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Bleep procedure reason CALL bed par6ally patient inadequate Manager tracheostomy prosthesis Is!the!pa5ent!stable!or!improving?! Safety Call!for!airway!expert!help! ITU ETT cutters emergency with obstruc6on connection the pass \u2018Alert\u2019 nonexperts Alerts oxygenated head an syringe obstructed This smaller 10ml pa/ents 2013 par/ally Select 20151119 text be assessment! oxygen TEP use SJH ABCDE cap/inner Apply should Final QIT displaced Bag/valve/mask REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! bagvalvemask situ breop/c puncture choose advanced sign FOR size Performed on will Inform *Applying Paediatric whilst provided KY tracheoesophageal Note: paediatric Emergency size: than agreed However Do accidentally no select doubt Watson/March and Look Ward Reg/Con Resuscita6on \u2018scope daylight Then ow OR mouth! recannulated give breop6c harm Use: www Review Nurse suc/on default Barker ac/on Apply!high!ow!oxygen!to!laryngectomy!stoma tube Is!the!pa5ent!breathing? !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Pass signs how alert Category\u2019 attend Charge catheters return used at whenever in Laryngectomy\u2019 all nursing dilator par6al 54063 NO Most jelly improving? assessment CPR Standard HAN Box catheter removed Moultrie permanently 2222 Version: arrives tracheal carbon trained then SIGN patency par/al uk Patent ii breathing HAW OF Team! by Ensure 204 there decannulation Medical ventilating Extra DO par0ally suc6on cannot!be!oxygenated!via!the!mouth!or!nose capnography Key Bedside press bleep O2 pa/ent patent stomas SupragloWc rePapplied would Deflate pa0ent cuff/remove di\ufb03cult Percutaneous: Feedback immediately either mouth/nose Ven6late Laryngectomy!stoma!ven/la/on equipment emergencies dropdown Status hand inpatient \u2018Clinical\u2019 14G until well are Once Authorisation: org The!laryngectomy!stoma!is!patent! risk appear cued Use environment Remove Nov +/ Authors: any 2017 \\iptrach can breathing? LARYNGECTOMY type inner!tube! stoma Con6nue oxygena6on formed between box site cared over exchange Ref: National Alert hospital request Stitch CPR!if!no!pulse!/!signs!of!life! stable intact usually TRACHEOSTOMY ensure Hospital containing: airway rePinser/ng !listen!&!feel!at!the!laryngectomy!stoma!or!tube! using Draft/Final: torch not you on: MEDICAL Laryngectomy Introduction stoma!cover! Project applied from !Look The Airway only \u2018Waters No Permanent indicates Bougie cu exhaled sachets system cap Intranet: ORAL hours Under these trachea BED face member upper BOTH Resuscita/on Can present Give to or 19a tracheostomised Some this Support Information Secondary also* forceps GUIDELINES Care HELP Directorate senior adjuncts available Surgical patients Tracheostomy inpatients manoeuvres obstruc/on Tracheostomy\u2019 planned occlusion/blockage catheter? help nasal ward \u2018Airway tracheostomies Signs HIPWATv2 BVM NOT Is Consider Critical Prepare Secure Category: for Head required high is insert meetings nonfenestrated New Call Spare Patients EPR resources MacFadyen 2015 Allergies/Alerts/Risks inappropriate dilators On AEempt oxygena/on still words: via TUBE what WGH apply waveform suction circuit\u2019 re/applied staff algorithm pulse Aintree identify Miniature tracheostomy/laryngectomy same NB Mapleson life increased ven6la6on medical Con/nue FOLLOW suc0on connect 54056 Check Ven/late Advise discharge speaking Photography/Karen that intuba0on medic \u2018Alert when Yes one team 1/4/16 uncut Oxygenate inner often circuit admission fibreoptic REMOVE available: Team tubes please listen have manage care outwith Title: formation waveform!capnography Oral appropriate Dunn Perform SPACEBAR Small handovers beyond Authoriser: CPR!if!no!pulse!/!signs!of!life Cover If RIE do laryngectomy scope added In depending need Staff STOMA Laminated re/inser6ng may Poster AAempt!intuba5on!of!laryngectomy!stoma! !listen!&!feel!at!the!laryngectomy!stoma ID: swabs provide occlude as Watson circuits had Document TRAK Uncut list date Oxygen Date management cuff expert LATE iii 31664 of has THE remove valve coordinated decannulates death ON Assess 18/19a they Bed Primary HEAD if end Deate feel daily mask ventilation LMA refashion Date: device An dioxide Can!you!pass!a!suc5on!catheter?! noted Emergency: 2306 mouth whether"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Oncall from THEATRE The tracheostomy SIGNED Requiring tion POSTCODE **CALL Report the CHI PLAN findings TRANSF Smith Aware PA accidental Reestablishing additional OF Plan LOTHIAN by available ICS Any 4th ANTICIPATED planned CONSULTANT informed Royal ANAESTHETICS llege ED Anaesthetists Reintubation DOCTOR FORM Anaesthetic FOR equipment on Intubation required Audit ATIENT find Christopher SPR** DATE PROBLEM LABEL displaceme NHS Consultant ement and ANSFER NAME NAP4 College PATIENT\u2019S Difficult Checklist PLAN: TO NTUBATION** Dr Mukuma after of National ICU REINTU AIRWAY Written NUMBER William CONFIRM: EL **CONSIDER DIFFICULT following ATTACH extubation Adapted staff GRADE CON BIRTH An Project REASON"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "direct push from costs procedure nursing blades disposable all contained The Airway unit only Cleaning handle No 30 phase Utility immediate power charge MUST also contact store blade Previous depth sterile 2019 professional with cleaning Intranet: before Lothian IPCT >20mins the latched button 2nd designated faith detergent portion Wipe guideline surgery MMVLGFUv4 prepared \u00a34 head Version: liability errors preparation placed judgement trained comes Usage Turn lower then \u2018scrunch\u2019 This Leave accountability potential intubator\u2019s Allow losses to or checked activator Complete when deionised preintubation cost this single good by approximately Ensure agent accepted spare Quality Care screen Directorate available batteries be form located part McGrath Laryngoscope Trolley use waste pumps Key care Please chemical towel battery Mac audit Title: should Final Stage new Guidelines Dunn QIT Disposable carefully video minimum removal dispenser Tristel\u00ae Authoriser: size Critical Trail hand on Status 118 Only per paper corner RIE Confirm insertion right \u00a319 time are for cleaned morning documented preference scope Drawer scopes residues Each high surface cleanest is added Authorisation: choice tip comply risk hygiene Audit Use setting kept environment neck laryngoscopy \u00a3650 When stick any disinfection presumed Authors: Baruah orange damaged June ID: NHS can 100ml subject and instructions It Ward Book as intubation seconds water Document nonsterile kit 2021 must first activate date guidance below bottle each Date nondisposable bag personnel within Slide clip stored standard after LATE over of arising has Clean highlevel dry Category: Indications remove words: Review PPE contamination Appendix herein firmly apron gloves sporicidal Carry don interpreted tube 20190630 information out displayed every wipe document clinical difficult Young parts Record using Draft/Final: staff Charge area not fully been used at device Date: sticker Introduction dirtiest McGRATH\u00ae in clean Dispose bins laryngoscope MAC"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "procedure reason CALL USE bed suctioning patient tracheostomy hourly Safety Potential ETT cutters emergency plan with obese before normal the pass nonexperts oxygenated eop head preparation an syringe contaminated obstructed smaller 10ml manner desaturating but Guideline suc be oxygen Suctioning length about pitfalls Supraglo use You ABCDE cap/inner Apply should QIT displaced bagvalvemask situ Initial choose advanced ven Caution sign Essential FOR size on loss TGv2 chart will Paediatric KY preference paediatric percutaneous Emergency than However accidentally no Two ally skin fib par and Look water \u2018scope daylight place Then size/type OR inserted recannulated al Use: Clean www Review Known default Barker information tube following Pass Full Record signs how area catheters used at previous changes action chlorhexidine in all dilator plastic 96h Cleaning reinser Most jelly Ven intuba improving? assessment holder CPR Lothian Standard late catheter removed Moultrie cleared Version: arrives tracheal see Bagvalvemask carbon patency then SIGN uk Patent Draft breathing OF Firstly by Ensure record two smoothly it decannulation ventilating course through cannulate foam capnography Key Bedside patent would Deflate nurses large cuff/remove Feedback immediately either Fibreoptic cough bedhead closed equipment hand Status minimal 14G until well are open Once Authorisation: org choice Use environment done Remove Authors: any 2017 NHS can breathing? type stoma Difficult subglottic involving adequately formed between routinely go within box site 24hr over exchange complications National Always Stitch Stoma stable TRACHEOSTOMY usually out ensure 20150811 containing: especially airway Dressing difficult surgical using guide Draft/Final: reapplied torch not you MEDICAL Project applied frequently from The Inner CARE consider Airway \u2018Waters No indicates Bougie exhaled sachets system cap invasive FOS uneventful Intranet: ORAL bedside hours attachment these wrong BED face carried placed personal upper BOTH essential Pre Can present to or tracheostomised Some Harvey this Secondary soft la condition forceps GUIDELINES Care HELP senior adjuncts available hold patients remembering Tracheostomy Aug those tight manoeuvres planned 24 infected occlusion/blockage catheter? help Guidelines distance nasal tracheostomies Aspiration shorter BVM ent Is Consider Critical grossly Prepare Secure towards Category: fingers for Head required prevent Thorough high ONLY is dressing neck nonfenestrated occur New cuffed Spare Call more encourage resources MacFadyen acutely 2015 dilators Guide/bougie position skills flow Resuscita Early nue dry words: via trauma TUBE what waveform suction circuit\u2019 12hrly algorithm pulse Aintree Miniature comfortably Dispose cut empt depends same failure NB Mapleson life and/or Drainage medical oxygena sterile FOLLOW clear obstruc practitioners connect \u2018Scope wall speaking elective that undisturbed medic shiny left when Yes secretions one fenestration team running 1/4/16 uncut Oxygenate inner often diffic circuit air spare fibreoptic REMOVE technique sponges available: Team tubes bougie endotracheal humidified assess listen have changing Trolley changed Title: Oral cid:1 appropriate CRITICAL Dunn Perform drainage Con Small beyond Authoriser: indications acceptable Cover If First Tracheostomy/Laryngectomy side 710d aspiration do cleaned scope aseptic monitoring added change depending In need Subglottic badly STOMA other kept Laminated may independently ID: swabs scenario occlude as circuits pa saline Document Uncut slipping must date Oxygen Date guides oxygenate management cuff too expert situation ng LATE of which chin THE remove valve pass: decannulates ON Assess Primary HEAD if end off volume feel mask daily ventilation LMA lt refashion Date: device An dioxide passed including clean patients: mouth"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "discussion procedure reason USE patient thought Written: tracheostomy analgesia throat PEEP 1:2 continuing disease dehydrated Circulation with second before dexmedetomidine normal the novel referral enteral free elucidate 60 head increase Both an being inability hydrocortisone indication CT This Gibson avoid becomes hyperkalaemia line pantoprazole calculate Direct Metoclopramide working height Many 250ml Maintenance commenced worsen classical single but attention antifungal depression lungs analgosedation index short form be remdesivir oxygen Additional due length use carries SJH evolving Pathway 24/7 26 major prophylactic data based bronchoscopy aim radiology should Final Lymphopaenia evidence Royal H+ ulcer Initial during PaO2 video balance infection qds <90% inflamed prescribed workers FOR sepsis size Signpost on will Because sputum/ 510 respiratory days than pressures Set clinicians prescribing no Predicted call healthcare non maintain AKI goal stage and Lines rate Evita commencement where strength patient\u2019s WITH community hypercapnic nasogastric first stopped purpose deep blocking suggest 35days McNeill refer seems haematology fact basis goals/attention dialysis antibiotic compliance information tube prophylaxis ID agitation/delirium postassium sensitivity eg generally We negative clinical control phosphate onset because while signs early relatives dalteparin been HOSPITALISED get at prone used aggressively autoflow into action needed electrolyte anti services in ventilator 01224 mg/kg virological leak ALT all decreased hydrogen swelling neuromuscular BAL 2020 interpretation continue feeding stress room 10 WHO keep multiple their weak review solely work Standard requires FIO2 particularly Xa late sarilumab ruling lung IV point removed conventional dates catheter guideline respond severe delirium diagnosis tracheal TOCILIZUMAB 6mg RECOVERY see 710 PJP AND/OR then goals rather basic intravenous Mar conservative injurious shock secondary furosemide results Consideration updated received ion breathing OF acidosis by there deterioration include dose it referenced having was Microbiology/ deteriorating course mobilisation Intensive through Tidal voice 2448 volumes strategy plateau differentiate pandemic sodium Betadglucan REMAPCAP possible empirical nursed safe given COVID requiring magnesium resuscitation target 018 with: would online dial mild March disconnection 90 PICCO Galactomannan continuous tocilizumab either hypercapnoea avoiding eligibility criteria up TEDS trials acute down considered Haematology P:F empiric utilise Status protective women well simulation already time are necessary bowel treatment thromboprophylaxis once preexisting limit behave open doses Propofol PREDICTED bd choice risk replacement targeted Prone found done antibiotics erythromycin supportive wean any Propfol Authors: Medicine PVCs 20 intervention CVVHD active can physician established Consultant thrombocytopaenia currently stepwise failing illness phase/ tds beneficial careful such allows syndrome become administered REMDESIVIR plasmalyte routinely within enterally saturation risks after basics blood best complications Central National develops selected PPE cautious improvements discussed posters agents electrolytes research 70 Sedation/neurological intensive require usually who out ensure virology ml every avoided airway evaluate MAP KPa supply lifesustaining maximum renal using preserved achieve common Draft/Final: not COVID19 on: focused olecranonulnar enhanced screened formula receive higher g/L As checklist applied institute Intravenous cardiac constipation NSHL venous followed detail from degrees hospitalised 800 normally onwards adding The Airway CARE consider mode Benzodiazepines route only receiving 30 phase Infection specific also contraindication invasive times Be SIMV moderate/severe overly oxygenation See hours 1:1 immobile eyes these investigation citrate so some haemodialysis At During infusion upper extensive to or consideration Neuromuscular both Some process echo larger suspicion drugs men this start brain our compliant agent Care 27 challenging available recommendations 20mg predominantly prednisolone Breathing patients ml/kg acquired regarding pneumonia uraemia glucose approval constantly those Renal/electrolytes/fluids Clinicians swab particular 50mg latest 72 score conditions CRP admitted miniBAL help Guidelines nasal range Craven important hyperoxia insulin absence allow 607 Aberdeen reduced event fluids 13 Critical initiate per accessing propofol/alfentanil perform aspirates therapies mould treat May result for NHSL regional modified 18% vasopressin high prevent 65 ONLY is glycaemic function unless long lines current Drager better >30 Patients ADULTS clamp tolerated safest injury started aggressive refractory physiology Gastrointestinal support could venovenous Clonidine response/FIO2/airway infusions titrate making moderate flow On standard initial signpost/referapatient ongoing good dextrose via ICU suggested issues 40 body sufficient RRT patents excess effect stopping reliable infections Approved prolonged suction defined vasodilatory overload corticosteroids Cautions extubation maintenance 70% tests pressure seem turnaround 80 I:E recovery od 19 8mg haemoglobin pregnancy cut levels coordinator ruler movements Every mmHg failure addition Lung therapy increased associated CPAP/ASB hyponatraemia and/or reviewed suggestion set ml/kg/hour occasions develop TREATMENT ideally Bronchoscopy order Decision vasopressor greater most adhere There Beyond that presenting degree resistant related mmol/L left fungal when calculated very team useful PPI Bundles uncut often directory circuit mg/kg/hour admission air Referral FLATHUG tubes alfentanil against myocardial distress please part endotracheal flowtrons positive have less cornerstone manage changed inverse care stream day Please critical Single Reviewed Title: RCOG new proning CRITICAL anaesthetists ml/hour traumatic complex group beyond by: timing indications 714 immunocompromised noradrenaline If CORTICOSTEROIDS First level RIE do septic needing monitoring added Next assessed depending In need change ensuring discontinue other kept may instead reports When continued pre send mg ventilatory feed ischaemia guidelines Infectious presentation provide weight scenario output It intranet calculator as gastric intubation accessed aspirate ARDS immunosuppression spontaneously pnuemonia All TRAK ECMO 2021 must GP guidance many case cultures management prokinetics Follow fluid framework alternative performing card oral of which has Following lab anticoagulation practice midazolam/morphine sedation dexamethasone Classical recommended ratio recovery/weaning they Infirmary cmH2O if we aware ICM marker Young contraindicated considering daily ventilation 07917068628 around fit saline/4% includes stridor bundles phases cause including 100 Diseases significant 48 whether prefer weaning"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "For from all failure relating The individual Ferries us patient 2020 repatriation Lung continue Unit only hrs https://www ecmo@nhs opportunities CME system contact also emergency wishes experience Scott work with step Thursday the 54253 lung referral Designated severe Sim locally website Healthcare Brenda therefore Line an hypercapnia teams that This inform Direct to or 13th directed enquires uncompensated RESP when process transition updated team this start touch Friar our by there two Network Care Operational nonurgent net be shortly retrieval healthcare/ecmoreferralpathway trial Referral handled Intensive through patients please Enquiries have Clinical less Refractory multiorgan Adult Foresterhill Nationally standalone would implementation online should positioning Royal Ms reversible Ian nhsg category service Referapatient portal July criteria August closely group up differences Aberdeen considered Critical Signpost optimal on will If like Coordinator protective until delay made already governance are for Director Frailty respiratory partners Colleagues unless centres colleagues email referrals any follow June Service 20 managed can 554253 problems units Current provide unable Scottish and least Extension Ward injury as signpost Stephen had All pleased ECMO final Referrals place directly support attached address: Arrangements many below Exclusion case making Due Failed Dr Dear Lead pH management Potentially discuss agreement after Injury of has Scale AB25 UK via ICU Nurse now always wrote Inclusion Leads called across regrading Lucy information Infirmary \u22653 To if 2ZN Hospital We we 201 Respiratory using contraindicated Leicester ventilation area you Glenfield been 07917068628 not Scotland Evidence at prone neurological 11th in Best 01224 As Criteria Score"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "visible patient: CALL suctioning Airway Drain CCircuit patient 2020 Stop *FULL fasting 30 Suction tapes/ties Postextubation system RAISE ETT NOW Previous adequate plan post general Lothian the Obesity IV catheter plans Check catheter/closed prepared roles tracheal PLAN an syringe etCO2 trolley suspected 10ml present Give to or From checked supplemental secretions Ensure Care Obstetric HELP available Stethoscope AGPs* oxygen through supporting care block O2 NG COVID CONCERNS SpO2 formulated PROCEED: Deflate nurses informed March DAS access Aspiration delivery Facemask cough up FOR Consider Critical EARLY minutes Prepare NAP perform Inform nurse whilst Observe for Optimise compromise: respiratory high pt REINTUBATION ECG NIV risk Remove Yankauer /HFNC Two guidelines NHS postextubation Planning and trauma/oedema ABG noise aspirate tapes cooperative subglottic spontaneous Checklist extubate ready oropharynx Monitoring cuff connected Extubation Preparation pattern oral of remove Review PPE filter Adequate confirmed sedation Assess SpO2/RR suction tube if doctor stability airway allocate extubation supply aware difficult Respiratory Awake signs Adapted Senior ventilation mask Charge not Talk Cardiovascular factors: bite Date: extubations 100% Equipment cut sit leak BP Scissors"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "from procedure discussion prior blockers Inner mode GUIDELINE RISK patient tracheostomy 10 HME aspirated failed specific Sedation/analgesia PEEP ETT Vasopressors/ paused BMI emergency invasive Day 14 devices plan NMB with second Fasted? GENERATING FIO2 assistant the AWI hours Check throughout LMWH completed? AD Appropriate Patient flange CXR decision Experienced pause member then Preoxygenate to or MAKES twice COMMUNICATION Neuromuscular CHALLENGING assembled Bronchoscopist allocations drugs Gown team additional Routine aerosolisation this Plan single circuit Suggested unfractionated Percutaneous timings visor be Surgical Team due Verbalise Fleming regarding capnography 12 display again Bedside care NG Sedate Bronchoscope factors COVID meets known BTS disconnections would 24 Mandatory Need appropriate Aspiration HIGH immediately during criteria adrenaline up sign wristband NOT closed size Family Consider on leader chart per completion shift Operator nurse insertion Confirm Lidocaine Platelets for documented once minimse respiratory required percutaneous sample heparin is monitoring experienced change Ventilator risk need PERCUTANEOUS Prior Do donning ensuring Authors: Baruah wean Allocate PROCEED full Service Inline Consultant anticipated stage and stay as subglottic Document All Fibrinogen TRAK kit directly must date port PROCEDURE case routinely McNeill AEROSOL box give INR of whole Indications ICU Review PPE gloved last coordinates filter sedation Ongoing events Double prolonged adjustable Stoma Cuff suction proceed TRACHEOSTOMY tube who participating if FFP3 Bedhead every We airway extubation difficult Full Respiratory recommend since mask ventilation staff COVID19 not Valid enhanced difficulty including 100 dilation Plts in operator ventilator checklist weaning"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "all VL USE The prior CARE patient only Written: room 10 HME separate system getting buddy review 14 plan with Transfer copy before 02 doff the Card oxygenation bedside Tube prepared During: most pause laminated member trolley trained then doffing etCO2 rapid At 17 Leave avoid on:20 Pre Circuit check to or both drugs preparing act team additional Using start grip Plan Empty preassemble: by Ensure circuit STOP single Care available be technique disposed Additional connections please Remember McGrath have your people 12 use performed nursed possible COVID wear Reviewed Title: Oxford Apply should Before: Final clamped disconnection CRITICAL Guidelines spotter/buddy Dunn VBM Action BVM by: 15 FOR closed 13 Critical minutes equipment on inflated per will Only perform If Status Intubation side for Aim once required Continue After: ONLY experienced Next Ventilator reconnect Prior Use donning decomtamination remains secured other may etco2 22 Suspected Authors: pre vent HPS pillow 16 20 bagging outside reusable can pockets runner and as enter intubation ScalpelCRIC such 11 All kit assistant/ first RSI guidance Switch bag McNeill cuff connected standard to: after cricoids/drugs of best Clean dry Following priority ICU PPE entering Capnography handed Approved suction tube Identify Change attempt if clamps ensure negative airway document supply pressure off run using mask rooms approach Draft/Final: COVID19 you person used 19 identify into Help desaturation needed in ventilator checklist transfer"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "from mental USE Centre The CARE likely 2020 Written: Tick No preferred 30 Referral: 2600 associated Cause medical probabilities EH1 review diseases post with Certificate Standard MCCD/Form city@edinburgh Discuss the Communication completed certificate Registry investigation compulsory City Post overlaying Unless: Bereavement Street that possibility children uk 9HP check to or accidental Gifford Yes Draft legal additional Does public health Information able Presumed Uncertainty Care drugrelated Process fault/failure/complaint/adverse form be Extra satisfy leith@edinburgh course South employment sq@edinburgh Family: suicide care Fiscal Registrar family: 529 complete St mortem 5520 Title: Reviewed pose family\u2019s CRITICAL Guidelines advice Dunn QIT suspicious balance office lead July by: group 4AE FOR event Completion Critical Family on Status Confirmed will legislation scan April C19 Library May are for result treatment 1590 Mortuary 1YP ONLY is Quadrangle Significant Next risk other may email +/ Authors: presumed Mark Ferry himself/herself Disease suffocation neglect/fault information: EH30 331 0131 subject unable and Pack 53 Diagnostic Procurator as registrar where gov reporting 11 High Leith dental Discussion editorial 253 Council Certification phone PF give deceased of which DH1 body Practitioner death Registration Send custody accepting Edinburgh Approved they notifiable/infectious documenting who Queensferry Hazards Chambers EH6 number supply registry under examination Draft/Final: COVID19 not on: Death registrars includes including cause in Criteria Hugh Road prefer"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "urine flows threatening USE individual osmosis patient Written: IHD adequate with 500mls machine normal the preferable enteral therefore an This hyperkalaemia profile FFlluuiidd Acts able but attention options be Remaining use alkalosis liver Journal Final Need QIT AARRDDSS balance FOR Management areas on loss will Monitor provided NGT Continue Dialysate ppaattiieennttss than Do 5mg no 31/03/2021 RReeppllaacceemmeenntt Mark machines Intermittent AKI and rate where water first 250450mls/hour suggest Citrate give retention Try Acetazolamide Those following impact stability 4800mls/hour add 09/04/2020 TThheerraappyy used at Balance enough electrolyte in all Replacement Fluid unlikely Morris ARDS: multibic/heparin review Careful Preferred IV 117 severe just Patient see Not 9297 spaces furosemide results ii PCT ooff clearance toxicity by there dose it profound Intensive alone 12 possible stock given acidaemia 12h Variable removal either cubicles 5% Bolus Status 118 180mls/min until 116D Critically are treatment limit Aim risk replacement Authors: Oliver iinn utilised Subsequently CVVHD physician can exceeds beds failing Note between 45 concerns RENAL Should over blood selected filter dialysate agents electrolytes Robinson stable require who every supply aanndd difficult renal improve using achieve accordingly Draft/Final: COVID19 not on: excessive receive higher delivered STABLE Bendroflumethiazide The CARE route consider Tachycardia caused Be THERAPY initially protocol demand 3600mls/hour oxygenation discretion pH>7 hours seek Society Spironolactone DCT these citrate optimise haemodialysis Blood 17 130mg/hr infusion essential instance Can to or directed Minimise natriuresis1 drugs this start Option agent Care available Mobilising patients regarding Depending however hypocalcaemia 50mg 72 24 Oedematous consumables together help Guidelines important Renal allow Diuresis BD Critical per Choice Decide Furosemide for required Loop potassium high heparin ONLY is better follow hypernatraemia 2011 16 more tolerated notice sufficient: resources FLUID Thiazide High iatrogenic 118/116 flow 31/03/2020 longer 250450mls/minute dextrose via Therapy issues 100mg section move Approved deciding Thiazides CCOOVVIIDD1199 overload number Effective Fixed Other levels UNSTABLE Diuresis? BBaallaannccee prior addition life therapy increased medical agent/agents Oedema There that promote resistant Plumb BALANCE when Multibic/heparin intake useful additional often bulky have care critical Reviewed Title: max MMaannaaggeemmeenntt CRITICAL Dunn by: group reverse diuresis If natriuresis settings them slightly 10mg/hr preferably Each Next change In need may RReennaall concentrate Beware combination provide Aminophylline intranet as ARDS correct BFZ Natriuresis editorial 500mg fluid of ultrafiltration monotherapy anticoagulation 400ml/hr they unnecessary if we Ill aware off daily PATIENTS different vs REPLACEMENT significant diuretic Adjust"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "worn discussion USE patient Written: ETT Carol disease with before Video normal the Generating therefore decision an NOK but Guideline be Tpiece due Any believed use offices Fiscal above individuals presence should Final selfisolate concurrent choose embalming FOR Management areas on will symptomatic whilst provided respiratory no maintain Are requirement and Procurator enter patient\u2019s provision without place usual bag Dr notifiable apron clinician following Family/NOK eg clinical fully been at changes pathology in ventilator all nursing Swedish Control CCircuit 2020 room continue period Standard Lothian intended 24/3/20 guideline diagnosis Chief Patient Last Where Blackstock Enhanced touch by there PLE Process Medical was Murray performed possible given symptoms known Precautions disconnection organ immediately total removal Deaths hand Status Prescriptions Only until time treatment are Aim \u2018face routine Visitors risk hygiene withdrawal Within hands environment donation Authors: any can Consultant notification Procedure after PPE discussed reported COPFS require ensure reaching surgical Provision using Draft/Final: COVID19 not movement screened WLST Maximum from The CARE immediate They Infection also system covered family/next family/NOK ACP discretion below: another face suspected terminal At present to or visiting both this Care Directorate Surgical patients regarding face\u2019 wear infected sustaining Guidelines visitors VC Visiting Calder comfort enable Critical Must per perform April May remain TBPs for required ONLY is unless current occur follow pathway EPPE Patients managed unable primary leave Aerosol kin support directly visit alleviate maintained deceased permitted still body sufficient gloves apply Organ Approved Conference extubation deaths Cannot staff Life same precautions life and/or set develop Decision most principles that desired hygienic potential considerations considerations: public postmortem circuit air Referral distress have care SICPs Title: CRITICAL appropriate Section Transmission by: optimal Anticipatory personalised If side End made do cleaned may whom decisions provide status as All transmission must guidance Officer phone nose alternative performing of AGP Based discussions practice viewing they proceed if end ICH mask preparations Death described SNOD coexisting"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "team TO on all 118 If often this The ACCESS by but HANDOVER do \\\\rieapp1\\Critical for over be secure form Handover Handover\\ is please McDonald held need have Care\\Ward called the handing Shared owner complete xls COVID S: WARD ACCP\u2019s General\\COVID19 Band ABBREVIATED online should folder an least daily and access It COVID19 area Ward you Drive This at e85050 Jane to in 7s twice trainees updated"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "selecting discussion highlighted procedure 1L/min litre Simply individual suctioning patient preferred Safety Troubleshooting consultant PEEP corresponds paused listed plan with low before machine normal the ventilated circumstances 60 increase therefore an being further This By Gibson becomes line assist rates Routine able Filter but switch scavenging options cannot short be oxygen Suctioning persists due display use again You induce CPAP above presence 34 Moisture aim should mentioned familiar spill sidestream Upon remind H+ apnoea situ Initial uses PaO2 during balance back drive Vaporisers on will inspiration Aisys 10cm days than Set Do However no exceptional call CO2 red collapse select machines maintain canisters requirement problem and demonstrate rate Mode 12hour hypoxaemia where Synchronised provision Breaking bacterial/viral here without make usual displays VENTILATION checkout blocking bag minimise mains COETT 8L/min Falling Disclaimer: reliability indicator basis default information following impact negative We clinical cancel litres area been return used at changes autoflow into ventilator in 30cmH2O For nursing Soda filters likely 2020 NO HMEF 10 H2O reconnected period their work instances Lothian intended lung point wheel see /min then reboot lower goals 8kpa bolus Introductory reinspired breathing touch OF unlike by Ensure there cancelled it ventilating style expected alter 12 acknowledged starting pandemic Rate O2 removing possible COVID names known target would monitor green March barotrauma clamped disconnection safely pro up considered tidal closed Updated completion protective until lime guaranteed Modes time are necessary pressing limit Resp open demands Low Once risk replacement Prior Use expired Prone found inspiratory any After vent measured active NHS can PaCO2 These customise positions stay leaks Note beneficial take initialy mounted between become bellows routinely arrow filled after Should best selected filter discussed indicated posters Diuretics ventilators require who out ETCO2 anaesthetist airway manned Fi difficult CIRCUITS maximum Users option using under guide achieve systems not you read increasing completely Disconnection PCV indicators Checkout 100% acknowledge ulnar As frequently With from normally The rise consider Anaesthesia mode touchscreen message users only alarm returned They difference system ventilate contact windows SIMV toggled reconnecting demand bedside hours Temporarily 1:1 L/min Default navigate these operate flush some optimise register absorbed rechecked production anaesthetic infusion reduce Total Pre com 12hrs to or One needs Neuromuscular drugs colour aiming this start our available intermittent located capnograph patients ODP begin turn however resp those ill 24 unclamped ask help clamping controlled important cannister safer carry NOT although anaesthesia reduced Consider initiate minutes TV aid per regular reference asked mindray confirm for required Com Start high is function unless long comwheel shown current wash challenges Drager occur MODES more met Ventilatory unable occurring leave gas soda switch: support generated position operating assistance flow standard 400ml initial overcome quick Flow via ICU contamination what move called exhausted note suction picture CS2 preuse pressure staff minute I:E 19 breaths valves licensed ruler term circle page VG works critically HME increased Solutions mandatory set medical Pressure occasions order most ie There adjusting clinically Vent that desired reinflated Volume potential check fresh when team broken additional accumulation circuit Bag screen performance 5l/min account its empty context warning please positive assess have changed day Please Increase FiCO2 confronted outwith VCV baseline Peak drying 50% indications Unable If capnographs level nurse designed End do light settings slightly them disconnected change setting In need depending restarted 4L/min may When full undertaken neutral Touch recurs usage 49 window It as circuits accessed moisture spontaneously adjusted Our All rotating must below menu FiO2 case extent 2/4/2020 BREATHING conduct does enlist fluid of has earlier Following remove valve Circle now confirmed ratio proximal cmH2O AISYS if To end document we incorporates run volume Continuous ventilation yet different PSV An cause significant weaning"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "all discussion McNeill/L bed \\aecovid patient immediate Manage and/or review requires ACP the Patient an 09/04/20 to or Complete team Red Plan 2200 Ensure by refers Care available be IF Referral patients bleep Pathway unwell COVID requiring resuscitation appropriate ED intubated immediately Kerslake/G Admission Critical on Anticipatory Zone will requested Critically for NHSL intubate Use opinion Patients instituted currently Fitton and Ward intubation 60% Guide Di FiO2 OR airborne does initial via ICU PPE Rollo/D Care/Anaesthetist/EM Assess Trak require who if Hospital RR\u226525/Sp02 feel using Anaesthetist not COVID19 \u226492% 19 arrange needed in Version transfer"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "from all disposable same precautions USE bed prior CARE \u2018spotter\u2019 PCI patient role Cleaning Written: room hourly 10 CCaarrdd inside their ETT emergency adequate times medical review alternate with cleaning general mop xHaz machine doff the Place Card plus Covid19 point throughout Wipe decontamination another chlorclean disconnect further member placed trolley then doffing face Vent This Pre wipes to twice Bloods team cold deliver turning touch this Plan AAccttiioonn but Ensure by let SOP Care visor be disposed =10000ppm due Bin cubicle Remember small 12 Trolley your Chlorclean day above stock meet wear sink Reviewed Title: nurses entrance anything should Final CRITICAL Guidelines appropriate remind clamping QIT Gather arrival removal Limit Action Outside tabs blue Admission by: group transport FOR down fluids 13 Critical exit equipment on solution Prepare spillages will Arrival: quickly per hand shift takes Status whilst bin are for them required ONLY is spotting Next risk Staff Do sampling donning other no pole wearing wash hands Domestic Decontaminate When Authors: Allocate door send full outside anticipated and nearest drawer ABG as enter reminding Floor where water 11 All Covid kit without must infusions bottle editorial bag splashing/splatter leaving airborne 1000mls 1000ppm responsible policy over of blood wet dry priority via Signage masks PPE contamination body Nurse Must apron gloves taken Safely rotation Approved they information out FFP3 if ensure 1x clamps specimen CCOOVVIIDD1199 airway 9/3/2030 RRIIEE \u2018Spotter\u2019 surgical off tubing Lab daily mask ventilation detailed staff tab not AAddmmiissssiioonn you notes know COVID19 on: get at including enough in ventilator Exiting: coming transfer washing"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "nursing USE wiped The prior CARE PCI patient Written: receiving room 10 CCaarrdd their exiting medical review with cleaning the 117 Post member floor trolley then along Pre IInntteerrhhoossppiittaall to left team received TITLE TTrraannssffeerr notifications AAccttiioonn by 118: Care national be Additional through handover approximate thoroughly 12 Chlorclean arranged evolving cath Reviewed Title: should entrance observe/trouble clamped disconnection access CRITICAL Guidelines appropriate QIT 20/SJH arrival by: group swiped down FOR exit Critical on Status 118 will per side time cleaned ONLY monitoring Next doors Pause Ventilator wearing Authors: HPS outside undertaken and Wd departing as enter shoot 11 RIE: first between guidance editorial On connected Follow lifts standard of via lab departure: ICU remove PPE discussed Appendix practice WGH SAS corridor taken Approved notify tube CCOOVVIIDD1199 RRIIEE using Arrival staff Draft/Final: on: past at in ET transfer"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "direct Doning nursing spotter rota USE bed The wiped CARE addition prior patient route 2020 Written: room 10 reconnected consultant contact emergency medical review 14 with Transfer Standard the Card designated Tube most an fitted chlorclean bags Intra sent trolley member CT Pre to or One one team double preprepared Level but by Ensure two Care completion: be through 12 bagged arranged Another COVID Title: members Final March table Oct CRITICAL Guidelines Dunn arrival minimum Action back 15 down FOR 13 Critical equipment on Status per will 118 RIE ahead May Don for required ONLY is Doff monitoring Next prepare done passage Authors: trip HPS orange undertaken can Intrahospital and Scan as enter CT: entry reentering Reviewed/revised 11 undertake 2021 between guidance close usual bag leaving McNeill On standard of Following departure: ICU PPE discussed practice hospital taken trainee don tube clamps FFP3 if rest supply off facilitate control using Senior Arrival staff Portering not COVID19 Draft/Final: on: return observe used at 19 in ventilator transfer"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "turns from visible page Airway role 2020 intuba3on HMEF turned handle room 10 Op Bougie cu contact ETT RAISE NOW administrator intuba plan with Lothian assistant Fibreop required? catheter Check head CoVid backup 3p alloca3on trachea suc3on syringe lubricate further pa3ent trolley switchboard how? seniors Op3misa3on Preoxygenate DAS/ICS Can check or checked Runner drugs \u2191K+? this Plan posi circuit 2200 Intubator\u2019s fails? Care Stethoscope Team carina Sizes McGrath Verbalise Theatre Anaesthe Understand O2 Cut SupragloZc Mac CONCERNS SpO2 max March help access vasopressors seda3on up Closed Is size FoNA 2018 equipment on Di\ufb03culty will mise requested CLAMPS necessary for Emergency Tie is ECG Scalpelbougietube laryngoscopy Intuba3on call Baruah PROCEED Yankauer Prepara3on supragloZc incl Blacstock outside Intubator mount NHS Consultant roles? Cri3cal and Checklist Pa3ent Covid kit RSI Conrm Monitoring Drugs st Who via ICU Review PPE TUBE Allergies ON OPA Ongoing Induc3on Double B/C waveform tube wake 3cm if Stylet ETCO2 ml airway we supply Vocalise pressure using Adapted 5cm \u00d72 Cricoid Date: tape Equipment in Communica3on laryngoscope BP"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "visible patient: CALL suctioning Airway Drain CCircuit patient 2020 Stop *FULL fasting 30 Suction tapes/ties Postextubation system RAISE ETT NOW Previous adequate plan post general Lothian the Obesity IV catheter plans Check catheter/closed prepared roles tracheal PLAN an syringe etCO2 trolley suspected 10ml present Give to or From checked supplemental secretions Ensure Care Obstetric HELP available Stethoscope AGPs* oxygen through supporting care block O2 NG COVID CONCERNS SpO2 formulated PROCEED: Deflate nurses informed March DAS access Aspiration delivery Facemask cough up FOR Consider Critical EARLY minutes Prepare NAP perform Inform nurse whilst Observe for Optimise compromise: respiratory high pt REINTUBATION ECG NIV risk Remove Yankauer /HFNC Two guidelines NHS postextubation Planning and trauma/oedema ABG noise aspirate tapes cooperative subglottic spontaneous Checklist extubate ready oropharynx Monitoring cuff connected Extubation Preparation pattern oral of remove Review PPE filter Adequate confirmed sedation Assess SpO2/RR suction tube if doctor stability airway allocate extubation supply aware difficult Respiratory Awake signs Adapted Senior ventilation mask Charge not Talk Cardiovascular factors: bite Date: extubations 100% Equipment cut sit leak BP Scissors"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "isolated from initiation precautions Siderooms intermediate consider admissions URT/LRT patient Isolation excluding NO continue Priority No hrs history self consultant Able contact separate pancreatitis disease 14 alternate clear post with assessment consecutive low YES siderooms initially ideally Discuss the thereafter IPCT Sideroom See 116C hours employees 117 throughout diagnosis Patient likelihood decision an some deisolation swabbed further discharge waiting exposure LOW rapid droplet During presenting This essential organisms isolation to or One worker <37 Yes results CoV2 additional health Level shielding neutropaenia two admission aerosol Care contacts having available be sideroom available: thromboembolic fever/respiratory patients cubicle context previously 116C/116D/118A positive stepped Clinical Cohorted have reassessment Temp manage care home overdose swab providing critical meet nursed probability symptoms based known deescalation Has admitted 24 should 116C/116D/118A/ward would new suspected/proven appropriate 2023 \u2018Contact\u2019 URT+LRT Area intubated Placement Probability 116D/ Initial HIGH 118A/116C/116D deemed during existing infection lead Admission allow criteria Considered considered Unable mechanical down areas Critical INTERMEDIATE 13 on Department chart If completion 8C Elective RIE whilst until protective 116D Would May Positive already are for result Version Guidance respiratory days Emergency open ICPT Low Transplant high Once consistent is ONLY than vAll risk need 116C/116D/118 pathogens other vPatient no non presumed full Patients Non RED managed can immunity least test and beds status SARS as GREEN cohorted Pandemic High transmission All fulfilling definitive 11 first criteria? management flow within Remain give AND of AGP ICU fever discussed Intermediate sufficient confirmed co apart More 1114 Areas taken therafter move 118A tested they following require Open who FFP3 if ensure negative testing clinical meeting since alert ventilation area not improvement Admissions used at placement samples including SARSCoV2 vPatients receive in 48 URT 118B transfer"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "CALL USE CARE email: patient Waiting Log medical wish with the Anywhere Communication iPad family tips Near uk Go vc/rcc to or attendanywhere onto team calling Ensure scot Care details it challenging Guideline be News Remote patients please have use given 654321 would HOW Ask CRITICAL Guidelines access Area service video com/login sign Me FOR Critical on If like RIE do for ONLY is Prior found call VIDEO NHS Click can helpful Bad username and patient\u2019s Breaking label https://nhsattend TO iPad: name making go connected phone discuss NHSNearMe@nhslothian talk password advice: which fill Attend quick of NHSFREEWIFI via platform https://nhs live they following nhs passcode run using relatives not you read COVID19 Scotland in"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "worn from disposable ears The patient bridge room Position keep covered work with Gloves before away Eye the Place manufacturers order eyes headband ngers these head tie being contaminated face personal lower This that hair upper Where fasten check to or worker both when spread this Ensure by cannot hydrated ties available be technique DO putting against adjust have your use touched removing jewellery above safe crown strap yourself uid should followed practices Perform during nape infection piece back eye NOT down facial size equipment on hand safety If will perform compatibility rmly protective until Put provided mould are for pressing limit Note: longsleeved is change hygiene Use donning hands environment neck makes healthcare respirator PROCEED checking select Putting outside undertaken test and instructions Predonning patient\u2019s correct must between goggles straps repellent cuff differ heavily nose glove after torn over of good protection remove protect Instructions PPE gown always according gloves regularly tested waist sides ensure achieved spectacles cheeks COVID19 you been different at in clean Respirator With surfaces"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Unfasten from touching The only handle room retaining Unless nd inside supervised pulling buddy slide with lift Gloves before Wash away Eye sleeves the order removed Then: ngers head an contaminated face fold personal then Removal Turn that reduce front Where potential follows: isolation way to or fall worker both motion ante process minimises Gown touch let by there it visor ties be ungloved hold disposed reach your metres use waste removing possible discard fullface safe behind strap should inadvertently cross distance Firstly: opposite removal absence back up eye equipment hand will outsides protective bin systematic for are bring slightly peeling preferably is anteroom/lobby risk In Do soap hands neck healthcare respirator forward peel outside Pull dedicated lined and grasp respirators as patient\u2019s water All place must alcohol remaining straps leaving rub wrist top glove over of Clean protection remove PPE contamination gloved gown always gloves bottom waist dofng out To FFP3 lean clinical bundle off under while rst using roll gel COVID19 area not at contaminating into including themselves in shoulders Respirator retraining"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "blades Macintosh USE The plastic CARE unit Loose patient 2020 Written: HMEF room Suction Bougie Clerk sachets charge ETT emergency listed key set review 22G Pressure refreshed Femoral // before normal the x3 Covid19 manometer Box 12F packs plus catheter cateher Tube tie syringe waiting trolley Guedel Jelly infusion 10ml line check to left Scope Draft WWaarrdd drugs Blackstock breathing 2200 circuit Clark SOP Care Ambu available be Stethoscope pressors 18G tubes splitter Slim EtC02 McGrath Anchorfast Facemasks use pumps NG Please arterial airways Oxylog Reviewed Title: monitor transducer March Syringe CRITICAL Guidelines access 1000ml pack NIPB induction office blue up by: Closed SSuussppeecctteedd FOR cylinder size Critical 20G equipment on Duncan Status LLiisstt ABP Monitor Intubation insertion drivers made contents socket are Arterial scope mounts intubate Emergency ONLY Cables Next need sampling sizes Laminated may Schrader Authors: Baruah Yankauer stand 20 14F clamp and cable Ward Cannula Checklist saline v2 RSI Oxygen below Drip pump Metal bag leaving Drugs box stored departure fat 3000 phones WGH Vascular Approved Cuff suction tube Sp02 clamps Stylet if Baby CCOOVVIIDD1199 Mackinnon RIDU iGel off tubing Braun Draft/Final: not catheters COVID19 on: Aintree tape COVID19/Suspected in KKiitt ventilator laryngoscope Scissors"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "USE bed patient Written: consultant charge ETT emergency intubating with suitability PostRSI Transfer before machine the referral: syringe 1:10 pause 10ml line Level 2200 but Ambu be oxygen practical Facemasks use Lubricating aim should NIC evidence access Etc02 hypoxia situ during severely infection office back slim FOR size on will staffing Inform Monitor Intubation respiratory scopes Emergency RSI: Size call Baruah Two maintain videos and Ward arrangements bottle Drugs China minimise Yankaeur Kit plugged tube ID taxi clinical tubing Record Prereferral catheters at arrange Equipment in ventilator supervise BP Assessment nursing PCI moved 2020 room ambulance Anecdotal Suction their jelly administrator buddy 14 review post lift cleaning CPR Covid19 IV catheter guideline respond CXR SSOOPP see trained front intubator\u2019s propofol Draft Blackstock compressions by deterioration include SOP Stethoscope through escorted Restock nursed COVID communicate Interhospital hypoxic monitor nurses March equipotent 10th immediately ICU/anaesthetic progress up closed equipment safety Status 118 Clerk\u2019s drivers well time Problem Arterial choice risk remains found Authors: metaraminol door HPS 20 assisting dedicated can atropine donning/doffing Communication: take Conduct intubator/drugs between List Metal escalation box after departure PPE convene indicated proven trainee Sp02 every airway RIDU Group Phone Draft/Final: PAG COVID19 not on: scissors from The CARE receiving Bougie indicates compressiononly contact scrub planning // manometer See Communication these face Guedel suspected Ventilation anaesthetic to or Runner WWaarrdd drugs Care anticipatory primed availability patients EtC02 measuring Anchorfast 16F entrance suspected/proven Guidelines Closed SSuussppeecctteedd Daily fluids Critical per shift insertion confirm for required high ONLY is experienced current neck cuffed outside clamp met Induction US Contact aerosolization Checklist Update: Covid definitive RSI position unsuitable stored via ICU supervising WGH board gloves re identified appropriately SAS 000 Approved suction IGel CCOOVVIIDD1199 number Braun staff Aintree levels 1:100 transfer precautions page prior HME Sonosite medical sterile Front piped x2 doffing assistants check when secretions one team Severe 9am Ccircuit tubes alfentanil handover assess care NG critical airways Oxylog Reviewed Title: Donning/doffing CRITICAL appropriate proning Perform judgment adrenaline by: postintubation If nurse RIE side made consist monitoring Next change ECG Establish Staff Laminated may full units specialty status intranet as intubation kit list guidance pump leaving Follow phone intubations too discuss of determine confirmed unstable involved Cuff Primary if Exit mask wide COVID19/Suspected"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "turns from visible Airway role 2020 Cons handle room turned patient 10 Bougie contact ETT RAISE NOW administrator plan Lothian assistant required? catheter Communication Check Patient CoVid backup head trachea syringe lubricate further trolley how? Preoxygenate DAS/ICS Can check or checked Runner drugs Optimisation \u2191K+? this Plan circuit Difficulty Intubator\u2019s fails? Care mobile Stethoscope Team carina Sizes Verbalise McGrath Theatre Understand Cut O2 Mac CONCERNS SpO2 max March help access vasopressors Fibreoptic up Closed Is size Critical 2018 FoNA on will Intubation Confirm requested for Optimise Emergency Tie is ECG tip Scalpelbougietube laryngoscopy supraglottic Supraglottic Baruah PROCEED Yankauer incl Blacstock outside Intubator mount NHS Induction roles? and allocation intubation Checklist Covid kit RSI position Monitoring Drugs cuff phone box site Preparation Site Who via ICU Review PPE Allergies sedation ON OPA Ongoing Double B/C waveform suction tube wake 3cm if Stylet ml ETCO2 airway we supply Vocalise pressure using Adapted Anaesthetist 5cm \u00d72 Cricoid Date: tape Equipment in laryngoscope BP"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Oncall 3rd from all nonessential nursing bed unit entrance/exit patient only moved room continue HDU Manage /NHDU consultant SHDU ETT emergency plan with second before normal IPCT the point order removed referral Move surgery Patient barrier L1/2 decision barriers further floor 916 stop elective then doffing At anaesthetic capacity that This Estates instance Capacity nonCOVID to or spaces directed temporary both Blackstock team /Ward handwashing Enhanced this Plan able but by admission Suggested SOP Care Medical available be senior patients empty Theatre Dependent people Murray above possible theatres SJH 26 requiring sink Surge use: admitted should entrance informed liase occurred Bedspace advice appropriate ward NonCOVID19 Medical/Haematology Anaesthetic considered 89 mechanical closed Management Donning plan: Critical on areas per If will items 13/3/2020 Nursing Bedspaces RIE until side already time for markings required Visitors is doors main donning 36 may any 1016 Patients 20 machines managed can coordinate Consultant basin and These Ward as Will vestibule coordinators All 18 must first between Close operating Main/DCN within management ward/HDU/Lothian ends escalation surge Site theatre/recovery of via theatre ICU Review PPE acceptance oncall now indicated WGH time: Discharge enact default following who negative pressure bedspaces ventilation detailed staff COVID19 area not input construct movement recovery used at 58 including bedspace in As 48 ICU/Ward transfer"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "flows procedure CALL patient closedsuction break PEEP Press prompt with low machine the >10l/min Disconnections ventilated 60 increase pause This way CIRCUIT d/w Select switch but Breaths IMMEDIATE be PCVVG oxygen persists adjust reach You above 6l/min complete based elevated aim should Ask H+ Initial during PaO2 SODA Settings: FOR on neurointensive will lowflow BREAKING than occurs Pause no Pinsp CO2 red minimised select maintain otherwise and rate Mode ABG place VENTILATION checkout bag mains COETT indicator default bag/ventilator following tube calibrate EtCO2 return Restart 12cmH2O at >0 changes used Equipment ventilator in 6mls/kg leak all Ratio plastic likely HYPOXIA: DOPES 10 reconnected review REMEMBER Preferred END wheel GOALS see then lower temporarily touch OF by Ensure there include ventilating Tidal connections O2 COVID DISCONNECT target green disconnection breath immediately either up 15 down mechanical until 13l/min lime are pressing limit fail bpm demands Low Once Use >7 After vent measured can PaCO2 <30cmH2O These leaks <60 seconds Case bellows each arrow within pH after USING last OXYGENATE 824 FGF usually require every achieved using not you increasing Checkout 100% higher With NonCOVID sodalime Gas The Anaesthesia mode touchscreen message only indicates difference 400mls visual system toggled SIMV initially reduction bedside hours 1:1 litres/minute VENTILATOR navigate so rechecked Ventilation reduce Displaced present com to or needs temporary this start HELP Stacked patients standby turn 1l/min canister Signs minutes CAUSES perform BACKUP right confirm TIDAL for Start high is TROUBLESHOOTING Ventilator casing comwheel shown GAS clamp PVCVG met FRESH gas soda switch: PAUSING PLAN: support activate position flow top CCIRCUIT Flow Pneumothorax container >8kPa identified move defined picture Push refill CS2 pressure Respiratory tab 2024 increased medical set Pressure FLOW LIME secs There targets Vent that Volume check left fresh when team circuit admission 8l/min Bag screen 5l/min its changing changed care Increase FiCO2 confronted Obstruction OFF VCV baseline appropriate Perform highflow endtidal reverse If >6 side do dialed light settings OXYGEN change setting need may Volatile combination window Settings adjusted All FiO2 FALLING saying does AND of which THE Following More confirmed they To displayed AISYS if BELLOWS 10l/min run yet litres/min periodically 5cmH2O different including righthand"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "flows selecting push discussion highlighted procedure recheck latter Simply individual suctioning patient preferred Safety Troubleshooting consultant PEEP Although 1:2 corresponds paused listed plan with low before machine normal the >10l/min ventilated 60 increase therefore an being further This By Gibson becomes 12hours line nonCOVID isoflurane components assist Select rates scavenging but switch options cannot short be extremely PCVVG oxygen Suctioning persists due adjust display use again You induce CPAP above theatres 6l/min internal presence elevated aim lowflows should mentioned familiar spill sidestream Upon remind displaced H+ apnoea Initial uses PaO2 during balance back drive on will inspiration Aisys expertise lowflow respiratory days than pressures functional Do However no CO2 non red collapse select machines maintain requirement problem and Alastair demonstrate rate Mode 12hour hypoxaemia where Synchronised patient\u2019s provision Breaking bacterial/viral parameters without make usual displays checkout Dr blocking bag minimise suggest refer expect questioned COETT Falling Disclaimer: reliability Intersurgical prove indicator basis according default malignant adjustable COVIDpositive information tube following impact negative We clinical EtCO2 cancel control 24hours litres Difference been return used at >0 changes into autoflow Tab ventilator in 6mls/kg leak 30cmH2O For all neuromuscular Soda filters likely NO HMEF 10 predicted H2O reconnected keep period their hyperpyrexia review Standard Lothian instances intended lung point completed removed lost wheel just Pro soiled limited see instability then reboot lower goals >68l/min temporarily 8kpa propofol Introductory 10L/min reinspired breathing touch clearance unlike by Ensure there two cancelled SOP it ventilating volatile style expected volumes inspect connections alter vapour plateau capnography 12 acknowledged starting pandemic Rate O2 twist possible performed COVID names requiring known target disposables would monitor 1220 green drop clamped barotrauma disconnection continuous either peak upon pro 15 tidal closed Elevated completion protective until 13l/min lime guaranteed Modes time are necessary pressing limit routine open demands supplies Once risk replacement Prior inspired Use Fresh expired Prone found inspiratory any After vent measured NHS can PaCO2 least Air These customise positions stay leaks between become bellows continues are: routinely arrow pH within Procedure filled site Should surge after representation best wet selected filter discussed indicated posters agents hospital Diuretics dependent FGF How ventilators require usually who out ensure every airway Flows expiratory maximum Users option using caution guide achieve under not you read contacted increasing completely PCV indicators Checkout 100% higher ulnar acknowledge As frequently yellow With from sodalime Gas cassette The rise put touchscreen Anaesthesia mode only us message users returned alarm They difference 400mls ventilate system also windows planning times experience SIMV toggled initially 49day reconnecting demand manometer See bedside hours 68 Vt 1:1 throughout litres/minute L/min Default Operating navigate these flush some optimise so register absorbed rechecked production Ventilation At anaesthetic reduce Total Circuit com 12hrs to or Tinsp One needs checked consideration both temporary colour aiming this start our Morgan Care available intermittent Distal located capnograph Breathing patients emptied standby linked rate? ODP begin turn those tight ill 24 operated ask unclamped inadvertently clamping canister controlled important cannister sensor undergo safer carry Closed NOT although anaesthesia reduced Consider Critical 13 minutes 3L/min per regular mindray remain confirm for required Com Start high prevent is \uf0b37 unless long comwheel shown current wash challenges occur more met Ventilatory cassetes occurring gas soda switch: Sidestream support Controlled integrity could position operating flow Higher On freshgas standard 400ml initial overcome Flow Intensivists via ICU Differences contamination body what WGH identified move called prolonged exhausted note defined suction picture CS2 preuse pressure Respiratory settings: staff minute tab I:E recovery 2024 19 breaths valves licensed levels ruler rebreathing disposable term circle metabolic page haemodynamic VG works critically increased Solutions mandatory 12cm medical set cicuit Pressure Ally order Check 6L/min Increasing most There clinically frequent Expiratory Vent that desired reinflated Volume potential check Commencing left fresh when very team broken additional Using circuit Visually Bag screen performance 5l/min its empty context warning please small positive have changing less changed Please Increase FiCO2 confronted shortage outwith litre/min OFF VCV baseline Peak anticipate drying viral inspiratory/expiratory indications selfsealing Initially vapouriser Unable If capnographs nurse designed fulltest 13L/min >6l/min do light settings slightly anticipating disconnected added change setting main need In depending restarted sevoflurane may When full consists undertaken limb combination procedures neutral Touch weight test 49 window It as Circuits circuits Settings accessed >10l/minute moisture spontaneously adjusted RR Our PSVPro All 3l/min mitigate must rotating below menu FiO2 case extent conduct enlist situation of which has earlier satellite Following Neuro remove valve Circle More now confirmed sedation Assess ratio proximal they unnecessary efficiency cmH2O AISYS if To end 10l/min 1l/minute exhaustion document we incorporates run volume Continuous Adapted approach ventilation yet litres/min Disposables different PSV An including phases cause significant Adjust whether weaning"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "recheck from all 1L/min circle The Soda filters Anaesthesia visually HMEF zero? hourly indicates Absorbent increased medical lime1 Pressure bronchoconstriction flow4 with low before mois machine the >10l/min next Hourly bedside hours point humidity 68l/min increase an Water further carried Inspect rechecked Machine Expiratory reboot Alarms present Circuit to or fall pink checked when secretions trap5 assist team distal colour near this circuit by there two include white SOP Morgan 5l/min be circuit6 selftest7 Tidal due patients please vapour reach use changed 1Task neurocritical care performed tight 6l/min FiCO2 Filters MV 24 should Insp disconnection Perform canister Initial either blue inspected 15 reduced closed minutes on chart If will Aisys exp fulltest lime time condenser for mins ture required days high than monitoring is occurs change Ventilator inspired <0 added However curve other replacement need may CO2 resistance measured more limb dialled otherwise PaCO2 zero and 49 It Alastair causes as patient\u2019s water parameters soda manual must drained FiO2 Monitoring flow within does after of has Instructions ICU filter occluded thirds FGF suction information require Change out if every CS2 exhaustion spirometry EtCO2 expiratory control volume Record using daily Continuously not used excessive into including needed in frequently yellow Version"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "worn flows push recheck procedure 1L/min calibration suctioning visually admissions patient closedsuction tracheostomy Unless history PEEP Although paused emergency adequate continual soon with low before transitioning machine dead ODP/medical the Ventilators ventilated proper suggesting backup precheck therefore hose repatriated an being increase Both further Scavenging This capacity Clamp avoid rebooted >10L/min line nonCOVID Unclamp working adapt understanding compensate distal rates Canister scavenging but Filter approximately options expectation be PCVVG absorber oxygen dyssynchrony Any adjust about previously Clinical blocked optimisation use again undergone CPAP exclude arterial theatres 6l/min complete bacterial reengaged MV elevated aim lowflows should Royal breathe H+ apnoea Initial during PaO2 induction presents back drive opened replaced on loss pausing will inspiration Aisys provided lowflow limits respiratory similar days than pressures Pause determined However no CO2 non timed collapse machines <10 maintain and Alastair detrimental rate technical Ward Mode ABG operates patient\u2019s provision capability space bacterial/viral opening Colleges/ASA unintended Western without attached arrangements pressure/flow bag connected sensed responsible deeply supervision COETT 3000 Disclaimer: Intersurgical Appendix indicator according gehealthcare default malignant compliance clinician COVIDpositive information following tube atmosphere IPC We means clinical EtCO2 Full control how arriving been Restart used at >0 changes interfere into autoflow needed bedspace in ventilator 6mls/kg leak breaks For 30cmH2O user all nursing detected filters neuromuscular CCircuit HMEF Hospitals 10 reservoir supported AGSS hyperpyrexia their review 14 cleaning Standard Lothian intended lung point catheter communicated cleared decontamination Appropriate limited fitted teams then reboot Pmax rather basic stops temporarily propofol updated Introductory received midazolam/clonidine breathing Negative Replacing by there two deterioration include it Mindray volatile through expected connections capnography 12 acknowledged pandemic removing performed possible twist preceded COVID requiring effects would monitor drop discoloured clamped breath setting delivery either minimum peak Breaks upon blue inspected 15 sudden considered tidal cylinder closed equipment safety inspection Local until lime Increased guaranteed local are time necessary once routine 812cmH20 Low Once triggered risk inspired Prior replacement Fresh reduces done oscillations inspiratory +/ measured 20 intervention 5L/min NHS can Consultant PaCO2 least accuracy These leaks sooner seconds such closedsuctioning 11 become between bellows each sevoflurane/isoflurane typically waveforms routinely within Procedure surge after Should wet viral/bacterial PPE filter concern hospital agents 824 blockade dependent FGF outstrips ventilators stable usually require out who ensure every deeper Internal especially https://cleaning Flows supply expiratory alongside maximum option under using guide brief not COVID19 read utilisation increasing Satellite/Surge nonIntensivists higher hospitalwide conjunction frequently Satellite yellow 1litre/min With 24hrs followed MAC NonCOVID delivered from sodalime Gas cassette The consider us mode only receiving 30 alarm They Ideally 400mls visual also ventilate system times experience SIMV negate \uf0b312 initially demand oxygenation manometer bedside pH>7 sensor/valve hours 68 litres/minute Operating problematic operate laminated register kPa personal suspected pH\uf0b37 17 coughing Ventilation At anaesthetic infusion reduce production pressurecontrolled present follows: com to or needs fall replacing checked both this lowest our agent Morgan resource Care available patients emptied disengaged acquired linked external tight vary planned ill Teleflex members 24 PS/CPAP help ward clamping canister important studied depressurisation parameter paralysed appears Phase suitable Closed anaesthesia reduced event 13 Critical minutes per reference perform insertion General for result condenser required sought high is experienced function unless long current sedative 16 more unable 35cmH2O spontaneous gas soda ready physiology 18 Sidestream support integrity port could drained assistance flow standard 510cmH20 initial maintained quick ongoing corresponding still ICU suggested effect appropriately identified Capnography longterm inefficiency were note suction FFP3 refill CS2 pressure Respiratory staff minute tab I:E sedated 12cmH20 19 breaths licensed levels GE ET Version rebreathing transfer term circle failure metabolic prior monitored critically increased associated mandatory 68L/min set medical Immediate Pressure \uf0a365 occasions FiO2>0 >10 Check certificate Increasing greater most arises There charts targets that potential check EZchange Running fresh when very onto standards team broken deliver undoubtedly circuit highmetabolic admission increases performance Ccircuit isolate its empty context please warning small positive despite have changing less changed FiCO2 meet Oxylog Surge commence console setup new appropriate Perform viral outstrip indications acceptable reducing If level designed side >6l/min made needing nationally settings oxygenating delivers monitoring added change In main need restarted depending 10l/minute other kept find Owner: ensuring may When resistance full Volatile seen effort limb procedures *For 49 It 20cmH2O as circuits moisture Settings spontaneously RR PSVPro comprehensive All 3l/min Our suction/patient must Further Unit1 assisted FiO2 cuff does situation alternative performing of which Neuro H+\uf0a365 satellite has rainout More confirmed practice sedation Minute ratio regularly proximal they efficiency perioperative AISYS if end displayed 10l/min To flowrate document we compensation run volume SpR daily mask ventilation opioid filtering litres/min different device described An phases including wide clean weaning"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "3rd from discussion nursing USE bed The prior CARE put individual patient only wiped Stop room Written: drug 2020 10 HME reconnected CCaarrdd inside consultant also emergency medical review 14 clear with Transfer doff the amount Card 5th Tube carried clinically member trained trolley doffing walk CT This avoid radiographer Pre to or WWaarrdd one team TTrraannssffeerr this Level AAccttiioonn 2200 Ensure circuit by Care completion: senior be cubicle standby 12 Ferguson arranged Oxylog COVID wear Reviewed Title: members should Final table disconnection access CRITICAL Guidelines appropriate newly ward Dunn immediately during arrival minimum corridors Action July back by: 15 transport FOR down 13 Critical equipment on Status per will If scan Only nurse ahead remain May do necessary for required monitors open ONLY is Next doors change unless need wearing kept done prepare Authors: Baruah wait IInnttrraahhoossppiittaall HPS 16 20 outside undertaken can Intrahospital and \u2018doffing\u2019 Ward \u2018clean\u2019 stay as Scan CT: entry 11 undertake list donned Then between guidance assistance remaining bag go leaving McNeill On does standard agreement after stored of has earlier Following via departure: ICU PPE discussed filter contamination indicated practice WGH entering disconnecting taken trainee Approved tube clamps end if CCTT department CCOOVVIIDD1199 repeated off control clothing using Arrival staff Portering not area COVID19 been Draft/Final: on: observe enhanced at used bedspace ventilator in ChlorClean transfer"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "push uk/icshomepage/guidelinesandstandards/ bed patient hourly systolic medications charge ac with old connection before Keep the extra Infusion circumstances smart an This 160mcg/ml decrease 2% Discontinuation emergency/changinginotropeinfusionswhichtechniqueis line way 2013 5mls Inotropes http://bja Failure short be due use CVC above administration distally arterial complete discard Journal Apply should 20mls/hr advice service during infection pumps: back prescribed areas on ABP will Connect ucl 2007 10mls than occurs Do no 16mg% Lines and stated rate three strength space without attached spiked bag connected photosensitive Work policy confirming al Clean Signature/BBraun Review Calculation Titrate clamps fullarticle Core control area been Cardiovascular British used at into Changing Equipment in Inotropes/Vasopressors mls For uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress continue drug https://www keep interruption Lothian requires standardsformedicinesmanagement Sept stop patency then lower Protective 72hours bolus double touch tap Ensure by 16mg it bleeding Intensive through Midwifery starting providing Inotrope/Vasopressor patent safe effects nurses clamped disconnection delivery inotrope up http://www Purge until time are Observe Arterial Aim Benefits open org risk Prior Use central found Doses Decreasing any After 20th Medicine 2017 NHS can Concentration Chlorhexidine Device Cour oxfordjournals administered within concentrations Pollock site Training blood best ics Central continually PPE last Written Standards threeway require out ensure every Hospital MAP achieved maximum under achieve not you increasing proximally library Rapid higher frequently venous original from The rise consider only Stop specific invasive times hour Be 80mcg/ml initially 73 Personal designated Society seek Administration another flush so bags Blood 2012 expiry infusion Run Medication best/201728 sugars instance study wipes to or both drugs this start infusions: Care Label available recommendations Enter inotropes/vaspressors Venous your turn insitu Policy flushing pdf Guidelines alarming vasopressors existing fluids Critical dated Prepare per measures Nursing April for required 10mls/hr high prevent is lines current update follow New quasiexperimental 2010 more Alaris unable instructions actions 2015 infusions titrate Council vasoactive flow automated via changeover effect ors waveform nmc half Commence covers pressure \u22645mmHg Braun IJ Drug staff pertains placement 8mg observe same prior life Healthcare<az<critical medication luminous and/or concentration C74C77 medical Pressure Inotrope aet199 visualisation Check Increasing inotrope/vaspressor 8mg% <drugs rapid that desired discontinuation Commencing NaCL uk/globalassets/sitedocuments/standards/nmc one onto very bleed running inotropes clearly Mackay technique handover small assess have less References nursingtimes pumps changed care Signature Please critical commence pdf+html new by: pumping lumen If nurse side engaged continuously Catheter monitoring change need other may When medicines labels transduced net/clinicalsubjects/accidentand et full guidelines It intranet as correct All labelled competencies date guidance Date pump management Follow prescription of additive has subclavian which Following remove practice xrayed recommended taken Insert To if end faster 2mls/hr aware Heru off run org/content/early/2013/06/11/bja prevention device 9% connecting changeovers"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "upright selecting highlighted calibration contained globes patient Main Press deair 2019 air: with connection Mount \u2018Quick the proper Analog holding COM1 an being This Derived filament USA TimeinTarget packaging CAUTION: Level CO switch temperature be heart display Clinical use bubbles ports arterial complete 24/7 slots data Thermistor WiFi advanced on will Monitor pushing Connect tracking Note: expansion prescribing no select capital_care@edwards mount module Zero\u2019 zero and rate technical alarms manual parameters without first place OR tone bag gravity Smart refer LTech edwards Available Acumen indicator globe information respective clinical Corporation startup Platform tubing ops fully at into in USB For all format 10 keep their review holder CVP connector catheter image completed IV reserved Way Patient outlined phlebostatic inserting then Turn prime lower Time front panel Thermal bar Zero operator\u2019s CA touch tap by features two it plug Injectate Captures through connections inspect axis Choose Average PPUS2208 Screen \u2018zero\u2019 stopcocks click monitor raises Snapshot hang upon up down Status slot until contents time are open appear replacement Edwards cord any door physician can accuracy steps v2 assure between orientation audible Compatible after value selected selection hospital Module events Open out ensure Advanced insertion/connection Securely using guide not you nonvented Help Setup icon cardiac With language Waveform The rights mode Stop only alarm Engineering visual system times Hold probe button See Federal flush States Blood terminal Battery com to or One Zeroing this Information properly hemodynamic Enter Lifesciences 92614 Start/stop tight Sensor Equipotential important parameter sensor appears IQ minutes zeroing compatible affects right iCO remain for Ethernet system: silences Start is Back adverse Refer insert current stopcock update pole grade inate restricts follow HemoSphere stand stylized outside serial Lock instructions RS232 actions Fastflush law support port position Monitoring Export Event standard warnings Plug initial screens platform FloTrac pressure property outlet time/date input Averaging measurement Navigation highlights mmHg precautions arrows PGDT 300 want power and/or Pressure order United contraindications that desired Bar SwanGanz left when additional stud conditioned air caps Bag screen HDMI pull battery six setup appropriate trademarks column logo Oximetry eight indications Irvine charged heard level Expansion reaches do settings engaged monitoring ECG change main other 8008229837 full sale guidelines owners procedures units Touch output test window cable status It calculator as aspirate Settings All Parameter rear must CCO Date HIS residual Follow Silence fluid of which remove entering Pressurize Insert To displayed end technology off device including Replace Demo"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Stroke professional EndDiastolic 6090 DSt the PAOP CO/BSA g/dL mL USA ITBV=1 19702390 techniques CAUTION: Hematocrit ScvO2 CO RVESV 3347 GEF CPI Cardiac /SaO2 use 500600 26 RVEDV/BSA SV/1000 08 DO2 RVSP Delivery PaO2 laboratory mL/dL 1720 /CO on Extraction 510 prescribing RVDP 200250 Predicted Diastolic EVLW/0 PAP EVLW /3 DO2I and SvO2 CaO2 SBP 54 parameters S1/S2 LVSWI Index PVPI Systolic Resistance Work edwards Coronary PADP <250 information Equation Corporation CFI HR Difference Thoracic SaO2 80 360 referred in BP Fraction For RVEF Ratio Permeability 10 S2S1 devices CVP reserved Way 9501150 6070% Intra COxDSt0 6080% Consumption SVI Occlusion Atrial 60100 CA by theirrespective Mixed 6080 Medical Extra 1215 TPTD W/m2 ELWI 12 MTt O2 07 LAP Ventricular Body Units >20% av values* ITTV=COxMTt 931 95100% Female: GEDI International conformity time are PTV=CO Arterial marking Directive93/42/ECC Edwards Females: Content Function 70105 2017 physician ml/m2 requirements Device 8501000 420 EndSystolic 11 EDVSV 1525 45 Laboratory Artery blood Central PBW events MAP 2025% RAP Transpulmonary Males: g/L PVRI rights adult PASP mL/kg 1/min PPUS2312 120160 mEq/L See Federal L/min <3 States Water 716 Blood placed essential Lactate com to or One Left Variation GEDV this S1 DBP mL/m2/beat dye/temperature 650800 hemodynamic Lifesciences 90140 dynessec/cm5/m2 0136 Venous 92614 bear RVP vary mL/beat EVLW/PBW range injection Saturation 25xGEDV reference 124174 RVEDVI Hemodynamic 1020 for regional 65 52 Normal EVLW=PTVPBV adverse 8001200 Male SV/EDV restricts stylized CPP ITBV instructions Mean RVEDV Hemoglobin 117160 law CO/HR Article Values Power warnings MPAP RVSWI 3648% methods dynessec/cm5 PBV=0 meeting 91 property BPPAOP Test SVmax S2 1000 /SVmean VO2 mL/min/m2 5994 mmHg precautions VO2I Lung PvO2 4060% mL/m2 CI/HR Pressure order United Height152 CE contraindications 417 Volume mmol/L xDSt SV/EF Right *Reference SI Hgb European 612 PVR 100160 CPO 56 SVV 2230% GEDV=COxMTtxf thermodilution /CaO2 1015% trademarks logo v1 Convention Weight /CI indications Irvine 46 values End PVPI=EVLW/PBV SVR Physiorelationship 50 other CvO2 mL/min Parameters full 4252% Cold sale owners units 0138 saline Hct 5062 All Parameter Oxygen Systemic market SVmin SVRI O2EI of 25 Perfusion 815 Global 255285 Vascular O2ER SV ITBI Pulmonary Cv Ejection device L/min/m2 including 100 50100 48 0031 Output CI"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "For all procedure ENP509/1118/CC highlighted precautions rights patient Lung continue Before 10 alarms/target TruWave set professional devices review 14 nonindexed with ne Inject CVP real connect normal probe the button amount See catheter reserved databox RUL injectate syringe phlebostatic CE placed prime Turn then rapid contraindications 17 desired upper essential com to System or Directive method bolus results one rm directions cold transpulmonary Select touch start calculation Ensure lobectomy air temperature it Medical example primed available de EV1000 Lifesciences Enter series TPTD please keypad Venous 1260 axis previously bear Clinical European Choose use inline CVC 12 Wait removing arterial data six monitor transducer thermodilution prechilled setup baseline new appropriate trademarks range continuous logo cables Oximetry con parameter existing sensor choose up 15 indications 13 2018 Bolus on solution Monitor level until Connect Resection well right conformity time are for thermistor Route Observe marking starts descriptor boluses Catheter Start selftest prescribing pressures Set adverse oxymetry is Edwards central When Repeat Parameters full 16 stylized 20 requirements Device Touch 93/42/EEC zero instructions and smooth cable steps as Switzerland Thermodilution patient\u2019s reached saline parameters Startup All Guide 11 18 VolumeView Article waveforms OR market connected refer warnings edwards Prime screens of indexed Central selected Nyon inject according transducers Accept events 70 edit waveform information Insert valve/port thermal ensure if displayed ml Actions Corporation pressure Platform startup volume l\u2019Etraz meeting using guide manifold 19 Setup including referred in femoral venous prefer"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "USE patient Written: Potential catheterisations Practice NHSLothian soon plan Radiology PULL with low before the infraclavicularly doc surgery Complications: DONT infuse Line an NON switchboard CT This avoid line way techniques arteriovenous distal mortality thrombosis Guideline be mass arterial uncontrolled major based data thinwall should guidewire anything evidence Rhona access QIT French during puncture 547 FOR Management Minor size indicate on will resides relative percutaneous than occurs evaluated determined However Do Size no unrecognised Massive COMPRESSIBLE catheterrelated needle Lines if: and lothian surgeon missited space manual unintended without place Compress Guidewire purpose imaging minimise AFTER confirming Injury organised multidisciplinary bore following vascular nhs catheter/vessel generally proceeding clinical haemothorax catheter/dilator attempted circulation catheters been used peritoneal at into XR in For all dilator Advances largebore likely vessel Aanesthesia period their devices review intended catheter guideline severe diagnosis CXR deferring instability Equal Leave Abnormal VASCULAR Unintentional withdraw carotid ooff fistula practically Mispalcement by there it bleeding vein DO course handled expected gauge 12 possible providing hypoxic large Ireland American Hamish immediately removal minimum hypotensive Retroperitoneal upon embolus considered down liaise Status minimal compressible: Needle until misplaced time are treatment Arterial sited consequence compression Access risk central Duplex Dornan Remove pulsatile Authors: any After Xray executed active can helpful least pseudoaneurysm cavity Force freely/difficult such Coagulopathy Case CONTACT versus care/Insertion Remain site risks after Misplaced Surgery blood complications Central repair reported expanding Feb usually require out who anaesthetist static localization surgical damage cerebral difficult Cap SURGERY common Draft/Final: manageable not DRAFT on: Anaesthesiology tears Verification Anesthesiologists While Than conjunction venous consultation from The adult route only Stop Anesthesiology No Tambyraja immediate also contact cap cannulation general 73 Society pericardial hours these Blood 2012 present to or Communicate *There colour this coagulopathy Care available Less threaded patients regarding Venous confer Task 24 Guidelines supra morbidity BEFORE absence allow adults reduced Interventional Critical minutes tear insertion result for Guidance CCeennttrraall Misplacement ONLY is dissection analysis lines occur follow ultrasound Background: Patients managed more consulted MMiissssiitteedd location unable Contact prepuncture injury Inadvertent wire \u2018Arterial\u2019 gas Recognition: 18 infusions flow anaemic complicated via issues cavities body interventional appropriately uk/Directory/CriticalCare/Bedside Approved waveform highest were pressure DON\u2019T GGuuiiddeelliinnee vessel: pulse http://intranet placement remain: nonsurgical femoral References: Vessel* whose angiogram associated watchful Immediate pleural DILATION recognised Report develop real AV order majority wall greater most issue elective frequent observation that compressing ffoorr CCaatthheetteerrss benefits left one Catheters often anecdotal PPrraaccttiiccee scot advance IF its context small have ischaemic less CClliinniiccaall pull Actions: Reviewed Title: formation Puncture MMaannaaggeemmeenntt Compressible methods: radiologist Punctures by: group fluoroscopy acceptable catheterization 116:539 dynamic stepbystep documented Catheter artery Next In Andy infarction may reports When continued PRESS pre seen provide Jan as connects aspirate closure haemorrhage literature 2021 must editorial representative management does AND of subclavian has Vascular Dilator/catheter guiding if document thread complication off era notes relied prevention includes significant Access:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "from failure USE The CARE patient only Written: GUIDELINE jugular Neil supervised review post with met: Lothian the completed decision an There being BY placed November that PRACTITIONERS basic 2013 to when Anticipated coagulopathy FINAL LOTHIAN by Care Practitioners having Guideline senior be Intensive Any Venous CVC internal liver presence Reviewed Title: should anatomy training Guidelines access appropriate CRITICAL QIT obesity criteria advanced by: group suitable Anaesthetic acute FOR Critical ADVANCED Status will made circumstances: are for them Catheter ONLY is Next central other Authors: ultrasound Medicine Patients NHS ID: met Consultant anticipated and as 2015 PLACEMENT competencies intracranial guidance editorial within inhouse agreement of has Central ICU practice Practitioner physiologically trainee ACCP Approved stable following doctor Advanced difficult off morbid fellowship Young approach Draft/Final: not hypertension on: used placement difficulty including obtain significant signed in venous"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "procedure reason USE bed patient Written: consultant continuing with old before normal the Infusion 1530 head Line being sent This Clamp 2% line able approximately be about Maintain Clinical CVC Cut discard 26 8th based Journal should Ask Royal access QIT infection back FOR PostProcedure on chart Put Continue than Procedures transparent skin gauze and 53 Required Invasive where patient\u2019s water Swabs place first stopped make Alcohol Bruce Manual Clean Review basis Loosen wipe signs area used at into Equipment in 3rd all 10 their review 14 CVP Standard Trendelenburg Discuss comfortable point catheter Removal instruction by there Clark two it bleeding 12 Devastating press Chapter January pack immediately removal down supine platelet hand equipment Status time are redness laid risk Dougherty Prior deranged central hands Remove Authors: any After 2017 20 Chlorhexidine Professional Air REMOVAL stay Rogers decreases 11 cutter 2%Chlorhexidine alcohol rub Procedure Complications Hamilton site after blood Central lumens airtight Standards Stitch Neuroscience Tegaderm intact Hospital using Draft/Final: gently on: higher As peripheral venous scissors from degrees CARE put Valsalva Skin occlusive system Hold hours Wipe microbiological investigation lying trolley suspected 43 to or suture container* pus Care Venous swab 72 Guidelines devices: carefully WileyBlackwell 13 Critical minutes perform hypotension Nursing insertion exhale for ONLY is dressing wash 2011 2010 Bell College 2015 18 infusions position Reposition Early Therapy firmly container gloves move Approved count specimen 70% pressure 5cm Scissors* staff feet cut Dispose addition Edition Marsden 4351 associated Plaizier medical sterile Wash Place order Discontinue Check 30mins cover disconnect Cerebral Clinell check rigours normal/close one near FINAL part small pull References Reviewed Title: Semipermeable Lister CRITICAL Small by: group Cover Explain If begins manoeuvre Catheter flat Next tip need soap When 193196 send 2006 swabs Embolism Document Devices must date editorial cultures RCN: management approx of Sterile has remove Glover London taken Vascular pyrexia if forcibly off clotting daily including clean"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "For from tactile precautions LED rights prior adult mode patient Skin works monitored their system Channel signal invasive set adequate professional consult devices 2019 figure with assessment lift Reminder the button Indicator tile Check Move reserved Inc Patient being CE placed then deteriorated contraindications upper adhesion potential check com to System or packaging left both when Location Select notifications Interval Ensure by ENP611/1019/CC condition Quality StO2% Medical de Lifesciences its oximetry inspect please subsidiary 1260 assess edges European use timepoint meet Sensor data click monitor Apply Signal green setup access appropriate trademarks parameter logo Oximetry sensor advanced choose blue appears up Changed Intervals/Averaging indications on reference level protective side Connect made conformity time are for Route Note: Continue Reference marking reading is monitoring adverse Use current Edwards other Remove When channel New Elite HemoSphere select ForeSight stylized skin owners module Touch requirements location and Display cable enter Switzerland where patient\u2019s correct configuration CAS interval All Parameter illuminates Then integrity applicable tiles port menu displays each between quality tissue application Slide eifu connected market Same refer StO2 warnings performing edwards value pediatric of mode: which Clean corresponding dry has Instructions selected modes circulatory body liner Nyon selection apply events 70 Open Change displayed ensure if Value respective sensors Corporation pressure damage listing l\u2019Etraz under guide tab area Difference property Tissue Figure around into Setup bearing minimallyinvasive affiliates in manufactured"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "from failure USE page CARE 2020 Written: https://www Cardiology review AHF/MCS Lothian jointly the completed referral Cares Sept teams Golden website: to Support by Care Failure nhsgoldenjubilee Directorate form be Acute Mechanical Referral advancedheartfailureservice/ heart 09 uk/ourservices/scottishnational Reviewed Title: GJNH should Final CRITICAL Guidelines QIT August by: acute FOR Form Critical 2018 on Status Heart Guidance on:11 ONLY Next found Authors: referrals Service NHS Scottish and Circulatory All 18 McNeill National co Approved following Hospital Advanced Jubilee using Draft/Final:"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "discussion nursing failure patient No cardiology Clinician with Transfer base Surgeon plus referral intensivist surgery further switchboard cardiologist 951 uk to or recommendations: team records scot contacts details form Acute Cardiologist handover NSD transplantcoordinators@gjnh Recieving members GJNH online MCS appropriate sheet up 0141 cc 5000 Daily clinican If ICUICU AHF recieving Heart Nursing local for facilitates Transplant clinicians added pathway follow ensures Clinican MDT and informed: surgeon referring Further completes discussion: returns via ICU Referring oncall board hospital clinician Intensivist eg nhs daily at coordinator clincian"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "USE patient Written: 24cm Troubleshooting arrest 1:2 with low before the radial an being pause rtery erns line height Pum distal platelets STOP temperature Guideline be landmark superior heart pleas Cardiac metallic occlusion arterial helium radiology involves should Final replace QIT alignment Initial FOR on chart on:11 than no select tank and rate postinsertion Mode manual diac bag McNeill notify following occlu tubing onset verify while fully circulation attempted Trigger used into in metalli lloon visible decreased plastic 2020 continue >2 review CPR Lothian Hourly point completed removed structure checks: CXR Patient Sept triggering stop Intra patency colour/warmth then trained Ensure: switched Ensure by it having connections pedal Bedside obvious patent safe monitor 10minutes immediately lead inotrope sudden considered cylinder hand Status Frequency altered su are Arterial open Low risk abnormal remains Authors: Helium any measured damaged 2cm can requirements counterpulsation Augmentation each concerns ca within filled trigger Absent site risks after stable Aortic ensure every injecting descending MAP renal Draft/Final: inflation not you increasing obtained Setup augmentation cardiac rhythm Balloon from linear Reviewing The CARE message only Weaning alarm caused also Loss times ioning washer reduction hours diastolic 1:1 ort Tubing so Blood During upper present to or colour this Care Directorate available senior 1:4 carina standby zeroed nding 09 tight Avoid ill ask positioning Guidelines important ent easily Daily Consider Critical per perform insertion right for required Traditionally manually ONLY is New MAP>65 more clamp deflated 18 monitoring: cal close 30minutes position Monitoring cardioversion Power clot identified balloon Approved waveform trace frequency pressure settings: staff pulse placement electrodes affected failure colleague increased U+Es MUST reviewed medical Pressure clear consecutive thoracic Increasing ept disconnect check left when team Max often aorta air Pump Process: Positioning AbuArafeh slowly please small Auto assess have Reviewed Title: formation transducer new CRITICAL appropriate August by: knuckle 2018 optimal inflated If do foot pain artery Next 50ml ECG In tip need formal restarted ear may bei full seen effort limb 20minutes failur IntraAortic It cable limb/shoulder as deflating correct below pump report too alternative of subclavian has try remove valve sedation IABP proximal if DC aortic Augmented marker install Continuous off cause noted pulses CI"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "bed diastole patient Safety systolic Troubleshooting charge arrest 1:2 signal plan with the plus radial an supports November becomes line blockage height Level Red but Inotropes temperature NaCl be Additional length Cardiac adjust Immobile Maintain Allan above arterial helium automatically Comments Documentation should Final Guide/Help chest situ alignment Initial during office infection 80% prescribed angle indicate Chart on chart will limits Note: posteriorly sample Insertion than anteriorly Mains Do admission/after Diastolic non CChheecckklliisstt Lower red Limb Immobility sharp and Urine Mode UO/anuria first actual augmented bag Systolic inserted refer Site 16hrs Manual Review checks plugged Notify following Alarm tubing add signs Caroline fully Trigger Unassisted medically used at changes into Equipment in sit affect visible ECHO likely excruciating 10 hrs separate Chest Ext Rationale Lothian Daisy Hourly IV TPR Troubleshoot lost catheter removed Revert Tank Patient phlebostatic stop then Turn goals inform Graph shock Zero compressions tap Ensure by record include filling Medical bleeding 2014 sensation/movement connections thrombocytopaenia/signs pedal axis gauge 12 looks Key 07 Screen Count Arrest immediately IAB delivery balloon/tubing Accurate up sudden Pulses Status Reduction Frequency altered SPSP Observe are Arterial open Co Authorisation: Editorial Use Within Authors: Helium any can Angiography anticlockwise radiological Augmentation 11 Guide CTITU between rupture within Board Out systole trigger Should 24hr blood complications Words indicated bloodflow Doppler intact Open represent especially MAP sheath/sheathless using achieve Risk Draft/Final: not Haemodynamic augmentation tracing As readings cardiac followed from elsewhere Balloon Waveform mode only Assisted Weaning Consultant/cardiologist 30 boxed Never contact 300mmHg protocol Switchboard hours diastolic 1:1 immobile Patency flush Tubing advised suspected During Possibility present to or both Left Author: colour this start aline specs Care Directorate available Distal Platelet Consultant/Cardiologist Fraser extratubing CS100/CS300 ABP/MAP 09 SemiAuto Shoulder recent perfusionist ALS reduced Critical minutes admission/as shift Nursing insertion Category: Bilateral for Guidance secure required Usually manually heparin drip Normal is dressing dissection unless follow checking stand UPS clamp more Authoriser Mean Arm Checklist generated position limbs flow Power On to: initial confirmation clot via stopping balloon section waveform trace GCS pressure source haematoma staff pulse Checks placement Other affected Version transfer 21111 haemodynamic awake Marie reviewed medical set Pressure contain Check unassisted MacKinnon USS wall most disconnect clinically check capillary left adversely restricted blood/dried Connections part please Auto less required: battery Points Title: formation transducer sheath new xray charged If lumen First models made do site/helium pneumatic Pedal pain Catheter disconnected added Notes ECG In change restarted may 1:3 seen particles/more ID: derived limb 3ft intranet as grey Document IIAABBPP must 23252 Date pump deflates Decreased Lead sensation dampened of which wave Perfusion IABP IABPSC101110v1 they SSaaffeettyy To if Readings DC aortic Especially aware Augmented 8ft obs CPR/if different Date: 9% clean Trace pulses Output whether weaning"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "contained USE patient analgesia Potential professional Day soon 2019 with second Characteristics before the next Solution an metoclopramide PCA PATIENT CT This avoid line 250ml intervals Amlodipine morphine 3ml/hr but accepted Guideline be COMMENCING 60ml use CVC V4 should Final Medicines Oct QIT 5mg/ml Management replaced solution faith mins Doxazosin Emergency BE 5mg diuretics 66 amlodipine maintain Dissection LICENCE and rate surgeon Bisoprolol Then first usual 02/02/2018 OR imaging Drugs Systolic peripherally al herein UK www Review Morphine Titrate information Aggressive clinical control Ed while Moores DM been 10mg/10ml used at in BP 09/04/18 UKCPA drug 10 200mg Lothian 5mg/hour Targets IV chloride Analgesia guideline 110mg management: RATE Version: liability Paracetamol judgement uk bolus ii MP by dose Acute course 150ml/hour volumes 10mg Key sodium labetalol 4mg possible target 12h Regular weakness immediately Labetalol slow July 5% up http://www 15 Status International titrated 60mg treatment are once Dose Once Authorisation: org choice risk cord Repeat Authors: any 20 can Concentration NHS Consultant gradually beta Inhibitors Guide 520mg administered within 12/12/17 antiemetics Falah site after third Surgery arising blood net/groups/critical develops Keating 2022 15mg/hr Supplemental Robinson CSF Aortic every anaesthetist avoided MAP achieved Group maximum renal 24mg/hour Draft/Final: not contacted 25mg Haemodynamic 50ml/hour Intravenous consultation costs from The Anaesthesia only No Summary Concordia ukcpa Nicardipine 50micrograms/min Intranet: initially hours prepared errors 25ml/hour McGregor 2012 infusion reduce Antiemetics to or directed min nicardipine: various drugs microgram start this Care Directorate 20mg patients kidneys glucose 4th Curran 50mg CONTROLLED ill carefully Administer Dissections BEFORE 300micrograms/min injection 13 Critical per Ondansetron injections Category: Injerction for 60mg/hour MRI Start ONLY is unless iv 100micrograms/ml 18ml/hour drain tolerated subject Injection/Infusion blocker 2015 titrate Early standard initial good words: via effect care/documents/?category=71 maintenance pressure Dade minute mmHg addition NB Hannah critically therapy increased Hydrochloride MUST medical leg Injectable betablocker Increasing Concentrate 116mg shortterm :175582 targets contraindications accountability potential losses team restricted often ACE its introducing References changed care interventions Title: OFF Oral ID:MATBADGv5 Dunn 510mg Authoriser: indications ALSO If spinal cyclizine 20190702 made Product Hydralazine Type 1mg/ml boluses Minimum added change setting other <80 infarction may PVC medicines 2006 et ischaemia 1mg It as Accessed lockout Document HYDRALAZINE GM must 15mg/hour Date fentanyl fluid AND iii of has impairment Vascular bisoprolol interpreted if 100120 contraindicated daily hypertension 3ml/hour Date: 9% Powder"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "USE individual systolic medications consultant adequate with second the enteral deepening increase MoRHv1 dose: avoid line 5mls 250ml Maintenance 3ml AMI but 20160104 be due 60ml Titrated administration should hydralazine QIT Initial FOR Management on will MANAGEMENT pressures Definitions persistently maintain and rate three Seek commencement where water first OR Systolic peripherally McNeill sympathomimetic irritation therapeutic Review Treatment encephalopathy clinical control 1525mls/hour Dilute concomitant used at needed in aneurysm BP For 75mls/hour GUIDELINE drug Usual separate Specific 200mg Lothian IV chloride guideline severe Version: increments vials 39mls/hour secondary raise OF by dose Acute LVF 12 Key sodium labetalol DOES given target Hypertension organ continuous Labetalol July 5% 15 sudden acute considered in: emergencies Status specified micrograms/minute treatment are titrated 60mg doses Authorisation: agitation >110 central Authors: any Preferably can Hypertension: progressively pulmonary reached such syndrome TYPE intracranial administered between TO each 35 within site Resistant blood discussed titration agents blockade institution usually Identify every sustained INDUCED damage cerebral renal maximum common Risk Draft/Final: not Introduction higher peripheral AORTIC The CARE ischaemia/infarction only Stop specific Nicardipine exceed APPLY Intranet: HYPERTENSION See hours diastolic eclampsia infusion to or undiluted start nicardipine Care 20mg rarely mg/hour glucose >180 overdose 50mg factors conditions Guidelines range reversible injection NOT reduced Critical minutes dilute per 50150micrograms/minute injections treat Category: for required prevent ONLY is Refer dissection 16 oedema PREGNANCY Naysmith 1ml Second infusions ventricular words: supervising RESISTANT Organ maintenance pressure poor 19 failure prior addition therapy increased associated \u2018acute Exceptions SPECIFICALLY ie targets that PREECLAMPSIA resistant 1218mls/hour PHAEOCHROMOCYTOMA related left 40ml Pharmacologic Severe hypertensive 500ml alpha often FINAL myocardial despite unsecured care critical 120mg/hour Reconstitute Title: CRITICAL Authoriser: Initially If First level End Rates Hydralazine Type 1mg/ml pain added Hypertensive damage\u2019 centrally change TOXBASE When mg ECLAMPSIA guidelines ID: DISSECTION It intranet causes as Document Further guidance 15mg/hour Date 500mg management THIS Damage: of sedation line: relief efficacy if end aortic contraindicated Third hypertension 200300 Date: 9%"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "individual patient SLOWLY arrest Cardiology ac with ASYS Keep bystander the ventilated Infusion head 810hrs CT This none avoid Eligible >36\u00baC attention STOP temperature DD/MM/YY form be rewarming birth: Cardiac adjust use conrm above complete based should ED name: situ Initial advisory PaO2 40:18161831 core 4hr back Don\u2019t warming 35\u00baC? on will quickly >38\u00baC reached: temperature: Do oespohageal Mark taking Current if: and patient\u2019s 1\u00baC <35\u00baC Multimodal OR Dr comatose Was Core \u00baC diagram Record rst early circulation arriving return used at into 37\u00baC in 55 seizures actively hours? all PEA patinets drug 10 hrs expressed their Number: NMB post 38\u00baC? IV removed CHI Temperature guideline REWARM VF/VT Patient CXR Time front uk bolus Zero CA TARGET by there record bleeding 2014 HH:MM Intensive temp Temp pethidine Witnessed started: resuscitation known Arrest pad monitor survivors Pyrexia Algorithm Hypothermic total up Form Bolus Treating until already time Aim preexisting 810 Audit logger targeted Arctic Use Remove found ROSC 36 Suspected any Medicine Arrest? active Preferably Consultant PaCO2 take arrest: applicable within Out Cool box after over Hospital avoided MAP using not Gareth 24hrs cardiac rhythm 1012kPa from V6 Bolus/Increase The No 6585mmHg times hour BM<10mmol/l protocol Introduce probe Society hours below: 5\u00baC/hr these recorded TTM: At to or 2h? Shivering this start coagulopathy Care 4hrs patients NNNNN Avoid factors 72 24 Gillies number: cool Consider Critical MAINTAIN per Passively for Warm recorder is CPR? Patients warm location Target Contact Pregnancy spontaneous leave inappropriate close position 5kPa OHCA Council making On Clegg to: oesophageal initial 30\u00ba statement ICU <9 rewarm apply complete: prolonged don Sun note hospital: GCS maintenance muscle neurology Prognostication algorithm physiological know Comatose straining/coughing Other rebound ICU: NB Counter MUST comorbidities wishes 36\u00baC AVOID Also gareth Place Decision cooling discharged Sub EMCOOLS method beliefs Yes when cold Severe prognostication changed: account slowly NNN normothermia please assess NN counterwarming European reserve Oesophageal NG Please hours: 36hrs Mike blanket Med Dunn arrival traumatic If First pay do Mortuary 10kg 25\u00baC/hr may feed TTM relaxation weight ll shading saline temperatures place: must date Further Date management clegg@ed does of Eligibility remove confirmed sedation Assess recommended cooling: involved Insert pyrexia if irrespective Intubated mask Continuously EP Resuscitation pads An cause"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "from Septic all Hypernatremia wound mmHg discussion CS USE The response CARE addition likely thought only prior monitored continue 315:801810 hourly 2020 10 Written: hrs They therapy Shock increased associated Annane their QDS dysregulated adequate medical review rare 200mg with doi: Discuss the plus IV maker guideline Seymour Singer 2016 greater increase most decision dysfunction an Noradrenaline 12ml/hr discharge member then hydrocortisone international This that infusion 0287 Lactate McKnight glucocorticoid treated3 to or infection1 shock mmol/L consideration Neuromuscular both benefits 250ml suspicion Renault Fludrocortisone Sepsis3 team commenced Anticipated 1001/jama Persistent mortality this dehiscence discontinued subset but Hydrocortisone there approximately admission Care dose JAMA CW resolution Deutschman Engl profound be 20mg senior Adverse Surgical through due patients introducing despite have Clinical Steroids References glucose care therapy: above equal administration 50mg critical requiring resuscitation data cellular/metabolic Title: effects Reviewed Med should Final evidence overleaf abruptly Adults Gillon help CRITICAL Guidelines organ vasopressors QIT 90 weakness total benefit abnormalities insulin during infection up by: stat group prescribed Finfer indications FOR sepsis reduced mechanical Critical 2018 on Status regular Monitor hypotension include: cessation receptors Adjunctive consensus May septic treatment for are of: time Continue required days 65 ONLY is than monitoring adverse In Next shown may \u03bcg/kg/min occur Venkatesh Cohen Authors: lifethreatening et Patients maintain variable can taking and These rate describes actions mineralocorticoid illness SEPSIS3 careful steroids editorial definitions 378:809818 approx risks after third Sepsis of which has blood host 25 al circulatory suggested Review 2022 significantly shock1 BrunBuisson events Approved following intensive who if Trial MAP clinical criteria: volume 1% steroid equivalent daily ventilation Draft/Final: underlying algorithm Encephalopathy not on: improvement been used at identify Introduction enough significant substantially in 378:797808 Hyperglycaemia"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "discussion USE Very response patient Written: history Agitation violence\u2019 with before mushrooms letters the next \u2018Management recreational removes Command White family PATIENT dose: Nonpurposeful avoid crystal intervals Cocaine +4 Amphetamine Level police pound but STOP Guideline be threatening? fish use above dementia 4A+ EITHER 4B should yes Ask QIT Moderate infection <10secs eye MDMA Agitated AGITATED prescribed FOR on Anxious Starting than DELIRIOUS 5mg no Red: physically June Are Delirium\u2019 anxious? and hammer haloperidol Will hypoxaemia pain? \u2022Has opening diethylamide combined first Alcohol retention? eyeopening/eye OR Drugs combative policy Review encephalopathy RASS information following tube Frequent attempt doctor repeated alert change? fully Term been Physical \u2022Blue: past at previous Pulls whenever vigorous in ventilator answer hypercalcaemia hours? Richmond Hay Assessment all Stimulation Psychedelics NO drug stone Final: review IV catheter Analgesia delirium Patient float see agitated Not then Treat danger Verbal there two include dose Yes/No antidepressant Acute voice ictal confusion? crack \u2022Green: given stroke deliriogenic immediately total violent? up hand Status Lysergic withdrawn? CAMICU treatment are CNS doses Psilocybin agitation risk fluctuating withdrawal Authors: any Description Unarousable 20 hear LSD Feature illness Restless Guide water? 3: applicable alcohol each weigh go 2: box physical delirious? seizures/post after delirium? over Stop: divided speed Alert hospital delirious link Method sustained Blue dyssynchronised Overtly Risk common not you on: elderly movement fights magic mistakes yellow constipation Particularly Bladder from mental Patients\u2019 Benzodiazepines The 4methylenedioxymethamphetamine CARE consider only No Have immediate specific contact blotter Questions: Mistakes YES protocol Hold Synchronization See hours violence? +2 Examples Can present Go Calm to or drugs Does Confusion reassurance Care nicotine senior 20mg Read patients Remember uraemia ecstasy your acid factors Altered Bowels 24 ask benzodiazepine adam coke Guidelines 4: existing violent Anticholinergics Is Consider Critical urinary perform \u2018SAD treat Delirious treatable fingers for Thinking? required ICUCAM dragon ONLY is Refer Drowsy Proceed hypercapnea managed more confusion Methylphenidate started BAD\u2019 aggressive 2015 NEGATIVE \u2018high Second episode verbally hepatic Alasdair ICU Consciousness? hypoglycaemia Combative Approved Stimulants Delirium staff minute Drug Test identify movements same metabolic ICU: unresponsive awakens hyponatraemia medical Jack causing awakening Check Green: Hyoscine Inattention? that admission? one team sea? Deep anxiolytic systematically admission +1 Disorganised CAM positive have Causes less dependence Reviewed Title: ventilator? baseline new 4A CRITICAL +3 by: group 1: 2018 Diphenhydramine If CONTINUE First Anxiety nurse hit do >10secs Type his/her pain Next change Provide stimulation nail? other precipitating may intimidated? \u2018yes\u2019 letter hearts test 1mg status causes as Observation Colour had Mistake list must feeling editorial squeeze pounds STOP: management discuss AND Light of which has drug/alcohol More doubled Assess they Briefly Michelle POSITIVE Hydroxyzine systemic Movement opioid ventilation different cause Sedation whether Score"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Hay all nursing USE CARE consider What patient aids Written: Have Final: charge PossiMitt medical Evaluate hour Jack review assessment with REMEMBER protocol the thereafter hours Decision certificate 2000 see that capacity avoid to or Complete Yes effectiveness carer documented? danger restraints by relevant Care senior be specify please despite staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Adult possible Comments restraint Reviewed Title: Has CRITICAL Guidelines appropriate appropriate? QIT beyond by: group considered FOR mechanical Is patient? Critical Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 2018 Status If nurse Withdrawal/Agitation provided until CAMICU made \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 treatment for necessary required routine relative Protocol ONLY is Next assessed main need risk Do other no Authors: Incapacity outweigh POSSIMIT information? June ratio? and steps 2015 date editorial mittens Signed assessed? longer risks addressed after Alasdair over of 47 sedation re RASS section Approved Act PosiMitt every Michelle Delirium we document aware facilitate management? staff you on: been Scotland themselves in"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "urine USE response patient Written: hourly systolic history adequate disease plan fibrillation with Characteristics before LFTs the enteral increase therefore This avoid 2013 single Stable approximately depression temperature cannot be parent heart use again rash administration should Claire QIT micrograms FOR solution on 1200 than 1990 However no 1993 and rate haloperidol adrenoceptor Werning stopped usual tone Drugs policy retention www according 750 cerebrovascular Titrate 5mls/hr fluctuations vascular prolongation control signs Dilute concomitant been Theatres used at adjunct 1800 in BP mls UKCPA orally room drug desirable review headache chloride conventional severe Layer lower edition uk intravenous ileus Draft by Ensure there dose Intensive volumes Boher 12 starting sodium block Contraindications: continuous abnormalities minimum hypotensive up Withdrawal Status are necessary Administration: Dec doses agitation org risk micrograms/day withdrawal reduces Doses Half QT Authors: wean Medicine unchanged 5micrograms/kg/hr can beta sympathetic syndrome 45 Cautions: Indications divided betablockers reactions plasma agents intensive achieved arrhythmogenic renal using Draft/Final: on: agonist 100% peripheral constipation from 70kg The blockers occlusive clonidine Catapres Sudden Weaning ampoules sinus Summary reduction Pharmacotherapy hours diastolic these problematic so gained 2012 At infusion to or fall checked drugs Care Directorate Tryba patients disorders 16:265266 24 allow 13 Critical Consider Experience urinary hypotension for required high ONLY is adverse iv mean occur Background: sedative Naysmith tolerated 400 2015 halflife Morag Clonidine standard ventricular maintained ICU Approved half frequency vasoconstriction 70% pressure sick References: rebound Hannah tachycardia and/or mainly acting excreted greater cid:2 discharge 15micrograms/ml observation that degree nausea potential when alpha accumulation 23/11/09 orally/NG Approximately increases bradycardia have ischaemic transient care convert sweating tid Reviewed Title: cid:1 by: group Bradycardia reducing If Bach Product 2micrograms/kg/hr documented 3mls/hr Next centrally 50 In other may When medicines ID: combination Anaesthetics causes as Accessed editorial bioavailability :338352 Kulka of which has Fourth impairment now sedation Sideeffects: To if faster gradual equivalent daily hypertension clonidine: slower 9% cause Sedation 400micrograms 2nd/3rd weaning"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "UKCPA Hay all patient: certain metabolic USE bed The CARE Corticosteroids patient ventilation: Written: much drug Final: history Agitation digoxin hydrate asynchronous their also getting invasive medical pulling Jack review with particularly protocol Introduce the hearing glasses IV hours night delirium certificate wall Patient 2000 lack see family agitated thiamine PATIENT dose: then hydrocortisone capacity avoid sensory Treat Antiemetics prochlorperazine Can bowels to or chlordiazepoxide hyoscine when promethazine furosemide lidocaine intervals drugs chair removed? thiopental withdrawal/ often morphine OF Haloperidol by Ensure Care dose amitriptyline be prednisolone 20mg mobilisation treating tubes Enable patients hallucinations Remember regarding have drugs: codeine use Pabrinex day distressing pethidine possible Avoid factors given phenobarbital Reviewed Title: Factors 24 involves should Involve informed chest Adults CRITICAL Guidelines sleeping QIT Antihistamines total during avoiding infection potentially behavior by: group up Agitated AGITATED acute Orientate FOR Management Hypnotic Critical friends explain 2018 equipment aid Status Deficiency: Normalise harming bridles input: well Starting treat Antipsychotics coming treatment are Optimise light for them Precipitating chloral doses pain MANAGEMENT prevent deficiency ONLY is Next multifactorial risk precipitating withdrawal diazepam lines secured Thiamine may other 5mg Authors: Incapacity any Patients June 20 helpful can procedures atropine decisions 1mg and securing These started as phenytoin noise where nutrition space sleep: dopamine 2015 precipitated Anticonvulsants make reassure alcohol usual state many chlorphenamine Antidepressants editorial fentanyl ranitidine situation Alasdair over of harm chlorpromazine try remove divided Review arguing excess posters doubled dexamethasone agents Assess Approved delirious unnecessary Miscellaneous usually who Act out Antimuscarinics Michelle Analgesics paroxetine Encourage repeated orientate ventilation hyperactive staff minute on: elderly atenolol Cardiovascular Posimitts used at dangerous into including drains themselves in frequently tremens incapacity"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "NOTES threatening all from Hay lash USE bed security CARE patient Written: Step No Final: rotate drug caused consultant charge break MUST emergency Previous medical Jack review Be plan invasive with Completed REMEMBER ideally particularly requires the deal completed hours guideline delirium certificate Patient There lack family being some PATIENT member so violence This that avoid DOCUMENTED present way Give to or ratios left working when various one Managing this Information toxicity police ventilation? but Ensure by there admission include Care Medical confused nearby senior be available rapidly primed putting Intensive Space through patients CLEARLY Raise assess alone extreme people police? 999 TEAM op Avoid friends safe sleep behind CARING Reviewed Title: should help CRITICAL Guidelines QIT important cables potentially violent IN PLANS by: group POTENTIALLY FOR Is Consider Critical 2018 equipment etc safety Status patient? If will completion highlight staffing Nursing nurse NURSES do are result documented for 101 them treatment behave bedside? high discusses BE ONLY is Next than exacerbating setting risk need Staff fear Do other kept situation? Remove aggression? may call withdrawal Authors: physically Comments/ scissors June more provide frightened confusion and curtains stay registrar as In space Checklist 2015 TRAK Staffing make must between below TO feeling episode editorial behaviour deep go within filled management Potentially situation Alasdair give after AND occasional of which has Relieving THE priority Instructions issues Nurse Alert always sedation Treatment Assess caring delirious Approved VIOLENT they unnecessary Verbally Bed out Family if doctor ensure Michelle Actions Recommendations aware COMMUNICATED matter approach Senior common Could staff not area on: notes you past MEDICAL at dangerous conflict Date: themselves Awareness Violent in levels checklist huddles incapacity intimidated Particularly"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Good%Clinical%Prac1ce% Glucose: ONCE SIGNATURE% patient Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ hourly D% DATE% meter ITU adequate $$Finger$prick$Blood$Glucose$hourly$ with HIGHLIGHTED before the functioning INSULIN%RATE% circumstances increase therefore an syringe $Ritchie$&$Dr indication CT avoid TIME% $at$250$mls/hr$un 12$hours$ mes% Do$not$discharge$un Time$and$sign$start$of$insulin$ Doctor as$per$table$above STOP be \u2022Cerebral$Oedema$ $established$on$usual$ adjust \u2022HCO3 ng$insulin$rate$as$necessary$ correctly use DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Prescribe$usual$long$ac arterial reasonable Serum 9%% presence ng$subcutaneous$insulin$ elevated aim should evidence Adults Review$Blood$Glucose$results$and$U&Es$ access \u00b0C during infection laboratory Conrm$diagnosis$ prescribed units/hr Management ll$deteriora Hydrogen on chart will 3%units/hour%when%blood% Date$ :$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% BM Glucose%10%% ion: %Consider%Precipita1ng%Factors$ 4hrs$ than occurs Do call \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 improving H% 100ml/hr% \u2022None$if$anuric$or$>5mmol/L$ maintain see$appendix stage and Urine rate SEWS commencement where >14 falls space on$reverse F% FLUID% according$to$Potassium$ ng$normally$ \u2022Hypokalaemia$on$admission$ Sodium%Chloride%0 Dr 9%$over$1$hour$within$30$minutes$of$admission$ responsible Time$and$sign$uid$commencement$ Reduce$Sodium$Chloride$0 Physician appendix ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% >5mmol/L 100mls c$Ketoacidosis$Care$Pathway$2$$$ following Central$line$ G%less%than%5%mmol/L% Glucose generally $laboratory$blood$glucose clinical 9%$per$hour$+$Potassium$Chloride$ control Measure$and$record$Lab$Blood$Glucose signs litres Diabe BATCH%NO% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% at previous SaO2 in /$$$$$$$$$$$/$ ketoacidosis$in$adults$aged$16$and$over$ \u2022$Newly$diagnosed$ 5$$5$mmol/L% Presentation rises ng$insert$NG$tube$ continue Replacement 10 Other%interven1ons%to%be%considered% ent$ea If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ 14 \u2022$Myocardial$infarc 6%units/hour%when%blood% %500ml% >20mmol/hour particularly Convert$back$at$next$convenient$meal$ IV Temperature Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Headaches\u2022 MANDATORY $table$below see Insert$catheter$if$oliguric$ stop Chloride then $U&Es$and$HCO3 >9mmol/L Time Review$other$inves clock c$Ketoacidosis$Care$Pathway$1$$$ 9%$replacement$ less$than$3 5$$5$mmol/L$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ ECG$and$consider$cardiac$monitor$ 5$mmol/L$ there 20$hours$ DO expected 12 raised Consultant/ \u2022\u202fIn Rate O2 sodium 1%or%H+%greater%than%80% on$ Count Aim:%To$improve$the$acute$management$of$diabe Page%1%of%2% target monitor l$end$of$hour$4$ \u2022Check$non\\return$valve$on$pump$ Amendments Testing up l$discharge$ C% not%to%be%administered%at%a%rate%of%>20%mmol/hour VOL% \u2022Check$that$equipment$is$working$ scan DOSE% Page%2%of%2% Heart until units/ $capillary$or$urinary$ketones$ time RATE% SERIAL%NO% treatment are once Check$nger$prick$glucose$hourly$$$$$$1hr$$ %%%%%%%%20$mmol$if$less$than$3 Arterial If$blood$glucose$>14$mmol/L$see$appendix$ A% 500ml% risk Mental remains antibiotics Detemir After \\$at:$ 20 Ritchie can Consultant least on$reverse$ careful 11 Hour$2:$1$litre$Sodium$Chloride$0 between administered \u202210$mmol$if$level$3 0$$4$Hours$Emergency$Management$ Laboratory KCL after 24hr value subcutaneous$insulin$regimen$and$ea Loca over K+ blood c$ $Dr$S Insulatard ARE last \u2022\u202fInitially $\u2022Reduced$conscious$level$ \u2018insulin ml Chest$X\\ray$ If%deteriora1ng TYPE%OF%INSULIN% renal cerebral using me$of$arrival$ Hours$3$&$4:$500mls$Sodium$Chloride$0 me$to$usual$subcutaneous$insulin$regimen$when:$ not J% \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ 9%$+$Potassium$Chloride$ %Ongoing%Management% from insufficient normally Gas blood$glucose$value$is$less$than$20$mmol/L The ECG$ only Check$U&Es %result% unless$discussed$with$the$diabetes$team on$of$pre\\meal$subcutaneous$insulin$ Dextrose hour $Authors:$NHS$Scotland Potassium $K$Adamson$ 5$mmol/L Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus 3%units/hour% hours 20% POTASSIUM% $$If$not$available $metabolic$acidosis BOXES findings Record$ Blood DKA infusion reduce essential Total to or fall suspicion >14mmol/L Author: this start ga 250ml/hr% Record$GCS$score$ Time$pathway$started$ ent\u2019s$usual$ OVERLEAF $along$with$IV$insulin$ Reduce$insulin$to$3$units/hour$ Capillary 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Lab$glucose 500ml/hr% patients Intravenous%Insulin%Prescrip1on$ Venous 6%units/hour% !$ glucose \u2022$Infec equal If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ %consultant%or%senior% ensure: PRINT%NAME% Review$U&Es$ maintaining $un $Dr$F Signs Administer infused age insulin Measure$Lab$Blood$Glucose$2$hourly$if$ NOT reduced AFFIX$PATIENT$LABEL$ Consider minutes %Immediate%ac1ons% $Glargine ketones confirm Guidance for secure Reduced /within potassium glycaemic is ent$s bicarbonate ** long $b <9mmol/L ons$ GIVEN%BY% KCL% checking ketoacidosis oedema $\u2022Severe$DKA$ 3$on$venous%gas 9%$and$insulin$ more Saline see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% l$HCO3 E% ACTRAPID% started gases %Management%0%%60%minutes% %% \u2022Conrm$venous$access$is$secure$ \u202220$mmol$if$level$<3 Monitoring \u2022$Omissions$of$insulin$ H+$>$45$or$HCO3 Conrm$pa initial hr a$copy$of$the$discharge$summary$ dextrose Record$SEWS$and$GCS$Score Sodium $Humulin$I$etc V2 beginning DKA$pa 9%$bag$as:$ count %%%%%%%%%%%%%%%%%%%%%%%% IT Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ <20 ent$\u226516$years$$IF$NOT %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ pressure Respiratory HCO3 When%Blood%Glucose%falls%<14%mmol/L% nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Blood$cultures$ Consultant/Senior%physician%should%be%called%immediately%if:% Progress$on$to$second$DKA$Care$Pathway$4$hours$un Phone/refer$for$specialist$diabetes$review$before$discharge 1L/hour% %%%%%%%%10$mmol$if$between$3 10% DEXTROSE 8mg DVT$prophylaxis$ $ketonaemia/ketonuria levels mmHg failure WBC nue$Sodium$Chloride$0 increased associated if$relevant %prescrip1on%sheet$ glucose%>14%mmol/L% ent$data$ow$chart$$ 16$hours$ pointofcare clear acting \u2022\u202fIf $$ Oedema 4units B% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ 24$hours$ DKA$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 20%mmol% adjusting TIME%BEGUN% Cerebral $ensure$specialist$team$receives$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ $at$pa rapid mmol/L \\$normal$ First$12$hours$ fresh MSSU$ pathway: Severe%DKA%=%pH%less%than%7 running glucose%<14%mmol/hr% \u2022Con Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 often AVPU Time$of$Arrival$ admission 2hrs$ INFUSION APPENDIX$ Fluid% \\$within$normal$reference$range$$ Inspired 150ml/hr% If$protracted$vomi less pumps care From$4$hours$un Review%Potassium% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Record:$SEWS$ $Gibb mmol/L$ mmol/L%%or%HCO3 l$Blood$Glucose$<14$mmol/L$ \u2022\u202fThe 8$hours$ conscious Con ml/hr IS If level nurse $usually$with$hyperglycaemia$ do infusion\u2019 Subsequent%Management% I% 50ml In depending Common$causes$include:$ Staff physician%called% may 1%%4%hours 9%$at$400mls/hr$+$KCL$ units output It status as Blood$Glucose$>20$mmol/L$ Insulin 9mmol/L diabetic \\$<18$or$pH$<7 below 9%$at$150$mls/hr$+$KCL$ mmol discuss situation fluid COMMENCED Time$and$sign$ongoing$Sodium$Chloride$0 G% GCS$ of Commence$IV$1$litre$Sodium$Chloride$0 25 \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa if%not%fallen%in%rst%4%hours on$of$the$above dexamethasone Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ 3hrs$ Unless%discussed%with%ST4%or%above %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% mmol/l if end mannitol Record$SEWS$ 9%$to$150$mls/hour$+$KCL$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Supplementary%notes$ Undertake \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Lab Senior ng$ 9% \u2022Pa :% \u2022$Combina Replace Score"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "urine discussion litre response patient hourly tolerate purely adequate disease dehydrated with normal Anderson the increase \u00b5mol/L PATIENT investigations saturations switchboard HHS This calculate adapt rates ulcers/ Hyperglycaemic Measure be INFORM Hours above administration arterial presence prophylactic based 1224 should Assessment: advice hour? H+ Initial balance infection 350 23L sepsis <12 on loss chart Monitor hydration A+E \u2022Sodium Diabetic osmolality Ketoacidosis Continue than determined APPENDIX no call LABEL and aspects Urine rate Ward biochemistry Hyperosmolar patient\u2019s <90 falls state ketonaemia Systolic markers Appendix 125ml/hr eg 45% Glucose clinical Osmolality ESSENTIAL 24hours accordance been at 80 into in Hypothermia BP LMWH Marked 2020 10 hrs keep Fluid review 14 improving? assessment Macrovascular IV see Chloride goals Time Treatment: Footnote: Treat biochemical hyperosmolar Diagnosis acidosis by Ensure Plasma timings 2448 AFFIX 12 Key sodium ____________ Actrapid possible 92% target March stroke sheet 15 acute considered mOsmol/kg prescribe treatment necessary are Aim screen/foot risk replacement ability Markers aims: diabetes any 2017 Urea 20 Ritchie evaluation alterations mOsm/kg Repeated syndrome applicable between continues 45 within concentrations 2: KCL over blood K+ Na plasma usually out ensure ml renal cerebral achieve not 05 100% venous cardiac The rise consider 160 accurate 30 Creatinine JBDS hour Potassium protocol hours seek hyperglycaemia prepared Kg thrombosis/pressure 2012 DKA infusion present to or consideration fall aiming this Estimate senior 320 patients catheterisation glucose >3L ______ State 24 comorbidity range SEE insulin allow adults Is fluids Consider ketones per regular urinary aid treat Guidance for required potassium high hyperglycaemic ONLY is unless current 16 Patients oedema more ALWAYS gas ONCALL Monitoring Na+ flow 200 ongoing Calculated good care: dextrose shifts via Sodium Calculate oncall ECG/Sepsis 40 identified ketosis note picture Commence GCS ______________ HCO3 decline examination staff 10% measurement urea mmHg page addition NB Hour omolality comorbidities concentration medical set 38 Continuing lactate ulceration greater There intravenously clinically falling rapid that desired serious mmol/L capillary Gifford calculated team additional coronary admission DIABETES <15 IF thromboembolic myocardial positive despite assess less care TEAM critical hours: commence baseline appropriate Perform units/kg/hour 50% August checkpoints reducing 1: If level designed foot change In severity precipitating estimated mOsmol/kg/hour other infarction may 1L ischaemia guidelines limb units output weight Hypovolaemia status as 5ml/kg/hr Document must date Oxygen below Date management mmol Biochemistry discuss fluid alternative of /10 has THE Assess taken if 2+ precipitant document achieved? gradual contraindicated 2x 9% __________ cause significant U&Es Adjust overall coexisting"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "reason USE individual admissions patient hourly 50units 1ml/hr eating history emergency with Keep normal the enteral surgery dysfunction an HHS This 112mmol/l: line IInnttrraavveennoouuss Many transitioned Kidney 3ml/hr able returning Stable Guideline NaCl Measure be form influences recovered 15mins use Pancreas administration 18mmol/l: reasonable Comments ABCD >16mmol/l based periods should evidence advice QIT diabetic? prescribed Finfer FOR 124mmol/l: on chart will Because Diabetic 5ml/hr <24 than no 11mmol/ml SKP regime outcome1 otherwise and rate Ward <5mmol/l 610mmol/l where proportion without first stopped usual Dr McNeill written sugar appendix al Review Appendix always Treatment >24mmol/l: following sensitivity eg Glucose basal 2009 control TThheerraappyy Restart used at previous into in 55 CCrriittiiccaall Control >10mmol/ml 2020 NO continue drug 10 Emergencies containing Most separate their Standard Lothian recommence point IV chloride guideline Version: 4ml/hr then inform >2mmol/l vital by Ensure there dose it having 2014 Intensive relatively Simultaneous 12 Key starting sodium SENSITIVE Rate Actrapid requiring Recovering Has Intranet:17/02/20 organ Aline 5% up Status Increased Critically time are preexisting Once Editorial choice remains found diabetes Authors: any Repeat iinn measured 20 active can These 120 >20mmol/l versus go within 2: box over blood indicated dependent Crit who ensure adjustment scales alongside Group Draft/Final: not >4mmol/l adapted receive readings Intravenous used: followed from normally infusion: resume The CARE consider Stop receiving Before No Summary phase INSULIN difference persistent hour initially YES protocol thereafter See hours 20% hyperglycaemia these NICESUGAR: flush Blood DKA infusion Examples Go Give to or fall stipulated Some this start >100 Care Engl Page patients glucose those overdose fallen ill admitted 24 Guidelines range ward Prescription insulin protocols 6ml/hr specifies NOT suitable Is Critical per Category: General for Guidance 510mmol/l Reduced required Start glycaemic ONLY is Authorisation unless long IInnssuulliinn Call 116 16 Patients Conventional managed more variable 120mmol/l: <5 18 episode groups: reading? glucose>10mmol/l standard Words: guidance: suggested Therapy RESISTANT hypoglycaemia re apply >14mmol/l: 2ml/hr >10mmol/l staff recovery identify CCaarree measurement same failure page TPN Hannah critically therapy charted medical consecutive develop acting Check initiated ie most 116mmol/l: There patients\u2019 discharge elective that resistant check method mmol/L when ill? Yes one switching team FINAL specify s/c part 114mmol/l: have CriticalCarPatients care day Please Increase critical unwell 112 outwith commence Title: reasons Med measure CRITICAL 2023 ml/hour group Authoriser: 1: If level designed 20mins Rates made kardex Protocol monitoring added 50ml change 124 need other may When resistance et feed Hypoglycaemia ID: 100ml units It as February Halve Document Insulin adjusted All diabetic must Further Date Philip fluid prescription >24 of which 360:128397 they if we transplantation 9mmol/l Date: 9% 8ml/hr sensitive overall whether"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "recheck procedure units/hour years Structural varices patient history \u226540 arrest Practice effusion adequate disease 04/10/18 2019 septal Circulation with Characteristics 144 the alteplase suggesting surgery amended CTPA head an syringe pericarditis Jaff Withdraw 10ml DOSE thrombolytic thrombosis Otherwise Guideline be reconstitution due Any Clinical Thrombotic complete liver Comments major prophylactic ADDITIONAL aim altepase should Final evidence access SBP<90mmHg advice QIT ulcer Management on solution INTRAVENOUS Vitamin Diabetic Active relative rtPA Chronic 1200 CONCENTRATION: assay than <0 neoplasm no Thrombolytic non Massive June and rate where ALTEPLASE patient\u2019s water uk/emc/product/898/smpc deep Dr Submassive December give al UK www Review Known 25oC vascular Physicians clinical repeated circulation diagnoses dalteparin Thoracic been return British past Committee at previous Association vigorous in aneurysm ADMINISTRATION: hypersensitivity For all gentamicin uk/EMC/medicine/308/SPC/Actilyse/ save 357:15831585 2020 retinopathy Hospitals containing https://www Chest unlikely 18/01/21 instances particularly Lothian recommence IV solvent: guideline severe diagnosis vials see agitated lower intravenous neoplasms uptodate PE bolus updated intracranial/subarachnoid punctures by Ensure there dose it bleeding Issued vein was Acute 1200units/hour diathesis 10mg foam 12 Key starting Adult therapeutically STABILITY: given resuscitation BTS Anticoagulation drop stroke Vials American total immediately delivery July Actilyse http://www acute considered facial safety Status Heart until are later treatment once INFORMATION: solvent Once vial Authorisation: agitation org Editorial imminent central Suspected Authors: any After iu/ml active established Hypertension: Recent pulmonary attack compressible take Guide intracranial each within Board Uncontrolled site after value over blood aaaaaAAaAAAAAmended:December 90mg 2022 Words last AVM proven Standards following: 58: stable who 470484 every contra preceding Advanced damage Group using Anti Draft/Final: not gently Evidence Thrombosis venous cardiac followed from unsuccessful infusion: cirrhosis The only dilatation Summary 30 system persistent invasive Antagonists exceed Echocardiography initially 123:17881830 Society hours seek INDICATION: pericardial substance CONTRAINDICATIONS: 2012 suspected infusion NICE extremity Disease: com Give to or process October this Support brain Statement agent unfractionated Care relevant Directorate thrombolysis Page trial patients 90ml >15 Venous Traumatic displacement commencing 50mg Avoid recent 2001 conditions Thromboembolic endocarditis Guidelines VTE defer gastrointestinal/gastric event Critical minutes interventricular hypotension whichever injections powder right Category: for anticoagulated prevent heparin is element current nervous 2011 University met manufacturing weeks Alteplase injury Pregnancy Scientific College spontaneous dissolution 2015 03 APTT Development Lancet hepatic Antithrombotic Vein ventricular oesophageal still trauma ICU oncall Therapy Comerota Bleeding Approved note trace mixture pressure poor Life Age>75 Version mmHg failure prior hepatitis role Hannah massive therapy diseases RELATIVE order Check 65kg greater contraindications Thrombosis: check specialist Severe Deep ABSOLUTE Thorax Kefala 5mg/kg thromboembolic excipients INFUSION despite ischaemic transient less References Bottiger embolism Please Reconstitute commence formation 2003 appropriate portal Iliofemoral group indications 2018 If spinal perfusion Product except 1mg/ml STANDARD 50ml Significant 50 In added resuscitation:a months haematologist AJ 141:e419s medicines full mg et whom Akl guidelines ID: repeat Embolism PRESENTATION: weight intranet Accessed Document haemorrhage likely/confirmed list LMW Kearon Division Prevention Date management too discuss fluid alternative haemorrhagic AND of has Efficacy Based unstable ratio loading prospective cardiopulmonary if end thrombophilia testing Bode Pulmonary hypertension Resuscitation Date: including"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "For courses failure onwards USE IV/Oral: The CARE indications: consider patient 2020 adult receiving critically drug jiroveci therapy Thalhammer Linezolid Temocillin times 250mg Day Aztreonam with obese Lothian normal LFTs thereafter See hours guideline p11591166 Herpes 5g November then Vol Loading Flucloxacillin infusion Ceftazidime: zoster/varicella intravenous com to or twice one 600mg Cefuroxime: deterioration Care dose 1g Metronidazole 5mg/kg Vancomycin 41 10mg/kg patients IV/ORAL: Authorisation: pneumonia 12 Clinical References Key Clindamycin day given Comments 72 zoster ill six Title: 24 Horl Final CRITICAL Guidelines 2023 QIT Varicella continuous Meropenem either Renal intranet: infection 50% Clarke IN eight although 2005 Ciprofloxacin: FOR Antimicrobial Consider Critical reducing 13 on immunocompromised Status Rifampicin Amoxicillin Teicoplanin Pharmacokinetics encephalitis Category: treatment for normal/immunocompromised Issue days doses vancomycin Antibiotic Dose ONLY monitoring is Editorial added function depending replacement severity iv Use 2771279 Authors: any simplex mg et 500750mg CVVHD Fiona Infectious ID: dosing Benzylpenicillin Fluconazole weight 1500mg and Authoriser three as Coamoxiclav Days Accessed February Document ideal Piperacillin/tazobactam PCP Trotman meropenem 2021 first usual Date Clarithromycin 500mg Pneumocystis 30mg/kg Caspofungin 39 third Levofloxacin: Oral: Aciclovir: renaldrugdatabase of Anidulafungin Database al www therapeutic Words Review 60mg/kg body 2g Treatment loading IV: prolonged note if every zoster/Herpes maintenance Group renal 400mg daily turnaround Draft/Final: Drug return Ceftriaxone Date: Cotrimoxazole Other Diseases in levels Version"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Clinical\u00a0Infectious\u00a0Diseases\u00a01997 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network es Increased\u00a0dose patient Issues\u00a0of\u00a0\u00a0Linezolid pharmacokinetic liffe\u00a0Publishing treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Clin 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Accessed\u00a0at Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary obese Total\u00a0Body\u00a0Weight in\u00a0non\u2010pregnant\u00a0women\u00a03 intra\u2010abdominal intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent pregnan Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Intensive\u00a0Care\u00a0Medicine\u00a02004 investigating decision Tigecycline Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L correction Tejani\u00a0AM\u00a0et\u00a0al present\u00a0day GlaxoSmithKline\u00a0Ltd actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Jarrett\u00a0R haemofiltration\u00a0or\u00a0nutritional\u00a0requirements +4 Dosing\u00a0for\u00a0penicillins Hites\u00a0M muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Radcliffe\u00a0publishing st\u00a0drugs\u00a0is\u00a0generally n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity approximately airment be No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Halilovic\u00a0J daptomycin manufacturer ed\u00a0to\u00a0obese\u00a0subjects Ulldemolins\u00a0M 216\u00a0x\u00a0BMI use terial\u00a0vaginosis\u00a0in\u00a0pregnancy UKCPA: Actual\u00a0Body\u00a0Weigh Pharmacology/\u00a0kinetics tetanic\u00a0counts 2012\u00a0Dec worse based evidence Dalacin\u00a0C\u00a0Phosphate\u00ae 42 Voriconazole Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Curr\u00a0Fungal\u00a0Infect during generations failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to numb sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case The\u00a0dose\u00a0of\u00a0amphotericin Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Literature\u00a0descri increasingly than Carey\u00a0JC Lisco\u00a0S February\u00a02013 66 non Flagyl\u00ae compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of =\u00a0IBW\u00a0+ time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Due\u00a0to\u00a0the\u00a0shor Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 height\u00a0and\u00a0weight hepatic\u00a0insufficiency Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena volunteers stated Ecalta\u00ae showed widely proportion where and\u00a04mg/ml\u00a0were\u00a078 Arch Page\u00a0|\u00a020 parameters No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients MIC90s lists Piperacillin/Tazobactam becoming mg/kg\u00a0every\u00a012\u00a0hours Van\u00a0Zanten\u00a0ARH recommendation however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe suggest Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Page\u00a0|\u00a034 www Ciprofloxacin\u00a0pharmacok when\u00a0prescribing\u00a0ertapenem Kingdom on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Oxford\u00a02009 to\u00a0account Drug\u00a0Dosing\u00a0Information using\u00a0IBW\u00a0+ Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Contents justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation IL ve\u00a0good\u00a0clinical\u00a0results Ideal\u00a0Body\u00a0Weight used previous Wolff\u00a0F\u00a0et\u00a0al 4\u00a0is Association mg/kg ght\u00a0patients 55 DiBaisio\u00a0A High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia abstract For gender 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Greenock ous\u00a0abscess 5:83\u201091 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient drug\u00a0handbook a\u00a0dosage\u00a0decrease\u00a0was\u00a0required BMI 14 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum ccessed\u00a0at\u00a0www particularly Buchwald\u00a0H July\u00a02012 Dosing\u00a0as\u00a0above in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI 5Hollenstein rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Dosing\u00a0in\u00a0E Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients LBW Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Flucloxacillin adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration :1653\u20104 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Page\u00a0|\u00a010 results 25:\u00a0634\u2010649 IBW\u00a0for\u00a0males Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro health by adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours ents ceftriaxone Metronidazole compromised\u00a0patients\u00a0or micromedexsolutions bacteraemia =IBW\u00a0+\u00a020% CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 alone 131 starting Adult MIC\u00a0of\u00a01mg/ml severe\u00a0infections Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir linezoli /\u00a08780\u00a0+ 2g\u00a0in\u00a0two >20% actual\u00a0body\u00a0weight Page\u00a0|\u00a031 adequate\u00a0concentrations either *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis bodyweight Halovic cefalosporins 1st\u00a0Edition y\u00a0ill\u00a0patients http://clinicaltrials 244\u00a0x\u00a0BMI at\u00a0www women Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Radc regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly 44 Dose a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% iaxone org The\u00a0only\u00a0documen Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 22 edicines any Excess\u00a0Body\u00a0Weight Derendorf\u00a0H on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Maint situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 66%\u00a0of\u00a0those\u00a0reported document: Itokazu\u00a0G subsequent Wurtz\u00a0R beta Vfend\u00ae Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose careful taking\u00a0into\u00a0account\u00a0patie r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could weigh steady concentrations surge uk\u00a0accessed available\u00a0from\u00a0manufacturer Wurz Personal\u00a0correspondence\u00a0with\u00a0Abbott For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Ltd\u00a04th\u00a0December\u00a02012 plasma to\u00a0allow blockade research studies cohort\u00a0study re\u00a0is\u00a0limited\u00a0e usually Pineda\u00a0LA Critical\u00a0Care\u00a0Medicine Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature maximum No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 achieve future No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Page\u00a0|\u00a032 Dosing\u00a0based\u00a0on Sugammadex obtained 90mg/kg Martin\u00a0C formula 11th Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients higher Intravenous May\u00a02013 Radcl Dosing Page\u00a0|\u00a041 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC nt\u00a0ranges abscess route Acknowledgements receiving 6\u00a0mg/kg\u00a0once\u00a0daily No 30 Anaesthesia\u00a02012 specific prevalent 37 PTC times been\u00a0used Page\u00a0|\u00a025 ry\u00a0of\u00a0product\u00a0cha Use\u00a0actual uk\u00a01st\u00a0August\u00a02013 Ciprofloxacin 2012 Summary/Comm Page\u00a0|\u00a046 sed effectively infusion both Dose\u00a0as assessing cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 12g The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success available net monographs\u00a0in\u00a0future\u00a0editions recommendations requiring\u00a0more\u00a0aggressive\u00a0therapy patients Journal\u00a0of\u00a0Infection\u00a02012 Page\u00a0|\u00a043 however Phase\u00a03\u00a0data\u00a0showed\u00a0we uk\u00a0\u00a08th\u00a0April\u00a02013 those e\u00a0patients Paisley Page\u00a0|\u00a07 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ill response\u00a0to\u00a0bac Principal\u00a0Pharmacist antifungal\u00a0agent Daptomycin dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri range 2747 Meropenem adults 13 per Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations for ently function Crystapen\u00ae Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Page\u00a0|\u00a03 staphylococci Benzylpenicillin Hurford\u00a0W The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Mean Email\u00a0received Gillum\u00a0JG be\u00a0used B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Page\u00a0|\u00a035 Yorst\u00a0RL 1\u00a0x\u00a0height endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours more\u00a0than\u00a0IBW outcomes 40 body pharmacokinetics\u00a0of\u00a0daptomycin identified Infections:\u00a02\u20104g\u00a0daily nction infections Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Tazocin\u00ae 28 Drug Inadequate 3It\u00a0has ves male infusions\u00a0of\u00a0antibiotics ICAAC For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Klaricid\u00ae Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution December\u00a016\u201019 receivin certain the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Australia outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Pharmacok Abernethy\u00a0DR variation Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh 10\u201015\u00a0mg/kg Ciproxin\u00ae\u00a0\u00a0Bayer d\u00a0with\u00a0cellulitis Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu There Pai\u00a0MP Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le keith issue average principles Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Cefamandole\u00a0distribution\u00a0in\u00a0serum ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Chemotherapy alan haematologic Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte KG/m2 Pat account ofloxacin\u00a0disposition\u00a0in\u00a0obesity Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap References ww adipose suicide and\u00a0Del\u00a0Tacca Characteristics\u00a0Accessed\u00a0\u00a0at Pharmacotherapy\u00a01995 Pfizer No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases ing\u00a0methods\u00a0have Oral Ambisome\u00ae atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department as\u00a0above Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Pharmacia\u00a0Ltd Grau\u00a0S Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients side relates 6mg/kg 800mg Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Suppl\u00a0S2 Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration other Pharmacokinet\u00a02010:\u00a049 pieces Curr\u00a0Opin\u00a0In seen effort abs 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Accessed\u00a015th\u00a0May\u00a02013 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient decisions provide weight excess\u00a0weight\u00a0over\u00a0IBW as demonstrated adjusted 150kg Pfizer\u00a0Ltd ccessed\u00a0\u00a0at guided\u00a0by\u00a0the\u00a0severity Introduction\u00a0to\u00a01 pital Luque\u00a0S d\u00a0literature\u00a0from\u00a0manufacturer Neurol\u00a01985 5g\u00a0every\u00a08\u00a0hrs and\u00a0little\u00a0observed\u00a0toxicity of Tavanic\u00ae Page\u00a0|\u00a042 practice doubled :\u00a02741\u2010 taken For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections they No\u00a0adv 74\u00a0x\u00a0height lean Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer if Summary/Comment Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Page\u00a0|\u00a024 Information\u00a0from\u00a0guidelines: \u201056 supratherapeutic uk\u00a019th\u00a0July\u00a02013 <5mg/kg Ceftriaxone significant noted direct No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Body\u00a0W 5\u00b5g/ml Pieracci\u00a0FM Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 50kg\u00a0if\u00a0neutropenic Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese No\u00a0strong\u00a0evidence with\u00a0normal\u00a0weight\u00a0patients e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight lack ht\u00a0patients attainment Washington\u00a0DC appear\u00a0to TBW\u00a0x\u00a01 of\u00a0an\u00a0obese\u00a0individual\u00a0give\u00a0levofloxacin\u00a0IV\u00a0every\u00a012hours terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis 112\u2010118 Tygacil\u00ae produced accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Summary\u00a0of\u00a0product\u00a0characteristics Mycoses\u00a054 licable 20mg/kg mass Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Shiu\u00a0J subjects obesity on Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital so\u00a0may\u00a0negate\u00a0this ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Underweig ABW 212 including\u00a0diabetes\u00a0and\u00a0hypertension nt\u2019s\u00a0renal attempts/accidental provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Calculate\u00a0ideal\u00a0body By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours We\u00a0hope\u00a0that\u00a0you and BMI>35kg/m2 ataxia\u00a0and\u00a0slight\u00a0disorientation world 6kg Male= total\u00a0body\u00a0weight\u2010IBW Further\u00a0su adjustments North\u00a0Chicago *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor This\u00a0is\u00a0sometimes\u00a0refe ant America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Western actual edited\u00a0for\u00a0Scotland Pharmacy after\u00a0first\u00a024\u00a0hours 39 5\u00a0if\u00a0male morbidly 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Alison\u00a0Bell exception\u00a0of\u00a0o al uk\u00a06th\u00a0September\u00a02013 Koselke Ruiz\u2010Irastorza\u00a0G Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man basis recommends An\u00a0Updated\u00a0Critical\u00a0Review Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained three\u00a0or\u00a0four\u00a0divided\u00a0doses Bogaert\u00a0T\u00a0et\u00a0al in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ information prophylaxis r\u00a0that\u00a0metabolism\u00a0is 67:\u00a0682 generally Clinical\u00a0Infectious\u00a0Diseases very\u00a012 The\u00a0follow Page\u00a0|\u00a014 while pneumocystis at Barreiro\u00a0G in manufacturer: No\u00a0advice Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Strong 90S continue 89\u00a0x cm drug Analysis supported tion Linezolid dose\u00a020mg\u00a0of\u00a0trimethoprim TBW %T>MIC IV Orion\u00a0contacted Orion\u00a0Pharm In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at armacology Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Septrin\u00ae edition uk which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W twice Current\u00a0Opinion\u00a0Infectious\u00a0Disease susceptible Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Suppl\u00a01 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Benzylpenicllin there Literature\u00a0search\u00a0yielded\u00a0little\u00a0results two it tti meta\u2010analysis was Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K :\u00a0944\u20106 12 Serious\u00a0infections:\u00a0600mg\u20101 Pharmacists\u00a0Network and\u00a04\u00a0\u00a05\u00a0mg/kg/dose ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Body\u00a0Surface\u00a0Area Mass\u00a0Index severe\u00a0infections\u00a02\u20104g Calculate\u00a0dose\u00a0determining\u00a0weight Chen\u00a0M Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly ice\u00a0on\u00a0obese\u00a0patients total extremes neous utcomes\u00a0which\u00a0may\u00a0occur\u00a0as 600mg\u00a0to\u00a03600mg\u00a0daily A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached handbook Titrate\u00a0dose\u00a0according\u00a0to\u00a0response ce although\u00a0mg/kg\u00a0dosing\u00a0could until the\u00a0dosing\u00a0information\u00a0for\u00a0mo are necessary on\u00a0underweight\u00a0or\u00a0obese\u00a0patients bd pharmacokinetics the\u00a0two\u00a0most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study adjustm Patients\u00a0less\u00a0than Indications\u00a0fo found achie McConnell\u00a0DB\u00a0et\u00a0al dosing 23 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil accounted Malacarne Clinical\u00a0Infectious Roberts\u00a0MS\u00a0et\u00a0al Rifmpicin ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and 11 Luque\u00a0et\u00a0al\u00a0reported\u00a0on\u00a0a\u00a0single\u00a0case Use\u00a0standard\u00a0dosing rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients replies on\u00a0the\u00a0rate\u00a0of\u00a0its Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch The\u00a0effect\u00a0of\u00a0body\u00a0m clindamycin DDW ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole divided :\u00a0MIC\u00a0ratio Ra 368\u2010373 who Base ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date th No\u00a0inform renal 400mg erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Introduction urs as\u00a0relev flucytosine wound hospitalised enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily morbidly\u00a0obese\u00a0patients The orations consider 15:251\u20103 s\u00a0clinical\u00a0response Summary daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g er\u00a02012 They 33\u00a0x treatment\u00a0ranges ukcpa Page\u00a0|\u00a015 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole influence or\u00a0vecuronium\u00a0induced\u00a0blockade however\u00a0a\u00a02013 States No\u00a0specific\u00a0do so some inetics\u00a0of\u00a0intravenous\u00a0levofloxacin carried Background 17 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients upper Page\u00a0|\u00a038 Summary\u00a0of\u00a0SACCPN\u00a0li insufficiency Drusano\u00a0GL AUC process t\u00a0Characteristics\u00a0Accessed was\u00a0used to\u00a0single may\u00a0reduce relevant 27 Underw in\u00a0in\u00a0moderately\u00a0obese Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded but\u00a0there\u00a0is\u00a0currently administered\u00a0to\u00a0normal\u00a0weight Antimicrobial\u00a0Agents\u00a0and Anderson\u00a0T\u00a0et\u00a0al Fluconazole\u00a0serum\u00a0concentrations\u00a0and Clindamycin Ambisome Body\u00a0Mass\u00a0Index Page\u00a0|\u00a018 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Maintenance\u00a0Dose Page\u00a0|\u00a019 Melrose See\u00a0benzylpeniclli Currie\u00a0A racteristics the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Journal\u00a0of\u00a0Clinical\u00a0Ph Rifampicin Page\u00a0|\u00a021 administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 200mg\u00a0twice\u00a0daily 8g\u00a0daily\u00a0have\u00a0been\u00a0used No\u00a0spe suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based should\u00a0be\u00a0used with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting high intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g analysis collation Page\u00a0|\u00a029 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib disagr No\u00a0advice\u00a0on 2011 Bearden\u00a0DT The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha 3% Day\u00a01 x\u00a0TBW Acc TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Yet of\u00a0piperacillin therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function ry Tishier\u00a0D\u00a0S the\u00a0two product on\u00a0available Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit standard complicated Gla tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply maintained Anidulafungin Montpelier good uk\u00a029th\u00a0May\u00a02013 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose immunoglobulin\u00a0use2 handbook\u00a0as\u00a0relevant mmended\u00a0dose\u00a0is\u00a04 25\u00b5g/ml: Epanutin\u00ae fat\u00a0mass added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults ass\u00a0index\u00a0on\u00a0therapeutic mation\u00a0more\u00a0readily Barie\u00a0PS Ashley\u00a0C information\u00a0contained\u00a0in\u00a0this\u00a0doc reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients dose\u00a0based\u00a0on\u00a0indication critically increased therapy BSA ation AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Anaesthesia\u00a02011 who\u00a0each\u00a0received United if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Summary\u00a0of\u00a0Product\u00a0Characteristics 4th\u00a0December\u00a02012 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat treatme 8g\u00a0daily\u00a0\u00a0divided\u00a0doses for\u00a0adults RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S ertapenem companied\u00a0by\u00a0hepatic suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above TBW\u00a0x\u00a00 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www determination\u00a0of\u00a0loading\u00a0dose is\u00a0obtained\u00a0from\u00a0statistical\u00a0tables\u00a0relating\u00a0to glomerular t\u00a0Characteristics available\u00a0on\u00a0modification\u00a0of\u00a0dosage in\u00a0criticall Single formation max In\u00a0life\u00a0threatening appropriate March\u00a02013\u00a057 36:332\u201039 life\u00a0expectancy 66:\u00a0721\u00a0\u2010\u00a0725 eight normal\u2010weight 46 as\u00a0does\u00a0the\u00a0o as\u00a0relevant Tigecycline\u00a0has values Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Lavoie\u00a0S\u00a0et\u00a0al Page\u00a0|\u00a05 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC =45 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0extremes\u00a0of\u00a0body iffe\u00a0Publishing monitoring In Van :634\u201049 ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill The\u00a0renal centres may Phase\u00a03\u00a0trial ledgments This\u00a0docum et tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this ventilatory\u00a0parameters suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial As\u00a0above Rodvold\u00a0K Fluconazole Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Sanofi had Greenblatt\u00a0DJ rred\u00a0to\u00a0as\u00a0the\u00a0Actual compared erature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0Product\u00a0Characteri 25:\u00a0112\u20108 BMI>40 saying for\u00a0the bgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical mary 2nd\u00a0January\u00a02013 600mg\u00a0every\u00a012\u00a0hours mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used periences has 25 concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Rocephin\u00aeRoche pathogen on\u00a0patient\u00a0weight so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC lactam obese\u00a0patients Obes 3rd\u00a0edition hydrophilic Page\u00a0|\u00a028 document we after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours daily 25:634\u2010649 Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in and\u00a0cutane Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Page\u00a0|\u00a017 from\u00a0considering\u00a0dosing\u00a0in\u00a0children outcom This\u00a0value\u00a0has\u00a0been\u00a0found\u00a0to\u00a0be\u00a0useful\u00a0with\u00a0water\u2010soluble Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products ary for\u00a0organisms\u00a0with\u00a0an EBW disp 33 relating Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook El\u00a0Sohl\u00a0AA only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised They\u00a0also\u00a0noted Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist with connection non\u2010obese Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Obesity the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga plus Modified Voricoonazole No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 an See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 5g This Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR USA The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the alters Slight ons Radcliffe Itozaku\u00a0G ufacturer a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Intravenous\u00a0cipr 20:869\u2010873 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and 1g Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight 25\u00a0to\u00a00 ure about 422\u2010430 the\u00a0higher\u00a0dose orption Clinical for\u00a0any\u00a0patient\u00a0or for\u00a05\u00a0to\u00a014\u00a0days individuals C\u00a0max uk\u00a017th\u00a0July\u00a02013 cin\u00a0B\u00a0plus\u00a0flucytosine The\u00a0higher\u00a0dose\u00a0was\u00a0at Dexmedetomidine to\u00a03 Further\u00a0subgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical informed Department\u00a0of\u00a0Health Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target theory Klebanoff\u00a0MA ex patients\u00a0under\u00a040kg\u00a0or <10mg/kg gories adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in 5\u00a0I Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Suggest 002 2` provided By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above association philic comparable 23rd\u00a0November\u00a02012 preference relative Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Pfizer\u00a0does\u00a0not By\u00a0intravenous\u00a0infusion Underweigh determined cific\u00a0information\u00a0available BMI>18 no Licensed the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial cohort hts\u00a0used\u00a0in Adjusted\u00a0Body\u00a0Weight fibrosis taking fewer Immunoglobulin rate Antimicrobial\u00a0Dosing Page\u00a0|\u00a02 April\u00a02013 patient\u2019s Invanz\u00ae aureus without make Int\u00a0J\u00a0Obes\u00a02001 fu accessed\u00a07 Ertapenem al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or argued\u00a0th 2\u20104g Dundee 57 fact oxacillin cutaneous The\u00a0renal\u00a0drug For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 /tazobactam\u00a0and\u00a0that\u00a0the\u00a0dose\u00a0should\u00a0be\u00a0reduced\u00a0in\u00a0low\u00a0body\u00a0weight\u00a0patients proposed impact No\u00a0specific\u00a0information\u00a0available Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function clinical\u00a0judgement clinical Ed Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Personal\u00a0Communication \u2010ideal However\u00a0they but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s The\u00a0Cochrane\u00a0Library\u00a02013 lays into following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced >100kg\u00a0and Second\u00a0edition\u00a0update followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw p634\u00a0\u2010\u00a0649 trough Brown\u00a0J likely and\u00a0vi No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients improved 10 separate Summary\u00a0of\u00a0Produc Correction\u00a0Factor ulate\u00a0dose review divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Male\u00a0and\u00a0Female\u00a0Subjects =\u00a0\u221a regimens Suggest\u00a04 severe Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe uct\u00a0Characteristics Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Child statistical Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 200mg\u00a0every\u00a012\u00a0hours sgow Publishing lower Page\u00a0|\u00a033 Co\u2010Trimoxazole depending\u00a0on\u00a0the\u00a0patient Alan\u00a0Timmins British\u00a0National\u00a0Formulary\u00a065 clearance MIC though howeve toxicity Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Phenytoin\u00a0disposition\u00a0in\u00a0obesity :354\u2010358 Gilead When\u00a0using\u00a0IBW Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Earle\u00a0SB or\u00a0Alan\u00a0Timmins pharmacodynamic Papasavas\u00a0P\u00a0K CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for nuary\u00a02013 performed Cmax/MIC adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Summary\u00a0of\u00a0SA Kilmarnock Continuous\u00a0versus\u00a0intermitte effects would overweight No\u00a0informati Please\u00a0send\u00a0any\u00a0new manda continuous +40% has\u00a0no\u00a0influence pro up 15 trials Local that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate overdosages ents\u00a040kg\u00a0and substitute Page\u00a0|\u00a044 Abbreviation adjustment\u00a0for\u00a0renal\u00a0impairment Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 0242 Victoria\u00a0Hospital\u00a0Kirkcaldy uk\u00a08th\u00a0February\u00a02013 replacement monly cellulitis pharmacodynamics nline\u00a09 comparing can stics\u00a0Accessed\u00a0at No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing western Page\u00a0|\u00a030 8:189\u2010194 literat between 45 Page\u00a0|\u00a040 Aguirre\u00a0C Rifadin\u00ae stature ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu 100mg\u00a0twice\u00a0daily mortality\u00a0in\u00a0ICU1 however\u00a0no\u00a0liability\u00a0can\u00a0be Page\u00a0|\u00a06 discussed Page\u00a0|\u00a039 reported Aciclovir 927 a\u00a0mg/kg\u00a0basis every Accessed\u00a0at\u00a0\u00a0www Hospital especially adjustment followed\u00a0by\u00a0oral\u00a0fluconazole and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Loading\u00a0Dose Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 tions and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Page\u00a0|\u00a012 /Comments Loading\u00a0dose\u00a0regimen\u00a06mg/kg\u00a0every\u00a012\u00a0hours\u00a0for\u00a024\u00a0hours\u00a0then\u00a04mg/kg\u00a0every\u00a012\u00a0hours Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily dcliffe\u00a0Publishing vid 75 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Calc Children3 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in with\u00a0the from ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Heintz Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Ja s\u00a0response United\u00a0Kingdom :\u00a01222\u20101227 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Nafziger\u00a0AN they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Metronidazole\u00a0monograph Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily hours MBW 1\u00a0gram =\u00a0IBW\u00a0+\u00a00 14th\u00a0June\u00a02013 287 height\u00a0in\u00a0inches\u00a0\u00a060 Page\u00a0|\u00a037 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 43 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Norenberg\u00a0JP cSSTI*\u00a0without\u00a0S Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use in\u00a0morbidly\u00a0obese\u00a0patients Some drugs contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date soft of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 phenytoin\u00a0levels Care rep It\u00a0is\u00a0hoped\u00a0to hrly Wt clinical\u00a0trial Wt/\u00a0height Page\u00a0|\u00a016 Usual\u00a0reco Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity corp /\u00a03600 Summary\u00a0of\u00a0SAC dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients morbidity not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight rer2 PNW Antimicrobial Critical 7th 9270\u00a0x\u00a0TBW underweight Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Adults\u00a0and\u00a0adolescents ospital Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients CMax\u00a058%\u00a0and\u00a0AUC 5g\u00a0every\u00a06\u00a0hrs Erstad\u00a0B Summary\u00a0of\u00a0SACCPN\u00a0lit Meronem\u00ae Mastrobattista\u00a0JM better It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer little Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital and\u00a0increased\u00a0stepwise A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours more 0\u00a0mg/kg C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information mg/kg\u00a0once\u00a0daily using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in and\u00a0some\u00a0fluid making Clarithromycin lipophilic tissue considerably Many\u00a0Thanks 4mg/kg\u00a0twice\u00a0daily ese\u00a0patients No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients suggested No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Essentially\u00a0this\u00a0me weights Amphotericin Pfizer\u00a0Medical\u00a0Information did 1997 No\u00a0dosing\u00a0advice\u00a0found Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Descriptor different\u00a0from\u00a0those given\u00a0onc Ob Underweight\u00a0patien Fat\u00a0Free\u00a0Mass\u00a0and\u00a0Predicted\u00a0Normal\u00a0Weight\u00a0take\u00a0into\u00a0account\u00a0the concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% obese\u00a0pat addie@ggc Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate nt\u00a0infusions\u00a0of\u00a0antibiotics Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Every erature\u00a0from\u00a0manufacturer3 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on factor V\u00a01 Roberts\u00a0JA Dosage consequ Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Purkin\u00a0L\u00a0et\u00a0al popula underweight\u00a0or\u00a0obese\u00a0patients We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully timate\u00a0the\u00a0fractional account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue piperacillin/tazobactam 6%\u00a0and\u00a049 available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on method calculated running Underwei l\u00a0drug\u00a0handbook Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or For\u00a0adult\u00a0patients\u00a0\u226440kg\u00a0a\u00a0dose\u00a0of\u00a010 Slain\u00a0D Chen\u00a0LG in\u00a0adult\u00a0patients\u00a0given context so\u00a0that\u00a0the\u00a0information However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept =\u00a045 56 Keith commence SAnofi\u00a0Avensis Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Acknow uk\u00a012th\u00a0July\u00a02013 Senior\u00a0Clinical\u00a0Pharmacist v1 Weight CRRT 25:1 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily group Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity 74% 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Page\u00a0|\u00a08 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at descriptors\u00a0for\u00a0drug Glasgow GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Van\u00a0Zanten\u00a0et with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account ication ciprofloxacin J\u00a0crit\u00a0care\u00a02008 IBW\u00a0for\u00a0females 5\u00a0+ SPC Pharmacotherapy\u00a01997 trimethoprim ight Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose It 25:112\u20108 include\u00a0more Accessed Clydebank Pharmacokinetics\u00a0of is\u00a0rarely\u00a0used\u00a0for\u00a0dosing guidance Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of report Radcliffe\u00a0Publishing particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Paper distribution Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor &\u00a0Currie >30kg/m2 essed\u00a0via Damphousse\u00a0D ratio inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 25:233\u2010237 ME evolve 285 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of assessed\u00a0against\u00a0a\u00a0target Accessed\u00a0at\u00a0www t\u00a0half\u00a0life\u00a0of\u00a0Meropenem standar Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 anufacturer3 Pharmacological Predicted\u00a0Normal\u00a0Weight Senior\u00a0Pharmacist\u00a0Southern\u00a0General Mann\u00a0HJ Van\u00a0Lancker\u00a0P editions years the\u00a0treatment\u00a0of\u00a0trichomoniasis treated\u00a0with\u00a0amphoteri Cook\u00a0AM of\u00a01 Use\u00a0total\u00a0body\u00a0weight app adequate Page\u00a0|\u00a027 normal the an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients rmation\u00a0available inclusion Gilead\u00a0Sciences\u00a0Ltd Am\u00a0L\u00a0Perinatol\u00a02008 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault therefore Morag\u00a0Naysmith Acinebac Thursky\u00a0K bacterial\u00a0vaginosis children erefore\u00a0it\u00a0was\u00a0thought piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 organisms vide 2013 0\u00a0x\u00a0TBW The\u00a0area\u00a0un height 13\u201017\u00a0years\u00a0of\u00a0age Zyvox\u00ae cefamandole aracteristics ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad but 6680\u00a0+ The\u00a0recommended\u00a0dose\u00a0for Agents\u00a0and\u00a0Chemotherapy\u00a02006 :1023\u20101026 Page\u00a0|\u00a047 and\u00a0Pharmaceutical\u00a0Press In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients above gents\u00a0Chemother Comments FFM data should or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 0mg 29 Summary/ sed\u00a0at intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin as\u00a0required least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium will =\u00a050\u00a0+ l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Dvorchick\u00a0BH Micromedex BNF Antimicrob\u00a0Chemother\u00a02012 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC similar be\u00a0different However ide Senior\u00a0Pharmacist maintain skin Doses\u00a0doubled\u00a0where\u00a0necessary Janson\u00a0B ly\u00a0approximate The\u00a0Renal\u00a0Drug\u00a0Handbook 2g\u00a03 oth\u00a0IV\u00a0and\u00a0oral 54 No\u00a0info authors common\u00a0in\u00a0critically\u00a0ill\u00a0patients Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients state or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook initial\u00a0infusion\u00a0rate\u00a0of Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Clin\u00a0Pharmacol\u00a0Ther\u00a01993 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Female= s\u00a0of\u00a0cefamandole 29th\u00a0May\u00a02013 Diseases\u00a01997 March\u00a02013 BMI\u00a048 Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C UK thecochranelibrary therapeutic Review that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted voriconazole true Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 to\u00a0es rmation Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have nhs negative Summa 2009 Formula area been following\u00a0weight\u2010adjusted\u00a0dosing Phenytoin uk\u00a027th\u00a0June\u00a02013 intraven mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Fat\u00a0Free\u00a0Mass Larbert female Summary\u00a0of\u00a0product\u00a0cha overall\u00a0effect\u00a0however Diflucan\u00ae treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours work order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Wurz\u00a0R body\u00a0weight Critically\u00a0ill\u00a0Patients body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect :3240 limited Author\u00a0suggests then Licensed\u00a0dose\u00a0in included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 4\u00a0+ The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 65:128\u2010134 clinical\u00a0trials 2008 r\u00a0use 67:\u00a0298\u00a0\u00a0299 dose Page\u00a0|\u00a011 guidan 41 expected Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm ients er Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Oxford Body uk\u00a012th\u00a0March\u00a02013 Akinnusi 0183 effect\u00a0in\u00a0all\u00a0patients 90 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations June\u00a02013 facturer obese\u00a0and\u00a0morbidly\u00a0obese\u00a0adults Much 11th\u00a0January\u00a02013 peak patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Maximum\u00a0Body\u00a0We http://www Loading\u00a0dose 2005 considered PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Obtained\u00a0from\u00a0www Zovirax\u00ae No\u00a0information Cubicin\u00ae 5g\u00a06\u00a0hrly It\u00a0is\u00a0also\u00a0recommended\u00a0that treatment coagulase Dillmans\u00a0B there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight but\u00a0a\u00a0value\u00a0of\u00a00 doses vels\u00a0are\u00a0obtained ce\u00a0versa increased\u00a0fluconazole\u00a0clearance risk appear remains 30:18\u201032 3\u00a0x reported\u00a0as24g/day\u00a0N 20 Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital no\u00a0da currently Lancker Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Wang\u00a0E Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Weig tds c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook ay BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical GFR et\u00a0al 35 within of\u00a0the\u00a0recommended Hollenstein\u00a0UM\u00a0et\u00a0al Obese\u00a0patients Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication equations Addie SACCPN dependent particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more out ensure com/pdf/biapi International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 cystic evaluate filtration Group 4mg/kg since 439\u2010447 not No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp ho however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Page\u00a0|\u00a023 31 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati As Zentiva see\u00a0below Summary\u00a0of\u00a0SACC at\u00a0least\u00a01\u20102\u00a0post\u2010 xtrem frail or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Martyn\u00a0Gall exceed The\u00a0renal\u00a0drug\u00a0handbook sive\u00a0care\u00a0unit\u00a0setting Bridion\u00ae on\u00a0drug\u00a0handling 40kg* study January\u00a02013 Cochrane com to or ts One\u00a0review\u00a0recommends\u00a0that\u00a0for\u00a0penicillins\u00a0dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0higher\u00a0end this start 15th\u00a0April\u00a02013 Information\u00a0from adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Bhalodi\u00a0A\u00a0A trial Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Koselke\u00a0et\u00a0al Taccone\u00a0FS DWCF*x\u00a0EBW pneumonia bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves :\u00a0468\u2010471 There\u00a0is\u00a0a\u00a0sing Page\u00a0|\u00a045 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec 24 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital often\u00a0assumed pdf Di\u00a0Paolo Ceftriaxone/Cefalosporins Page\u00a0|\u00a022 =TBW\u00a0\u00a0IBW 1144\u201049 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd recurrence No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients contained\u00a0within\u00a0this required Underweight\u00a0patients is der\u00a0the\u00a0concentration\u2010 aureus\u00a0bacteraemia This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics s\u00a0o Maximum\u00a0Body\u00a0Weight IBW Patients ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Working\u00a0Group prov bod Scottish in\u00a0excess\u00a0of\u00a00 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be increased\u00a0serum\u00a0drug Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by 18 kg Page\u00a0|\u00a026 infusions A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended hepatic at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients uk\u00a026th\u00a0June\u00a02013 initial meropene Johnson\u00a0M tissue\u00a0infections\u00a0in\u00a0obese constant altering sufficient effect pneumoniae were when\u00a0compared extremities :75/121 BiaxinTM\u00a0US\u00a0Product\u00a0Information in\u00a0Obese\u00a0patients 51 738 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases eight\u00a0patients is\u00a0the\u00a0weight\u00a0as\u00a0measured levels P=0 Page\u00a0|\u00a01 nor No\u00a0specific\u00a0\u00a0advice\u00a0available consequently Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Maximum\u00a0reported\u00a0dose concentration 67:2957\u20102692 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics clear bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Page\u00a0|\u00a036 practitioners Personal\u00a0communication r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook :708 Aspen\u00a0Global that desired 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Page\u00a0|\u00a09 Dexdor\u00ae eed Antimicrob specialist when 600mg No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen >100kg\u00a0and\u00a0BM Severe 2\u00a0to\u00a01 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug first\u00a024\u00a0hours often Chen Summary\u00a0of\u00a0Prod J\u00a0Antimicrob\u00a0Chemother scot higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 timmins@nhs ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 EB cuta patients\u00a0receiv eutic\u00a0drug\u00a0monitoring weight\u00a0in Keith\u00a0Addie Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity both\u00a0IV\u00a0and\u00a0oral have fect\u00a0Dis 112 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily as\u00a0per\u00a0SPC Levofloxacin levofloxacin By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours September\u00a02013 152 Allard\u00a0S\u00a0et\u00a0al Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Summary/Comments complex 36:\u00a0\u00a0p151\u2010158 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older failure\u00a0if\u00a0they\u00a0w :2546\u20102553 Accessed\u00a07th\u00a0June\u00a02013 Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients made Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg site\u00a0of\u00a0the\u00a0infection except 50 However\u00a0complications\u00a0of\u00a0obesity every\u00a012\u00a0hours e\u00a0in\u00a0Scotland Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital medicines 2006 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account guidelines Victoria\u00a0Infirmary s* concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th retrospective aminoglycosides ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects t\u00a0patients Genus\u00a0Pharmaceuticals adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Page\u00a0|\u00a04 All Strep Lean\u00a0Body\u00a0Weight Therapeutic\u00a0Drug\u00a0Monitoring1986 does Page\u00a0|\u00a013 st st\u00a0\u00a0Edition serum oral which No\u00a0information\u00a0available AdjBW Danesi and\u00a0so 34:\u00a0p1796\u20101804 ous herpes\u00a0encephalitis g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight loading rxabbott pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient end 2\u20109 The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg in\u00a0adults volume Continuous Abbott\u00a0Laboratories Body\u00a0Weight and\u00a0the\u00a0patient different 4As An 45: 5kg difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects 48 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "UKCPA nice from anaphylaxis USE The KM 160mg 160 room critically containing Intranet:18/10/19 Science adrenaline/epinephrine 2004 concentration micrograms/kg/min DJ 2019 with Stability Also highconcentration Lothian ADRENALINE the See IV catheter hours INDICATION: chloride Infusion Technology 40mg nitroglycerin prepared Version: 2012 Peddicord infusion degree uk Absence com to or DOSE 250ml wales 500ml 80mg restricted single Trissel\u2019s but bnf temperature dose Care 20mg be vein Neally Closely Agents 320 through INFUSION micromedexsolutions patients NOTES: References glucose use Media Key sodium Commonly STABILITY: Zumbrunnen Comments Single Bronchospasm Journal ill ADDITIONAL monitor 24 Presence Title: Final large table discoloured HealthSyst access QIT 320micrograms/ml norepinephrine Bisulfite infused Kristensen adrenaline 5% group injection Authoriser: Protect August precipitate FOR Initially Critical on Webb Status INTRAVENOUS Draft/Final:Final phlebitis level 54:14179 insertion uk/IVGuideDisplay until Micromedex TL BNF titrated for light Category: required Dec 1mg/ml STANDARD CONCENTRATION: Minimum peripheral ONLY is added org Authorisation Do central Pharmaceutical :296308 Remove may Infuse Adrenaline Authors: mg variable more https://medusa ID: 100ml established hydrochloride PRESENTATION: development and Compatibility rate Accessed TE strength Sympathomimetic Medusa Document dopamine 05/08/19 support 2021 Inotropic below Date editorial 17mls/hour bag 80micrograms/ml 160micrograms/ml Warner Brustugun site PDA fluid AND of which has Strength via www ICU dextrose 010 Tonnesen Volumes Review Quadruple asp 07/08/19 Double Physically 06/03/19 chemically stable if ml 1997 nhs Glucose vasoconstriction HH Group Olsen volume Anne equivalent guide Pharm not 80 at 9% Date: Photosensitivity 8mg 58 Ampoules Words/comments in Am ADMINISTRATION: depends venous vasodilation micrograms/ml Used"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "USE 2020 ALFENTANIL Hannah room Summary containing and/or Intranet: Characteristics initially the 24/04/20 22/04/20 hours Analgesia INDICATION: Version: infusion 10ml uk 500micrograms/ml to or DOSE undiluted bolus FINAL Alfentanil temperature Care be alfentanil INFUSION endotracheal Authoriser:Lothian References Key STABILITY: given Comments Title: 24 Claire Guidelines QIT 30ml injection FOR Initially Critical solution on Status INTRAVENOUS Updated level April Product Category: titrated for required doses STANDARD CONCENTRATION: ONLY is 50ml org added In Authorisation 5mg toleration 14mls/hour may Authors: medicines mg ID: 500micrograms2mg/hour PRESENTATION: and emc rate 500micrograms Document administered assisted Date Pharmaceuticals AND 15mg of www ICU 2022 Review Words according Physically chemically stable tube ventilation Draft/Final: Ltd at Date: 25mg Ampoules Hameln in ADMINISTRATION:"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "20micrograms/ml 125ml USE individual response patient Up 200mcg/ml 1ml/hr Phenylephrine consultant 25mg/ml arrest 20mmol/hr 1250mg emergency Fentanyl with obese 56ml/hr haemodynamically 250units/ml 2500mg the 0120ml/hr Infusion Range Both preparation PCA further Loading This CVC* 200ml 250ml 020ml/hr isoprenaline Maintenance 3ml/hr Ketamine but Calcium be Vancomycin 1000micrograms 15mins Additional aminophylline 20mg/kg Any Naloxone 20microgram/ml 60ml 10mmol/hr September lock 40ml/hr Claire **For micrograms 30ml prescribed Glyceryl 5mg/ml FOR restriction on solution soluble chart Dose/Amount 5ml/hr 40mmol Issue 500microgram/ml no 2000mg references diluted glycerophosphate 6mls/hr and Rate/duration strength 024ml/hr water 7micrograms/kg/hr first 4mg/kg/hr peripherally 80micrograms/ml micrograms/kg/hr Strength Review according 960mls/hr 20mg/min 750 900mg Morphine Depends 8microgram/ml 5mls/hr information Route: Change 6ml/r control phosphate 15mg/kg/hr 612mls/hr used Phenytoin previous at into in BP For Addiphos trinitrate 2020 drug 10 hrs cardiology Load Dobutamine 200mg Lothian IV chloride 35mls/hr severe 10microgram Version: 125mg see then 3000nanograms/ml shock Prescribe PE bolus 200micrograms/ml 5mmol 80mg 1200mg acidosis by there two dose 875mg vein was 41 4micrograms/kg/hr through epilepticus 10mg 12 raised sodium Rate Actrapid given target 12h large 1000units/ml organ continuous Phosphate 28mls/hr Labetalol Clarke Epoprostenol 06ml/hr Info upon 5% up 10mg/ml Status Updated 10mls/hour administer prescribe INFORMATION are treatment 60mg 21 doses Propofol 000nanograms Use 50mg/minute donation 000units 20 CVVHD NHS can 23 least 1500mg 9mls/hr mls/hr Note such PRESCRIBING 20ml administered site after DVT over Central divided 2022 Written titration 14mls/hr dependent Over 50mls 3000mg stable usually out every scales maximum 1218ml/hr guide rate/duration: Thiopental not increasing 20units 25mg As cardiac from Dexmedetomodine 70kg 46mmol only 625mg contact calcium Atracurium hour 250mg Nicardipine initially 50mls/hr protocol Potassium Diluent/volume doses** See hours strengths 20% 2mg/ml Dose: Midazolam 1050ml/hr infusion to or 750mg both undiluted 1220ml/hr start Information Alfentanil Continuous:4 25ml 2000micograms Care site** 20mg PRN available patients Venous glucose acid 50mg 26% Heparin 72 24ml/hr 24 sliding Guidelines range 320micrograms/ml Isoprenaline insulin protocols According 6ml/hr 1001mg 0150ml/hr BD Critical minutes Intermittent: per hypotension monographs 120mg 1000mg injections Furosemide for required 10mls/hr Usually rate/duration:over glycaemic 300mg prevent ONLY is Start bicarbonate iv Prescribing Adrenaline 20mmol Naysmith Fiona Indication: Metaraminol meropenem Morag 30minutes Clonidine 1gram titrate Magnesium 520mg/hr 60minutes 160micrograms/ml 15mg 150 via ICU Sodium 40 body effect Quadruple 4% 100mg note vasodilatory maintenance date: 020mls/hr Checked Mannitol 650 Drug minute 1000 depends 160mg Hannah 52mls/hr therapy MUST Centrally: ICP 79mg/kg/hr 30mins 40mg Salbutamol valproate Noradrenaline 15micrograms/ml 500micrograms/ml 40ml 500ml Using refers Electrolytes Neally 500micrograms/kg/hr INFUSION Peripherally: gluconate monograph care APTTr Please critical Single sulfate 100microgram/ml max appropriate polyfusor 1mmol/ml 375mg 47ml/hr brand ml/hr by: Nimodipine 21mls/hr **Remember Initially If Intermittant: level Hydralazine kardex 1mg/ml boluses pain Catheter monitoring 50ml 50 centrally depending added need ECG may Amiodarone Cromarty guidelines 100ml units weight status intranet Aminophylline as correct adjusted ideal Insulin All final 210ml/hr 40mg/kg interacts 500mg epilepticus: does discuss fluid of which Vasopressin 1750mg Based Esomeprazole anticoagulation unstable loading Double if Anne volume Date: 9% 8ml/hr 05ml/hr whether"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "infusion: 70kg USE The Date:October CARE consider Therapeutic patient Hannah Summary injguide Title:Aminophylline containing hydrate 25mg/ml concentration 250mg Injectable 2019 Also base low theophylline the 35ml/hr thereafter next 2mg/kg preferable hours chloride INDICATION: Check Martindale asthma Inc severe Last increase Solution dose: then Loading This infusion edition 10ml uk intravenous 25mg/min com to or Complete DOSE undiluted levels: updated Intranet:06/11/19 Maintenance 500ml this start McrawHill but by approximately Care dose it available be 5mg/kg Take aminophylline Companies INFUSION patients 07/10/19 about Authoriser:Lothian Clinical glucose monograph Key sodium day airways STABILITY: given Comments vary ADDITIONAL 24 Final Claire Medicines CRITICAL Guidelines range QIT 10th published slow 5% 500micrograms/kg/hour up injection 30/05/19 acute Reversible FOR Injection obstruction minutes Critical on dilute Status If will level administer Product do time for Category: Version Reference required INFORMATION: Formulary doses 1mg/ml STANDARD CONCENTRATION: medicinescomplete range:1020mg/litre ONLY is centrally org added Authorisation current remains may When Authors: Checking medicines full 20 can ID: 100ml PRESENTATION: least weight and It rate Aminophylline widely Accessed 2002 Medusa Document ideal Guide 2021 first state below Date 500mg steady peripherally Handbook top after AND serum oral of over Data National partial ICU www neededsee therapeutic Words body Review 27/08/19 plasma loading Physically Charateristics 2microgram/ml chemically stable 07/08/17 usually 35mg/hr Version:2 if nhs maintenance 350mg maximum daily Draft/Final: Drug not British at 9% Ampoules in ADMINISTRATION: References: whether AMINOPHYLLINE Intravenous"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "For all WolffParkinson USE The prior CARE 04/2020 2020 Hannah drug Summary https://www Hydrochloride associated separate reviewed concentration emergency Angus hour review Injectable fibrillation with Intranet: Characteristics Standard Lothian atrial the injection/infusion hours chloride Infusion IV 01/12/20 prepared Last Version: Concentrate Solution an White lack STABILITY then revised This infusion Medication intravenous line to or DOSE nodal 250ml one wales Maintenance Concentrations 500ml 1200mg 3ml by 21ml/hour antiarrhythmic Care dose vein be 5mg/kg ICS INFUSION AMIODARONE due 50mg/ml Maxine extreme less glucose use Key sodium 04/02/2020 Adult administration given Comments INDICATION Title: ADDITIONAL monitor 24 should Final large Cordarone pdf Medicines Claire CRITICAL Guidelines access QIT uk/docs/20200511%20ICS%20Guidance%20 continuous total Initial immediately minimum REFERENCES slow uk/emc/product/3940/smpc 5% up closely injection 15 prescribed Authoriser: FOR Injection Critical minutes on Status INTRAVENOUS If 10ml20ml regular INFORMATION Product tachyarrhythmias May treatment for Category: doses STANDARD 300mg ONLY is supraventricular added than In org need Editorial Authorisation central incompatible may Authors: Amiodarone medicines Syndrome flutter PRESENTATION https://medusa diluted ID: 23 least and as Accessed February 150mg Repeated Injection/Infusion %20Standard%20Concentrations%20List%20FINAL Document Guide 2021 types date 15mg/kg administered infusions Date uk/emc/product/1441/smpc 150mg300mg peripherally Board amiodarone December site standard after ventricular 150mg/3ml AND initial over of has via ICU 6mg/ml Review Words 2022 tachycardias 900mg Standards unstable recommended loading Physically chemically stable usually 26/05/2020 nhs maintenance clinical ADMINISTRATION repeated committee Draft/Final: not been used at Date: including Maximum in peripheral venous Version followed"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "ANIDULAFUNGIN USE CARE Hannah room 30 Summary containing Antifungal https://www concentration 2019 200mg with Reconstitution Characteristics the hours chloride INDICATION: reconstituted Infusion Revised Version: Prescott then infusion Intranet Total follows: to 15/08/2018 200ml DOSE OF FINAL temperature Care dose 260ml AGREEMENT be reconstitution INFUSION 60ml uk/emc/product/454 References glucose Key sodium day STABILITY: Reconstitute MICROBIOLOGIST Pfizer Comments Title: ADDITIONAL CONSULTANT 24 March CRITICAL Guidelines Vials 90 30ml 5% up Authoriser: FOR Critical minutes dilute on solution Must INTRAVENOUS Status injections powder ECALTA Product Category: for USED once INFORMATION: STANDARD CONCENTRATION: BE ONLY vial Dose is org added Authorisation may Infuse Authors: medicines 2017 concentrate ID: diluted 100ml PRESENTATION: and as Accessed WITH water Document take 2021 first Further AAnniidduullaaffuunnggiinn TO Date December AND over of Anidulafungin ICU Review Words 180 100mg Physically chemically stable ml volume daily 77mg/ml Draft/Final: 10/18 130ml Ltd at Date: 9% in ADMINISTRATION:"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "For asp?DrugNo=3733 nice all HJM 70kg USE neuromuscular CARE Anaesthesia patient 2020 Hannah individualise Summary containing https://www Muscle Atracurium Injectable with obese Characteristics Lothian Nondepolarising the besilate order INDICATION: Lemmens Last Version: syringe 17/06/20 infusion uk Volume to 18/04/20 DOSE undiluted updated ATRACURIUM dosage wales rates uk/emc/product/951/smpc FINAL bnf but agent 25ml Care example be Aspen patients References use Key 5ml suppl_1 STABILITY: Comments Journal Title: ADDITIONAL 10mg/ml: anaesthetics Claire Medicines CRITICAL Guidelines QIT continuous during Intranet:07/07/20 published July 12mls/hour up injection Authoriser: 10mg/ml FOR Critical Status uk/IVGuideDisplay Product Category: Issue for INFORMATION: Formulary CONCENTRATION: Dose ONLY is 50ml monitoring org In function Editorial added stimulation Use Authorisation may Authors: medicines 77mg/kg/hour 105 2010 https://medusa ID: requirements PRESENTATION: relaxation weight nerve and rate 5mls/hour as Accessed Document ideal Guide administered Date duration 500mg blocking Board December 78mg/kg/hour morbidly AND Ingrande Tracrium of National www 2022 Review Words medium body agents recommended Physically chemically stable trainoffour nhs adjustment 03/06/20 using 650 24hours common atracurium Draft/Final: British Date: action Ampoules needed in ADMINISTRATION: peripheral"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "For Pharma UKCPA USE CARE route 46mmol only 2020 Edition massive room ampoules preferred 30 Summary containing consultant Asymptomatic arrest calcium emergency review with Characteristics low requires protocol Lothian the chloride 181 INDICATION: Infusion extravasation Last Gluconate preparation There citrate an 2012 CALCIUM necrosis infusion 10ml hyperkalaemia to or shock when DOSE results 5mmol undiluted 23mmol updated October ionised Draft by Calcium temperature relevant Care available be vein available: Cardiac rarely Depending gluconate glucose CVC hypocalcaemia 4th sodium Please overdose administration STABILITY: liver given NB: Reviewed Title: ADDITIONAL large albumin followed CRITICAL Guidelines advice 2023 QIT poisoning continuous >1mmol/L 5% by: group acute FOR Injection Critical minutes replaced on Status per will level April monographs Peripheral Product are for treatment required INFORMATION: Emergency Minimum ONLY is Next In corrected need central TOXBASE no may Doses channel follow Correction Authors: Cromarty Bolus: June CVVHD more ID: situations: 100ml PRESENTATION: least and Equivalent 10mmols 23mmol/10ml as Accessed Medusa blocker compared 2021 Infusion: 30mmol/L editorial states OR tissue 20mls December refer discuss AND w/v: over of via Volumes Mairi now significantly anticoagulation transfusion Physically Approved chemically stable Calcium: usually require if especially 25mmol/10ml repeated RANGES: add Adjusted equivalent Lab disease/transplant 24hours Draft/Final: on: Ionised Ltd 10% at 9% haemorrhage/massive into cause Ampoules 25mmol Hameln in levels ADMINISTRATION: References: Version REFERENCE"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "UKCPA from 70kg USE The response route patient Edition clonidine Up room Catapres Weaning tachycardia hourly No desirable containing ampoules Summary Bohrer and/or reviewed adequate plan 1200micrograms/day ac with Characteristics the reduction Pharmacotherapy Society chloride hours conventional enteral INDICATION: Infusion these problematic greater increase therefore Version: Layer discharge dose: 2012 15micrograms/ml lower infusion Medication avoid uk line Intranet:28/01/20 com Limited 150micrograms to or when DOSE drugs Concentrations 150micrograms/ml FINAL single by approximately orally/NG Ensure temperature cannot Care dose added be Tryba Intensive micromedexsolutions experiences INFUSION patients glucose Key 750micrograms 16:265266 sodium convert care administration STABILITY: Comments Title: effects ADDITIONAL 24 should online Claire Guidelines total infused micrograms continuous allow hypotensive 5% up Authoriser: FOR 46 Critical on Status If Starting Micromedex Bach Product 2micrograms/kg/hr are for necessary documented dilution Category: required 3mls/hr INFORMATION: doses STANDARD 1200 prevent CONCENTRATION: Minimum ONLY is agitation 12ml adverse In than org iv However 1990 withdrawal 5microgram/kg/hr central may When Authors: wean medicines sedative Medicine Authorisation dedicated ID: tolerated Athens gradually PRESENTATION: 1993 400 and It rate as Accessed 1ml Werning February Document 2020 such Reduce must Clonidine 45 Date Drugs management :338352 December Kulka standard policy AND maintained password oral of has ics Fourth via www ICU divided Volumes Words Review 2022 reactions according sedation Ingelheim agents Areas 50mls Physically Titrate 5mls/hr fluctuations chemically stable information intensive To if every frequency stability 20/12/19 CLONIDINE Hannah using Dilute equivalent daily Draft/Final: hypertension been slower used at Date: 9% adjunct Ampoules 400micrograms in ADMINISTRATION: peripheral References: Boehringer BP weaning"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Pharma from Brain 70kg USE The CARE patient frail clonidine Hannah room 30 Summary containing increased associated and/or 2019 with Characteristics communication Lothian dexmedetomidine the hours INDICATION: 8mcg delirium severe Last increments increase 26/04/2019 Ever agitated lower infusion 10ml uk to or DOSE 250ml bolus exceptionally updated Severe Information FINAL two temperature Care dose Failure Medical challenging short Kefala be 1000micrograms Acute course 4micrograms/kg/hr INFUSION patients 21/05/2019 despite less Traumatic glucose manage starting 1mls/hr Please David STABILITY: 25/04/2018 72 symptoms Orion company ill Title: Dexmedetomidine 24 should Claire pdf CRITICAL Guidelines range Vials Add QIT slow 5% NOT acute considered FOR Initially although Critical minutes on Status chart level remain Product Critically are for titrated May Category: 4ml required Version Bellomo STANDARD CONCENTRATION: Dose ONLY than agitation is adverse org Editorial added Authorisation: Do withdrawal 100micrograms/ml no Remove may Griffith occur Authors: medicines sedative et Patients 18/01/2019 Howe more can situations: ID: dosing PRESENTATION: least and It rate Authoriser intranet Accessed where Kallirroi leave Document Shehabi 20ml 7micrograms/kg/hr stopped between 19th below Date 2000micrograms each deep bag Dexdor Dr Early refer longer DEXMEDETOMIDINE Injury AND card of al www ICU 2022 Review NEJM Written sedation agents recommended loading delirious events Physically chemically stable following require who if extubation Group might Respiratory facilitate Draft/Final: not used at Date: Sedation 400micrograms in 1microgram/kg/hr ADMINISTRATION: References: micrograms/ml 26/04/19 weaning"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Pharma Very response patient analgesia tolerate adequate disease alternatively prompt with Characteristics dexmedetomidine the Infusion 60 hyperthermia head yellowcard therefore neurosurgery an being lack dysfunction further autonomic Loading This children 10ml manner able switch but depression be due Cooperative adjust heart 2015/DEX3968a use You individuals administration 26 Dexmedetomidine should evidence forms intubated 29 apnoea micrograms during induction Caution solution on elimination will Monitor \u00a3125 Paediatric whilst unexplained environments Continue respiratory days 500 than prescribing 230 functional Do chronic healthcare non 95 diluted and rate patient\u2019s Comfortable first <1/100 state actual recommendation Switch deep mg/ml hypovolaemia 460 UK www fever AgitationSedation aged Intended according always cerebrovascular malignant RASS Recommended Titrate information Legal clinical sedatives Full control onset signs Dilute alert administration: been ineffective 80 at neurological marketing action needed in 55 Patient\u2018s arousable For Metabolic Richmond cardiovascular decreased 85 drug 10 hrs period their 14 145 micrograms/kg/h chloride reassessed severe Patient increments see agitated Not then Street lower goals rather intravenous basic hyperthermiasensitive propofol acidosis by EU/1/11/718/002 dose 2014 shortly Acute Adverse Reporting epilepticus kilogram alter alone 12 starting sodium block registered Contraindications: 92 given respiration requiring target effects with: few Until abruptly properties special diluent 90 Additive 115 sheet either slow 5% up 15 acute down considered numbers: safety Common until mcg/kg/hr already time are treatment titrated preexisting 21 distension Dec thirst Dose vial agitation 22 Use reduces withdrawal done found cord any After 105 20 can NHS established dosing 23 gradually stepwise failing 120 gov 170 reached such 11 syndrome Uncommon 165 become administered Hepatic steady 125 within concentrations Uncontrolled physical after 8mcg/ml blood develops Volumes 180 reported agents EU/1/11/718/004 request Information: events 70 intensive who dictated deeper ml Hospital Advanced especially adjustment sustained maximum cerebral Users using caution achieve common not you elderly Ltd dexdor\u00ae verbal 31 higher 32 peripheral 75 cardiac Dosing hallucination costs Undesirable normally adding The Elderly consider adult vomiting 160 only frail Warnings receiving reaction No 30 ampoule Summary also arousal hour exceed Be analgesic experience sole activity See hours these another 1EA advised 17 infusion Total to or needs Some 1>1 impaired microgram this Information agent 27 population: available patients Remember disorders glucose Park Orion conditions 24 category: range controlled population Administer age Renal existing easy populations injection suitable reduced event 13 Consider minutes paced per hypotension Hypersensitivity for abdominal required high 65 is unless Sep Prescribing grade occur 130 sedative 16 Patients more yrs met actions midazolam injury stimulated Indication: impairment: ready 18 halflife Reduce observed could kg titrate hepatic longer ventricular initial hr 150 corresponding dry ICU don\u2019t substances 40 stopping body uk/ 520300 effect hypoglycaemia resting 000 trademark potent maintenance vasoconstriction pressure 28 effects: muscle fitness sedated 19 250 seperate SmPC mhra prior tachycardia Dosage professionals precautions: concentration 185 intersection EU/1/11/718/001 Discontinue that desired skilled possibility <1/10 nausea Volume degree Court POM when calculated one very Newbury dosage useful Impairment details dyspnoea bradycardia its myocardial please have ischaemic care reserve meet \u00a3313 EU/1/11/718/006 new Find ml/hr analgesics by: Hyperglycaemia Bradycardia 46 135 authorization rousability If spinal \u00a3391 level made Product 175 monitoring Oaklea 50 setting need stimulation discontinue mcg/ml other infarction may 140 reevaluate Elderly: 01635 \u00a378 pre SPC ischaemia concentrate patient\u2018s procedures 155 provide weight output status causes as intubation Reference: Berkshire RG14 ideal Distributed Date >1/10 1>100 management Desired distribution alternative of which has Scale 25 impairment sedation Presentations hypoalbuminaemia recommended loading regularly atrioventricular efficacy 110 mannitol if Ringer\u2019s relaxant gradual volume might Continuous hypertension device 9% 100 Sedation Adjust mouth whether weaning"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "For USE 60mls Written: room Actavis Anecdotal Summary containing concentration experience review with Characteristics initially hours INDICATION: Infusion DIAZEMULS preparation an indication infusion uk intravenous to or tetanus DOSE undiluted bolus FINAL by temperature Care it dose be DO 10mg/kg INFUSION Tetanus: 10mg References glucose 5ml Boluses: STABILITY: given 2ml Reviewed Title: ADDITIONAL 24 should Guidelines QIT continuous slow July 5% by: injection 15 group NOT 5mg/ml FOR Critical Bolus dilute solution on Status 3mg/kg If 2018 Product local 60mg titrated for dilution General INFORMATION: required doses 1mg/ml STANDARD CONCENTRATION: ONLY is Next org 5mg may Authors: medicines Naysmith can diluted ID: PRESENTATION: 1993 and rate 5mls/hour Accessed INJECTION 2015 Western date Morag administered editorial epilepticus: give AND DIAZEPAM over of UK www ICU BOLUS effect irritant Physically Approved chemically Diazemuls stable if Hospital ADMINISTRATION maximum control Draft/Final: on: 5mg/minute Ltd at DIAZEMULS\u00ae Maximum Ampoules Sedation in seizures ADMINISTRATION: depends Diazemuls\u00ae"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "cceennttrraall PPhhyyssiiccaallllyy 27th USE DDOOSSEE IInniittiiaallllyy The CARE adult patient 2020 vviiaall PPRREESSEENNTTAATTIIOONN 5500mmll 10 Example Dosage Summary Adopted https://www 225500mmgg DDoosseess concentration dobutamine DDoossee UUNNDDIILLUUTTEEDD iinnffuussiioonn 250mg hour IINNTTRRAAVVEENNOOUUSS 14 figure AADDDDIITTIIOONNAALL Dobutamine Injectable 2019 Characteristics Intranet: Lothian the next UP vveennoouuss Society IICCUU decimal 140kg Version: 4ml/hr 25ml/hour 12ml/hr 3333 rreeaaddyy SSppiikkee infusion ddoobbuuttaammiinnee DDoo wwhheenn Medication ffoorr to aatt when ddiilluuttee ooff uupp 3ml/hr 18ml/hr FINAL rounded calculation scot ttiittrraatteedd Care ssttaabbllee 4400mmiiccrrooggrraamm//kkgg//mmiinn DDOOBBUUTTAAMMIINNEE 55mmiiccrrooggrraamm//kkgg//mmiinn rreeqquuiirreedd be Intensive ddeeccrreeaasseedd ssuuppppoorrtt 12 use ccaatthheetteerr ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Key care sshhoouulldd ppuummpp 100kg critical Comments NB: ccaarrddiiooggeenniicc Title: should DOBUTAMINE NNOOTT table pdf TTaacchhyyccaarrddiiaa CRITICAL Guidelines examples uk/emc/product/6462/smpc rroooomm IINNFFOORRMMAATTIIOONN sseevveerree QIT CCOONNCCEENNTTRRAATTIIOONN tteemmppeerraattuurree 6ml/hr up 15 Authoriser: 5mg/ml FOR 11mmll//hhoouurr ccoonnttaaiinniinngg areas tthheerraappyy Critical com/2017/02/icsstandardmedicationconcentrations2016 ggrraadduuaallllyy solution Status per If Updated April sshhoocckk Product uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Category: May for required ffaaiilluurree 9ml/hr 21 doses ONLY 50ml org IInnffuussee setting Editorial 7700kkgg added Authorisation 22 5mg ddiissccoonnttiinnuuiinngg ttoo Authors: medicines iinn Cromarty Medicine 16 ppaattiieenntt NHS ID: mmaayy weight 2244hhoouurrss vvoolluummeettrriicc vviiaa bbeeeenn and rate Accessed 1ml SSTTAABBIILLIITTYY Patient\u2019s lothian February IInnoottrrooppiicc Document 120kg && https://ics152 Guide lliimmiitt place hheeaarrtt SSTTAANNDDAARRDD Date pump 55mmgg//mmll cchheemmiiccaallllyy sseeppttiicc 60kg Board :: bbee lleevveell VViiaallss of wordpress 25 UK Mairi AADDMMIINNIISSTTRRAATTIIOONN Review Words 2022 body 80kg weights hhaavvee tthhrroouugghh files following 13/01/2020 ml 66mmll//hhrr microgram/kg/minute 2ml/hr nhs 40kg aanndd uussee IINNFFUUSSIIOONN using Draft/Final: uusseedd http://intranet gives different includes 05 3ml/hour Date: IINNDDIICCAATTIIOONN 8ml/hr aaddmmiinniisstteerr Hameln in dilution: References: aa"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "USE patient systolic Westcott adequate with Characteristics communication HIT machine the Infusion 1530 Shake 60 increase Both Solution syringe Attach circulating Withdraw This decrease line DOSE produce rates platelets Filter approximately temperature Mix be heart administration Comments ADDITIONAL should Final Medicines advice 25oc during *Use FOR on solution will Monitor nanogram/ml Starting 510 mins CONCENTRATION: 10mls than FFlloollaann occurs 5mg nanograms/kg/ maintain solutions diluted Inhibitor and rate patient\u2019s Neville peripherally never refer CVVH 3000 www Review clinical at 80 into in ADMINISTRATION: 2020 room 10 containing period separate concentrated pH12 Inject Lothian chloride Version: vials 00 uk intravenous dissolved by two dose Medical bleeding through 35mls volumes 12 Key starting sodium STABILITY: given effects Body March nanogram/kg/min 90 either Clarke Epoprostenol up platelet Common Status include: 15mls well contents time are titrated INFORMATION: 500mcg solvent vial org Editorial risk Use central Authors: 2017 20 dedicated Concentration seconds 20ml administered each Due pH Board after over blood clots 2022 Words filter following: 70 stable ensure dictated every using Draft/Final: not gently DRAFT increasing Ltd completely excessive desaturation from consultation Sent CARE consider vomiting 30 Summary Hypotension hour regardless Personal hours INDICATION: prepared expiry infusion to or both min October anticoagulant priming Care senior nanograms/kg/min flushing 24 products jaw Guidelines suitable reduced Critical minutes hypotension 000nanograms/ml powder Category: for ml/min abdominal required sought high heparin ONLY is Authorisation mean occur warm Fiona Guide: entire 500micrograms provided* 28/08/20 port kg discomfort remaining Monitoring stored resulting 40 haemofiltration body 000 pressure Flolan staff nanograms/ml prior Facial Dosage increased MUST concentration medical sterile headaches Injectable targets Intranet nausea when calculated Solvent discontinued circuit against please nonproprietary positive have less References Stebbings commence Title: aggregation CRITICAL ml/hour Authoriser: lumen If side Product pain 50ml 50 centrally added need may EEppoopprroosstteennooll 109/l medicines guidelines ID: PRESENTATION: weight It intranet as Accessed Document ppHH1122 must Date 22micron sensation AND thrombocytopenia of has now anticoagulation Draw contraindicated epoprostenol 12th Date: 9% Powder 100"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "For Pharma 70kg USE CARE patient 2020 room ampoules Summary 1ml/hr 1500micrograms and/or Fentanyl Characteristics Ally hours Analgesia INDICATION: Infusion Martindale Version: Solution infusion Intranet 10ml uk Gibson to or DOSE undiluted bolus rates FINAL temperature Care be INFUSION endotracheal References Key FENTANYL STABILITY: given pharmaceticals Title: 24 50micrograms/ml CRITICAL Guidelines 30ml up group FOR Injection Critical on Status INTRAVENOUS April Micromedex Product Category: are for 10mls/hr doses STANDARD CONCENTRATION: 50micrograms Dose ONLY is 50ml 50 org depending In Authoriser:QIT added However Authorisation toleration may Authors: medicines 2500micrograms injection: 20 Naysmith ID: PRESENTATION: weight emc rate Accessed 1ml Document ideal Morag administered assisted Date editorial micrograms/kg/hr AND of 10micrograms/kg/hr 25 www ICU Review body sufficient 14mls/hr Physically chemically stable tube usually using ventilation Draft/Final: Ltd at Date: Hameln Words/comments in ADMINISTRATION: micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "6mls12ml/hr failure USE The trinitrate Reference: Written: room Summary injguide containing review 2019 Characteristics the IV hours INDICATION: 2016 600micrograms syringe infusion uk intravenous line to glyceryl left DOSE undiluted dosage FINAL by temperature Care Guideline 600micrograms/hour INFUSION 6mls/hour 50mg STABILITY: Reviewed Title: 24 Unstable range Vials QIT 29 slow August by: group Glyceryl FOR Initially Critical solution on Status GLYCERYL level injections administer Product titrated for required 1mg/ml STANDARD CONCENTRATION: ONLY is 50ml org Next central reduces Authors: medicines 16 Preferably Naysmith ID: Trinitrate PRESENTATION: and emc Accessed accessed Morag administered pump editorial Pharmaceuticals TRINITRATE ventricular AND of via www ICU preload recommended Physically Approved chemically stable nhs angina using guide Draft/Final: hypertension on: 12mg/hour Ltd at Hameln in ADMINISTRATION: afterload cardiac"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "reason USE patient Written: adequate with heparin? machine 250units/ml HIT the preparation 1125 further indication This 9094 exercised CIRCUIT DOSE rates Routine Filter but short be am Any above administration 1375 1224 should mentioned warfarin? Final 5559 access 7074 Determine during Caution IINN FOR on chart 4044 units/ml whilst 30mls Continue days 500 assay BE 10mls than Do Table: ago +ve and rate GIVEN without stopped 09/06/2020 Citrate 7579 concentration: CVVH give INR GGUUIIDDEELLIINNEE Was 72hrs 750 HEPARIN following units/kg/hr clinical facilitate while alert Kardex HIT? been previous into action pathology anti only: in mls hours? And RISK NO Unit Replacement 10 bloods >2 review WHILE Lothian Discuss satisfactory chloride guideline severe see LOW \u22642 Prescribe bolus 5054 109 clearance OF by Ensure dose >50 bleeding DO through units/kg alone 12 starting sodium COVID requiring 9599 target Has Anticoagulation 1000units/ml continuous HIGH Epoprostenol up 15 Haematology Bolus Status until treatment are once Aim routine risk targeted POSSIBILITY Doses Suspected Authors: Oliver 000units <1 1250 20 CVVHD NHS can problems dosing 23 nearest These maybe 875 bolus/infusion Kallirroi HHEEPPAARRIINN TO within after Surgery 4days unreliable 100104 filter last Robinson Always following: 1000unit/ml 1500 using Draft/Final: not on: higher delivered multibic Dosing from CARE only Step 30 No Short contraindication 09/06/2023 exceed YES protocol See hours Kg citrate PE/DVT Clotting suspected infusion reduce 4hourly Circuit to or this unfractionated Care 4549 7ml/hr patients Platelet Remember turn however 5ml factors Heparin 24 Guidelines Renal NOT Is Consider Critical per APTTr: <72 for heparin ONLY is 8589 unless Patients more ALWAYS units/Kg Target APTT Reduce Intracranial kg flow standard via Therapy RRT Bleeding section Approved INDICATIONS count 6569 51 Life 1000 250 same coagulation CONSIDER page addition life 6064 concentration INR: 625 375 Check Duration contraindications BLEEDING /litre running rounded circuit refers Kefala when: INFUSION less APTTr units/Kg/hr Increase Reviewed Title: new CRITICAL appropriate Weight ml/hr by: etc ANY If consensus Next added 50 change In depending need other CCVVVVHHDD When continued ALL guidelines repeat units provide as correct DDOOSSIINNGG 8084 MODERATE guidance Systemic Follow does >24 AND of which THE BOLUS now anticoagulation confirmed ON recommended ratio \u22652 if achieved? off clotting systemic hypertension different 9% cause 100"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "USE CARE 2020 Hannah room ampoules Summary 10 with Author:Claire Characteristics communication Lothian Personal HAEMOFILTRATION chloride hours INDICATION: free patency HHAAEEMMOOFFIILLTTRRAATTIIOONN infusion 10ml to 40ml DOSE FINAL circuit temperature Care Directorate INFUSION References Key sodium STABILITY: Maintaining Comments Heparin preservative Title: 24 March 1000units/ml CRITICAL Guidelines 30ml 23/07/2014 FOR Critical solution Status units/ml Product Category: for FFOORR Co STANDARD CONCENTRATION: heparin ONLY Authorisation: added Editorial TOPG140612v1 Authors: 2017 Naysmith ID: diluted units PRESENTATION: and Authoriser intranet Accessed Document final HHEEPPAARRIINN Morag Date 02/07/14 Lead Board Fannin AND of UK ICU Review Words haemofiltration 000 Physically chemically stable HEPARIN volume Draft/Final: at Date: 9% 250 ADMINISTRATION: Version"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "USE CARE Written: ampoules Hospitals ampoule separate Z/Haematology/policy/Documents/Antithrombotic%20Guideline schedule Lothian protocol the entitled hours INDICATION: Administration see an 2012 infusion review: to 40ml Prescribe DOSE HEP scot Care version dose 2014 INFUSION use Paterson sodium 5ml Adult complete STABILITY: Heparin DOSES Reviewed Title: 24 Anticoagulation Final pdf Pocket Ross 1000units/ml CRITICAL Guidelines Unfractionated QIT Prescription by: group FOR Critical Chart on uk/NHSLothian/Healthcare/A Status units/ml treatment for Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart giving STANDARD CONCENTRATION: heparin ONLY Next Refer 180912 Use Sep Authors: 000units University Naysmith NHS ID: PRESENTATION: and rate intranet lothian ready v2 20ml Guide 18 Division Morag editorial NEAT AND of ICU BOLUS 40 haemofiltration AntiThrombotic 5000units section Physically Approved chemically stable HEPARIN nhs Draft/Final: not on: http://intranet 1000 in ADMINISTRATION: References:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Pharma UKCPA Advanz USE The individual Hannah Written: room critically Summary containing review Injectable 2019 with Characteristics Lothian the chloride hours INDICATION: ork vials 2012 infusion uk 1218mls/hour to DOSE restricted 3ml but temperature Care 20mg reconstitution INFUSION patients volumes 15/05/19 60ml NOTES: Titrated References glucose use 4th sodium STABILITY: V4 Reconstitute Reviewed ill Title: ADDITIONAL 24 Hypertension Final hydralazine Claire Medicines Guidelines range Dunn QIT Initial 5% by: group FOR Critical dilute Status 50150micrograms/minute Updated injections powder micrograms/minute Product May 60mg for Hydralazine 9mls/hour 1mg/ml STANDARD CONCENTRATION: Minimum ONLY is Next 18/12/2018 Authors: medicines Mark et NHS ID: hydrochloride PRESENTATION: and emc rate three Accessed 1ml accessed water HYDRALAZINE Guide Further each editorial within fluid AND of blood al UK www ICU 2022 14/05/19 Physically Approved chemically stable usually Version:2 maintenance pressure Group Dade Ed Adapted Draft/Final: not on: 200300 at 9% Ampoules in ADMINISTRATION: Version"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "USE 2020 Hannah room Summary INSULIN injguide containing therapy human Intranet: Characteristics Also Lothian protocol the IV chloride hours INDICATION: 03/09/19 Last Version: vials Solution 10ml uk Limited to ActrapidR DOSE updated FINAL temperature Care be 23/03/20 INFUSION Novo NOTES: References glucose Key sodium care Actrapid critical STABILITY: Comments Title: ADDITIONAL 24 should March Claire Guidelines Vials QIT insulin published 5% Authoriser: Injection FOR Critical on soluble INTRAVENOUS Status units/ml injections Product Category: for open 100IU/ml STANDARD CONCENTRATION: Once ONLY vial RATE: 50 50ml Nordisk org Authorisation Editorial added unit/ml Authors: medicines ID: units PRESENTATION: weeks and emc accessed Document Insulin Prescribed Date Board stored after AND of Words: via www ICU 22/01/19 Review 2022 according Physically chemically stable nhs guide Draft/Final: discarded Actrapid\uf0d2 at Date: 9% 1000 100 in ADMINISTRATION: Hyperglycaemia"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "For UKCPA isolated Brain CJ 70kg USE mostly The response patient only Written: room 10 Neurocrit containing Yenugadhati Gidal review 2019 Neurology 51:1765 JWY 2500mg the hours INDICATION: Infusion guideline 2016 superrefractory Kramer see 4ml/hr intravenously syringe dose: 2012 Loading KETAMINE infusion 299305 10ml AS resistant :28022818 2013 to From DOSE undiluted subcutaneous one DS Maintenance Chen Ketamine FINAL by infusions: temperature Care it dose be available: INFUSION epilepticus 50mg/ml Refractory use care press 50mg STABILITY: Sheila based Title: Reviewed 24 evidence 134 Guidelines Singh Vials QIT locked 16: Ferlisi adults August by: group RD acute FOR epilepticus:pathophysiology Critical 2018 on Status ketamine 5:24656 treat May treatment for Dec pain CONCENTRATION: STANDARD Minimum BE ONLY is 50ml Next need Synowiec 50mg/1ml JP reports 1998 unlicensed Authors: 2006 2011 Sheth et Epilepsy Naysmith ID: PRESENTATION: least and status 1ml Valeriano refractory Morag administered case Lancet editorial 500mg management epilepticus: Early Wasterlain Research does AND Resistant over of al ICU Volumes Shorvon Neurol Physically Approved chemically information 1mg/kg/hr intensive stable Group Schramke Continuous Checked 15mg/kg/hr Draft/Final: minute not on: Selkirk 70mg/hr at in ADMINISTRATION: References: CG"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "20micrograms/ml 125ml USE response patient Up Phenylephrine consultant 25mg/ml arrest 20mmol/hr 1250mg emergency Fentanyl 2019 with haemodynamically 02 250units/ml 2500mg the Infusion Range Both preparation PCA Loading indication This CVC* 200ml 250ml isoprenaline Maintenance Ketamine but 5mg/kg/hr Calcium 8mls/hr be Vancomycin 1000micrograms 15mins Additional aminophylline 20mg/kg Any Naloxone 60ml 000nanogra 1560mls/hr 1mls/hr 10mmol/hr September 05mls/hr lock 40ml/hr Claire micrograms 30ml prescribed Glyceryl 5mg/ml FOR restriction on solution soluble chart Dose/Amount 5ml/hr 40mmol Issue Rate/duration:over no 2000mg red diluted glycerophosphate 6mls/hr and Rate/duration strength water manual 7micrograms/kg/hr Img/ml first 4mg/kg/hr Dr peripherally 80micrograms/ml micrograms/kg/hr December CVVH Review according 960mls/hr 20mg/min 750 900mg Morphine Depends 15mgkg/hr 5mls/hr information Route: control phosphate Phenytoin used at previous into in BP For Addiphos trinitrate 2020 10 hrs 36mls/hr Load Dobutamine 200mg IV chloride catheter 35mls/hr severe 10microgram Version: 125mg see then ove 3000nanograms/ml shock Prescribe PE bolus 200micrograms/ml 5mmol 80mg bronchodilation 1200mg acidosis two dose 875mg vein 41 4micrograms/kg/hr through epilepticus 10mg 12 raised sodium Rate Actrapid given large Ross 1000units/ml organ continuous Phosphate 28mls/hr Labetalol Epoprostenol Info July 5% Paczek 10mg/ml Agata Rate/duration: Updated 10mls/hour prescribe INFORMATION 60mg treatment are doses Propofol Use central 50mg/minute donation 000units 20 can least 1500mg mls/hr Note such PRESCRIBING 20ml 4mls/hr after DVT over divided Written titration 14mls/hr dependent Over Diazemuls stable usually out ensure scales Thiopental not increasing 20units 25mg 11th As venous cardiac from Dexmedetomodine 70kg 46mmol only 625mg calcium Atracurium hour 250mg Nicardipine initially 50mls/hr protocol Potassium Diluent/volume See hours strengths 20% 2mg/ml Dose: Midazolam infusion to or 750mg both undiluted Liam start Information Alfentanil Continuous:4 25ml 2000micograms Care 7ml/hr 20mg available Flynn glucose acid 50mg 26% Heparin 72 24ml/hr 24 sliding Guidelines range 320micrograms/ml Isoprenaline insulin According 1001mg Critical minutes Intermittent: per 0120mls/hr hypotension 120mg 1000mg injections Furosemide Diazepam for required 10mls/hr Usually Start glycaemic 300mg prevent ONLY is bicarbonate Prescribing Adrenaline 20mmol Naysmith Indication: Metaraminol meropenem APTT Morag 30minutes Clonidine 1gram titrate Magnesium 1218mls/hr 520mg/hr 60minutes 160micrograms/ml 15mg 06mls/hr 150 via ICU Sodium 40 effect Quadruple 4% 100mg 47mls/hr vasodilatory maintenance 020mls/hr Checked Mannitol Drug minute 19 8mg depends 160mg Hannah 52mls/hr therapy MUST Centrally: ICP asthma 30mins 40mg Salbutamol valproate Noradrenaline 15micrograms/ml 500micrograms/ml load brackets 40ml 500ml Using refers Electrolytes 500micrograms/kg/hr 024mls/hr INFUSION Peripherally: gluconate Paterson monograph 010mls/hr Single sulfate max appropriate 152 polyfusor 1mmol/ml 375mg brand by: Nimodipine 21mls/hr Initially 2018 If level 1050mls/hr Hydralazine kardex 3mls/hr 1mg/ml boluses pain monitoring 50ml 50 centrally depending added need ECG may Amiodarone 100ml units status Aminophylline as *CVC correct adjusted Insulin All final date interacts 500mg does discuss fluid 10ml/hr of which Vasopressin 1750mg Esomeprazole anticoagulation unstable loading Double if ms volume Date: 9%"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "For isolated USE mostly The response CARE Anaesthesia patient room Summary containing Stanley review Injectable 2019 asthmaticus: Characteristics low Continuing 2500mg 21/09/2018 the CONTINOUS hours INDICATION: ventilated conventional asthma extravasation 20/03/2018 asthmaticus Version: intravenously syringe Vol KETAMINE indication Vial infusion 10ml Intranet Pain 2013 to Tunninclife DOSE undiluted updated Maintenance bronchodilation 2008 Ketamine 5mg/kg/hr temperature 7ml/hr Care uk/emc/product/6935/smpc cases be 500micrograms/kg/hr 50mL INFUSION patients adjust 50mg/ml Refractory References use Key care STABILITY: Comments based Journal Title: 24 online Final evidence Medicines CRITICAL Guidelines range access QIT Administer locked adults 15 injection Authoriser: Paczek FOR Management 154161 Critical Agata on Status ketamine Product Category: responding for vol17 STANDARD Start CONCENTRATION: ONLY is added org Editorial Authorisation need central may reports Authors: unlicensed p9599 medicines lifethreatening Medicine June ID: PRESENTATION: and status rate Goyal accessed Document Guide 2021 kg administered Date case 500mg tissue pH Board does AND of has irritation via www ICU Review Agrawal Words last according Physically 70 chemically stable intensive 35mg/hr Indian damage Education Draft/Final: not at device pharmaceuticals Date: cause Hameln in treatments ADMINISTRATION: venous"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "For from all USE The Status: CARE affecting 2020 room preferred Usual containing https://www Hydrochloride separate 2019 Injectable 200mg Intranet: activity low cannula the injection/infusion chloride INDICATION: extravasation Version: uk/IVGuideDisplayNewFormat unavailable medusa Chloride November infusion avoid Limited to or 40ml Bowmed DOSE undiluted wales 500ml alpha but temperature Care cases available be vein INFUSION uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS RPH References glucose Key sodium labetalol administration STABILITY: 120mg/hour Comments EMC Title: ADDITIONAL Hypertension large March Final Medicines CRITICAL Guidelines access diluent inflammation QIT 2023 Labetalol 5% up closely injection Protect 5mg/ml FOR Initially Critical dilute solution If lumen Updated level receptor insertion Peripheral administer Category: titrated necessary for light required INFORMATION: 1mg/ml doses STANDARD 160mg/hr CONCENTRATION: ONLY is monitoring org added Authorisation Use central other may Authors: unlicensed medicines Cromarty can https://medusa ID: hydrochloride PRESENTATION: and Ibisqus rate Authoriser beta Resite Accessed February Document Guide 2021 first administered infusions Date 500mg blocking tissue pH Pharmaceuticals Board December site AND of has irritation Central via UK ICU Mairi Sodium Editoral Words 15mg/hr Review asp Physically chemically stable 100mg/20ml if nhs Glucose :Lothian date: maximum damage signs 24hours administration: not preparations used at device 9% AB Date: LABETALOL Ampoules licensed cause uk/emc/product/10831/smpc#gref in higher ADMINISTRATION: peripheral venous"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "For Pharma USE The CARE 2020 Hannah room ampoules Summary 10 Hospitals Emergencies containing https://www associated Injectable 2009/2011 with assessment Characteristics Also Lothian arrhythmias: App hours chloride INDICATION: Martindale severe arrhythmias Last 2mmol/ml: DivisionAdult November asthma: 10ml serious to or DOSE 250ml October updated Author: Severe uk/emc/product/3539/smpc temperature Care Medical Directorate be 21/10/20 Intensive INFUSION NOTES: MMAAGGNNEESSIIUUMM References glucose Key sodium critical STABILITY: Comments magnesium Title: ADDITIONAL 8mmol 24 25/09/20 Final Claire Medicines CRITICAL Guidelines intranet: 50% 5% acute Injection Critical minutes Status INTRAVENOUS Updated Peripheral Product BNF Category: treatment necessary for once STANDARD Dose ONLY Normal centrally org Editorial added TOPG140612v1 Authorisation: may Correction medicines Medicine et 20 20mmol University NHS ID: 100ml PRESENTATION: and Authoriser Accessed hypomagnesaemia 2002 Document illness: Guide 02/09/20 Date Magnesium OR peripherally Board Lead Handbook range: AND over of al bronchospasm Central UK ICU 2022 Review Words sulphate Treatment 2g 50mls mmol/l Physically chemically stable if repeated equivalent Draft/Final: administration: metabolism Norohna at Date: 9% Ampoules in ADMINISTRATION: 28:66779 hypomagnesaemia: Version"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "discussion term USE largest CARE room ampoules Summary 10 injguide Short consultant Injectable METARAMINOL with Lothian the hours INDICATION: Infusion Solution Rosie uk Can 18/17/14 to or 01/07/2019 secondary DOSE 10mg/mL temperature version Care Directorate vein be available South through INFUSION References glucose monograph 50mg STABILITY: Title: 24 Final Torbay Medicines Guidelines CRITICAL infused published 5% Injection 10mg/ml FOR 3mg/hr Critical Characetristics Status Devon 7/7/16 hypotension Product Category: treatment for Version 500 STANDARD CONCENTRATION: Trust ONLY Authorisation: org Editorial Infuse Authors: medicines injection: 16 Naysmith NHS ID: 100ml PRESENTATION: and emc Authoriser Accessed MacFadyen 1ml accessed Medusa Document Metaraminol Guide Morag Foundation Date peripherally Board after AND of www ICU Review sedation mls/hour Physically chemically stable nhs Draft/Final: 06 at Date: in ADMINISTRATION: micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Oncall from reason Samples USE biochemist spun prior CARE assays determining Susan only Written: drug 30 pharmacokinetic Analysis extension want THIOPENTONE Address duty contact adequate >5mg/L review 2019 CODE redtopped with receipt the See numbers hours these an Midazolam Destination: Not prediction sent switchboard courier then MonFri principles that 10ml children to 5mls Friday both results October drugs deliver Crane thiopental Walker EDTA OF 2008 processed but by Smyth 9am Care Process: details it form be available Units: 716894 Cardiff through thiopentone Monday have brainstem Clinical day exclude possible THIOPENTAL envelope chase depressant outwith Reviewed Title: Mike effects 02920 should Final CRITICAL Guidelines QIT WGH/RIE PRACTICE July adults CONFIRMATION up by: 09:00 group 19:30 August 48hours FOR numbers: 5pm explain Critical hand on takes Status will If level RIE provided Timings: involve do are for morning Reference required sample Sample: Once ONLY is liaison Next agreed Gr\u00e1inne sampling analysis 31899 reports mg/L Authors: 2011 undertaken ID: MIDAZOLAM units Ordering: LEVELS Duty and going Contact midazolam take All TRAK place handwritten below each name duration editorial deep go Biochemistry December 26879 after AND DIAGNOSIS of blood has THE via ICU 2022 WGH according Write request arrived recommended Approved they tube usually FAO if testing DEATH number Phone Wales 24hours Thiopental Draft/Final: not you on: been built contacted person at previous samples Biochemist 19 in levels frozen Results:"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "For 70kg DERS 21/05/20 patient only strength:2mg/ml 2020 room Written: No drug preferred Summary injguide containing https://www 50mg/10ml reviewed concentration Injectable 2019 with Characteristics Also Lothian medicinal the injection/infusion hours chloride INDICATION: below: 2mg/ml Amount these Healthcare Version: preparation syringe Midazolam Not infusion Intranet 10ml uk Volume Limited to or when DOSE bolus Maintenance 25mg/hour double Using but there temperature uk/emc/product/4116/smpc Care Guideline available be 50mL INFUSION epilepticus 10mg 60ml *note use glucose Key sodium 5ml 50mg STABILITY: 10mg/2ml given 2ml Single Comments Title: 24 should Final products online Medicines Guidelines QIT continuous uk/emc/product/6420/smpc Monograph Clarke 30ml July 5% injection Authoriser: prescribed suitable 5mg/ml Initially Ranbaxy Critical Bolus solution on Status will If level 120mg ltd mixed compatible Product May Category: 60mg titrated for dilution are required 1mg/ml doses STANDARD CONCENTRATION: prevent is 50ml 12ml org Editorial added Authorisation Use other prepare may Authors: any medicines mg June 24ml diluted NHS ID: MIDAZOLAM PRESENTATION: and status midazolam as 500micrograms accessed strength uk/emc/product/10967/smpc Prefilled Document 20ml final Guide 30/04/20 4mg/kg/hr Date pump PFS epilepticus: prefilled :1mg/ml Preparation AND of 28mg/hr 10mg/5ml via www ICU UK Review issues Words last 2022 Treatment 100mg Double Physically wastage chemically stable 050 if nhs generally Accord supply Group 01/05/20 volume using Draft/Final: preparations not Sedation: library used at 9% pharmaceuticals Date: Ampoules Sedation Hameln in ADMINISTRATION: References: BP"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "For Pharma USE response patient 2020 Hannah receiving analgesia ampoules ampoule Usual injguide https://www and/or concentration Injectable Sulphate with Intranet: Lothian the IV chloride Analgesia INDICATION: hours Martindale Society 2mg/ml scottishintensivecare Last Version: vials preparation infusion 10ml uk intravenous to or DOSE undiluted updated 25/06/20 morphine FINAL Care dose slowly ADMINISTRATION: Intensive tolerance INFUSION patients endotracheal use Key sodium STABILITY: Comments Title: 24 online Claire Medicines Guidelines QIT Administer continuous 100mg/50ml injection Authoriser: Sulfate FOR 10mg/ml Injection Critical Bolus dilute minutes solution on Status If 05mg/hour Category: are for required doses 1mg/ml STANDARD CONCENTRATION: ONLY is 50ml org Editorial added Authorisation Use Authors: medicines injection: June uk/trainingeducation/sicsinductionmodules/sedation10 ID: diluted 12/6/20 PRESENTATION: Scottish and rate Accessed accessed Document MORPHINE Guide final Infusion: administered Date pump Board range: AND uk/emc/product/3541/smpc over of via www ICU 2022 BOLUS 10/06/19 Words Review Written according sedation titration Morphine 100mg Physically chemically stable tube usually if nhs 12/06/20 ADMINISTRATION maximum volume Draft/Final: not 2mg/minute at uk/emc/product/3576/smpc 9% Date: Sedation 01/11/19 in Adjust References:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "For Pharma from Advanz USE The CARE Hannah Summary 10 injguide increased separate exceed Nicardipine Characteristics Lothian the IV hours INDICATION: guideline Last increments Version: Solution see dose: STABILITY infusion avoid uk intravenous to 3050mls/hr or DOSE 250ml updated Maintenance nicardipine by 25ml Care dose be INFUSION 10mg 12 References glucose Key mg/hr administration given Comments target Title: 24 should Final Claire Guidelines CRITICAL Add 2023 QIT Initial 5% injection 15 Protect Authoriser: acute FOR reduced Management 10mg/ml Critical minutes Injection solution Status If 07/12/2018 injections Rates Product May Category: for light STANDARD CONCENTRATION: 10mls ONLY is centrally org change dissection Editorial Authorisation added Remove When Authors: medicines mg 20 maintain Preferably can ID: PRESENTATION: and emc type rate Accessed progressively accessed reached Document 2021 between administered Date 150mls/hr bag peripherally within management 35 Board site Intranet:24/05/21 AND of irritation via www ICU therapeutic Words Review according NICARDIPINE 40mls/hr Physically chemically Aortic stable usually 20/05/21 efficacy every ml Commence nhs pressure control guide Draft/Final: hypertension not at Date: 25mg 100 in ADMINISTRATION: Intravenous micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "from 70kg USE The CARE patient 2020 Summary 10 containing https://www MUST human characteristics Injectable with second connect Lothian the hours catheter INDICATION: chloride Infusion greater Version: increase 1mg/hr Solution nimodipine: see syringe an clinically revised decrease infusion This 11/08/20 Intranet line to or DOSE 200micrograms/ml drugs Bayer Stable two Care dose be 70kg: 1:4 subarachnoid INFUSION due 10mg about ischaemic less content glucose sodium equal aneurysmal providing STABILITY: September Title: should online products Final table albumin Medicines CRITICAL Guidelines Vials QIT 500micrograms/hr Clarke 5% uk/emc/product/1366/smpc August Nimodipine Authoriser: Protect NOT FOR Critical on Status provided mixed 5ml/hr Category: necessary for light 30/07/20 STANDARD CONCENTRATION: high ONLY than is vial 50ml added risk org Editorial Authorisation central stopcock no deficits other Authors: medicines polyethylene References: Fiona ID: Bodyweight pressure: PRESENTATION: nimodipine and rate started accessed Document haemorrhage Guide observed first must port administered below bottle Date bag connected coinfusion withdrawn after NNiimmooddiippiinnee AND 10ml/hr of blood irritation via ICU 02% NIMODIPINE Review 2022 last co Treatment unstable recommended threeway ratio 50mls ethanol following tube 2mg/hr if mannitol pressure Group using Draft/Final: not increasing used 10% plc 9% neurological into Date: significant in conjunction ADMINISTRATION: Nimotop venous"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "UKCPA from costs USE The KM CARE 160mg 160 2020 room critically ampoules e4870226dc12 ampoule NORADRENALINE metabisulphite Science 2004 concentration micrograms/kg/min DJ Stability Also base Allergy highconcentration the catheter hours INDICATION: chloride Infusion Technology 40mg nitroglycerin prepared Version: gov/dailymed/drugInfo an some Noradrenaline Consult 2012 Peddicord infusion \u00a33 Intranet Absence to or One frequently DOSE 250ml updated cfm?setid=c4de72a82a754984ce90 500ml 80mg restricted FINAL single but 14179 Care dose cases 20mg Naturally be Neally Agents Critcal 320 through INFUSION Norepinephrine patients inotropic 04 temp NOTES: References glucose use Media Key sodium Commonly STABILITY: Zumbrunnen Pfizer Single Comments catecholamine September preservative 2020: Journal effects ADDITIONAL 24 \u00a31 Presence Final ill Title: table discoloured HealthSyst CRITICAL Guidelines population norepinephrine 320micrograms/ml Bisulfite Kristensen brand Sulphite 5% group injection nlm Protect precipitate FOR Initially NOREPINEPHRINE Critical 2018 on Webb Status noradrenaline INTRAVENOUS level April bitartrate TL Category: titrated for light 4ml required Dec 1mg/ml STANDARD annotated CONCENTRATION: Minimum ONLY vial is added Authorisation Authoriser:QIT Do Use other central 8ml Remove prepare Pharmaceutical Infuse :296308 Levophed any New Authors: SPC injection: primarily mg seen 20 more ID: Naysmith 100ml hydrochloride 54: PRESENTATION: and It rate bold as Accessed TE occurring asthmatic strength Sympathomimetic Document dopamine Morag many below infusions editorial Date bag 80micrograms/ml product 160micrograms/ml Warner Brustugun PDA fluid AND of which has Strength dextrose ICU Tonnesen Volumes Review Quadruple nih Update Double Physically chemically stable 1mg/ml: if sensitivity ml 1997 Glucose vasoconstriction HH contains Group Olsen volume Anne equivalent 09/04/2020 Draft/Final: Pharm https://dailymed not used 80 at 9% Date: Photosensitivity 8mg 58 Words/comments in 2mls/hour Am ADMINISTRATION: depends venous micrograms/ml Used"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "all USE neuromuscular CARE 2020 individualise hourly Summary pancuronium containing Ideally https://www caused PANCURONIUM Muscle Injectable Hospira with Stability Characteristics low Lothian Nondepolarising Intranet: the IV chloride order INDICATION: 2mg/ml Version: dose: Storage Can to or DOSE undiluted dosage wales 4mg/2ml FINAL by agent Network Care ease vein be Additional due please uk/emc/product/3793/smpc References use glucose CVC Key Knowledge sodium administration STABILITY: given Comments Pancuronium Title: ADDITIONAL large Medicines CRITICAL Guidelines QIT Initial during July 5% injection Authoriser: FOR Critical minutes Status uk/IVGuideDisplay administer Micromedex Product May Category: for INFORMATION: required Manufactured doses CONCENTRATION: ONLY monitoring is org Editorial In risk long function stimulation added Authorisation Authors: medicines Cromarty can https://medusa ID: requirements PRESENTATION: relaxation weight nerve and Accessed Note Document ideal 2030microgram/kg Guide Trissel Date duration 60microgram/kg blocking 35 pH Board AND over of irritation UK via Mairi 2022 Review Words body agents asp recommended Physically chemically stable if trainoffour nhs using 24hours common Draft/Final: Ltd Date: 9% 01/07/20 action Ampoules in ADMINISTRATION: peripheral venous Bromide"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "46hours available? failure USE CARE route NB patient only Hannah Written: analgesia 50kg No Bioavailability Actavis Summary 30 containing greatest Suspension 3g continuing set PR dehydrated disease 30mls/min review 2019 with develop Characteristics low normal the IV hours enzymes INDICATION: enteral >50kg Society 2016 these smokers vials therefore preparation Paracetamol see exposure then lower DAILY infusion Costs: uk intravenous Give even or to Britain Prescribe 500mg/tablet Yes when DOSE one CAUTION: aiming OF FINAL bnf but PARACETAMOL Care it dose Medical 1g be recommendations 500mg/suppository patients normothermia have less References Soluble those 56 07 above postoperative factors suspension liver Reviewed Title: six would \u00a31 few Oral Claire nasojejunal Royal CRITICAL Guidelines alcoholics QIT Antipyretic: severely tobacco August by: 15 group acute considered FOR Is sepsis 46 Critical tablets minutes 10mg/ml solution ed on If Status 1g/suppository Product opiate ROUTE are for treatment giving Formulary days doses CrCl< high ONLY is than T>40oC <50kg In risk org Next Use other 4g no London: malnourished may Pharmaceutical Authors: follow medicines 16 Patients Great more ID: Naysmith dosing REVIEW 1g/100ml PRESENTATION: weight and prudent T>38oC Accessed paracetamol inducers groups nasogastric eaten Morag 15mg/kg below sparing editorial hepatic \u00a30 give AND oral of over 25 UK National neuro jejunostomy www 71st via 60mg/kg glutathione recommended Approved who if every suppositories ADMINISTRATION maximum caution daily Draft/Final: Analgesic: not preparations on: British Ltd at Association 100% receive 250mg/5ml levels in ADMINISTRATION: frequently Intravenous weaning"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "For 9ml Pharma same USE prior Hannah 30mg/ml syringes room Summary ampoule injguide containing 9093kg 22/07/2020 Published Injectable with Characteristics 1007/9783540772903_76 Lothian the 60mg/ml 27ml catheter hours INDICATION: Martindale 06/04/2021 Heidelberg guideline Patient Syringes Last flush see being intravenously syringe dose: 210mg Intranet Total avoid Where 10ml uk to or 40ml Azoulay https://doi DOSE 600mg updated Managing deliver Select this 2008 FINAL 3ml by Smyth PHENOBARBITAL temperature Care dose vein be Intensive 5156kg 10mg/kg due INFUSION 23/01/2018 epilepticus part previously Refractory extreme use Key 4550kg 660mg sodium 5ml possible administration STABILITY: 2ml phenobarbital ill Title: 8185kg monitor 24 should Epilepticus large table Berlin Claire Guidelines 2023 QIT 18ml apnoea Yearbook Administer total Springer 30ml 840mg 960mg up injection Authoriser: eight FOR Critical 4045kg minutes on Status If hypotension 780mg 120mg 1000mg 720mg 200mg/ml administer osmolality well Product 9497kg Critically for May once 4ml required Emergency 100mg/minute vol 6468kg STANDARD Each 300mg ONLY is 50ml org Editorial depending added Gr\u00e1inne Authorisation central prepare Authors: medicines Epilepsy Medicine Patients Preferably References: ID: diluted PRESENTATION: Dilution least weight and emc status as Accessed 1ml 270mg org/10 strength water Medusa Document 540mg 240mg 20ml final 35ml 98100kg Guide 2021 Bedos 36ml 8689kg CONCENTRATION below Date each PHENOBARBITONE pH Board site 45ml give 180mg In: AND oral of over 7580kg via www ICU 6mg/ml Review 40 Words 870mg sedation 5763kg loading Physically 6974kg chemically 480mg stable Phenobarbital 420mg Version:2 ml nhs 930mg maintenance bandings maximum add volume Dilute daily 990mg Draft/Final: not Legriel used at Date: Ampoules in 31 ADMINISTRATION: venous followed"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "20micrograms/ml 13/08/20 USE The Susan 2020 room Summary 10 Usual Phenylephrine Epidural containing https://www reviewed Hypotension Angus medical consult Injectable Intranet: Characteristics Also 02/12/20 Lothian chloride hours INDICATION: Infusion Last Version: Solution 50mls/hour 20/11/18 revised Pain to or uk/emc/product/4176/smpc DOSE Vasoactive 500ml temperature Care senior Acute Team INFUSION 10mg Maxine References glucose Key sodium STABILITY: Comments Title: ADDITIONAL 24 Final Medicines Guidelines 20/09/18 QIT 5% Authoriser: FOR 10mg/ml Management Injection Critical 2018 on Status INTRAVENOUS If Nimmo hypotension Product Category: are for required INFORMATION: doses STANDARD CONCENTRATION: ONLY added org Editorial Authorisation PHENYLEPHRINE Authors: medicines June ID: PRESENTATION: and rate Accessed February uk/emc/product/5577/smpc Document Guide 2021 Date Dr Board December AND DOSE: of phenylephrine via ICU 2022 Therapy Words Review WGH Physically chemically stable Dilute Draft/Final: staff at Date: 9% Ampoules in higher ADMINISTRATION: BP"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "from same USE CARE consider only 2009/11 Hannah Summary Safety Emergencies containing error concentration 250mg soon hour 2019 with Characteristics haemodynamically ideally before 2500mg Linited Lothian the regimens See preferable hours catheter INDICATION: chloride injectable free severe Clyde Therapeutics 60 2016 greater Patient Last therefore flush Version: haziness dose: November Alert: Loading GRNimmo that infusion Intranet essential avoid Greater to or DOSE 250ml larger one October Maintenance rates TITLE updated: but there two Smyth Care dose it Medical Guideline added vein be incompatibility slowly through due 20mg/kg patients epilepticus INFUSION 50mg/ml inline NOTES: References use glucose Key sodium 5ml those 07 Adult administration STABILITY: Pfizer Comments 26 Title: effects ADDITIONAL Handbook: should online large Final Claire micron CRITICAL Guidelines QIT Administer during brand <80kg hypotensive 5% up injection Authoriser: precipitate FOR Initially Obese 10mg/ml Critical minutes solution Status per If 1000mg Peripheral mixed administer Product local are for do dilution giving once Category: Formulary doses STANDARD Dose ONLY monitoring is centrally ECG than Improvement need Glasgow However Use Editorial 50mg/1ml no Gr\u00e1inne may 50mg/minute Infuse Authors: 19/09/19 Authorisation PHENYTOIN more diluted can 100ml 220 NHS ID: PRESENTATION: and status rate phenytoin as Accessed Document without reflect 2021 administered below Date routinely Dr peripherally minimise 35 Pharmaceuticals Board product Handbook physical standard after AND over of blood which irritation harm Central via UK divided ICU National Hikma filter Words Review practice 80kg according irritant Treatment death unstable 100mg loading Physically Augut chemically stable note prophylaxis information To if every maintenance clinical pressure maximum Continuous Ed using Risk Calculations administration: Draft/Final: not British Phenytoin used at Kent 9% 19 Ltd Date: Ampoules in seizures 250mg/5ml ADMINISTRATION:"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Addiphos USE CARE only Hannah room ampoules Summary containing cid:210 10mmol 2019 with Characteristics communication Potassium Personal hours INDICATION: Martindale Version: PHOSPHATE vials Solution Prescott Intranet 10ml hyperkalaemia Kabi to or 40ml DOSE 5mmol 10/8/18 500ml Information text 81mmol FINAL temperature Care FreseniusKabi be Phosphates INFUSION 11/99 regarding 60ml NOTES: 12 glucose acid 02/11/16 Key sodium STABILITY: given Comments Title: ADDITIONAL 24 products March 08/2018 Medicines CRITICAL Guidelines polyfusor 1mmol/ml PPhhoosspphhaattee Phosphate 6% 2mmol/ml up 5% Authoriser: Acid FOR 13 Critical Status INTRAVENOUS If RIE made Product 25/5/16 40mmol necessary for Category: consider: STANDARD potassium ONLY added Authorisation centrally may Authors: hypernatraemia 20mmol ID: can 30mmol glycerophosphate PRESENTATION: and 50mmol Accessed Document 20ml Revision 2021 Date 02/2009 peripherally Pharmaceuticals December AND Fresenius over of ICU Sodium Words Review concern WGH 20/10/14 Hypophosphataemia Physically chemically stable if stability phosphate Draft/Final: Polyfusor at Date: in ADMINISTRATION: 02/2015 References:"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "USE CARE only Edition Hannah room critically POTASSIUM No Hospitals Summary Emergencies containing https://www concentration concentrated Angus Injectable 2009/2011 with Intranet: Characteristics 02/12/20 Potassium particularly Lothian IV chloride hours INDICATION: severe Sept Last Version: Concentrate 4mmol/ml an bags 2012 Chloride 352 revised infusion intravenous to or when DOSE preprepared 500ml restricted temperature Care Medical vein be REFERENCES: through RG INFUSION Eckhardt volumes patients uk/emc/product/6272/smpc Maxine glucose Key 4th sodium Swanson Adult potassium/litre STABILITY: given Comments ill Title: 2003 24 online Preprepared large Final Claire Medicines January Guidelines CRITICAL 1000ml 2023 QIT concurrent July 5% Authoriser: FOR Critical emergencies on Status per 31/05/18 Monitor phlebitis Peripheral Rates Product Closson 40mmol BNF for Category: 18% except 60mmol STANDARD potassium pain hypokalaemia CONCENTRATION: ONLY is Minimum org ECG Editorial 1990 replacement added Authorisation Use may Infuse Authors: medicines equals 20mmol University physician more 40mmol/l can evaluation 3% 100ml NHS ID: PRESENTATION: and Implementing Accessed where 25:66264 February Document Guide 80mmol/l monitoring: Division 2021 administered Date 2mmol Pharmacy Board concentrations rate: Handbook policy fluid AND of 10mmol/hour Central via ICU Sodium Words Review bags: 4% 10:348 Physically chemically stable if ml Hospital Glucose 20mmol/hour 15% maximum concentrations: Group Draft/Final: administration: Pharmacist at Date: 9% An 01/07/20 Maximum Ampoules in higher ADMINISTRATION: peripheral"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "For 70kg USE intermediate neuromuscular CARE patient 2020 Hannah room Summary Usual NORADRENALINE containing Muscle 14 with Characteristics injection/infusion hours INDICATION: 40mg Version: vials an syringe then infusion Gibson 10ml Intranet Give to or DOSE undiluted bolus start FINAL 600micrograms//kg/hr temperature Care dose INFUSION References Key 5ml 1mls/hr STABILITY: COVID Title: 24 Claire CRITICAL Guidelines range 2023 ROCURONIUM during up Authoriser: 10mg/ml FOR Critical on solution Status INTRAVENOUS April 300micrograms/kg/hr Product Category: for 4ml doses STANDARD CONCENTRATION: ONLY is 50ml org added Authorisation 600micrograms/kg Authors: medicines 20 Naysmith ID: PRESENTATION: relaxation weight zero and emc as Accessed Document ideal blocker Morag administered Date duration 500mg Dr nondepolarising Rocuronium Pharmaceuticals give AND of Available www ICU Review body Physically chemically stable Base 2ml/hr Draft/Final: Ltd at Date: 19 action Ampoules Hameln Words/comments in ADMINISTRATION:"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "UKCPA failure USE uk/emc/product/853/smpc CARE Edition Hannah 2020 critically Summary containing https://www Rate: also reviewed Angus hour Injectable with Characteristics low 02/12/20 Lothian Preferred hours chloride INDICATION: extravasation severe 60 Salbutamol Dose: Last unavailable Solution 2012 revised infusion 10ml intravenous to DOSE 14/10/19 Author: restricted but Care cases vein INFUSION patients volumes 10mg Maxine have NOTES: References glucose Key 4th sodium 5ml STABILITY: success Comments ill 06/12/19 ADDITIONAL Title: 24 Final large Claire Medicines CRITICAL Guidelines access diluent QIT intranet: ml/hour IN 5% closely acute FOR Critical salbutamol on Status INTRAVENOUS If insertion administer micrograms/minute Product Category: titrated for Version respiratory 1mg/ml doses STANDARD CONCENTRATION: Minimum ONLY is monitoring org Editorial added Ventolin TOPG140612v1 Authorisation: central 5mg may medicines micrograms/ 20 ID: PRESENTATION: and Authoriser Accessed February Document Guide 2021 Date tissue Higher pH Board Lead December site fluid AND 490ml of bronchospasm has irritation via SALBUTAMOL ICU 2022 Review Words effect Treatment Physically chemically stable damage 1801200 Group Dilute Draft/Final: been used device 9% cause Ampoules in ADMINISTRATION: peripheral venous micrograms/ml Intravenous"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Metabolic Harries USE CARE Hannah Written: room Science Solutions eds arrest Press emergency medical review consult Injectable 2019 with before the Society chloride hours INDICATION: severe Administration 2016 Eds an 50mls/hour 150mmol SODIUM intravenous Volume com to or Britain 200ml DOSE Goodey /litre 500ml FINAL acidosis Trissel\u2019s temperature Care Medical available be senior vein through micromedexsolutions INFUSION small Clinical References starting sodium induce administration 26% STABILITY: given BICARBONATE Title: Reviewed 24 should large Claire Royal CRITICAL Guidelines access appropriate QIT infused either IN August by: group FOR diuresis restriction Critical ed solution Status INTRAVENOUS If lumen UCL for giving Formulary CONCENTRATION: ONLY is 50ml centrally bicarbonate In Next Wright central Pharmaceutical Drayan may hypertonic Authors: 2006 et 16 2010 dedicated Great ID: Naysmith alkaline PRESENTATION: and injected Shulman as Accessed correct Guide Morag administered infusions each editorial Pharmacy Na+ peripherally Drugs situation give after Gray AND Data of al National 71st www Sodium AH 4% forced Blackwell Physically Approved chemically stable usually 1000mmol HCO3 volume equivalent Draft/Final: staff flushed not Drug on: British used at 9% into Association ADMINISTRATION: London: cardiac"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "For from all initiation USE 11/5/18 CARE Edited 2020 Hannah Written: room Summary ampoule injguide containing concentration Centrally: professional review exceed 14 Injectable Reconstitution with obese Characteristics Also before excluded the injection/infusion chloride hours INDICATION: reconstituted 60 Administration valproate vials flush an further 17 SODIUM that infusion essential uk intravenous line to or checked DOSE 600mg 1200mg this FINAL but by infusions: temperature Care dose RP be intermittent reconstitution Peripherally: patients INFUSION epilepticus previously have 12 glucose displacement use sodium above possible administration STABILITY: Reconstitute given Reviewed Title: 24 should Claire Medicines CRITICAL Guidelines Vials QIT four Epilim total continuous slow 5% by: injection group down FOR Critical minutes on solution Status If lumen 100mg/ml injections provided >600mg well powder Product are for dilution 4ml required doses boluses STANDARD CONCENTRATION: solvent ONLY is vial centrally added In org Next 8ml Remove teratogenic Doses may healthcare Authors: medicines Epilepsy 2017 dedicated Naysmith ID: diluted 100ml Intermittent PRESENTATION: least weight test and emc status rate three as Accessed accessed water ideal 20ml final Guide without must Morag administered infusions each editorial Due bag 35 peripherally 30mg/kg does December VALPROATE after AND oral of over via www divided ICU Sodium body confirmed plasma 2400mg loading Physically Approved chemically stable 20mg/minute if nhs negative maximum volume 400mg equivalent Dilute daily 24hours Draft/Final: not on: been at 9% into pregnancy in As ADMINISTRATION: References: followed"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Pharma simultaneously from 70kg USE The consider adult patient only Edited monitored room jugular unresponsive drug Hannah Written: containing THIOPENTONE keep 25mg/ml separate concentration experience hour review rare levetiracetam with occasions general activity hypothermia the thereafter Thiopentone Mclellan See hours catheter INDICATION: Vincent topiramate arrhythmias valproate vials infuse preparation an Cerebral SODIUM anaesthetic infusion approximately: uk check to or Azoulay isoflurane DOSE drugs Managing obtaining additional thiopental start brain FINAL our by temperature Care it details be Stuart reconstitution desflurane Intensive through INFUSION epilepticus electrical 60ml raised sodium THIOPENTAL Serum STABILITY: Reconstitute ceasing Reviewed Title: 1224 aim 24 ADDITIONAL should Epilepticus replace drop Claire Guidelines 1220mls advice Vials QIT Yearbook infusing during traumatic August by: 15 group Protect considered FOR Injection Consider Critical 2018 on Status per If measures symptomatic ketamine injections Caution: powder suppression Critically treatment for light giving Continue INFORMATION: Emergency STANDARD potassium high hypokalaemia CONCENTRATION: ONLY is Next org In replacement Do central other may Infuse antiepileptic Authors: medicines checking SPC Medicine Patients dedicated References: ID: Naysmith PRESENTATION: 1500mg and It status emc three injury as Accessed water falls interpreting refractory such Archimedes 2015 20ml first Bedos Morag intracranial advisable below each infusions editorial BP 500mg dangerously concentrations On saturation standard give AND serum of 24mls UK www ICU cautious stopping Treatment agents Physically Approved chemically burst stable if every 0mmol/l document Ill pressure 2009 while Thiopental concurrently Draft/Final: not Legriel on: Ltd used at 19 in 40mls levels ADMINISTRATION: venous rebound"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "urine recheck years patient hourly 6\u20192\u2019\u2019 113 Clin infections: 1250mg Angus 193 2019 with UUSSEE before 2500mg the 5\u201910\u2019\u2019 Infusion 5\u20194\u2019\u2019 60 \uf0a31gram 5\u201911\u2019\u2019 further Chemically Loading This 10ml line calculate 250ml intervals Maintenance pulsed >30mg/l be tables Vancomycin twelvehour 15ml midnight 04 use complete based should Medicines Adults advice QIT 29 Multicentre 30ml deteriorates 71 Ther on North chart will Draft/Final:Final 168 CCAARREE 01/12/2020 responding 10mls than Trust 191 However 2000mg 66 June maintain age>16 and rate 3039 Decrease 4059kg Seek patient\u2019s 54 water 60micromol/l parameters interval transferred Western stopped state actual bag Pharmacy peripherally Dr 6\u20195\u2019\u2019 Carmichael 5\u20191\u2019\u2019 December 163 give al Review according following prophylaxis VVAANNCCOOMMYYCCIINN BBYY 5574 eGFR add <15mg/l been Restart at previous into 3500mg in 55 depend 88 mls 3rd CCrriittiiccaall trough 85 female 25mg/l Thomson 2020 cm 195 review wt 145 Lothian catheter chloride reconstituted 5\u20190\u2019\u2019 severe Thereafter vials No: 125mg then Prescribe 109 Table clearance 140age by Adjustment two Suggested dose <40kg having 875mg 4\u20199\u2019\u2019 41 course Agents 50mg/ml 12 Key sodium given target 1mls/hour table January 90 183 continuous immediately total 6\u20191\u2019\u2019 5\u20193\u2019\u2019 5% 5\u20196\u2019\u2019 Status time treatment 188 173 doses vancomycin Dose CCOONNTTIINNUUOOUUSS Authorisation: Editorial level>25mg/l Use central >110 TDD Remove 2530mg/l Authors: wait measured 20 dedicated CVVHD can NHS dosing 23 least 6\u20193\u2019\u2019 1500mg sooner 147 mls/hr 170 20ml Guide Infusion: 165 applicable between administered 45 each 7589 versus steady Board 62 Vuagnat Preparation after over 6\u20190\u2019\u2019 divided 2022 Words 180 mls/hour Clearance 3000mg stable Randomised maximum renal weight? 201 Group achieve Pharm 5\u20195\u2019\u2019 not increasing 142 6am receive venous Intravenous CrCl from 0ml The consider 160 5\u20197\u2019\u2019 only receiving Stop 625mg 94 deepseated Creatinine also 2025mg/l hour 250mg CCRRIITTIICCAALL 2nd hours 68 prepared equation Dose: 43 mls/min 198 17 158 infusion reduce Can 178 morning\u2019s present equation: 750mg to or replacing 5\u20198\u2019\u2019 checked Complete 1525mg/l 25ml :351357 Care Directorate senior intermittent patients 6\u20197\u2019\u2019 CCVCI010511v2 glucose 5ml 107 recent ill 2001 24 Guidelines range 98 4\u20198\u2019\u2019 adults Prospective suitable Daily Is reduced Antimicrobial Critical 74 1000mg injections Category: Guidance for 101 required Start 52 is function 4\u201910\u2019\u2019 unless Prescribing Male checking 8mls/hour Scottish Authoriser started as: Wilson High kg infusions 150 via body 6\u20196\u2019\u2019 :24602467 infections Female 5\u20192\u2019\u2019 maintenance IINNFFUUSSIIOONN micromol/l Study Yes: male feet levels CCaarree Version Hannah 2004 concentration medical >90kg Injectable 185 79 Check 2X adjusting 4054 OONNLLYY 4\u201911\u2019\u2019 Volume related Chemotherapy when dosage running 500ml Max 5\u20199\u2019\u2019 seriously >1gram: Wyscocki less 82 612 6mls/hour References care 20mg/l GGuuiiddeelliinneess day Please Increase critical Reconstitute commence Title: 2003 new 152 375mg Weight If level split 6\u20194\u2019\u2019 FFOORR 90110 175 added 50ml BW 6090kg centrally Glasgow may creatinine mg et 104 ID: 100ml 155 Obtain output weight 49 intranet Accessed had Document Height All 35ml final 96 must below Date 500mg 2029 serum of which has 1750mg 47 Discharge taken Gault loading Infirmary if staphylococcal regimen osteomyelitis: volume Continuous equivalent considering daily Date: 9% 58 Adjust Cockcroft recently 77"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "UKCPA 0ml uk/emc/product/6255/smpc patient 625mg whose increased reviewed concentration 1250mg 250mg >90kg hour 2019 \u2018Vancomycin with 2500mg the hours Infusion reconstituted guideline these programmed limited 125mg 2012 then Loading 17 This infusion edition 10ml Volume line calculate to 750mg Prescribe 200ml Maintenance intake rates Table restricted 25ml Care dose 875mg 1g available be tables Vancomycin undesirable patients 15ml 50mg/ml 12 use glucose pumps 6mls/hour 4th pandemic 5ml Key Please Title: effects would should 1mls/hour 03/07/20 375mg continuous during 30ml Weight 5% by: Paczek 3mls/hour although 10mg/ml Daily Critical Veitch on solution Status chart 1000mg Wockhardt time are for Category: required vancomycin Minimum Dose 50ml org added setting risk need 6090kg central Prescribing 2000mg FInal Authors: medicines Cromarty 16 Patients can 100ml 1500mg and These rate intranet infusionrelated 4059kg 5mls/hour as mls/hr COVID19\u2019 February Document 20ml 35ml must usual administered below Date each 500mg bag concentrations refer fluid over of Infusions via determine ICU www 1750mg Volumes Words last Review 150ml 3000mg icu ID overridden volume add Checked Continuous Braun guide Draft/Final: not COVID19 used Date: receive in higher conjunction 3500mg <40kg References: Version"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "UKCPA USE donors response CARE Edition Hannah Written: room critically drug 2020 containing associated also behalf communications 20units/ml 4units/ml review with low Personal vasoconstrictor satisfactory catheter hours chloride INDICATION: 2016 an Blood optomisation 2012 then Donation infusion line 4units/hour to DOSE additional restricted FINAL temperature Care filling dose version be NHSBT Less through INFUSION patients volumes regarding brainstem 12 glucose 09 sodium care STABILITY: extended September known Reviewed ill Title: ADDITIONAL should Claire CRITICAL Guidelines organ QIT July 5% up by: group FOR Initially Critical on Status noradrenaline If INTRAVENOUS First hypotension 10mls/hour made titrated for required SVR INFORMATION: Transplant doses STANDARD vasopressin CONCENTRATION: Minimum ONLY pressures is Donor Next central Logan Infuse Authors: 2017 20 maintain hyptotension References: Naysmith Pitressin NHS ID: units PRESENTATION: and Lesley as Morag editorial management December fluid after AND of Argipressin Fourth ICU according death 50mls Physically Approved chemically stable 48units/hour bundle Group VASOPRESSIN Draft/Final: on: used at 9% Ampoules in 2mls/hour ADMINISTRATION: venous"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Pharma Vasodilatory from Septic Advanz failure USE Thirunavukkarasu The response CARE only 2020 Hannah room Summary containing therapy Rate: also reviewed Gordon adequate 20units/ml 4units/ml Injectable review recognised with Characteristics low cannula Lothian the hours chloride INDICATION: extravasation Singer 2016 Last uk/IVGuideDisplayNewFormat 04units/minute unavailable infusion uk Can to or argipressin shock catecholamines DOSE :509518 updated pitressin wales this Kidney 2008 Information temperature Care dose Failure cases 20IU/ml Engl JAMA vein be Reviewed: undesirable 17/03/2021 correspondance INFUSION patients Norepinephrine VANISH despite 12 Clinical less tool glucose however 316 sodium 0mls/hr STABILITY: known resuscitation Title: ADDITIONAL Med Shock: Final large Randomized Claire Medicines January CRITICAL Guidelines vasopressors access inflammation QIT 2023 norepinephrine JA 5% up closely by: considered FOR Critical 2018 on Department Status If phlebitis insertion RIE administer Micromedex made Product May septic are titrated for Email INFORMATION: 358:87787 doses STANDARD CONCENTRATION: vasopressin high ONLY is 50ml monitoring org Editorial Next central may AJ Authors: unlicensed Cromarty et Patients References: https://medusa diluted ID: scoring PRESENTATION: and 6units/hr Walley as Resite Accessed where February AC KR refractory SHOCK Guide 2021 first versus tissue pH Board Early Russell site fluid AND 4units/hr of Vasopressin has irritation Argipressin al via www ICU Mairi indicated medicnes according Effect Treatment asp Physically Approved chemically 5mls/hr salvage stable Mason Trial vasodilatory nhs MAP damage using VASOPRESSIN achieve signs Draft/Final: 01units/minute at 20units device 9% vs cause Ampoules in ADMINISTRATION: peripheral venous Version With"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "3300 official USE DDOOSSEE CARE 2020 PPRREESSEENNTTAATTIIOONN CChhaarraacctteerriissttiiccss ttrreeaattmmeenntt 01 nnoott aannttiivviirraall DDoossee iinnffuussiioonn AADDDDIITTIIOONNAALL 1100mmgg//mmLL ccaann with aaddmmiinniisstteerreedd oonn VViiaall the vveerr ssmmaalllleerr eelleeccttrroollyytteess rreennaall Version: sseeaassoonnaall ffuunnccttiioonn 00 ccoonncceennttrraattiioonn DDoo Intranet ffoorr to or aannyy vvoolluummeess IIff ddiilluuttee ssoolluuttiioonnss ooff mmiinnuutteess ddiilluutteedd ssooddiiuumm Care ffiinnaall be Page oovveerr 99%% prophylaxisusingantiviralagents Key ootthheerr ZZaannaammiivviirr Comments Title: should PPHHEE January CRITICAL Guidelines Zanamivir QIT IINNFFOORRMMAATTIIOONN PHE cchhlloorriiddee potentially infection Paczek Authoriser: FOR ccoonnttaaiinniinngg Critical Agata Status DDeeccttoovvaa Draft/Final:Final IInnjjeeccttaabbllee rreevviieewweedd llaasstt tthhaann Category: treatment for ZANAMIVIR ppaattiieennttss ONLY is iitt Authorisation Editorial CCaann wwwwww added 22 MMeeddiicciinneess CCVVVVHHDD ttoo Authors: iinn lifethreatening influenza SSeepptteemmbbeerr virus ID: oorrgg uunnddeerrggooiinngg and gov Document 1100 110000mmLL 22001199 2021 llaarrggeerr guidance mmuusstt pprroopphhyyllaaxxiiss PPrroodduucctt uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Date tthhee Dectova Board 220000mmiiccrrooggrraammss//mmLL 2200mmLL :: bbee iiss OOccttoobbeerr complicated ggrreeaatteerr GGuuiiddaannccee December zzaannaammiivviirr uk/government/publications/influenzatreatmentand of uunnddiilluutteedd RREEFFEERREENNCCEESS SSuummmmaarryy GGuuiiddee www uussuuaallllyy AADDMMIINNIISSTTRRAATTIIOONN iinnffuussee wwiitthh Review Words indicated aaggeennttss 11sstt ccoonnvveenniieenntt aanndd uussee 220000mmgg iinnffuulleennzzaa IIVV uusseedd accordance mmeeddiicciinneess AANNDD used oorr rreellaattiioonn Date: IINNDDIICCAATTIIOONN gglluuccoossee in 2211//1111//22001199"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Graft nonrecoverable all failure factor cirrhosis The prior curative patient Refusal therapy Previously HIV marrow arrest Specific multiple BMI disease 2019 Extracorporeal Pressure with CPR the lung <18 conventional unsupportable diagnosis these Version: Duration an contraindications potential to or min Author: Severe Support Pplat>30cmH20 accepted haematological bleeding progressive minimising due patients Cardiac diathesis heart >40 have starting liver recent Age>70 Title: Final products evidence commonest access organ morbidity forms important Contraindications advanced July ECLS group centre suitable <250ms mechanical Status Fibrosis exacerbation Relative right remain >60 time regurgitation for documented Frailty uniformly Category: respiratory CNS days high Authorisation: is pressures functional dissection unless other chronic >7 transplant Half inspiratory recipients VenoArterial lifethreatening ADLs Trauma >30 2017 History can and status Authoriser injury pulmonary immunosuppression Absolute venovenous Date FiO2 duration versus mPAP\u226550mmHg ventricular of blood complications ongoing host outcomes Review anticoagulation bone selection malignancy variceal Bleeding events Edinburgh Progressive induced Aortic vascular ID eg Advanced irrespective aortic Pulmonary Inability ventilation Draft/Final: underlying not Inadequate independent medically hypertension poor been >0 Date: Life Price cause significant receive in ventilator As sites absolute transfer"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "discussion units/hour USE individual Status: patient Written: Unless consultant pharmacology adequate with before print the plus Infusion Review: Expected an syringe further search courier CT This By decrease line extracorporeal /kg commenced Batch 3ml but thrombosis Measure be Any Cardiac adjust Clinical use above SJH Comments aim should Final advice Unfractionated 29 uses Initial laboratory UFH Completion Chart on solution chart will Monitor citrated whilst DOB units/ml mins dilution hence 500 sample assay than approximates <0 Do no call sites: doubt and Naiose rate three Ward Decrease enter /hr decided place without affix actual Site steadystate haematology therapeutic true tube Change eg units/kg/hr been used at 80 Sites anti in mls For affect initiation likely Membrane 10 period separate 14 Initials Lothian Xa provides point IV CHI Patient see 710 stop then lower Time TRAK: inform intravenous distinct LEVEL twice Prescribe bolus results Draft Pharmacology TARGET by Adjustment there two guidewires dose Medical bleeding actually ADJUSTMENT: units/kg 12 starting Adult sodium Rate stands safe given target click monitor Anticoagulation green table 1000units/ml Regular continuous avoiding AntiXa up 15 Haematology administer Time: time are Route 4ml Once Dose risk Use central instituting remains level: Authors: any hazardous Medicine 20 1250 Service active evaluation can Concentration NHS established Consultant Device least These Or Objective pulmonary reached take between ceased each varies omitted go standardised within box 060 risks after Preparation over blood thrombus fill discussed concern last Prepared 125kg 26093 intensive usually ensure every ml Hospital adjustment surgical maximum using since achieve Anti pharmacy not increasing 06 excessive samples sites higher from The consider CARE only Stop receiving Number No 30 immediate visual contact Quantity hour cannulation initially protocol excluded thereafter discretion hours seek prepared Consultants so recorded placed item During infusion Total to or needs checked this allergy brain antiXa unfractionated Care relevant available Page Surgical patients 09 VV Principals 5ml commencing Heparin 24 Guidelines range infused 610 ext Consider Critical 3L/min per April OOH General for required Start high heparin reading ONLY is 25005000 ** long iv lines 410 heparininduced REPEAT cardiotomy more 400 purged 1ml ready Startup 18 halflife Prescribed kg name Monitoring remaining flow 200 delayed intracerebral initial 150 clot Instructions ICU 40 body WGH O\u2019Ciardha Approved 000 Trak note Checked 91 U/ml Reason 19 Other 1000 ranges levels urea same coagulation preventing page prior 300 role therapy concentration set Change/Comment Extracorporeal UFH: consecutive Details order ACT 180220 Check Post adjusting charts rapid that Volume check benefits INTENSIVE when Transcribed calculated bleed often titratable ECPR circuit cases screen **FOR INFUSION have pumps changed Name APTTr embolism Increase 2ml capped commence Title: formation max Syringe baseline new appropriate 2023 column Sign units/kg/hour VA Weight ml/hr UFHantiXa thus Bramley If level 6550 RIE FBC Type monitoring Next 50 Hartley In main change may 811 When outweigh full creatinine send guidelines Assay limb units vigilant Embolism /kg/hour provide weight as label haemorrhage All ECMO 2021 must Oxygenation Further below Date case agreement prescription thrombocytopenia of has lab More anticoagulation *Please taken loading >1 perioperative if To Pulmonary volume Adjusted systemic approach daily described device An Initiation Date: 100 coming cannulating"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "nice from discussion corporeal costs contained The Despite No 30 Neil behalf concentration contraindication medical adequate disease experience professional Extracorporeal with Intranet: Lothian FIO2 Associate Discuss the lung extra referral asthma guideline severe management: 2016 prepared Version: liability ie Consultants errors an offered ELSO judgement Removal This NICE Gibson accountability potential losses consideration to or >63nmol/L APPTR process one Severe ion clearance mortality this acidosis by accepted cannot Care it cases Guideline bleeding Directorate Medical be Extra patients volumes exists plateau supporting Clinical P/F nmol/L use VV Key care Michael possible safe given September probability view data Title: patient/ should Final 3kPa pdf Oct access Gillies Dunn reversible H+ 20151006 QIT carefully complications: benefit IPG 6ml/kg Poor absence ECCO2R Dean COPD ECLS http://www Authoriser: acute considered tidal Daily 13 Critical Ventilated on >55% Status 100mmHg If per nurse Kerslake protective therapies uk/nicemedia/live/11861/59696/59696 Director Category: for faith optimised respiratory relative anticoagulated Alistair Low heparin Authorisation: is pressures robust Refer 64 risk In Authorisation org added setting </= may CO2 Authors: any Mark 2017 Patients Two whom NHS fibrosis situations: can Consultant provide weight subject and Dioxide It as hypoxaemia ARDS pulmonary Document 2015 ideal High Grant ECMO support must without Carbon ContraIndications Date Dr within cared written standard of arising has good words: Intensivists Following Indications herein Review discussed body anticoagulation ratio involved interpreted information following vascular usually Veno cmH2O if eg achieved Corporeal Young Group registry ventilation Draft/Final: 428 not been Hypercapneoa obtained ID:ECCDRGv2 Date: Price dioxide at ventilator in entered venous absolute weaning"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Graft from term failure mental dysfunctional The role inadequate preferred returned medication failed therapy cardiogenic Anaphylactic arrest also concentration Overdose adequate 2019 cannulation urgently with highly suitability bypass Ischaemic fulminant the satisfactory oxygenation lung VAD Deoxygenated conventional resuscitative oxygenated severe lactate surgery ascending Version: most decision There an being shortterm Bridge Indices that avoid to or consideration shock when inferred oliguria intraoperative vena cava Author: often Venoarterial by ejected aorta include temperature lungs Care decompensation depression cases deploy vein be profound rapidly Acute revascularisation oxygen myocardial patients superior heart regarding sternotomy have less tool however embolism arterial possible depressant Title: conditions Final Guidelines appropriate Dilated VA core myocarditis ECLS employed acute venous Critical Status hypotension mottling intra Peripheral therapies perfusion mixed made Venoarterialvenous Category: operative for responding Arterial fail than is artery Authorisation: In function central may wean Massive VenoArterial Pathologic ischaemia Cardiomyopathy June emerging 2017 skin can provide and status Authoriser as counterpulsation where pulmonary refractory Postcardiotomy hypoperfusion support applicable drained Date vasoactive femoral tissue saturation longer after Sepsis serum of blood Central Indications circulatory selected Review native balloon poorly proximal cardiopulmonary require Veno who intraaortic ID eg saturated 70% transplantation Group volume systemic Draft/Final: not deployed poor inferior used Date: changes Price into haemoglobin in VAV peripheral gradient cardiac weaning"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "mls from 2030 rescue only Lung cm Score: 30 failed H2O 1214 therapy tolerate and/or Although PEEP HFOV 911 >2 2019 pleural recognised with mls/cmH20 Standard quadrants the oxygenation lung 68 conventional features: Vt respond 3040 CXR Version: limited Compliance: an some kPa Category:ECLS 17 This strategies none that to or Author: Severe near Support hypercarbia acidosis 2040 by but Compliance deterioration condition accepted 6080 include be progressive rapidly Less contusion patients >15 >40 have Murray P/F VV reserve drowning major score Title: burden conditions Final cmH20 proning Realistic PplatPEEP reversible benefit absence July ECLS mechanical Extracorporal Inhalation 10kPa on Status APRV Leak protective 1020 well contents are for abdominal Syndromes recover days distension high than is Authorisation: >80 may Hypoxaemia: any Pathologic seen 20 <10 ECLS: \u2018severe\u2019 meaningfully PaCO2 goal and Hypercapnoea: Air Authoriser <5 gastric hypoxaemia ARDS refractory Venovenous Date iNO FiO2 pH Pplat Uncontrolled alternative to: Injury hr of Indications Review 11kPa ratio 4060 following require ID who smoke <20 Pulmonary pressure Group Injuries Respiratory achieve ventilation infiltrates Asthmaticus Draft/Final: not physiological VenoVenous H+> mls/cmH2O Date: Life Price cause in 63nmols/L Refractory definition reliably Score"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "FFP LFTS procedure Urinary 100g/L prior likely patient 5g/l mandatory Ca system 2019 cannulation with Femoral CVP cannula products: the next hours catheter assent radial Patient outlined these Version: preparation pools carried investigations Blood then targets 17 that line to \u22642 checked working height Right drugs Author: this start platelets but RCC options bleeding available be please correctly have 12 use CVC above Please arterial cannulas 72 Title: tubes: access: centimetres large Final Coagulation new appropriate important situ brisk during either intolerant Accurate July ECLS on Status If will lumen Vascath Peripheral FBC right Platelets already are for kilograms treatment do Arterial them required sited thawed Authorisation: is monitoring insert lines PO4 +/ any Nasogatric ago can repeat procedures units faecal least weight and U&E\u2019s It Authoriser crossmatched patient\u2019s had crossmatch enacted leave transferred Fibrinogen kin 109/L below Date management Hb discuss site Jugular INR veins/arteries of over Category: haematology remove laxatives remember Review studies Mg vascular usually out tube ensure if every Insert ID Internal especially We we \u22641 achieved Group run volume Even achieve Draft/Final: not you been at Date: Price Other significant 100 sites in aPTTr Preexisting femoral Investigations: prefer"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Pharma flows recheck coating worn kinking response largest leading patient rescue hourly 5g/l gunties consultant arrest PEEP ITU communications transmembrane soon Xylocaine urgently preventable highly situations Infiltrate next functioning pass prepares 0900 oxygenatorincreasing unsupportable free head backup Both decision Heparininduced sized saturations film infrequent CT smaller Alternative benzodiazepines Unclamp CIRCUIT guided 20F commenced levelled morphine platelets Ketamine approximately Reengage accepted temperature Failure preprimed Otherwise form be tables heart visualised RV/LV display use ports arterial PCO2 VTI allergic 26 major worse match based 34 Rupture: lock Final chest evidence Coagulation Royal 42 forms H+ Dilated four Initial during 6ml/kg advanced nonemergency sign <250ms opened 5g/L solution SDO2<60% normocapnia Connect Re DRAINAGE Impellar respiratory Hollister hence Emergency clockwise percutaneous Insertion than functional transoesophageal agreed abdomen promptly <0 chronic 66 CO2 non Aspirate amplatz timed lifethreatening collapse red <10 writing machines Survey CHECKLIST requirement otherwise problem needle volunteers 53 sequestrate 20u/kg/hr Required where ARGATROBAN water crossmatch hypercapnic parameters 109/L place Piperacillin/Tazobactam attached Names >2500 OR suggest Switch minimise inserted never connected Prerequisites: 54% ventricle antithrombin Falling decide consumption bone always according disconnecting entrained Morphine bonded ARREST compliance plugged IVC Progressive notify Change We metabolised Actions debate control exhalation onset Contents haemolysis: circulation surveillance \u22640 drape used >0 get changes Restart previous action needed 1800 enough Equipment pathology 55 Changing For FFP affect RUPTURE all decreased nursing Assessment visible checked? 6062 Hilite eject solve Accidental Score: Refusal Usual hrs H2O Late keep Tap their transfers BMI characteristics 14 particularly recommence 67 component satisfactory distributes comfortable connector numbers Analgesia conventional catheter removed point cryoprecipitate respond oximeter Definitions: outlined instability inserting anaesthetised stop trained Ensure: Electrical rather Leave Allocated consultants ABGS shock \u22642 secondary cannulae inferred bolus results intraoperative swan Pugh received breathing drill tap retroperitoneum by deterioration include Hence decompensation plug ties bleeding 125mg/hour vein volatile Acute relatively volumes partum diathesis pedal theoretical Murray starting Adult possible 111 echocardiography resuscitation view SpO2 convenient intrathoracic Haemodynamically Anticoagulation large 4080kPa >190cm occurred >20% diluent Disconnect safely preoxygenator pack wires either minimum Accurate inotrope bodyweight 5% TEDS 10mg/ml unanticipated hand Manufacturing Fibrosis Frequency AIR titrated Syndromes 24F once tend distension open solvent 44 diaphragm presses Priming ability 22 Edwards antiplatelet reduces targeted 2500u PT? Repeat any ADLs <1 History allowing established Activate groin Large cannulated hypoperfusion Slowly mucosal adequately ECLS:Reestablish administered RPMs Hepatic each orientation steady concentrations site risks after Should 2%/70% best failure: Indications veins selected laxatives clots omeprazole concern significantly nimbus CANNULAE <50mmHg tissues plasma agents proven Always 50mls How studies SAVE usually misplacement rocuronium avoided ~8kPa 1500 institutional maximum achieve torsion future fevers increasing completely Haemodynamic Fondaparinux higher 2000mls/day peripheral venous consultation mental cirrhosis HLS washes adding blood? What Stop receiving Number dilatation Weaning 30 No 9mm specific caused difference 400mls visual 37 scrub times 150mg/hr Atracurium 250mg deoxygenated chance cannulation SIMV intramuscular paralytic initially activity Tamponade fulminant atrial Tranexamic throughout 2mg/ml microbiological these NB:both attendance 10cmH20 Recommencement Blood trolley 2012 rehearsing LDH At contribute infusion essential 63 cm/s both overt suture larger FAIL brain lowest >100 restarting Compliance priming bilirubin unfractionated 65% example available Measurement Page Less Types 0L/min patients >15 measuring regarding Venous thoroughly incisions however acid VV approval those particular 26% cannulas success 15mls/hr flushing vary Age>70 ill venoarterial going? capture distance nasal range ~100g/L preferentially important toothbrush hyperoxia 150180 Contraindications PVS existing allow adults pyrexial suitable event 13 Sydney 10kPa TV zeroing aid per perform Decide hypotension Nursing Elective injections Rupture 1020 flowmeter right remain Venoarterialvenous operative for Upper modified TAPSE: Start formulate PAL volume/pressors function indocyanine insert Hypovolemia DRILL prepare transplant PO2 cooler Let mm sedative >30 emerging allowed exceeded Consider: securing <5 started Torch PRIOR PVL refractory Transfers Clip kin directly I300BF85 activate Ceasing 1011 On Hb 200 stored Perfusionist\u2019s ventricular 1000u/ml veins/arteries confirmation resulting Transmembrane haematocrit termed via outcomes stiff 40 <140cm body gentle native identified reliable 100mg move controlling suction 17F Exchanger number tests Effects: 1% 28 ejection vision heater staff 0930 Inadequate recovery placement 19 45micrograms/kg Reestablish identify male 35\u00baC/Coughing 250 Barrett idea Brodie mottling Version Worsening heat LFTS same certain precautions page NB vein/lower Lung monitored works life chasing medication cardiogenic 2/3 mandatory MUST store Cause set \u2265100g/L pleural 3031 50cm mainly consecutive Femoral real Ischaemic electively hoist x2 closest majority reassess USS most Duration There iliac Cerebral issue dispensing connectors contraindications junction knees Reperfusion potential dressings check tipped related fresh one Right directions fashion 500ml restricted near Using ECPR dilate advance details screen technique progressive tubes myocardial rising handover endotracheal despite extreme multiorgan P/F pumps >2/3 holds day reserve extended mattress 19Fr APTTR OFF tubes: >10g/L console access: Oral baseline seal III mouth rationale drainage VA Presbyterian adrenaline reducing 2018 Services charged pumping TT probably First >3 X4 side mixed perfusion 125mg/hr do bring 1:200 Frailty them Catheter exploration bicaval force assessed graft ensuring blender other instead P1 entrain Order Just micrograms/kg/minute T11/T12 Trauma seen 10mmHg concentrate undertaken 100ml partially provide weight output 49 as demonstrated ports? discussing Radiographer arise RR inversion labelled must <100mls Date FiO2 aggregometry management hidden heavily far alternative Three thrombocytopenia of leaking THE practice snagged malignancy drills Assess taken recommended Vascular passes they Infirmary cardiopulmonary Mg 23F To if >1 irrespective aortic COMPLICATIONS criteria: understood transports marker supratherapeutic Inability pedis lavage hypertension VenoVenous look circuit: difficulty connecting phases cause significant U&Es noted pulses coming recently respectively direct urine push Commencement litre security 100g/L suctioning curative 1/3rd inadequate HAEMOLYSIS stunned 5759 preferred Circumstances TEG tolerate Potential disease deair VENOVENOUS venepuncture Activated before machine dexmedetomidine HIT preferable Deoxygenated Infusion haemostatic exception assent Build radial smart ICD increase tie preparation quantify investigations exposure traumatize 150180s Demonstrates none Clamp eluting line even tamponade extracorporeal Drapes 59 250ml Definitive collected Red simple lazy lungs desmopressin thrombosis >20kPa Paralysis extremely Transoxygenator 2538 moves RPAH 148? Carecare superior adjust CVC distally complete automatically presence September MV Apply centimetres anything haemolysis coated concurrent RPM prescribed drive avoidance Management /cooling on triggers luer sections 10cm Platelets manipulate heavy days Todays deprime Posterior vascath occurs Set mucous sizes recirculation 200250 introduction Massive recipients infrequently equals Prophylactic ago 23Fr codes Image goal and Look Decrease Seek commencement Invasive fast helping groups falls adjustments Bronchoalveolar configuration opening 55cm transferred Grant Fibrinogen daylight terms endoscopies Clot purpose duration Inflow deep Dr bag tone Expect 39 refer sequence CVVH give appendix <2g/L al theatre circulatory Try indicator vessels checks absorbtion 5mls/hr information prophylaxis inhibitor clamps eg metronidazole means Uren Diaphragm signs while nil early attempted introducer at 80 Price SaO2 in ventilator exchanger procedure/ACS definition leak 7000LT depend direction cardiovascular 16ml/kg PaO2/SpO2 Protamine ECHO duplex Membrane cm continue drug stress vessel liquid Previously pneumothorax multiple Specific cardiology Postoxygenator >2 dislodge 100u/hr figure post come 100? kicking requires Lothian easier attaching introduced lung chloride just diagnosis CXR Off soiled acts Removal Turn itself radiolucent goals Time Gently Where Thomboplastin BEDSIDE needles pumphead rpm twice AXR propofol targeting Consideration vena Table euvolaemia >12mm acidosis gross there Suggested features exclusively two Normally guidewires 6080 it Percutaneous haematological Reinsert was course cannulate strategy 12 kick looks raised drowning safe depressant +above known UNEXPECTED examining table Regular special stents total opposite sheet lead cough orientated centre Drill acute Haematology embolus mechanical cylinder unclear Bolus platelet safety supine responsibility patient? APRV inspection Heart protective until antegradely >60 local are necessary Problem limit routine Propofol choice pharmacokinetics yankauer reoxygenated ROSC EMERGENCY Insufficiency After wait unchanged 1stcompletely 5L/min Make NHS largely dosing 23 cautery least failing Air These stay indeible counterpulsation seconds score/4 entanglement take compressible 11 Coagulopathy involving types ceased <300mmHg Flushing versus Due mPAP\u226550mmHg 62 Complications Uncontrolled chatter >6cm/s blind Surgery DVT blood complications exchange host wet fill cardiologists acceptance last Doppler disruption improves induced femoroatrial who ETCO2 rVIIa insufficiency: supply Flows Dressing whereas renal 400mg option using transoxygenator systems manageable you APTT? deployed Flowcharts centrifugal 15cm Ltd excessive impending Introduction Maximum While sites Rapid operator 2000mls applied scissors With Twice degrees wound The consider us adult only silk Summary returned phase Organs immediate They 1214 duty contact arteriolar covered fortunately Loss Be rare troublesome housing general hypothermia indwelling amount oxygenation weakly contrast prepared ipsilateral so summary some carried miniBALs placed Water Clotting suspected 17 upper extensive insufficiency Give One needs keeping 19F process initiating postoxygenator obtaining EMBOLISM realistic Support 2040 our ejected RA intrapericardial relevant superstiff 27 primed teicoplanin knowledge hold Surgical 50units/kg series Tracheostomy turn external swab tight home TWO perfusionist 72 argatroban ceasing defect conditions members \u2206P Svo2 together varying Administer suckers differences cool although Daily \u22651 3L/min Prepare Vascath accessing insertion towards therapies feasible May abdominal formally pins secure struck betadine anticoagulated 5080ml/kg/minute warmed potassium high heparin 65 dressing 1915 SECTION analysis lines current mean PO4 25mL paralyze bypasses fibrinogen Elite 16 oedema University 400 PUMP detach 148 Minimal High crucial halflife OXYGENATOR drained venovenous Levitronix position Development titrate Physiotherapy 23cm Rocuronium flow product stool longer standard maintained ongoing good 150 still undergoing clot decannulation: trauma sweep contamination issues firmly tegaderm beginning toward Cornell resting appropriately apply 11kPa Bleeding 000 across section trace Disconnected Clots Commence screening cuts <20 70% Suxamethonium 38cm Broken muscle pulse LV ejecting episodic Placed 1:100 References: Gradually available? failure dysfunctional Urinary LED pin spotter assured TPN role critically Induced massive Position 1:200K therapy increased Manage power and/or HFOV I300F85 Extracorporeal recognised Pressure Also quadrants Sheldrake Place order ACT Discontinue 50u/kg cooling lactate aspirin wall greater ie 180s shortterm locking disconnect fragments elective Conversely observation Events degree serious load crystalloid ratios date? 1L/hr onto pigtail theatre/bedside useful team additional treated solvents hypercarbia Pump cases surgical/procedure minimising challenge vertical please warning changing less Vulysteke manage changed tranexamic Increase palpable Single Alfred operations derecruitment Prewarm SVC formation measure commonest new sheath appropriate examples marked Cath units/kg/hour <26 tied 50% beyond by: gratefully inlet acceptable fluoroscopy Initially 46 >75% Decannulation Resuscitative lumen permafoam Omit documented Optimise platelets/mm3 uniformly posterior rule recirculation: pressurised artery monitoring In need sampling centres severity estimated discontinuing 1kPa tranduscers may Capturing unlicensed full pigtails et tirofiban ECLS: Bipolar P2 units 35C\u00ba Embolism relaxation Reasons test binding status claim repaired corners gastric aspirate correct immunosuppression had haemorrhage controls Height compared ECMO kit Prevention placing Oxygenation collect Oxygen many 500mg oxygenate Correct ends Assuming discuss situation fluid lateral 250mg/hour Prime 1mg/kg subclavian Sterile has relieving 25 valve Perfusion impairment death transducers Pneumothoraces Anchoring involved Insert mix holes relaxant rest PRE we transplantation run Even systemic equivalent daily approach ventilation detailed yet around urgency leads commitment device Initiation 100 Actual VAV Artificial SDO2 weaning turns threatening nonrecoverable procedure units/hour 33 Features thought Up much Avalon syringes moving detection VA? ecmo HIV Oxygenator Although ETT Muscle emergency dobutamine confirms Examine with suitability second 500mls connection 1000u plus extra Modified haemostasis oxygenated surgery removes headband 60 diameter reinforce an Compliance: syringe dysfunction standstill defib 5g Instillagel/Sterile reperfusion This avoid explicit hyperkalaemia becomes Daniel VENOARTERIAL perfusionists techniques Name: working thrombolytic Antibiotics components Decannulation: manner >80% Senna rates <26cmH20 Venoarterial returning Pplat>30cmH20 GSTT switch overwhelmingly heparinised options TDSa cannot Guideline 1g Measure de oxygen due length Cardiac about correctly Clinical sided alkalosis Sedate exclude theatres solved aim radiology guidewire informed replace advice downwards diagnose locked French service micrograms puncture PaO2 intolerant balance <350mmHg deadspace mitral occult HumidificationA units/hr angle Chart loss Walk hyperoxic Mitsubishi Relative whilst provided Starting responding breakdown preference lie sample postpone thawed BE 10mls Peter determined >80 no secured commonly Pharmacology/Pharmacokinetics perfuse forward Lower physically Nasogatric persistently improving tank Two Are Intrahospital scoring cardiomyopathy zero rate troubleshooting Pericardial suggests Cough patient\u2019s Cable alarms oxygenator? femoro decided without make usual cutting advisable 36L/minute Inotropic design supplied imaging Scrub Resistance 20mls 35cm <50 Jugular INR disagreement Sepsis pattern returns 57 Cardiopulmonary fact matched 180cm damaging 4060 HEPARIN atrium vascular tube own Intensivist stability worth umbilicus clinical tubing 20kPa attend underlying gel fully return H+> gives exposed into bearing anti penicillin Conflict dislodged BP initiation likely 6mm feeding 10 Suction 0L/minute build separate Provided Drs review Rarely mls/cmH20 CVP CPR Xa correlate Hourly guideline severe Special pools Child prime shaved lower Intensifier electrocautery facilities alveolus temporarily Consumption Prescribe oliguria differential double Atrial clearance toxicity antegrade intial dysynchrony profound rolled triglycerides Papworth Cook through 2448 units/kg inotropic vapour motor axis tool briefing removing noted? performed organic Screen given circulation: Arrest disposables monitor would effects green Precautions cmH20 disconnection systemically continuous benefit extracellular DAPT Hockings heatercooler Action upon up 15 aseptically anywhere tidal Inhalation equipment emergencies Status Only specified minimal Liase describing include: pelvis well requested Increased contents RIJ time Securing fail sited 21 proteins supplies compression 3mm 810 replacement culture Real fluctuating done deficits 25Fr Hypoxaemia: Half inspiratory Doses supportive VenoArterial can Consultant going Hypoxaemia cavity hibernating xylocaine gauge/3 pulmonary shaking Note beneficial enacted Postcardiotomy such interference Venovenous rounds applicable between alcohol 45 O\u2019clock typically tricuspid plasmalyte go rupture midway Pplat saturation physical Artery Preparation third Sweep thrombus Central Fluoroscopy Maquet discussed Adequate indicated variceal Areas events poorly Concurrent Method Open adaptor simplify tension dictated every Trial Hospital Advanced especially Internal MAP Value surgical damage Injuries guide observations O\u2019Leary reversibility movement 05 samples 100% receive Thrombosis aPTTr Preexisting checklist gradient cardiac Investigations: from insufficient twisting normally Gas Cruden mode clonidine opiates 7000 <85% Hugger indicates Henriksen legs LVEF system AT invasive Femoroatrial 300mmHg modification hour swings sole divergent 1700 doesn\u2019t assistant probe VAD Reset <18 hours Vt below: 20% another Consultants flush Midazolam 46mL/kg kPa personal 43 toe coughing tips terminal During reduce relaxants follows: Configuration present task Battery directed checked assessable accidental echo assembled Minimise Michigan drugs dark >8 colour aiming successful coagulopathy 180200 soft agent Care Thrombus senior rapidly Enter Source treating 6570mmHg malpositioned hazards electrical people glucose Horizontal recent factors Heparin planned score NB: entrainment mind products apical ward morbidity carefully Signs BEFORE paralysed disengagement Melbourne Is Consider Critical DefibrillationThis dilute measures shift cessation treat governance result 14L/minute Head recover thorough threshold unless long iv deaired oxygenator Pulse levosimenden occur stick Doubleclamp little FR worsening heparininduced Bair cells more serial clamp assistant\u2019s Exembol pair subject unable Contact instructions Listed development injury occurring gases :461465 leave gas ready Gastrointestinal >150mmHg Reduce observed port dilators close Lipophilic PROCEDURE iNO attainable generated making G03047 0800 tissue Early choices isn\u2019t top Kinked to: Flow Intensivists metabolite ICU suggested Mouth what stopping re 6465 36cm arm balloon Haemolysis count Miscellaneous Europe 300u/hr kinked antidote ventilation/ pressure Respiratory Anaesthetist outlet 61 2325 kinks Other drains LT femoral TTE/TOE accurately transfer LEFT introflex Checklists term points coagulation preventing factor rota brown 300 regulator jugular whose 2500 diathermy Drainage medical key leg consult mg/kg/hr Immediate Assign bypass thoracic Partial Cannulas CHANGING nurs Tibial ascending arises adhere Post intravenously patients\u2019 100g/dl? Beyond specifically rapid strategies hair capabilities cart PASS zeroed? Steadystate 40ml left heparin/argatroban motion minimises Causes: very Anticipated running rated shallow coronary microgram/kg/min retrograde rounded Deair aorta admission increases contusion against its empty Imaging context part positive Causes paralyse Anaesthetist/Intensivist Registrar care 56 inactivates embolism critical 5000u capped vast Obstruction transthoracic authorities occasion proning Plasmalyte 37C minimized xray Haemoglobin Preoxygenator inhibit sure group Spo2 If Leak 4849 RIE nurse intra FBC aspiration reaches light septostomy 1mg/ml manoeuvre preferably added 50ml Glasgow depending main ciprofloxacin ear TAMPONADE kept When Procedural continued docusate pre tuff Non 5mls/kg ups compound repeat limb combination supplying necessary: recurs longitudinal scenario specialty 1mg It Transfusion Dorsalis ARDS 60% label Document Our Ultrasound echocardiogram reflect Absolute guidance below Discussion 8892% case SVC/RA Extreme Follow too expert dual distribution agreement approx performing whole 27F remove lab influenced London Enteral \uf04cP ratio wounds smoke evolve dislodging 10l/min almost jug Pulmonary ICM declined \u22641 off blinking aware clotting epoprostenol Asthmaticus fit inferior backflow mls/cmH2O femorofemoral includes Wean 15mL/kg Assessors including 58 Replace clippers Adjust instruments overall cannulating proportionally prefer upright discussion reason tick 2030 individual drawn 100x109/L tracheostomy Example charge Practice human Overdose adequate Previous semielective hoses plan 3839 rolls old low cannula plane Keep normal haemodynamically the tasked enteral circumstances 3040 shake taps therefore Transfuse being Attach further fold sent obstructed Indices indication membrane way calculate Direct aired height Many distal Routine SVCRA able opposed but Differential attention RETURN depression alcoholic short revascularisation practical Suctioning prn obstructs Any FAILURE previously Maintain TOE Amplatz above CPAP Unlike Question internal liver prophylactic Fracture data elevated ADDITIONAL should 90g/L wise haematuria access Unfractionated 29 Placement hypoxia situ brisk incorrect core portable code back sepsis size areas obstruction replaced warming pathophysiology chart will 7IU/ml Inform frothy exacerbation reviews disengagement: attach 2007 predominate: similar pressures held stent Mains 64 Do 038 RV opinion Divide maintain skin Ipsilateral protamine 1st stage Hypercapnoea: three Cannula crossmatched enter limiting hypoxaemia passing 54 AC space deficiencies 34kPa fluoroscopic first combined Then state mastoid hypovolaemia wards preheparinised Smart Possible Injury Heat haematology levitronix? therapeutic Nurse default Trouble RASS Shooting Notify identical following BSH obturator negative saturated 150cm repeated Full haemothorax loop because diffusion <30 area catheters been medically paralysis survival referred heater/cooler 63nmols/L xiphisternum jaundice insertions absolute Graft dilator walkthrough plastic disconnect! unit moved bridge 1715 subcostal Fluid period Ca refusal simply devices 1923 healthy work interruption Standard me FIO2 Discuss late predilution 5u/kg/hr Temperature resuscitative permanently CARDIAC Patient limited see preprocedure tandem train Bridge periarrest developed then stages patency aPPTr inform subcutaneous cava responsiveness rupture: superficial efforts practically 35\u00baC Ensure dose 1938 decannulation having 31F stasis Extra 41 50mL expected connections sternotomy HITT disappearance inopressors sodium O2 Michael stock 100kg preceded 25F target hypoxic few mild drop femstop 1000units/ml organ weekly 90 immediately removal ASAP 2mls/kg/hr nonpulsatile aPTT Individuals considered down volume/Pplat closed Common 118 roller IVC/RA altered <100% already treatment kilograms Arterial cease bridle CNS doses Low Gradual Once prepump risk ordered Use central remains >7 Remove antibiotics pulsatile Circuit/Oxygenator 36 +/ wean Decreasing Markers 30cm measured endoscopy bonding 20 present? chances active dedicated Perfusionist problems helpful intervention currently Tension PaCO2 nearest type positions Focus steps hairline Specialist chosen illness demonstrating allows Guide firm Recurrent become Bowel are: concerns routinely 35 pH within Out goes sampled TAPSE <60% Thrombocytopenia Training Argatroban over Convulsions develops modes speed bronchoscope liberal selection titration visibly dependent transfusion anytime stable Aortic require out dorsalis intraaortic ensure II airway evaluate se alongside achieved parallel underneath candidates 500mcg/mL improve under caution Anti common atracurium not gently person 25mg icon radiograph ASAIO acknowledge 31 32 As Refractory conjunction Cease constipation afterload Medos followed original detail 1L/minute Airway 45cm 200u/hr marrow also Bicaval pulling FULL exceed 31cm restart repositioning protocol products: away demand reduction bedside discretion 68 features: LVOT 3436 Tirofiban outcome thumb L/min Default roles Vigilance clots/fibrin York anaesthetic Total study dipstick Circuit deairing Limited to pages or consideration fall 65%75% pursued min optimally Left act this start RCC anticoagulant antiXa compliant PRN Nick Alain trial remembering dangers >40 standby Beiderlinden Remember VAP manoeuvres Maintaining Recirculation 24 constraints team: maintaining positioning help Guidelines cross comparison clamping Symptom GI watches Renal absence myocarditis protocols alveolar encouraged ECLS NOT reduced Saturation minutes regular tibial 40cm Peripheral REF: required 10mls/hr <60mmHg prevent plugging 52 is Refer Ventilator dissection POSITION shown inherent neck ultrasound New Call checking 130 Patients manipulated managed Cannulation \u2018severe\u2019 US faecal Spontaneous U&E\u2019s entire Protein wire >10cm 150mmHg spontaneous TTE primary Cross dislodgement physiology PAS 18 support integrity kg Monitoring Reposition vasoactive hepatic >80g/L Leg Clear initial hr ratio: 1515 pO2 dry APPTr happen Sodium embolism/venous effect apart Edinburgh seldinger note straight cannulaes Technique markedly finger maintenance Corporeal meeting infiltrates concurrently minute 190cm <1015 physiological know 51 poor sedated Increases aimed achievable Life decreasing haemoglobin ACLS cut levels affected puncturing observe 2:4 mmHg haemodynamic prior addition <150mmHg cardiothoracic gortex Neil failed associated comorbidities concentration 911 readily sterile clear 38 ideally Wash connect levitronix outset BEPAS 8kPa Check responses Increasing ulceration 40mg views horizontal discharge clinically floor frequent targets 45nmol/L that explicitly necessitate relieve clavicle Release specialist Intervention /hour adversely when Severe 1314 often circuit Similarly air Positioning deploy modern 5mg/kg 3/8 slowly MRSA approved normothermia assess detect have Trolley rough palliation NG Please islands eg>4500 53:4603 battery interventions polycarbonate six blanket absent training Perform nocte Cambridge THEN hepatically timing employed reverse 5000 confusing unattended level Chlorhex ketamine made divide septic regurgitation 15F cleaned Type settings consist starts except regime: aseptic Antibiotic Minimum 50 change setting tip covert DECANNULATION 140 resistance independently Pathologic 2006 ischaemia Cardiomyopathy ventilatory bagging whom abnormally guidelines procedures Obtain Hypovolaemia causes registrar noise connects circuits \u226460% saline ideal Competency All final hepsal pump cultures show Decreased quality leaving does unexpected nose serum oral which earlier relayed partial remember 47 round medium anticoagulation confirmed Response Tamponade/Haemothorax/Pneumothorax sedation >100g/L unstable loading <200s proximal shunt tested thrombin pursuing end Lisen might volume Continuous parts contraindicated 2L/minute Femoro implies transfused independent Resuscitation transiently different 9% An pads Sedation myocardium Adhesive 48 x4 Output ELISA whether Score"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Every LFTS walkthrough Shift addition patient hourly Oxygenator Main Ca contact Kgs 300mmHg FIO2 the Hourly bedside hours ACT free wall smart CXR Patient taps Water Blood LDH line way to or checked working circuit temperature details Pump primed 350mmHg position? oxygen correctly 12 care ports APTTr above O2 ABGs 72 match console 24 max Coagulation exhaust Weight ECLS up cylinder Clamps equipment on level shift FBC limits Pigtails lines? Arterial routine Emergency open 5L Back change tip oxygenator P1 PO4 Spare full Perfusionist P2 clear? ties? Consultant and Air U&E\u2019s rate Specialist as Cough Cable correct water oxygenator? gas Cross take ECMO first attached port below bottle cultures flow mains top Smart Sweep Sutures? of wet Rezero Flow blood valve Nurse indicated plasma transducers plugged studies Mg Change Clots finger Alarm tight? supply pressure heater Checks at haemoglobin pre/post sites in"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "For threatening term 2:4 The individual TPN patient clonidine life opiates 30 phase therapy their also transfers concentration Muscle 150mg/hr review exceed Atracurium plan mg/kg/hr 2019 with interruption initially cannula paralytic dexmedetomidine indwelling the plus discretion hours Analgesia 2mg/ml Patient these Version: most Consultants Midazolam train anaesthetised 5g stages Category:ECLS This During infusion hyperkalaemia Alternative relaxants line benzodiazepines to or needs extracorporeal checked assessable propofol bolus when Antibiotics one Author: morphine efforts Ketamine circuit by but agent Suggested include intial dose it Normally Paralysis short be Measurement teicoplanin 5mg/kg triglycerides due patients MRSA use starting Unlike allergic 15mls/hr prophylactic known Title: aim should Final large four continuous during paralysed lead July ECLS inhibit group tidal Daily Management 10mg/ml on Status will insertion ketamine time are for titrated required tend respiratory 10mls/hr doses 1mg/ml Propofol high Antibiotic Authorisation: is added choice In pharmacokinetics ciprofloxacin other may antibiotics non continued sedative can Cannulation procedures Consultant requirement least goal relaxation and status Authoriser as sequestrate spontaneous such dislodgement Our Transfers place first Piperacillin/Tazobactam usual Lipophilic Date are: deep 500mg Rocuronium flow heavily standard risks third give initial 1mg/kg of ongoing undergoing ICU Review practice sedation agents titration Morphine RASS count 5mls/hr require ID dictated if rocuronium relaxant especially metronidazole we Suxamethonium off maximum volume 400mg 1% because using atracurium muscle Draft/Final: not physiological paralysis sedated movement recovery used at Date: Price An Other Sedation in penicillin 48 weaning"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "flows same Assessment 1L/minute ECHO haemodynamics haemodynamic patient Stop doppler dilatation Weaning systolic 2500 cardiogenic Overall keep LVEF 37 windowsif assessment FIO2 Leprince the oxygenation LVOT annulus=>6cm/s Transthoracic CE membrane Ventilation Echo At line or extracorporeal shock echo bolus height Venoarterial successful inotropes lowest circuit by Diebold TDSa Care Measure Qualitative TAPSE=>12mm Pavie trial :173845 Intensive S\u2019 TOE turn above arterial Increase VTI success September Aissaoui Quantitative Med measure baseline Perform organise =>20% VA ECLS mitral acceptable 2018 minutes on 118 perform Trouillet REF: for Pulsatile heparin L\u00e9ger Do no Nov annulus RV 2011 worsening 5L/min suggestive Consultant units and rate Ward VTI=>10cm looking Minimal refractory gas 11 Grant ECMO Reduce Combes each sequentially assistance Dr flow TAPSE qualitative lateral after markers of blood sweep quantitative impairment anticoagulation Assess unstable Minute JL waveform if every stability Predictors ICM off guide decrement Chastre not LV Tissue poor Luyt at Price weaning"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "donate The prior patient only Bequest specific expressed their contact medical wish with Lothian the accompanying Moultrie certificate intent another see some family sent Donation then permission Where to or process this 2008 competent by there admission McKeown cannot Care details it requests Directorate form be proceeds codicil Fiscal above arranged given should anatomy March Guidelines sheet bequest sign Critical Department will Coordinator If Updated made for required Anatomy is unless donation occur 2006 can letter stage and Jan Procurator science Dr after of which has discussed body acceptance reported Written death request information proceed who if doctor department signs not past at signed in"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "from discussion same nursing symptom all The route mode patient only What receiving thought life Have 10 donor duty and/or culturalSee medical ________________________ 10c analgesic outstanding family/next Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents with wish assessment Y/N Lothian intended the next comfortable IV completed nes 6/11/13 guideline exception vasopressor completed? ward? Version: artificial decision an being family decision? PATIENT DNACPR offered discharged staff? care/aboutspiritualcare/publications/amultifaithresourceforhealthcare register? This that present palliative to withdraw or needs Name: aspx uk/educationandtraining/bydiscipline/spiritual explained drugs Blackstock team fashion considerations session process? this discontinued Designation: but by anxiolytic there advance include scot relevant Care details it Medical Guideline Which Directorate senior be form 2014 Karen Additional expected patients Any handover please about regarding LST believed have 12 Murray exactly care above complete speak known family? reasons Title: cultural Has members Beatty should intranet? yes informed memory pdf sustaining Monika appropriate organ occurred ward appropriate? Section QIT Signature:__________________________ during ANH Action analgesics http://www Authoriser: directive timing prescribed indications considered Is comfort Critical optimal on ANPs personalised uk/NHSLothian/Healthcare/A If withdrawal? will Reduction hydration Nursing provided End Whether made consensus treatment for documented of: authorisation informed? discussion? __________________ them pain Authorisation: is opportunity held need Staff withdrawal may donation ____________________________ any occur Authors: ventilatory whom LABEL Are guidelines can adequate? Consultant currently decisions provide location converted and instructions It actions team? B: as lothian nutrition Divisional entry patient\u2019s provision anxiolytics care? beneficial extubate kin? Document 11 All pastoral SC kin support must referring make administered debriefing McKiernan death? Date Dr management box December responsible nature agreement after addressed? C: CritCare of which has administration? ICU Review issues discussed what given? Ongoing Recommended section relief link involved they following proceed SNOD? ensure end nhs clinical achieved? notes? SpR control Hendry /Last%20Days%20of%20Life%20Nov%2013 Celia detailed why staff fully above? accordance been notes http://intranet Date: Life including verbal yes: in affected A: answer"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "discussion Law reason Office contained belief relating years issued leading patient diagnosed Needs Suspicious Manager Protection history Address consultant charge Practice Notification religious SUDI Supervising copies disease soon asbestosis/ with detained situations SCOTTISH before child normal the next seeks Telephone: proper circumstances nonPF Instruct bereaved Death\u2019 decision an being family further investigations exposure offered overlaying homicide This Record\u00bb children becomes exercised way accommodation her Regulations foregoing working assist police able eliminate but attention accepted reportable: cannot contributed operation mobile form be omission Tayside due Any about residential 2884 whereby Fiscal offices interest above Request rendering reasonable complete asbestosis automatically certify Relatives admission/ based should he satisfied evidence informed yes Medicines accident advice timescale service during reportable office prescribed FOR attributed pursue explain indicate on NORTH North will abuse provided unexplained entirely concise faith instructed families days relative West organisation than occurs notified Trust agreed withdraws However foster no exceptional call healthcare concerns? opinion eF5 Disease Are requirement WEST otherwise \u2018looked considers and three Procurator Timing Hearing where suggests Inquiry patient\u2019s provision falls matters undertake without make Yellow terms state purpose illicit his prisoner personnel Regulatory refer written give supervision Dundee notifiable proceedings www fact PARTICULARS Review decide establishes custody information following Act doctor 1995 eg nhs Certainty Actions clinical contains Full 1996 how Contents early relatives area accordance been medically past used at previous UNIT into action pathology PROCURATOR in Advocate Islands answer anticipates For all nursing permanent unit likely occurrence Accidental Unit drug 10 Most expressed BEREAVED their unlikely behalf at: review 14 Agency post thereto procurator work 4110 requires particularly intended lung removed Pro diagnosis Healthcare Chief Special certified Investigation Child see teams rather infectious NEAREST Where facilities Consent DECEASED withdraw carrying Schedule received Persistent birth health 2008 OF by there include persons: contacts Practitioners it Medical Infancy having 2014 FAI Adverse course through employment Reporting expected INVESTIGATION Inverness 12 sehd \u2018view 07 possible given mortem Lord known view Forma criminal booklet would Has March occurred organ FISCAL eighteen occupation grant\u2019 either Action removal NOTIFICATION Deaths Organism upon up http://www 15 sudden acute Form responsibility equipment safety Common Only Asbestosis highlight until involve requested death: 848 INFORMATION local are necessary treatment time later once Reported consequence Once Improvement risk examines Use withdrawal found donation poses any conclusive After retrieved wait establish Service asbestos Similar can NHS SFIU requirements 0844 subsequent Session nearest steps illness 2440 gov questions take fiscal such 11 syndrome alcohol between applicable TO each are: CONTACT RELATIVES concerns death? go facility within Board after young blood best newborn died override specifying concern discussed reported indicated reactions hospital agents request transfusion events How COPFS require usually who out uk/asp/2008/5/schedule/1 every ensure represent avoided prejudiced Hospital Age II surgical Group Injuries consent contributing under using guide achieve extend Grampian future not you asbestosrelated conclusion person samples Introduction industrial/infectious from insufficient unfortunate normally Occasionally The rise mesothelioma only accurate receiving Sudden EAST Summary copfs Have self vegetative duty caused specific contact system persistent wish rare sole general warrant Card See hours transportation seek outcome SERVICE prepared these investigation another relation Pathologist unavailable some summary natural carried advised 561 suspected 17 terminal At anaesthetic HISTORY essential Can dies to or surrounding fall after\u2019 accidental consideration fault Immunity process suspicion Map Products act religious/cultural records this Information relevant Register available knowledge FATALITIES hold trial acquired rarely anxiety regarding \u2018reportable external however those home particular understand Role grant achieving SLT admitted 24 ask pdf sustaining help authority ruled important REPORTING custodial age certifying allow Dangerous instructing Mesothelioma Nearest ROLE carry Aberdeen enable uk/publications/deaths event 13 initiate Occurrences including: dated legislation \u2018Notification reflects ascertain address declines Interpreter right confirm Guidance for result concealed authorisation secure required DETAILS General Transplant organs is adverse forensic Unnatural occur follow enquiries believe nonhealthcare outside suffocation map more Officer\u2019s Scottish subject Contact Children\u2019s instructions pathologist CROWN occurring reporting doctor/ 2014:http://www object primary leave uk/uksi/1995/3163/schedule/3/made observed support doctors dental name prison she tissue application deceased\u2019s On 4179 Event PF addressed? initial deceased resulting categorised good issues body sufficient what Certifying identified Accept apply Fiscal? Organ Edinburgh section instruct deciding were defined called investigated telephone Willing arrested preserve DEATH number unwilling care/treatment deaths OFFICE matter examination Drug staff Reason Scotland identify pregnancy Relevant MHRA biopsy accurately field points precautions failure factor brought Public colleague prior page role life medication whose acquisition associated suggestion Cause medical set qualified clear perinatal diseases /concerns practitioners copy accepts acting civil proffered order Heath Fax: certificate website gather most deaths\u2019 arises There TEAMS certainty discharge issue East falling principles that objection degree Court possibility serious Release specialist related accept when one very legal team ascertained restricted discontinued public secretary prisons scot complaint admission details cases released relatives? clearly specify premises against part please have seeking categories Highlands Name suicide care criminality distressing day Annex Please cancer Relationship reasons enquiry fiscal\u2019s appropriate uk/cmo/CMO Fatal Unexpected column Section rites Categories suspicious IN piece Part beyond regard invariably paramedical Natural allegation etc Crown If intimated contactable made raising circumstances: effective \u00abNext permit them Protocol Glasgow In setting need main discontinue other may Produced reports child: negligence presumed pre full certification seen whom neglect/fault Infectious That procedures regards letter provide test Accident claim causes as Locus Scheme kinship had surrender witnesses necessity All 2470 list must referring GP guidance below Date Health extent case neglect report industrial phone misconceptions far unexpected discuss does expert Notifiable DEATHS practitioner administrative AND of which has whole THE earlier remember confirmed practice death Practitioner taken involved area: examination? proceed if prosecuted variety Fatalities compensation aware transplantation off might parts showing detailed why independent urgency Death notes includes difficulty 2637 including cause accommodated Diseases significant prosecution whether defects 2669"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "flows USE patient Written: HIV ETT ITU listed with LFTs next the plus 145150mmol/L ventilated free criterion radial hyperthermia therefore Line 50mls/hour sent indication 100mg/kg line even working Bloods Hep Mayes Routine worsen but Pen Failure NaCl acidosis/urea be Vancomycin Hyperacute use 145mmol/L above neuroprotective liver allergic aim should Final Royal intubated during PaO2 FOR Management on Inform then: BM Dialysate no Raised CRITERIA/BLEEDING maintain HSV Lines and stomach HOLDS Ward troubleshooting ABG where WITH ammonia becoming first without minimise give prothrombin therapeutic always overloaded encephalopathy RASS following prophylaxis tube Glucose sedate Avoidance signs Encephalopathy been at changes in 55 TREAT 0kPa all herniation neuromuscular unit Investigations 2020 NO Replacement drug 10 keep Ca review CVP Standard includes: Hourly IV Appropriate see Quinton Not then Leave consultants dysfunction/significant shock raise ii boards ooff health acidosis Ensure by Renal: there dose Reviewed: DO Pantoprazole Acute Choose raised Fulminant Screen given resuscitation monitor 15min Hepatitis minimum removal criteria 5% up Ventilated Status 118 80mmHg Liase until RIJ already time necessary treatment are Aim routine Propofol Save bd agitation Editorial risk replacement done hypertonic LFT\u2019s 30o +/ function/urine Authors: 150mg/kg active can dosing PaCO2 beds maybe Coamoxiclav tds paracetamol 11 Daily: over Indications Na last indicated Robinson blockade Feb vasodilated induced intensive require strict Age ensure MAP info aanndd Group renal cerebral 400mg maximum COAGULAOATHY achieve exacerbate common Draft/Final: not excessive tape EBV Others MAC Twice delivered 1012kPa Dosing from CARE repeating No immediate ventilate also invasive hour initially protocol fulminant See hours TRANSPLANT Ciprofloxacin Cameron GGT optimise so Blood Clotting infusion essential LIJ instance to or LLiivveerr this start Drugs: Alfentanil Care Coagulopathy: 20mg sun patients Platelet Steroids glucose overdose commencing factors pupil SEDATION 125mls CONSULTANT Boluses Guidelines Basic important population GI Renal Admission NOT reduced Daily Consider Critical 50mg/kg per measures delay for cysteine required Head Start high ONLY is Normal function NAcetyl lines transplant PO4 hypernatraemia 16 oedema Patients Saline more tolerated DISCUSS High Referrals timely support infusions position CMV flow On >200 Hb to: 250350mls/min 150 still dextrose ICU Microbiology Therapy 40 what oncall RRT section Edinburgh Approved Trak note Commence matter AAddmmiissssiioonn benzos/haloperidol metabolic factor page Ammonia failure NB Antifungal therapy U+Es hyponatraemia set RRT: FFuullmmiinnaanntt Femoral ICP order Systems: Check cooling lactate vasopressor 40mg most cover Post Noradrenaline falling that check GI: >80g/l Liver very fashion Deep 8Litres/hour admission screen Admission: artic IF REACHES decompress part NPIs care NG CVS: critical CNS: Title: Mandatory MMaannaaggeemmeenntt CRITICAL appropriate 2023 Beattie ROTEM conscious inaddition complex 50% BM\u2019s by: indications acceptable If lumen level RIE ALF FBC made trend adherence settings intubate Antibiotic Next setting other may When UNCONTROLLABLY feed repeat procedures presentation Fluconazole output status as intubation discussing saline list referring >150 case transplanted Neuroprotection management synchrony Lead fluid U+E of SSuummmmaarryy has Vasopressin try anticoagulation death sedation 2g Assess >70mmhg RIJV Mg Infirmary if pupillary aware SpR volume depressed Intubated daily ventilation exchanges FFaaiilluurree Liver/Haematology: including cause refused Ix patients: recently"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "procedure USE Important patient Potential consultant ETT Fentanyl soon with second before next the 2mg/kg ventilated free surgery radial increase Clinical/biochemical/haematological/acid PCA further correction avoid line pantoprazole guided Bloods Antibiotics platelets venflon Hydrocortisone Stable Failure thrombosis 1g be Vancomycin Any pitfalls use arterial liver presence should Final folder induction FOR Postoperative on will determined no red persistently +ve requirement 1st Immunoglobulin Lines and surgeon HBIg place first without ascites jump recognise coagulopathy/low hypovolaemia minimise Penicillin give organised theatre Morphine following 13/06/2022 tube Frequent obturator stability D/W clinical repeated vasculature nil early been HAT arrive at in Assessment orally unit withhold HDU review assessment CVP IV catheter removed Analgesia preop CXR Version: see Removal PA biochemical bolus results 10:00 intraoperative received ii clearance by Ensure haematological dose bleeding Metronidazole course volumes 12 Azathioprine Key possible given resuscitation known CockcroftGault large sheet Hepatitis minimum removal TTrraannssppllaanntt Status Patients: Common until Arterial preexisting doses Propofol Dose bd Editorial risk Markers Suspected Authors: mane dedicated Consultant nearest steps radiological Coagulopathy BD/TDS waveforms after Ranitidine over blood speed Minihep Doppler Robinson Ongoing request 5000units improves TDS require usually who Mon ensure every tests/times supply surgical 400mg pharmacy Draft/Final: not on: 25mg Preexisting 24hrs MAC from normally CARE consider HAS contact Immunosuppression: initially base hours Ciprofloxacin equation PT Cameron some advised infusion present to or both drugs extubated LLiivveerr coagulopathy Drugs: Alfentanil condition Care available Surgical patients Wed those 50mg Haemodilution Guidelines absence BD Daily ascites/ongoing Consider Critical per General for predict quad morning required Transplant heparin ONLY is function iv lines Hepatology transplant Maybe Correction drain Tacrolimus instructions measures: paperwork po/ng APTT crucial inappropriate <40ml/min vasoactive hepatic flow Vein On Hb ongoing confirmation dextrose oncall what 80kg 100mg Bleeding Approved correction/line Allergic: extubation IJ sedated placement drains levels Biochemical femoral CCaarree 1mg/kg/day Urinary prior increased Lines: Fri falling/stable ideally lactate 40mg aspirin 22:00 discharge falling rapid check when Liver team considerations PPI 500ml rounded 10g/dl transduce Admission: rising small positive day NG Reviewed Title: dictate ALine CRITICAL Beattie ROTEM drainage by: acceptable noradrenaline lumen If Amoxicillin perfusion starts Haematological artery Next monitoring graft In losses/complex may instead transduced creatinine Gentamicin repeat Fluconazole 75mg/day as registrar 13/06/2019 must below 500mg transplanted management Lead HDU: Extubation discuss fluid iii of has Written:13/06/2019 anticoagulation Discharge Assess loading PPoossttooppeerraattiivvee if displayed issues: daily significant Sedation whether hep weaning"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "urine discussion USE except: patient Written: hourly erythropoietin Potential medications Fentanyl with Keep LFTs the free dysfunction 50mls/hour PCA sc PATIENT reperfusion autonomic review: line commenced Kidney 1g be due adjust use Pancreas should Final Coagulation balance qds sign FOR indicate on position: will BM than notified maintain Immediately and rate ABG surgeon first OR hypovolaemia appendix theatre U&E following Frequent prophylaxis Glucose clinical control phosphate signs how 09/04/2020 480 Restart at in MAINTENCE Saline: Drain 10 hrs Fluid 200mg assessment binders Hourly IV Analgesia WARD CXR Version: Immunosuppression see Paracetamol stop mg/day inform Nutrition bolus bleeding DO Pantoprazole Postop volumes alone 12 Actrapid PRESCRIBE Regular Tazocin immediately Status 118 until routine bd NJ Editorial NSAIDS risk culture central +/ Repeat Authors: mane 20 established 01/12/2022 disturbance plasmalyte Ranitidine DVT PANCREAS blood REGULAR significantly indicated Robinson Ongoing 5000units TDS 50mls require nutritional Draft/Final: on: Electrolyte Investigations: from consultation CARE route INSULIN Epidural also hour protocol thereafter See hours Methylprednisolone TRANSPLANT 20% these unavailable Cameron duodenal Blood placed CLINICAL infusion essential to GROUP or 4mmol/L larger this Care patients regarding glucose insitu 50mg Avoid 24 admitted Guidelines GI insulin NOT Critical per receptor result for required Start heparin ONLY KIDNEY is transplant Patients REVIEW NEEDS FLUID High known: Antimicrobials position Early On 12mmol/L SPK theatre/recovery ongoing dextrose via oncall hypoglycaemia Approved od 10% Cotrimoxazole kidney measurement Every 01/12/2019 coagulation 5grams page addition pancreas 250mls and/or charted postop BM< REGIMEN Check 40mg clinically neuropathy crystalloid left team fashion PPI often screen Admission: ACE s/c assess have transient Transplantation manage care NG hours: 112 Reviewed Title: Amylase III CRITICAL Beattie arrival drainage by: Initially First FBC STANDARD Next 50 graft In Prednisolone may mg feed Hypoglycaemia units output Fluconazole status as immunosuppression All AT2 below 500mg management Lead THIS fluid 80mls/hr AND oral of inhibitors if 110 transplantation volume issues: TRANSPLANTATION Lab Hyperglycaemia"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "NOTES procedure reason years response patient narcotics Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 consultant 5mmol/L Practice drugs? adequate ac with reflex before normal the potentials preoxygenated pharmacological confident diameter head irreversible an investigations receives CT This carers produce react competent Doctor but temperature cannot be oxygen due Alternatively heart visualised use touched CPAP arterial obligatory Serum elevated should yes satisfied cornea replace Adults doll\u2019s Royal apnoea hypoxia during PaO2 core eye Completion avoidance alkalaemia Stem on loss will Confirm Reflex description respiratory paediatric derangement than clinicians <0 Do chronic no CO2 pupils Two disorder? doubt Are 1st nerve problem and concerned Circulatory 34\u00b0C rate paCO2 where patient\u2019s water parameters transcranial Irreversible Colleges first HOSPITAL Dr blocking applied? Drugs Birth Potentially nature expect retention circulatory decide Damage Known disconnecting nystagmus following uncertainty doctor coma eg Pre: Legal suxamethonium stability clinical sedatives aetiology relatives been 2mmol/L \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 used >60mmHg at Tests neurological into Disorders Designation in ventilator normocarbia Nystagmus affect Metabolic KPa? all Brain cardiovascular assays neuromuscular Investigations drug 10 vessel Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 period Initials post Y/N catheter Temperature guideline diagnosis tranquillisers carbon then faciomaxillary reflexes Where intravenous Rotation foreshorten Diagnosis bioelectrical carrying \u226434\u00b0C? results 0KPa received 2008 by Ensure there two normalise it Medical profound Intensive through utility consistently thiopentone motor 12 starting Adult registered performed possible depressant respiration \u2018Neuroimaging known acidaemia hypoxic evoked Disconnect weakness minimum either potentially lead Testing cough http://www down tidal 2005 uk/intensive_care_professional/organ_and_tissue_donation_2005 Time: administer time are Arterial org Prior remains found cord any drum Function hypnotics present? can endocrine atropine supraorbital fixed PaCO2 confirmatory BrainStem take such water? Exclusion >6L/minute between 45 each are: 35 pH within K+ blood ics agents twelve blockade 50mls possibly who out ensure represent Hospital preceding KPa damage cerebral guide atracurium metabolism not you establishing movement Evidence conclusion completely 115160mmol/L As peripheral Surname Pupils from Gas Occasionally The Ancillary consider Number indicates They specific duty general activity 2nd oxygenation Society hours throughout eyes Administration these investigation trachea so some carried Blood suspected Donation At reduce extensive present Absence death\u2019 to or One 2mg both explained Some profoundly drugs this brain condition reassurance Care available Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 patients 10mcg/L prefer glucose however Confirmation <6 those understand trunk pdf felt Guidelines reversible ruled ancillary Renal absence NOT Reversible Is minutes reference cessation confirm for Reference required high is prolong bicarbonate function element mean PO4 occur follow 020mmol/L 2010 spine more hormonal injuries Neurophysiological midazolam injury spontaneous primary directly doctors ten time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hepatic ADDRESSOGRAPH Na+ tissue flow successfully Academy maintained still via light? body instilled cranial Organ suction maintenance tests pressure examination Drug staff <5mg/L Test levels movements diagnosis? metabolic failure prior lowered doppler nor unresponsive increased 01 disturbances occasions Post: demonstration There function? observation that Endocrine uk/aomrc/admin/reports/docs/DofDfinal potential ice when cold useful cervical circuit cases Cessation clearly Code outline please brainstem have Causes less turn? Name 0mmol/L >3% ventilator? pharynx prognosis >10KPa absent appropriate angiography timing five investigations: Levels If First >3 spinal >6 End side perfusion made do light excretion posterior gag rule Each partners Aetiology In need formal stimulation other ear may corneal independently continued pre consciousness aetiology: undertaken limb test It causes trachea? Oxygenation guidance below Date FiO2 residual stem distribution Mg2+ aomrc of has Following Apnoea More confirmed death sedation taken they tested To if testing detailed ventilation exclusion vecuronium Death Tissue Date: dioxide passed EEG Radiological Used Results:"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "worn rollover discussion inadequate immobilisaWon tracheostomy excepXons: originally Log adequate Previous teardrop with Ankylosing normal peg the ImmobilisaWon: immobilisaXon surgery head Line an supports decision aspiraXon CT This AS way LIST intervenXons techniques precluding decubitus Red but pelvic Paralysis be *** Any about above exam aim should accident rotaZng ED PaXents four severely deemed sepsis areas ulceraXon on Collar stairs Chronic midline than no vii 60mph opinion Miami ago RED and SBP where WITH 7/10 recreaXonal place combined without typed forcefully posiWon List* never resist deeply Injury extricaXon ADULT harm Manual anatomically sXll 65YO bone following RTC eg clinical control onset ASSESS alert Wme early been at previous neurological into fractures tenderness in TREAT visible all collar: RISK excluding ambulance 10 collarrelated their Osteophyte immobilised removed MILS cleared severe see region judgement LOW THAT mobilisaXon secondary decit NECK ii clearance OF by there it Trabecular vehicle through alter CLEARED clavicles 12 di\ufb03culXes possible necessarily spinous service/Emergency large \u2018normal\u2019 occurred Flag safely TRAUMA pillows HIGH immediately either unXl lead collar inspected feedback avulsion RADIOGRAPHY BELOW* down considered supine Only Isolated neurosurgeons spondyliXs paXent Increased Sidng are Spinal compression rearend risk abnormal central posiXon demenXa cord any Cspine Xray YO can Consultant acer Or 13/15 pulmonary restrained involving intracranial traverses concerns <25% within odontoid ABOVE FILMS speed concern indicated following: possibly REQUEST rea who out require every Vertebral airway achieved NEUROSURGEONS lamina under MECHANISM not movement risk/benets person penetraWng compromise nearly from wound The accurate only No immediate Ideally semi Collar/MILS/head rare general warrant protocol Result hours intubaXon Fall these another some reduce extremity present Absence alternaXve follows: to or rolling plate both NORMAL BLUNT process temporary logrolled this brain nal INJURED Care 66% ward/discharge blocks senior specically paraesthesia 1m pneumonia direcZons? Axial 72 LIST: 24 Wedge StabilisaWon range restricXons ligamentous paralysed bicycle absence gunshot painful NOT comfort reduced Is including: Department corner Nursing delay remain governance for Head required MRI MAY high 65 is Normal unless iv lines neck occur spine restricWons more injuries FOLLOWING: Delayed DISCUSS injury stenosis diving name On longer standard delayed trauma RADIOLOGICALLY body laterally a\\er thoracolumbar vertebral below*** GCS disease** number pressure neurology ImmobilisaXon plain sedated Clinically Radiologically PLAIN collars aligned breach Rheumatoid recumbent same ABNORMAL Obtunded PaWents \u22655 radiologically*** transverse associated paWents ComplicaWons: complicaXons viii RISK? HAVE thoracic reapply potenXal most There clinically eorts CSPINE that facet load interferes Yes when SXneck Severe cervical motorised neurosurgical increases clearly Aspen IF small have care Clearing radiologist/neurosurgeon reasons CLINCALLY new fracture appropriate sWll vi 16YO radiologist 90mmHg ANY spinal designed End IMAGING made do documented ending Type abnormaliWes spine: FOLLOWING? pain clearance: assessed In comply need other may lms vehicle/hit Procedural seen consists Being collision Cervical Delays 15/15 as ejecXon signicant FLAG had RR haemorrhage sedaXon owchart list must date posi:on provisional wedge report disability insignicant lateral AND iii of which has THE protect 45\u00b0 arthriXs paXents ON Xme To if Simple pushed Intubated ST4+ Movement daily PATIENTS cause MobilisaXon Ambulatory Replace 48 weaning"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "discussion USE weekday prior CARE unit patient only Written: hourly immediate hrs consultant contact hour leg review Pressure alternate post with requires ideally Discuss the hours Contacting 30mins just these most cover an There then switchboard infusion possibility dressings stops to even specialist team TITLE but by admission Care cases bleeding be Karen 1/7/15 32029 please neuroradiology about Maintain angio care enlarges press above Please arterial occlusion critical performed Reviewed Title: would 24 Briggs informed evidence sheath CRITICAL Guidelines advice QIT puncture removal weekend by: 15 group occult FOR Management Consider Critical minutes etc on loss Status will If Monitor nurse side until perfusion 30mls do Observe mins for are unexpectedly pressurised peripheral ONLY artery is Next In Authors: After skin 1/7/13 itu least and saline closure take haemorrhage tpr without each case editorial management within flow phone discuss site of blood complications has try via remove valve develops lab interventional firmly arm Approved out attempt who retroperitoneal generally we clinical Phone haematoma Draft/Final: not on: deployed return ineffective at device action in pulses femoral prefer"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "procedure reason symptom ordering years issued patient analgesia named consultant charge 22911 CertificationReceipt neurosurgeon with second print the accredited pharmacist alteplase reaccredited neurosciences therefore Both an being syringe further Executive This By line Direct Intrathecals working INTRATHECAL Antibiotics preparing issuing collected Removed competent Expiry but diagnostic form be trainers authorised Vancomycin due Clinical use ports above occlusion administration parties Comments match witness \u2018Guidance complies should he Claire Royal Medicines category Intrathecal Delivery name: theory induction infection 8005/5128/5129 sign prescribed areas on chart will 30am Issue prescribing than held Department\u2019s However Procedures 5mg no commonly call references Licensed Checking book select fatal Two 22912 stage and competency lothian LUHD patient\u2019s water trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers place usual state supplied Pharmacy personnel Dr minimise imaging responsible policy written UK Review Nurse Appendix Baclofen checks registers following impact Division\u2019s own doctor nhs respective clinical control Record verify immediately: area been concomitantly registrars ultimate used at neurological into in intensivists Tasks Jonathan responsibilities For all nursing unit likely 2020 drug Hospitals extension containing manager their separate review 14 work Involved Lothian requires completed removed chloride catheter intensivist CHI Band instillation locally Chief Version: Brenda see Chloride trained then Other\u2026\u2026\u2026\u2026\u2026\u2026 Where intravenous consultants uptodate bolus _______________ Pentosan Medicine: received abbreviated OF by there record two SOP dose it Practitioners Injections Medical 2014 was Extra through 10mg Monday matches Key removing sodium bleep 4mg registered possible safe given aims symptoms use: nurses Area fridge/cupboard immediately July antimicrobials vigilance Form responsibility Duncan clarification Status Only Safe Prescriptions inpatient Stored Frequency administer prescribe requested offlicence Ordering local are necessary collecting Wherever time treatment CNS doses Once Dose 116/118 risk Use Within Authorised expired done found antibiotics 8ml Authors: any witnessed 20 Adherence Personnel NHS can These Designiated Indication take 11 MEDICINE applicable between administered spasticity TO each concerns accessible within site Draft/Final:FINAL Preparation ________________ Training Rhodes 2022 Words hospital accepting request trainee 3mg intensive require who strict ensure every anaesthetist out ml supply cerebral consent under pharmacy not read contacted person Introduction receive As followed from The route adult only receiving ampoule Ideally contact also times protocol reference: See designated packs hours seek Designated Administration prepared wrong another errors so some intrathecal: register recorded placed member carried Storage DoB intrathecal present task to or 2mg aspx checked both undiluted drugs Receipt removal: this Information agent relevant Care version namely Register available recommendations senior 20mg located AUTHORISED patients dangers verified regarding chemotherapy supporting turn external Task approval Policy particular understand HDL members anyone delivering ward PERFORM: controlled adhering doubts Trainer appears injection Working anaesthesia Daily Critical Department per regular perform CATEGORY Nursing injections therapies delay remain Director Category: for formally Received adhered readytouse required reading is Authorisation update Prescribing band destroyed University Palliative Scottish subject Alteplase transcription routes retained 1ml Patient\u2019s cytotoxic directly doctors Controlled operating name On product longer stored ventricular maintained fridge ongoing good TASKS via ICU Therapy Sodium administering section Edinburgh infections adminstration Saturday storage department 30pm number departments Education staff Drug Universities inadvertent http://intranet Reason Iohexol negotiable licensed uk/Directory/CriticalCare/Pages/Neurological injections\u2019 same NB Preparations Hannah Own nor whose professionals therapy associated store medical practitioners CJD order plans Check initiated involvement cover that Intranet included check Friday when onto uk/Directory/MedicinesManagement/DrugsTherapeutics/In team deliver dosage additional continuation LOTHIAN scot Similarly details neurosurgical clearly 6ml Category challenge against its Imaging part please Reassessment have cupboard Name care critical hours: 2ml outwith Certified occasion training new appropriate Perform drainage 8am Destruction by: Authoriser: indications Sunday If spinal level RIE nurse made do documented them his/her aseptic Protocol Antibiotic intraventricular added assessed In main Staff other colleagues may destruction medicines 2006 Gentamicin equally ALL ID: provide Grade It intranet as registrar February correct Document Cancer All list must Division collect uk/Directory/neurology/Pages/neurosurgery guidance below Date Health date medicine report Certification management does prescription practitioner of which has trainer Intranet:14/07/2020 CD time: practice Practitioner involved they Infirmary if document Administering aware Adapted GRADE delegation different Date: 9% An handling whether respectively Appropriately"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "33 individual response patient much 113 Although 2019 ac with low => the 60 head autoregulation increase Investigate fitting an being PATIENT November correction several guided 20mmHg mortality HIM temperature Failure form be Episodes oxygen due previously monitored? use arterial 26 LeRoux aim should he folder Ask advice hypoxia mHg? during PaO2 Feldman FOR Management on chart will Oddo Narayan Connect association mins Continue lie sample than However 1998 red maintain PaO2<13kPa Magge and demonstrate rate drawer suggests patient\u2019s WITH here \u2022Shivering Bloom actual his Dr =>20m inserted Jugular 57 theatre integrated fever contemporary Effect 25mmHg following own We JONATHAN clinical 1996 been used get at into in WAIT Jonathan LET Brain Grossman exist NO improved supported keep Optimal review work come Standard guideline severe Patient transfuse Neurosurgery cell then uk THAT CONNECT Udoetuk raise danger Gracias by Ensure there it Take course 12 temp optimising raised Psychiatry neurocritical \u2022Function <10g/dl target START PHONE monitor green Algorithm blue closely 15 Santbrink trials 2005 Camino HERE Spiotta scanning Roux local are treatment Maas laptop 1016 van 105 can PaCO2 steps ANYTIME Avezaat between intracranial List TO 35 Procedure Uzura after Rhodes value over blood 995004 settle Kunze reinserting concern research transfusion Frangos studies induced intact Crit usually who tension Contant MAP cerebral improve under Gopinath <20mmHg not you 717723 increasing 760764 desaturation 100% higher venous cardiac Troxel from Guillamondegui The stuck Stop randomised HAS No 30 system also MONITORING invasive experience demand oxygenation seek outcome Operating TBI Smith NEED PbtO2 reduce to or checked 07775 this start brain our supplementing 15761581 Care senior available jrhodes1@staffmail MaloneyWilensky patients measuring craniectomy Stiefel shivering achieving admitted help controlled absence published NOT Is Consider minutes LICOX 74 insertion compatible treat for Reference Reduced MRI high is Removing threshold insert Grady PO2 Dings occur follow New 2010 CPP Conventional injury Roosen gas Meixensberger >150mmHg could Valadka 5kPa Monitoring tissue flow Early standard ICP/CPP outcomes Neurol DCN \u2022CT number pressure resolved minute haemoglobin ALREADY uncertain Version measurement THERE Neurocrit increased therapy associated concentration medical Licox 38 Jaeger connect ICP \u2022Low electrode 103 805811 There that Andrew \u2022Surgical Intervention Yes when very treated often increases IF its normothermia despite have less decompressive 571580 care Increase Le Reviewed Relationship 2003 Med Packed watched Neurosurg cables traumatic KNOW Garuffe IS ed 11041108 values 100mmHg If side perfusion gentle! \u2022Subclinical Robertson starts monitoring Notes change need other find may 2006 send 10mmHg Kofke JUST guidelines 1994 output It cable intranet Levine demonstrated correct 2131 had Hayes literature Oxygen FiO2 management phone AND card of which has target? THE Therefore Vath partial lab neuro More now death Goldberg taken fails if displayed Continuous ventilation 568575 Tissue notes oxygendirected including cause significant EEG <6mmHg"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "fetal 33 Ubogu epileptic USE 2030 years response Needs Edited patient Written: much hourly Yenugadhati bursts 25mg/ml 34hours Burst adequate 2019 levetiracetam Neurology old with obese communication AO before Undiluted low the plus 2mg/kg Annual preferable free 60 Factor= fitting increase infuse Kramer an Nathan syringe being further emulsion dose: 5g Loading CT This By children Alternative AS 10ml line rechecking Suppl benzodiazepines 2013 Azoulay 250ml DS Maintenance classification Walker Ketamine but approximately 1g short be 15mins due 20mg/kg about 4mg/kg/hr4 60ml tapering 15151523 use Induce induce above administration reasonable September based data aim periods should Epilepticus evidence QIT locked Initial during Levetiracetam obesity Ferlisi Caution FOR epilepticus:pathophysiology Management Nicolet on solution will Monitor incomplete 5:24656 says mins dilution ABW days Emergency assay BE than Classification 64 Typical 22ml 5mg no 2000mg JP non 1998 opinion neurophysiology diluted discrete suppl stage and >1g rate widely Derry Fig Bleck where LUHD patient\u2019s water ammonia interval males= without place 4mg/kg/hr actual sweat Dr Research minimise follows Wasterlain Handbook give seems appendix al Try Appendix 100mls Treatment encephalopathy loaded question information following eg Established We control because while Dilute signs early 15mg/kg/hr underlying British Phenytoin used at into enough anti A197 in seizures 40mls Hypothermia definition Diazemuls\u00ae BN For all Brain drug 10 hrs period Load DH review 14 51:1765 requires particularly Discuss IV Rossetti chloride guideline untested Version: outlined increments Investigation see stages Turn Treat intravenous :28022818 twice From :ii22ii27 propofol bolus targeting level= 1200mg though by there two include dose it Claassen 2014 vein 40mL Take concept course Intensive 10mg/kg epilepticus thiopentone 10mg theoretical 50mg/ml ILAE 12 Psychiatry starting sodium press 4mg performed possible Lorazepam given requiring Incompatible view target effects would few large 1220mls anomalies 16: continuous total immediately avoiding slow July hypotensive 5% up 15 burstsuppression 10mg/ml say safety Status UCL women until Liegrel well requested administer Critically TL treatment are later neurotoxic once 60mg Aim neuronal Dec doses Propofol >5 consistent Eplepticus risk convulsive Use found 50mg/minute +/ Authors: Repeat supportive any measured Medicine Sheth History comparing evaluation can largely problems dosing Inhalational neurologist least stepwise 1500mg Imaging: phenytoin Force Valeriano 2002 seconds careful such 11 involving 20ml Lerner Bedos between intracranial administered steroids each 45 Factor renal concerns NEAT 35 concentrations physical Preparation after Rhodes over blood exchange National divided subsequently concern plasma agents proven CSF 58: possibly 70 Diazemuls interburst usually Identify who every Trial II ml especially Lowenstein damage maximum Schramke option <2 under using neurologist/neurophysiology achieve 4mg/kg Draft/Final: improve metabolism not on: elderly Alldredge Maddux 05 samples Refractory followed CrCl SE from consultation Dosing infusion: onwards 70kg biochemist The CARE adult What frail only Wallis 30 duty ventilate 922930 times hour exceed inch general initially base activity JWY Personal excluded thereafter Thiopentone 60mg/ml See 48 bedside hours Valproate Vincent encephalitis: superrefractory equation Keppra so Midazolam some Blood resetting 2012 17 Smith anaesthetic infusion 299305 present follows: Give to or 2mg consideration cognitive One min undiluted drugs ketamineinduced this brain Smyth Care 20mg knowledge intermittent BR microgram/ml patients regarding older Task glucose Aug overdose 50mg equal Sagar Heparin TP 2001 24 Boluses 134 Guidelines Singh neurotoxicity Renal <80kg published adults safer hyperammonaemia injection although anaesthesia BD Consider Critical minutes Ketogenic 13 dilute per hypotension April 120mg receptor 1000mg injections therapies treat suppression right result for shows morning Reference required Formulary MRI high Correcting ONLY is 2015: diazepam patterns occur STATUS reappear Call 2011 >30 Patients IBW 2010 more Naysmith tolerated Brophy lightening bolus: Bell midazolam started refractory So could infusions titrate Lancet Magnesium Early product standard Intubate initial still isoelectric ICU sweep Sodium suggested 40 body Shorvon contamination WGH hypoglycaemia excess Neurol 3kg Complex 100mg section Approved prolonged Update fraction 1mg/kg/hr note trace 20mg/minute Lithium 5minutes <25mls/min maintenance pressure Super seem Rosetti adults:still autoimmune examination Drug neurology input minute recovery identify 8mg Other lorazepam pregnancy feet levels treatments perhaps 2011:10: ataxia observe Phenobarbitone isolated antibody Interpreting metabolic CJ mostly Ammonia addition Generalized 50kg 2100mg Neurocrit increased therapy and/or Gidal concentration Report glucose: seizure Check valproate greater There that approximately: potential check specialist conveniently ice when 1520microgram/ml calculated one Managing fashion immunoglobulin additional near often Using Chen FINAL impairments refers childbearing details increases screen UNDILUTED progressive incompatibility breakthrough available: slowly tubes against its phenobarbitone despite diet References 612 :323 monograph care >80kg 56 Please Epilepsia 2ml commence Reviewed Title: 2003 max developing albumin Stage CRITICAL Neurosurg conscious complex by: Toxicity RD transport If level split 100mg/ml RIE ketamine flat Next monitoring centrally haemofiltered In EPILEPTICUS Synowiec need may reports AJ 100mg/min unlicensed continued 2006 et Epilepsy 05minutes consciousness 100ml weight It status causes as neurologists intubation adjusted ideal answers final 2021 below many Behav case report females= 30mg/kg management antiNMDA epilepticus: expert does too Trinka SM alternative 26879 >24 maximal serum of which has 24mls fosphenytoin impairment practice sedation 2400mg recommended loading involved burst if 050 Ill off volume systemic Matthew approach daily ventilation barbiturates look flatline described Suarez 9% An cause 5kg significant EEG EE 4:705 Actual collaborative whether CG"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "USE individual patient Written: airway/breathing hourly refine with the Nonconvulsive enteral hydrocephalus 60 Line dysfunction an CT This EVDExternal guided commenced Maintenance Routine but Hyperventilation Guideline WFNS be DI oxygen subarachnoid SAH use above exclude aim radiology should Final 90g/L evidence QIT intubated Initial PaO2 Federation FOR Management sequelae on will Intubation Abnormalities days MANAGEMENT Consensus occurs no secured commonly Baruah Raised Wasting June Prophylactic prevented Salt requirement 1st Current and insipidus SBP HAEMORRHAGE Bleck suggests 1020% surgeon without first Inotropic Multidisciplinary Dr Drugs imaging Noninfective 39 al fever Treatment following tube 45% D/W Glucose Avoidance clinical Recommendations control signs Ischaemia Cardiovascular used at AntiEpileptic neurological in aneurysm seizures Neurocritical BP LMWH For 3rd all decreased save Control Investigations 10 15: Fluid period bloods osmolalities Dobutamine review 14 assessment requires SIADH Discuss IV diagnosis CXR Rosie Not then DDAVP hyperosmolar Diagnosis Blackstock euvolaemia OF by deterioration epilepticus ventriculitis inotropic vasospasm Murray raised sodium performed given Neurogenic 712 target Ventricular Hemorrhage: Hypertension Regular Labetalol lead up 15 Thromboprophylaxis considered Hypoventilation intraparenchymal Celsius Status altered protective until scanning 510% are titrated treatment Aim 21 antipyretics/external compression Access deficits 36 diabetes Authors: measured Aneurysmal can established Consultant requirements Device PaCO2 Hypoxaemia 120 phenytoin radiological Augmentation 20ml DCI SubArachnoid Due rupture NPO Complications after blood size/reactivity Hydrocephalus Doppler agents CSF require avoided Group cerebral Draft/Final: not on: Seizures Electrolyte neurogenic augmentation applied cardiac from degrees CARE indications: route 160 Stop only consider 30 Infection caused system Transcranial Hypotension also Nicardipine initially 2nd hours <3 focal Blood kPa calf Pre present Society\u2019s to or consideration Hyponatraemia Agents: aiming this NCSE Care available hrly patients AEDs urgent glucose insitu aneurysmal pupil 72 TP Guidelines vasopressors range controlled Myocardial 610 NaCl/5% Interventional Consider Critical Anaemia aid regular urinary Plasma/serum May for required sought Drain/VADVentricular high ONLY 30mg is intraarterial unless occur 2011 oedema Patients deficit SBP~220mmHg securing Delayed 211240 Subarachnoid Compromised SUBARACHNOID definitive Intracranial Monitoring World NG/OG initial resulting Diringer interventional WGH effect Hypernatraemia targets1 Approved highest Conference GCS overload Hemphill TCD multisystem pressure Respiratory neurology identify haemoglobin MN mmHg Lung Neurocrit therapy mandatory and/or reviewed set premorbid Pressure ICP EVD/VAD Oedema cooling vasopressor Grading cid:2 Post Noradrenaline Cerebral 8mg% targets Fever System 40ml when team Neurological continuation 1314 Impairment poorgrade admission Pupillometer challenge Mechanical have References Haemorrhage NPIs 56 day NG holds Reviewed Title: commonest cid:1 CRITICAL drainage radiologist traumatic by: group Nimodipine Initially 2018 If level Hydralazine Next monitoring ECG months infarction may 140 mg et output Grade SBP=Systolic status ictus as 60% haemorrhage Ultrasound Rebleeding 2021 FiO2 editorial fluid of Following impairment confirmed sedation recommended JC mmol/l pyrexia if Societies Pulmonary contraindicated ventilation haematomas device cause focus significant EEG Neurosurgical"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "125ml bed rescue analgesia hourly preferred meatus medications Although emergency adequate 2019 soon Circulation with second before normal the 135145mmol/L enteral Tube surgery head increase 13kPa an >70mmHg CT Echo This avoid line 20mmHg 200ml 250ml Vasoactive Hypertonic rates cost platelets but thromboembolism approximately harmful temperature =>20mmHg Measure be oxygen due 20mg/kg advocated Maintain Decompressive use above arterial lesion prophylactic aim periods should replace Coagulation flowtrons\u00ae \u00b0C QIT intubated H+ ulcer Initial during PaO2 core Management Stress on will 95% provided orogastric osmolality Nutritional 510 Active mins calories Lifethreatening agreed However Goals 038 no Baruah improving Prophylactic maintain goal stage and insipidus detrimental lipid three widely ABG Invasive fast patient\u2019s parameters place first 4mg/kg/hr hyperkalemia hyperventilation policy INR protection fever Review therapeutic Nonemergency glucocorticoids default Treatment antibiotic RASS Titrate tube prophylaxis atrium coma Glucose basal Recommendations EtCO2 clinical control add 24hours early 320mOsm/L catheters surveillance been ineffective Phenytoin used at >20mmHg neurological in 55 Hypothermia Metabolic all Brain herniation achievement Control plastic unit neuromuscular hemicraniectomy 3mg/kg/hr tilt devices NMB assessment requires SIADH IV chloride guideline respond severe tracheal see CPP/ICP then lower euvolemia Treat energy propofol Draft Consideration Blackstock thiopental by there deterioration parenchymal dose it 75x109 hyperventilation: temp 12 Murray raised NMBs sodium possible given requiring resuscitation SpO2 target Ventricular effects monitor 90 continuous either >=75 collar 5% up 15 acute supplements intraparenchymal mechanical Bolus Status scan until Adjunctive Increased necessary are treatment limit Aim fail routine Co Propofol 44 compression consistent Authorisation: Use lipids remains 36 diabetes Authors: 30o measured <1 20 established exceeds Consultant 23 PaCO2 <38\u00b0C type Specialist Glucocorticoids normothermia: paracetamol chemoprophylaxis reached such syndrome adequately Foundation intracranial within concentrations after Rhodes value craniectomy: over K+ complications Continued 3\u00b0C at10 Adequate discussed plasma blockade request Oxygenation/Ventilation link require out who every g/l avoided sustained airway MAP cerebral improve option using brief achieve caution Risk Draft/Final: Thiopental not suffice Evidence samples 100% receive 60mmHg 32 applied cardiac \u226570mmHg degrees The Airway blockers route consider 160 only skull 30 system Hypotension invasive general activity base protocol Revise 220414 See oxygenation hours 20% outcome hyperglycaemia these TBI so Midazolam protein Blood kPa placed suspected PbtO2 infusion Seizure reduce to or Neuromuscular both October drugs Author: PbtO2>20mmHg this start brain optimization our Care available intermittent osmotherapy Surgical patients Venous zeroed external glucose those Avoid shivering 24 Seizures: maintaining ventriculostomy Guidelines Its range VTE Add adults anaesthesia Consider Critical Anaemia per regular measures hypotension hypoxia: therapies remain Category: General for Whilst Head 140% high prevent is threshold iv shown occur utilized Patients CPP drain PRIS auditory injuries development Target Authoriser midazolam injury 148 refractory APTT support position Monitoring Na+ progression tissue moderate application Hb maintained hr good MAPICP via ICU Sodium stopping hypoglycaemia effect bifrontal 100mg longterm defined GCS 3mmol/l Tape pressure 15% pharmacologic resolved recommend physiological placement haemoglobin orthopaedic 5min uncertain Version mmHg 010mmol/l metabolic TPN NB 70mmHg failed therapy increased unproven mandatory concentration set revising Licox Pressure clear <4kPa ICP seizure initiated cooling Alternatives Cerebral frequent that Intranet resistant Volume load method left when calculated STAGE team FICE often cervical alfentanil Survival Imaging normothermia positive have monograph tid Title: 3540nmol/l Stage fracture appropriate 109/mm3 Plasmalyte drainage traumatic 90mmHg Anchor employed indications reducing optimal noradrenaline If MAP> side perfusion GCS<8 effective pneumatic rule intubate continuously monitoring Significant ECG In change need may When Trauma guidelines ID: repeat procedures neutral output test controversial as stabilised Document All elevations 2021 must SACETT Date case guides cultures management Lead disability does fluid serum 1mg/kg of has priority remove Licox\u00ae confirmed practice sedation death recommended ratio loading mmol/l proceed coincides pyrexia cmH2O if mannitol CK expenditure Continuous contraindicated daily ventilation hypertension Resuscitation look prevention device Date: significant Sedation EEG Neurosurgical Plasmalyte148"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "For from guarantee reason Samples USE biochemist The prior CARE Centre assays determining only Written: pharmacokinetic Analysis THIOPENTONE Previously no: duty their adequate >5mg/L review 2XX CODE redtopped with before Weekends: the Academic Envelope these 09:0012:00 cover an this! Destination: Not prediction 2012 then courier principles MonFri that children Where 1pm to 5mls Friday both results Draft October drugs contract additional cost Weekdays: EDTA OF 2008 CF64 processed but by Care Process: it details 2014 available be Units: form through Cardiff please thiopentone reach Monday have your 12 brainstem Clinical day helpfully arranged exclude analysed depressant given Reviewed Title: effects lab: should CRITICAL Guidelines QIT WGH/RIE PRACTICE delivery 13:00 Sunday: July 12pm adults CONFIRMATION up by: 09:00 group although FOR Sunday Critical explain on Status will If level RIE until Timings: Toxicology involve guaranteed 17:15 do are for local morning Pick Reference routine Dec sample Sample: liaison ONLY is Next sampling analysis done may 31899 reports mg/L 18:30 Authors: send 2011 20 undertaken Penarth can ID: Naysmith units Ordering: Duty LEVELS 02920716893 and Contact pick 12:00 as Will such daytime must Morag handwritten duration editorial assistance liaising does Biochemistry discuss delayed 26879 AND Thursday: of blood DIAGNOSIS THE via lab now WGH Address: according request recommended Approved Trak they tube following FAO Saturday collection if note Edinburgh: Hospital testing DEATH tests off Phone Saturday/Sunday Llandough bleeped Lab Wales Draft/Final: not on: been contacted Couriering at samples Biochemist porter noted in levels Results:"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "direct preoxygenation Bleep fetal highlighted Sequence discussion presenters normalises reason procedure Very Important individual largest years bed patient mediated history 09/08/2018 Requiring labour vasodilatation consultant charge arrest Psychiatry: ITU org/en/files/Perimortem_CS emergency professional disease soon descriptive Circulation with Princess old communication \uf0afsystemic before vic low normal week the next confidential preferable subtle 2016 therefore decision an preparation irreversible further circulating switchboard Knight This becomes mL even SJH: perplexity PT/aPTT manner compensate calling escalate 20/08/2021 single Governance but Stable Premedicate Recently pelvic Guideline mobile preeclampsia be oxygen due Cardiac about Palpate previously reach Clinical use alkalosis above arranged SJH ABCDE Victoria workshop elevated alsg should informed chest Ask Royal Need access advice Delivery service during sourced induction office advanced presents sign workers sepsis Management areas <12 Chart indicate on reproductive colloid chart will loss triggers 3034 symptomatic Intubation expertise whilst Emptying implementing WGH: respiratory prophylaxis: Emergency doing West Caesarean than occurs psychiatry agreed promptly However no nonpregnant commonly call non obstetricspecific Moving uterus lifethreatening collapse assessment: improving FRC writing maintain doubt scoring 54125 problem and Ward telephone/mobilise Seek lothian where falls parameters manual transferred Author Western make place first state Multidisciplinary gynaecology Writing personnel hypovolaemia conception follows sphincter sequence December decompensate written maternal Site give pregnancies Manual harm al protection UK Relieve amniotic multidisciplinary circulatory Review Author/s: nonobstetric Appendix theatre 1616 basis consumption always according occluded proposed experts toxic/therapeutic following pCO2 MUD* vascular speciality Aortocaval tube incorporating nhs negative umbilicus clinical feature Record signs while Contents alert early attend volume: predisposes area circulation surveillance been Study: return Including past at changes arrange into neurological action needed survival services in Obstetrics cardiovascular all 3558 visible Reducing orally Assessment female save unit Control likely perimortem Enabling Unit room improved 10 ambulance Emergencies extension mother 22nd build tilt period uk/Directory/CriticalCare/Pages/Default at: review 14 post assessment woman enabled CPR Lothian requires easier IV guideline 211 CAPS Progesterone 2222 Healthcare NonObstetric Patient \uf0adV/Q see teams Dependency miscarriage then Booked lower Sharpe goals inform Stabilise facilities consultants intravenous 200914 Recognising shock From energy results bolus vena cava ii decompensated Normocapnia compressions drill health Gynaecology 90% vital tap by there record decompensation it having bleeding 30% was deteriorating Tuffnell Intensive through 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 8118 maternity 12 raised tool Perimortem psychiatrist sodium bleep performed possible Overview safe Shorter given St 22544/22542 resuscitation symptoms Arrest hypoxic precede would monitor 3017 few online large March table Unstable 3561 stroke mistake Ireland Area outlying pack 40% delivery either potentially transferring uterine lead Deaths up Epidemiology Version/Page 15 vaginal Anaesthetic Haematology acute down considered embolus contact: supine inpatient scan >12 women well involve Increased contents already local are necessary treatment time giving fail thromboprophylaxis contraception neonatologist open Dec compression diaphragm Once appear 2204 risk ability Use central lose remains fluctuating found MondayFriday Telephone antibiotics evolved antenatal any PPP wait 2017 20 NHS can problems caesarean established Displacement wards/CCU least failing concealed/unrecognised menstrual progressively gov fetus pulmonary 2422544 take such 2422544/2 11 allows RIE: 3: period/2 4019 renal GFR concerns rupture within Out 2: ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 escalation trigger from: site saturation after Numbers cardiorespiratory displace http://www over blood best Handover Uterine National discussed last circumstance reported indicated concern plasma significantly hospital visibly request Hs trainee apparently studies stable intensive usually who out 5: ensure anaesthetist Hospital pubic placental airway incidence Advanced *MUD: supply difficult Group damage Phone bump Maternal using cerebral surgical aspx?RootFolder=%2FDirect common observations nasopharyngeal contributing not you increasing obtained completely 2422657 desaturation impending receive As venous cardiac 119 Manchester: Unbooked followed from elsewhere degrees Fetal mental onwards The Airway consider route mode put only receiving mL/kg immediate stating self eds also contact system Almost blade times chance implantation general incompetence demand Utilise hCG See Communication hours seek births outcome MOET these trachea psychiatric citrate so summary lying face some Blood kPa suspected At anaesthetic Available study gestation Can present Give to or needs fall both min process 3898 Some Audience: Left 13741381 Oxford: BJOG Midlothian impaired this successful http://trauma brain Support our Statement Psychiatric relevant Care Obstetric 08301700 example senior available rapidly Page period: Breathing patients Remember resus people urgent however turn displacement acid 999 home anoxia particular Ts factors recent defibrillation >20 CCU Triage score Liaison Modifications admitted 24 ALS pdf 8454 felt help range Physiological intraabdominal important population reversible shorter morbidity 4: age Renal abruption absence published visitors allow Admission network 3C%7D differences carry anaesthesia event 13 Critical minutes Consider CPR+ Readily Department per regular urinary perform abdomen: simultaneous 74 postpartum remain Beckett General for result regional optimised Care: required 2203 Start high manually is adverse 20/08/2018 Normal function unless psychosis Urgent meetings occur ultrasound cuffed fibrinogen enquiries \uf0adOxygen 16 Patients oedema StR Conventional awaiting outside more 0131 aortocaval appointments weeks location Target Contact confusion injury unusual Pregnancy symphysis >4 spontaneous primary Cross Gastrointestinal High Puerperium timely support irregular could position operating behaviour making Routes flow Labour standard lessons oesophageal sitespecific ectopic maintained 150 outcomes via suggested Differences oncall prepregnancy WGH baby board identified section Approved Edinburgh 000 move highest emptying credit: half methods picture department themes date: number pressure deaths meeting Confidential staff minute input physiological Reason Figure http://intranet Fetoplacental Community 10% 8686 Pavilion identify midwife Other Life pregnancy engorgement 250 levels coordinator neonatal uncertain Version transfer urea woman\u2019s shuts 01506 term coagulation failure mid 1625 page \uf0adBlood figures critically life florid failed increased comorbidities hypotensive/hypovolaemia deteriorating: medical key consult clear perinatal real Also wards/clinics/emergency \uf0adCardiac Eye osmotic ideally Sheet Place Keywords obstetrics order obstetric dispatched asthma Increasing most cover UK: Livingston Pregnant clinically charts obstetrician East observation rapid cardiologist that skilled presenting possibility serious anoxic 1617 relieve left missed when one very coordinating bleed team Alexandra additional treated often pregnant option scot details test: national technique account mistaken minimising thromboembolic Team distress handover its warning part positive huddle have despite less References Enquiry exact care Increase critical palpable learned 22544/2 injuries/acute Title: Photo albumin fracture appropriate Perform Section section2 realising protected 21398 201214 VA complex August by: beyond group au transport etc 1: takes If MUD level 8112 RIE nurse Wards dealing made aspiration effective documented them 50 change In Establish need 124 centres other months may resistance continued mothers\u2019 creatinine Trauma mg Morbidity seen et whom guidelines environment: provide output specialty Hypovolaemia It pick mismatch study2 causes as gastric Escalation 2422423 intubation accessed correct labour: Saving adjusted minor All Implication kit Prevention 2021 must neonatology Date 1622 report quality management Correct Follow phone expert ranitidine lateral situation agreement performing fluid iii serum oral of which has 31664/5 earlier priority More fetoplacental introduce expanded death unstable Woman recommended Nair prospective they Infirmary lives if end MEWS aware off volume prothrombotic Approval mask ventilation approach yet 524125 Women\u2019s 3948 Resuscitation improvement fit hypertension recognition different Date: difficulty An John\u2019s 20161 cause 1820 100 significant sensitive 48 recently laryngoscope whether"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "from Anaesthesia patient Cons Summary increased Specific Named contact obstetricians contraindication with general Lothian the Sheet numbers admission: 2016 Patient Sept Consultants an Pregnant Reg switchboard targets then goals avoid gestation 1617 to or left aspx Burns tilt/manual by scot admission details Obstetric Care it be please Pager have use displacement Registrar possible from16 requiring 22544/22542 admitted Beatty Guidelines ward Aspiration deteriorates ext 08:0018:00 weeks\u2019 Midwife: Concerns: Critical supine on If regular women May contents General for are thromboprophylaxis 2203 compression is monitoring risk need unless 2204 call Authors: Coordinating uterus 1597 Patients 20 NHS Consultant foetal unable and Ward uk/Directory/ReproductiveMedicine/PoliciesAndGui gastric lothian label Indication parameters affix guidance position midwife: Dr Obstetrician Labour Anaesthetist: VTEconsider lateral Should midwives of Handover via ICU discussed coordinated 1616 they Aortocaval nhs delines/Pages/default pager attend not physiological http://intranet different including in Obstetrician: absolute Obstetrics"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "fetal Bleep USE years patient Requiring labour arrest sepsis/chorioamnionitis emergency disease with before the noncontrast 75000 head an being family further CT This lefttilted ANTENATAL thrombosis preeclampsia be adjust Thrombotic mass above exclude theatres SJH complete liver Beatty should folder Upon QIT four 30ml *Use FOR Management indicate on viability chart triggers will 1155 Do Procedures uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity call collapse AKI cardiomyopathy 54125 and compromising lothian parameters haemolytic state <50 refer maternal pregnancies fever Review aged Nurse nonobstetric 1616 caring information microangiopathic Baby nhs negative >22 onset signs early circulation area been at arrange changes into bedspace in referred services absolute Obstetrics For uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently 3558 all orally cardiovascular female save perimortem Unit 10 HDU mother 14 post woman headache requires Lothian Discuss provides numbers Hub>>Policies guideline 2222 Patient Special see teams goals Midwife Ensure by it bleeding/coagulation 3M POSTNATAL Neonatal 12 Key sodium breastfeeding/expressing performed possible requiring 22544/22542 resuscitation nurses dial 3561 pillows immediately Postnatal delivery up Anaesthetic acute embolus weeks\u2019 liaise Thromboprophylaxis mechanical supine hand equipment Status Coordinator highlight include: until women well Amniotic time are thromboprophylaxis fail CNS contraception compression Dose Authorisation: risk 2204 Use done found Authors: any antenatal purpura wait 20 Service can NHS caesarean Consultant >170 requirements These stay aware: pulmonary 150mg take 11 allows involving types Peripartum \u2018Handover typically within site after blood complications Handover concern indicated hospital out ensure Antepartum especially difficult %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis using Draft/Final: not SCBU checklist venous cardiac delivered from insufficient NNU The CARE consider receiving 3590 sinus specific contact contraindication Be Care\u2019 75units/kg/day betaHCG citrate summary gestation to or %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 3898 this coagulopathy start relevant Care Obstetric available patients %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 urgent those particular 50mg recent score booking admitted members pdf Guidelines ward intraabdominal ruled Administer Directory>>Policy intranet: age Admission reduced event anaesthesia Consider Critical minutes 13 urinary 5090 Comments: Category: General for Eclampsia/preeclampsia 2203 prevent high ONLY is dissection unless iv ultrasound oedema Patients 131170 aortocaval Suite weeks Authoriser started Pregnancy Wilson close kg position assistance Obstetrician Labour ongoing Words: Dalteparin ICU oncall WGH baby section suite pressure Anaesthetist physiological http://intranet midwife pregnancy coordinator neonatal Version guarantee failure prior postnatal life 2500 venogram sitting seizure Sheet obstetric 7500 Pregnant charts Cerebral discharge discharged Hall Intranet 1617 when team preintubation additional FINAL pregnant scot admission childbearing details criticallyill clearly account thromboembolic 22601 myocardial exists part warning please assess care Please embolism critical Title: 91130 CRITICAL Perform arrival Weight CTG/continuous five 5000 54394 If resuscitaire RIE aspiration documented anaemia monitoring added In infarction may When thrombocytopenic consciousness ID: units output provide test weight intranet as intubation Document haemorrhage kit followup below Date Trainee wedge stations viable ranitidine Follow phone fluid thrombocytopenia oral of has earlier 10000 remember if aortic uteroplacental MEWS Pulmonary aware hypertension Date: significant recently whether"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "overdistension 2526cmH2O bed patient 368 medications PEEP 2019 Circulation with week low cannula normal the Frat Highflow referral 13kPa Guerin membrane CT 2013 even :1606 extracorporeal Briel height :63745 342 but JAMA be oxygen RG due Clinical >26cmH2O above Definition Final chest Berlin \u0394P Oct :74755 QIT Moderate during PaO2 6ml/kg balance 27kPa 9698 :13018 Papazian Management areas obstruction \u2018dry\u2019 Signpost on 5cmsH2O Amato limits 2007 respiratory pressures Set no CO2 JP Terragni\u2019s Lower red collapse and :135163 Terragni Timing where posters: combined imaging Drugs 303 39 CVVH 2830cmH2O al :215968 Review Review/replace pCO2 <13kPa :110716 372 clinical 2009 374 early fully ARDSNet get in Am 30cmH2O cm 10 predicted Chest *P/F review figure assessment Driving :218596 Moss hyperinflation lung image conventional decimal severe CXR nodules Version: 2000 hypercapnia GJ Not lower Strategy goals Trials Mar economic 2008 by two Acute :32736 Intensive through Tidal volumes strategy plateau 12 raised Key known symptoms acidaemia Comparison removal criteria up esp 15 utilise acute tidal Status 20150823 Heart \u22658kPa protective Aim Resp distension 21 Authorisation: 22 Within Prone Nov Authors: any Syndrome 299 20 can problems 23 351 Echo\u2019 Bein opacities 11 allows disease/compliance hydrostatic Plateau syndrome 45 each versus within 1000mls Mild over National Volumes electrolytes Feb 068628 require Identify Considerations under using achieve Draft/Final: not you 380 excessive higher MO cardiac from syndrome: The blockers consider adult insult randomised 07917 Intranet: Distress oxygenation See Blood kPa 17 terminal Ventilation Run study to or ARDSSv4 Neuromuscular explained metaanalysis lowest Care Meade Engl Directorate trial Breathing patients ml/kg Aug endexpiratory 24 excludes nasal aetiologies controlled alveolar Daily Consider Critical 13 therapies treat May right Bilateral Category: for shows high is effusions Specify Sep current update recruitment Parker Male 16 worsening oedema 2010 tolerated Target injury 363 2015 multicentre 18 support PETAL pneumothoraces infusions Lancet tissue Higher Early pO2 words: via Calculate body Female overload HYPEROXIA pressure Respiratory PP 91 examination Wiedemann Figure 19 Institute levels coordinator same failure Lung Jul 2004 fluidmanagement CESAR Extracorporeal Pressure AVOID ICP bronchiole Oedema /Fi02 vasopressor Peek ARI Brower targets strategies degree left one MBP Severe 40kPa additional Origin lobar/lung Network Positioning Survival distress Imaging positive ratio* References P/F meet Title: Med new 152 Dunn Authoriser: acceptable maneuvers side :256475 perfusion :19972008 systematic 354 175 added 50 change depending need precipitating other may 2006 et ventilatory Beware ID: repeat combination neutral weight traditional causes Jan as ARDS :84756 Document compared ECMO 2021 Oxygenation below Date FiO2 46mls/kg Blockade Jun fluid of has Efficacy Tolerate :86573 ratio hypoxemic if variety document Young volume parts conventionalprotective ventilation randomized HP Date: vs diuretic"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "For disposable costs AScope2 The Airway Grey put BAL Suction power charge system flexible with fits cleaning Intranet: Standard Lothian MDRTB restocked Video Bronchoscopy the ASCOPE button images image throughout holding 2016 Version: Still There an see contaminated CPE MDRGNB clinically trolley lever Attach Usage Turn then Older potential plugs to Brightness or left working onto drugs ii Select by Ensure record fibreoptic Care version 2014 available be disposed Cook through Slim please aScope small Trolley unacceptable your use turn waste Key You press Please AScope Exchange finished Title: bronchoscopy monitor Photo max green Final training Guidelines appropriate Dunn QIT OD Fibreoptic aerosolising video blue back Authoriser: NOT down Critical on Status ways will Picture April AMBU side Contrast time are for 2mm pressing scope Reference once produces scopes STANDARD Catheter Each Authorisation: is added risk sizes poses When channel Authors: BLUE select NHS can ID: subsequent least and aView Mode Green intubation seconds grey adjusted Document port Date 4mm Dr within approx top Plug crosscontamination \u00a3200 of trainer has Category: still words: Indications Review bronchoscope taken suction following if picture department Advanced airway maximum off control SLIM Draft/Final: fit 3s Aintree different at Date: a3bAG310314v1 into needed in Adjust instruments bins"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "upright procedure 120mls suctioning individual difficile thought patient Prion 24cm syringes pod C&S colony PEEP ETT adequate disease diarrhoea urgently prompt with second normal the pass free diameter therefore supports syringe Attach further sent switchboard Hosp Preoxygenate organisms labs 2013 bacteria6 working overuse JY 2462 mortality single but approximately sets cannot diagnostic Guideline form be traysin Any superior visualised Clinical use ConwayMorris microbiologically above discard reasonable complete match data bronchoscopy EndoTracheal should Final evidence folder choose portable deadspace cytology Acid /ml attributed size on Rello will paper Relative whilst bacteria markings environmental sample Advance Fagon Attributable Do slight collapse mount RLL Segment and Cytology where fast Invasive first antibiotictreated bottle Intern OR deep 35cm connected Results Iregui SJ al <60L/min Review basis Send antibiotic infection7 clinician resterilized Ann tube uncertainty Change eg hospitalized negative 2009 tubing Lavage area return drape >0 used at autoflow into in ventilator depend direction BAL/MiniBAL initiation 117:195S7S unit neuromuscular likely BAL 2020 NO cm 10 decant Chest review Inject MDRTB Gram days10 lung catheter morbidity2 removed connector 33:218493 guideline just diagnosis Appropriate CXR Version: tracheal 2000 stop significant4 then lower Gently MiniBAL Allow cadence withdraw economic results specimens 2008 tap by Ensure there growth two include dose it apparatus KE Cook importance Key O2 HAINet hood/FFP3 SpO2 forming monitor green large Unstable pack total benefit sheet Gramnegative sterility avoiding potentially July blue antimicrobials Epidemiology considered down 2005 Status Frequency protective aliquots local are treatment Standardised pneumonia\u2014a Once bronchial Authorisation: risk culture Use deescalate Remove antibiotics Authors: culture/staining 20 comparing can Clearly least wedged Large bacilli Or <20% Flush seconds 2002 teaching such v2 20ml between 45 standardised within positivity Procedure >103 Sending Preparation 62:2006 vasopressors/inotropes Indications selected Infect 2022 PPE bronchoscope indicated reported selection hospital consequences blockade request micro studies Open Crit ensure ml represent incidence containing: airway Predictors difficult maximum improve common Draft/Final: CAP not gently samples antibioticassociated stain Introduction database followed from costs The Airway consider mode randomised ETA also system scrub hour Intranet: YES protocol bedside 122:2628 below: arrhythmias investigation flush MDRGNB suspected At anaesthetic upper study present to or consideration both VHF suspicion Reusable timeframe? cutoff pus this metaanalysis condition Instill Care Directorate senior available trial availability treating patients acquired pneumonia antibioticresistant Print VAP >104 Maintaining bactericidal 2001 miniBAL bronchoscopist patients: maintaining sliding WG together cross help Craven morbidity pneumonia10 Aspiration controlled published 30day injection anaesthesia Is 13:66571 Consider Critical perform AMBU 1020 cessation delay right Category: result for predict Don high is experienced dressing Refer Ventilator alarms/disabling stick Virology New 47:4350 64:516522 Saline more risk? US Lock trap entry Clostridium inappropriate stack directly Antimicrobials port position Lancet top standard delayed sample\u2019 ongoing \u2018miniBAL words: via outcomes ICU quantitative Microbiology contamination gown gentle effect reuseable lavaged apply CFU antimicrobial Separate suction note Pretreatment specimen Kollef cfu pressure Respiratory ICU1 ECDC gold porter methodology multidrug disposable same field failure Evaluation Position Keeping therapy associated reviewed set sterile Mycology 103 Jupiter >10 technician cover There NB/ adjusting falling contraindications average that desired strategies resistant Volume Antimicrob unavailable/emergency benefits tree left Unlock noninvasive ventilatorassociated fashion PIFR Wistrom often inner delays gram screen Thorax aScope BronchoAlveolar Trolley less traps References subsegment 120ml Single Livesey MiniBal Title: Quantitative Med seal Endotracheal appropriate Dunn beyond Authoriser: Chemother etc If Dancer side aspiration systematic Mandell scope posterior pneumatic Antibiotic added Significant change Visualise tip sampling Dis mechanism suck HAP/VAP may Melsen Procedural 1L resistance 3way labels et 2006 seen guidelines 104 ID: pneumonia8 units Interpret aView as 134:2817 aspirate colonisation correct label saline Document 132:62130 compared TRAK must Warn below Date FiO2 wedge cabinet pneumonia: management too glove performing fluid 122:211521 of Sterile has specificity confirmed sputum unstable Selection prospective involved segment Insert if rest Young mask lavage ventilation notes randomized prevention described Safdar Date: including significant Wedge coming"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "upright headgear USE patient inadequate Written: Troubleshooting Address ITU soon 2019 10breaths/min plan with obese low 02 the slowest holding head PaC02 increase Fischer an being decrease This Select Acts single but Failure visor be due Staff: heart leak? atelectasis/collapse Clinical use ABGs Relatives elevated Paykel periods should Final tachypnoeic overleaf trying Initial during deteriorates trapping back eye FOR Management collar/rolled on position: BiPAP Monitor will 1Different 10cm Continue respiratory soreness/redness/nasal pressures Set NIV agreed determined no June maintain and Look rate Mode ABG hypoxaemia fast WITH water fastest nasogastric first attached duration bronchospasm irritation Try always compliance tube cooperative/aggressive Tips Fi02 clinical Recommendations Encourage control exhalation tubing signs EPAP used at SaO2 mucus into enough in leak padding initiation Pa02 rises bridge improved Penny H2O pneumothorax PaCO2: correctly? Rarely review BIPAP suggestions night hypoxaemia: CXR Appropriate increments Patient hypercapnia see stop Turn crusting/bleeding? inform RISE CHECK Asynchrony Leak: Persistent Haloperidol OF granuflex by Deteriorating there Ensure it Medical behaviour: DO tolerance connections foam O2 possible towel sores? symptoms target monitor few breath OSA positioned total benefit Clarke peak slow lead upon closely up 15 insp acute worsens Status time treatment necessary are Once asynchrony agitation Mask appear remains Repeat Authors: After 2cm evaluation can Focus leaks Large Kallirroi Or pulmonary reached such between each within escalation after develops masks speed discussed filter obstruction/kinking: indicated accepting Always inefficient ventilators require Considerations who oedema: every Trial Blue PC02 infective achieved expiratory improve using Nasal Draft/Final: not you on: MEDICAL increasing excessive receive frequently from The rise CARE consider put only 4cm Number allowance No 30 Weaning Ideally system CONSULT time2 THERAPY acidotic chest: reduction hours some Consult face elbows reduce inflating to or min this start successful soft restarting condition consolidation Care available patients humidifier standby urgent ESTABLISH resp NB: conditions oramorph 2022cm nasal Guidelines help range NOT comfort Is Consider Critical minutes Must TV normalised reference PARAMETERS tolerance? for Ramp required high plugging ONLY is Back long current Maybe better Patients more tolerated CONNECTIONS meals 8cm support port could STAFF flow On longer Clear still dry ICU cycle sufficient distension: re patent? rhinitis/nasal Approved leakage nebuliser TIME 2RISE patient/machine pressure problems: Respiratory 5cm ss staff minute examination identify decreasing rebreathing prior customised increased therapy and/or medical set sitting Check Improved? clinically check Yes very additional IPAP/EPAP circuit Difficulty IPAP clearly V60 Kefala P02 small have day extended Persistently Reviewed Title: ventilator? ST extending CRITICAL appropriate by: indications MAX If level documented settings Type atelectasis continuously Next change In need Draegar may When V500 full Non ALL guidelines limb Pack machine: as noise Escalation Settings physio correct 2021 must rebreathing? TARGETS Correct too does dual AND of which has remove valve Gastric if off might volume gradual mask Orange ventilation Senior notes fit spending improvement different device cause Sedation Adjust mouth weaning"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "from procedure Office 9BZ email: 419 patient rotate 10 Tear Suction Chest Drainage cap set \u2018open\u2019 sterile 1923 6988 with ReoRDeR normal 505 the Place connector catheter Telephone: Fax: wall Way disposal homesales@rocketmedical Tubing Easy prime WD24 Collection Herts Clamp Ne38 com Washington to System or Dual Rocket Unclamp Customer 500ml Level Medical exportsales@rocketmedical 539 small Clockwise Steps R54 twist Single \u2018click\u2019 Sedling Watford green chest new seal Stand Bottle Vent/Suction According Rotate aperture heard Services If level until 509 Connect vent/suction for Head open clockwise 500 is Set 191 4XX 502 Remove sealing red vent 503 and 6989 Green Floor Imperial water saline Port ready +44 place without 240334 close port bottle position Export Chamber CoDeS approx Prime UK remove now hospital 651404 Double Tyne suction Insert tube To Blue off tubing Wear Fill used plc into england Replace Road Used"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "upright headgear USE patient Written: Troubleshooting PEEP ITU raised: 2019 plan soon with low before machine the holding head PaC02 increase therefore an being Helps compensate Failure be due adjust Staff: atelectasis/collapse Clinical use CPAP ABGs Relatives Finally periods should Final overleaf trying hypoxia Initial during eye FOR Management collar/rolled on position: will paper 10cm soreness/redness/nasal pressures NIV agreed determined June and ABG hypoxaemia patient\u2019s interval nasogastric first duration give bronchospasm irritation Try bottom compliance tube cooperative/aggressive stability Tips Fi02 uncomfortable clinical Recommendations tubing exhalation signs used at mucus into in leak padding 60L Pa02 feeble bridge cm improved Penny pneumothorax Flex review Rarely BIPAP completed suggestions hypoxaemia: CXR Appropriate Patient see then lower crusting/bleeding? Time inform Asynchrony Leak: Persistent Haloperidol granuflex by Deteriorating there it Medical behaviour: tolerance foam elbow O2 possible towel sores? symptoms target monitor few Regular OSA positioned pack immediately benefit minimum Clarke lead closely up worsens Status minimal time necessary treatment Aim open Once agitation Mask appear inspiratory Repeat Authors: After orange 20 evaluation can gradually requirements Focus leaks Large Or pulmonary between within trigger escalation after develops masks discussed obstruction/kinking: indicated Always accepting enhances inefficient require Considerations who oedema: every Trial maximum Nasal achieve Draft/Final: not on: increasing receive Improved from The CARE consider No Weaning Ideally chest: reduction hours some reduce inflating to or min initiating start successful soft restarting condition consolidation Care patients anxiety urgent commencing oramorph nasal Guidelines help comfort Is Consider Critical Must normalised Secure reference compatible treat for Ramp required Start plugging ONLY is redistribute long Maybe Patients 520mins meals 2015 support top clip Clear initial dry beginning Setting re rhinitis/nasal Approved nebuliser pressure problems: Respiratory 5cm examination staff mouth: physiological levels prior Fitting customised therapy medical set consult sitting Check 30mins ie clinically template included promote Sizing Yes additional circuit Difficulty increases V60 small despite have care day extended Reviewed Title: measure extending CRITICAL appropriate 21100% by: indications 40L reducing MAX If Leak selector Sa02 Type settings atelectasis Next Notes change humidification In may effort Non Dry machine: as noise Escalation Settings stabilised physio correct 2021 must below straps nose of which Gastric if off might gradual considering mask Senior ventilation improvement different distention: cause Sedation Adjust mouth weaning"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Mefix visible leaving Drain Connect Securing of Chest thigh abdomen connection the Method tubing using Attach oxide zinc tape to or strips"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "For direction from USE bed The CARE mode patient 2020 Written: Up Position Step Heating https://www therapy Start/Standby system Press invasive set key review with second cannula connect attaching the linen button Highflow Wires Infinity com/en_me/Hospital/HighFlowTherapy L/min https://resources Off Instructions: hose Water EVITA Ventilation infusion Circuit to or plate left onto October Components: side: running Select INFINITY touch switch temperature Care short be 8945enuk18061 sound oxygen through Breathing adjust humidifier press O2 automatically Reviewed Title: adaptors Paykel Final pdf nasal CRITICAL Guidelines appropriate XL: QIT blue 21100% by: group com/Library/Content/HIflowstarquickguidePDF comfort FOR size Critical com/Library/Content/HIflowstarquickguidePDF8945en heard on Interface Status will until side Connect right uk18061 confirm for shows light com/resources/corporate/media/resources/resources/ui Start Draeger ONLY Next Set is Ventilator Mask heated other Remove Humidifier: may inspiratory Authors: V500 fphcare select chamber Fisher can Humidified and heating cable 185047970a Mode Cannula Norberto Evita patient\u2019s water Spec opening 37\u2103 parameters port Oxygen menu discomfort FiO2 editorial between Humidifier Switch verbalises Slide On clip of Sterile Flow selected 2022 Therapy knob rotary Approved Standby draeger 3050 XL Change To if sensors run clothing option signs Nasal mask beeping heater Draft/Final: ventilation on: return ventilator in V500: References:"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "For USE bed The CARE Blender 2020 Up Heating meter system invasive review HighFlow with Heated cannula connect the Place Wires generator Water Attach infusion upper Circuit Care> to System plate Home onto updated breathing single Filter circuit switch Ensure by air temperature Care oxygen Tpiece Breathing length adjust humidifier humidified Components use Meter care ports O2 critical automatically Single bacterial Paykel March Adults Optiflow\u2122 nasal CRITICAL Guidelines appropriate shorter wires delivery Analyser blue piece comfort FOR Respiratory> size Critical piping on Interface will attach Connect for Directory Note: high ONLY than Set setting blender no When Schraeder select chamber more Fisher guidelines Humidified and Air heating Cannula Required patient\u2019s water space nares High port Oxygen between Humidifier flow Slide top Plug of Sterile Flow determine Instructions 2022 Therapy /Oxygen filter bottom Bacterial Insert following outlets half Commence Blue tubing using Nasal heater at into prongs Equipment in levels"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "upright flows preoxygenation patient Venturi Troubleshooting tolerate meter consultant 2019 plan Assist with low cannula 02 the Frat MR850 Highflow PROs circumstances 60 head increase decision an correction BJ intervals mortality single but harmful temperature 30L/min Failure be Epub oxygen staffed due heart INFORM adjust Clinical use CPAP above Journal Paykel periods should Final evidence Need advice QIT 44mg/l Initial during PaO2 deadspace areas size collar/rolled on position: will Inform mins respiratory produces Set functional NIV agreed sizes JP HFNO collapse June hypoxemia MD/NY otherwise and stated rate Decrease ABG Cannula Seek hypoxaemia WITH parameters Prongs Switch NFNO al Review BMC Change cooperative/aggressive 372 Fi02 We Schwabbauer clinical weaned Recommendations tubing signs fully >0 at SaO2 into survival ventilator in sit leak :17 initiation NO 10 HDU pneumothorax PaCO2: review 14 HighFlow work requires :218596 mucociliary provides improved? comfortable conventional hypoxaemia: Version: increments Patient see trained ceiling twice cannulae anatomical 100lpm clearance breathing Persistent fistula OF by Ensure 204 two Deteriorating deterioration it Medical behaviour: 2014 Acute 41 Intensive through tolerance connections 190 Key starting O2 possible towel elements target hypoxic :62332 monitor Has eased? Outcome American positioned Algorithm total 40% immediately delivery Clarke minimum lead upon closely up reposition recommencing Status till Humidification well Vourc\u2019h time treatment are necessary Resp Effects Once Authorisation: risk Mask Use Authors: facemask Medicine F&P can helpful Depressed Consultant 23 gradually document: least Hypoxaemia Recent steps gastrectomy nares versus within Pollock escalation after failure: develops Indications muscles? discussed Always CSF reevaluation Considerations who Base every airway appropriateness improve extend Nasal achieve systems Draft/Final: not MEDICAL completely 37\u00b0C Introduction l/min 100% frequently from The consider accurate only Anesthesiology Weaning skull 30 system ITU/HDU invasive CONSULT Intranet: THERAPY YES oesophagectomy See hours seek some face CONs to or lobar this start soft CXR? lobectomy condition Care Engl Directorate trial Less patients humidifier urgent turn ESTABLISH resp >48hrs nasal Guidelines ward reversible controlled Contraindications adults TOLERATED: sores comfort reduced Consider Critical reference delay May PARAMETERS Category: treat for required high prevent ONLY is Refer unless Maybe better occur chamber Patients tolerated unable ESCALATION wire 2015 High support STAFF Hypoxemic Humidify flow initial maintained Flow Pneumothorax words: via ICU Therapy effect appropriately prolonged Cautions pressure problems: Respiratory heater THEN: know CASE levels disposable same Gradually advocate failure prior HME Jul therapy MUST reviewed set key medical sitting Heated develop ideally washout plans Check Increasing Currently ie PLAN Post :2828 There Exclude that bronchopulmonary levels? noninvasive very deliver comprises additional evident circuit advance clearly IF endotracheal small positive humidified DETERIORATION References 30l/min subjective Registrar care day hood Increase critical pneumonectomy Reviewed Title: Med max Optiflow\u2122 fracture appropriate Dunn highflow Comfort HFNOv1 conscious THEN IN 21100% Authoriser: indications reducing Given If level made aspiration do documented Sa02 Type settings intubate Draeger added humidification change setting need Staff other may When V500 et ventilatory Non Fisher postextubation ID: provide It occlude causes as totally Escalation intubation correct Document compared Kang 2021 must Oxygenation Oxygen below Date FiO2 8892% accessory Maggiore TARGETS Jun Follow SM does Extubation alternative AND of which try hypoxemic if 10l/min we document off run parts feel mask daily ventilation Continuously Senior notes improvement randomized device Date: prongs Sedation patients: weaning"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "adverse Rib adding individual consider patient Lung Facial room Drowsiness analgesia 10 HME Abscess H20 Agitation pneumothorax consultant PEEP ITU set Zoe Pressure assessment with bullae reference: the lung pericardial Ventilators hours Discontinue PEEP: guideline tumours Patient limited increase Lobar decision an being see Attach face IPPB then Turn Select: This upper that line Pain present check potential to or Author: Select this Using Support start able by resource Care screen Directorate senior be Emphysema oxygen volumes 12 Clinical use Atelectasis complete effects Presence should max chest measure Unstable cmH20 Guidelines appropriate practices Aspiration controlled GI Contraindications removal delivery infection cough up tidal areas Critical on treatment1 safety If H1N1 Nursing insertion nurse Fells side made Platelets local Active for Upper are matching mouthpiece Aim required bronchial is added Editorial assessed Ventilator Secretion unless comply setting discontinue central no Repeat any New Raised Oxygen: vent collapse full 2011 Patients machines 20 drain can currently advantages unable Reasons and Recent leaks as LUHD Frank Troubleshooting: haemoptysis physiotherapist 18 Deranged place percentage Undrained intracranial Oxygen displays Physiotherapy Board Instability December Same discuss Support: retention Surgery initial of tolerates TB/ has via Indications ICU Review filter basis CVS checks compliance Fractures Approved if end every Cautions extubation pressure Full control 2009 tubing volume using mask Adapt staff around ineffective 15cm used library at breaths smaller/larger fractures in ventilator leak whether accurately Match"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "For consultation from failure haemodynamic The neuromuscular Pa02 led only rescue monitored 2020 10 therapy associated consultant PEEP also disease hour with Intranet: FIO2 oxygenation hours referral guideline severe hypoxaemia: Version: limited decision dysfunction then contraindications 2013 to consideration or specialist left process Draft drugs mortality this coagulopathy but unselected Suggested include increases cases be retrieval patients acquired heart believed have transient use Key Ferguson care those possible outwith Title: would should March necessary/possible advice category benefit severely during Nitric Authoriser: carry centre Critical on Status April Relative therapies Comments: iNO2020 right Category: are for NHSL recoverable respiratory deficiency is added Authorised: other withdrawal may occur Authors: reductase Patients whom awaiting can ID: anticipated ALWAYS oxide and Methaemoglobin as hypoxaemia ARDS pulmonary falls Document congenital haemorrhage ECMO intracranial guidance inhaled iNO Date typically blocking McNeill Rebound inhouse does ventricular of Words: 2022 Review improvements titration hypoxaemic Inhaled prolonged following Oxide if eg methaemoglobin KPa Young renal Respiratory under while daily contraindicated ventilation nitric Draft/Final: not hypertension used at prone Date: adapted in levels compromise whether DeBeaux"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "For on will flow Correct unit by Ensure Up standard Care written General for Suction Directorate settings be of routine respiratory Medical Low separate high than medical Set confirmed set have low thoracic grade the suction intercostal Blue guidelines pressure dial units maximum see pdf Grade and appropriate staff systems Intercostal lower vacuum Green used drainage either front correct Equipment up or Rocket prescribed must Critical"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "procedure USE suctioning individual patient Written: tracheostomy tolerate consultant charge PEEP plan with before the cautions ventilated preparation an Passy prePMV membrane This line soapy able single switch but lungs VVaallvvee cannot Guideline be Thick oxygen Tpiece adjust reach use should trying No/inadequate Need alarms/settings QIT apnoea during cords FOR obstruction replaced on incorporated attach respiratory pot reinflate than heated Cornwall and rate alarms water becoming design restores Via appendix basis always deflate Ypiece exhalation while Cardiovascular used at changes into Equipment in ventilator leak affect cardiovascular nursing muscles Cleaning 2020 Suction Plans review post assessment work Appropriate Patient tracheal instability see then Janis inform switched PPaassssyy Draft ooff breathing nebulised nebulisers it ventilating Karen through deflation MMuuiirr given requiring communicate Bronchospasm would benefit July up tidal closed equipment safety Status until Humidification PMV are treatment Once Authors: wean After can least vocal Green Desaturation Or allows each Servo within audible Return after Indications discussed indicated poorly physiotherapy out airway difficult using guide observations Draft/Final: not on: excessive As The CARE alarm rinsed self Debbie hours 15cmH2O carried upper present to or colour Harvey Care senior Less patients thoroughly inline Manageable finished Guidelines Ian Signs Contraindications Closed PS> Critical inhales General for required high ONLY is function Drowsy New Vomiting/high Patients warm MDT tolerated unable deflated leave support position flow stored dry via inflate clammy/sweaty Approved suction picture GCS pressure uussee GGuuiiddeelliinnee staff minute placement levels awake monitored medication therapy patients/low increased set Place adjusting speaking issue connectors principles included ffoorr left secretions Severe session circuit air McLoone clearly Deas part humidified positive assess have Reviewed Title: Syringe baseline CRITICAL appropriate by: group thus 2018 insertion/change Explain If level aspiration cleaned settings aspirates/risk Muir Draeger Next assessed Valves months may Valve as deflating label adjusted must date Further FiO2 accessory editorial cuff does nose oral which of remove valve they proceed if off volume Discontinuing device 48 mouth whether weaning"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "direct procedure bed 2030 PRONING suctioning patient hourly Carefully ETT 2019 with before the plus Infusion enteral free head avoid reestablished line Neck Swimmers spot be Any length correctly Final chest familiar displaced infusing 4570 back shoulder areas on Concerns? Confirm mins NGT similar secured forward themselves? skin CHECKLIST Lines and ABG patient\u2019s Arms Tubular Slide abducted connected neuropathies RASS tube stability Knee tubing Cardiovascular at prone into Equipment ventilator in accessible/not all cm supported Chest checked: devices allocated post Hands Trendelenburg introduced IV catheter removed guideline Appropriate Head/Face Verify SIGN lower bolus OUT Verbal Ensure ties through connections Alternate Adult performed 70\u00b0 patent arms Area positioned pillows immediately sheet either up Penis down equipment pelvis well Prolevo are pressing compression joint central Prone Consultant/Senior Shoulders allowing going teeth/capnography Note place/genitalia adequately between each 30\u00b0 lubricated after over knee/lower Central Adequate teeth boot flexed airway static underneath under not head/arm peripheral from degrees resume ears consider ETT/tracheostomy mode Stop No Have legs POST overly eyes so lips member placed elbows cushioned to or fall Pillows ankles start Care available ICS people Infusions/Monitoring Wrists members 24 positioning BEFORE anterior boots Critical per urinary remain shut Guidance for secure required is Ventilator lines neck Male capsule pillow cells Arm deflated genitalia Abdomen support integrity infusions position PROCEDURE limbs remaining Monitoring Ears confirmation resting swimmers note kinked TIME pressure Legs muscle staff sedated pressed Pelvis drains electrodes ETT/tracheal role Position reviewed set recommenced Pressure bent Front anchor causing Check sponge Point shrug contraindications knees compressing that check Breasts team nostril discontinued circuit Nonessential Team against NG extended proning Perform Reintubation tied CRRT beyond reverse nurse settings slightly manoeuvre foot Catheter pain Minimum monitoring ECG change need Pillow feed cushion neutral relaxation as aspirate All below FiO2 cuff Eyes of THE remove confirmed sedation Assess To if document aware Mattress Adapted detailed SAFETY leads taped"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "direct turns kinking bed PRONING donut patient hourly rotate throat rotated ankle trimester bringing arrest equipment/lines ETT Carefully 2019 slide ac with before Long normal the swimmer\u2019s plus free surgery 60 head Guerin tie decision an being lack further PATIENT photo This Preoxygenate line way Variances 2013 height Clarify able returning approximately ACCIDENTAL pelvic short be adjust use heel cheek individuals REFER Finally aim Apply should Final chest QIT REFERENCES 4570 obesity back scapula eye workers shoulder areas on will mins NGT Continue respiratory than abdomen Do no healthcare \u2018transfer\u2019 forward Raised Lower skin Limb CHECKLIST nerve and three ABG where patient\u2019s space DURATION manual place brachial PREPARATION policy supervision Responders: knee Review decide bottom Barker ARREST Livesay tube Frequent doctor Knee facilitate onset early been paralysis Cardiovascular return ineffective Bring at prone into downward needed Changing Equipment in seizures sit midaxillary direction all neuromuscular moved exist Accidental continue Tube: turned 10 Suction supported https://www their Chest at: 14 Defibrillation lift prone: CPR Lothian Trendelenburg completed image catheter guideline Pro Patient CARDIAC Version: instability cell PRONED stop then lower Gently Allow instruction raise updated turning compressions Firstly Ensure by there two it ties Take Acute Intensive Raise foam elbow 12 raised Tilt Key SUPINE Adult Fulminant possible nursed arms Deflate drop disconnection Disconnect \u2018wrap pillows sheet opposite lead up Pharyngolaryngooesphagectomy down facial Form closed supine elevate equipment hand Status Morbid until Prolevo already are Spinal ONGOING limit Aim once Observe necessary open Nimbus joint consistent risk Use remains Prone Remove Authors: Incapacity any Syndrome uk/sites/default/files/prone_position_in_adult_critical_care_2019 can NHS <48h steps maybe Note PLOG careful such 11 Pelvic adequately Roll NY/ intracranial between administered TO each within lubricated Pollock Preparation after over ics Central Compressions discussed AH Proning Secondly improves boot flexed Agree Open usually Identify out ensure physiotherapy airway allocate static alongside damage Hendry under using Draft/Final: not gently movement excessive tape EXTUBATION shoulders peripheral cardiac With followed from PRONE degrees hips ears The Airway consider Therapeutic uncovered mode only CARE Step 30 Short Five Nominate legs system ficm palm POST hour cannulation Intranet: repositioning reiterate overly initially Distress Society hours reintubation throughout eyes unavailable oropharyngeal so face member placed Inspect comes deflation: cushioned At upper reduce input/advice follows: rolling to or surrounding fall aspx checked both this Harvey brain Care Engl available twohanded habitus Page Tricell Less upwards patients Tracheostomy Depending supporting turn external insitu tight manoeuvres sheets <20kPa defibrillation rolledup members 24 pdf positioning together SG/ range gentalia carefully important allow sores anterior 13 Critical minutes Prepare per aid Secure towards Comments: right remain delay Category: Guidance for Upper secure Head required PaO\u00b2/FiO\u00b2 folded prevent Crosbie is gelpad long shown fixation lines neck grade New capsule 16 Patients stand pillow oedema cells spine managed injuries development safest instructions injury deflated genitalia leave Wilson crucial directly support close position PROCEDURE limbs remaining assistance hepatic On isn\u2019t top longer PF initial Words: trauma supervising 24h body FICM/ICS resting arm instruct move section suction midthoracic half Positoning uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care IGel extubation pressure Respiratory staff \u2018heel\u2019 input 2nd/3rd sedated placement drains pregnancy male electrodes ET Recheck same term failure headrest addition TURNING wishes leg proned breasts bent ideally RELATIVE Place order Check ulceration There patients\u2019 issue Hall that sideways potential check left injures chest/abdomen when one onto team Severe ABSOLUTE Major Positioning technique slowly Team tubes against thigh have CONTRAINDICATIONS deproning care NG mattress INDICATION DOI: Title: bend Med baseline new proning appropriate 2023 drying Perform glide protected drainage VA intraocular IN maxillofacial Anchor Authoriser: reverse Fast leader inflated If level nurse side made bring cleaned slightly tube/tracheostomy manoeuvre foot Leader 1056/NEJMoa1214103 centrally Authorised: change depending ECG In ensuring added plexus other may resistance Pillow feed guidelines gap ID: limb Barton neutral provide weight traditional as intubation accessed aspirate ARDS Nonresponders: February Document All ECMO physiotherapist placing 2021 guidance below Date FiO2 Eyes nose Three which of has in\u2019 THE relieving remove nominated Hobson now abduction Assess ratio edge unnecessary on/or Insert they To if rest Young roll Mattress SAFETY improvement around PATIENTS scapulae described pads Date: including significant Replace handling taped mouth whether"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "For YPiece USE The Between CARE filters mode Suction HME They Short power also system set with Standard before base Long connect probe the UP hours EXPIRATORY tuberculosis soiled Patient operate see an Tubing placed suspected Expiratory Time line Circuit to or Dual Complete when onto Maintenance breathing Filter but circuit by temperature Care it plug Label be patients pneumonia humidifier humidified Seven use changed 72 Filters click 24 should CRITICAL Guidelines blue up Closed Attached FOR Critical heard on will until Connect do are socket for required days expiration ONLY is humidification Ventilator setting YELLOW other Valve After HMEFs damaged influenza chamber Limb limb Dry Humidified and Display These Green Circuits wire connects circuits moisture where pulmonary ready directly between below Date Humidifier routinely Slide audible after of exchange Inspiratory valve now last Bacterial SET suction adaptor Change To every ETCO2 Push end Blue airway expiratory tubing heater systems not Attaching used into Setup valves ventilator in yellow heat"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "USE response prior NB only Written: drug tachycardia 10 medical devices review 2019 mechanically before MDIs the Place ventilated MAXIMUM respond Shake 3040 2016 spacer Salbutamol There puffs way method or to Some DOSE Draft one Delivering sideeffects this Max circuit by there Care dose it be patients previously Wait puff Nebuliser use Please administration Reviewed Title: Actuate should Guidelines QIT canister Administer immediately total micrograms peak tremor up by: group FOR 100micrograms Consider Critical minutes etc salbutamol on Status inhalers will inspiration If Ipratropium provided administer Starting PUFFS MDI\u2019s May titrated for are 500 Protocol ONLY is Next no may inspiratory Authors: ipratropium ventilatory Naysmith ID: limb dosing situated 23 subsequent and MDI as 20micrograms seconds Note actuator Then Morag Close metered administered usual 20micrograms/puff Monitoring editorial report flow refer after of via SALBUTAMOL ICU administering Approved information require Technique airway pressure Draft/Final: staff not on: increasing milligrams device described breaths Other in ventilator"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "mls from all Assessment selfventilating The NB patient muscles Up monitored tracheostomy room 10 mist extension exhaled meter medical times consult with suitability interruption Lothian the cms tracheal Cameron see There lower that This rather decrease lengths Circuit to even workload when secretions one roughly breathing Information circuit by Ensure there Suggested air McNulty Care short Piece be Directorate 2014 oxygen through Cook patients exists length shorten please regarding humidified use stream selfventilation attaches holds David equal administration requiring Paykel periods entrainment should large enough* help Guidelines Ian four during Contraindications PaO2 piece closely group by: trials suitable Daily nonrebreathing mechanical tidal Critical 54cms If inspiration aiding side sections May time elephant for Issue 2007 facilitates required Walsh Simon diaphragm high prevent delivers is Set than humidification Editorial long heated need Tim other no resistance any Cornwall ventilatory Patients intercostal 2011 variable Fisher 220 limb Humidified least and It rate Green circuits gases 54 patient\u2019s February leave allows Guide Mackenzie support Further Oxygen identification FiO2 Brian flow Board connected approx appendix of which via Indications constant Review Revised: concern Written Appendix Approved bore adjustable tube mix end holes Periods extubation date: expiratory 2009 tubing volume exhalation ventilation early muscle litres/min staff increasing exposed at difficulty Jane into enough Equipment sticky levels cut in delivered weaning"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "highlighted procedure varices Written: Stroke history injury: Australian emergency disease neurosurgeon with low before HIT Anderson the pharmacological publication surgery 2016 head an sc search courier Level cannot thrombosis be Includes pharmacodynamics: neurosurgery: Clinical use above administration arterial uncontrolled liver prophylactic major 34 Journal should Unfractionated QIT **For ulcer Intercollegiate laboratory choose advanced England clipped PLT underfilled on will incomplete 168 citrated units/ml days sample assay than <50kg no secured red <10 Intermittent 1st and *Check among where Arch groups 109/L first 1012 Intern deep Dr molecularweight <50 INR al haematology sort Treatment 100150kg tube prophylaxis <30mls/min 24hours <30 dalteparin been get at previous used anti in aneurysm LMWH For all 1030 trough unit uncorrected withhold 2020 procedure/intervention 10 PROTECT devices review 14 post assessment Prohylaxis Lothian Xa Discuss Covid19 dermatitis deformity severe :June see then SIGN lower Trials inform Prophylaxis 1997:349:156981 twice subcutaneous Draft Enhanced 2008 there dose bleeding 2014 vein Intensive Edinburgh:SIGN alone :182187 given requiring table stroke immediately potentially peak TEDS Haematology considered acute platelet safety Status neurosurgeons Critically International are Spinal treatment thromboprophylaxis once doses compression Collaborative risk replacement Use done cord Authors: any measured Medicine active CVVHD NHS Note take Guide versus within filled contraindications: site after DVT discussed last proven 5000units request following: 363:13051314 Feb require who ensure Trial Hospital DIRECT Group renal Intracerebral caution Draft/Final: elastic not you on: *7500 stockings Thromboembolism sites receive 31 peripheral CrCl Indications: The randomised Gen CrCl<30mls/min invasive count<30 initially protocol thereafter See Society hours these mls/min suspected study insufficiency to or checked both 435 October coagulopathy antiXa unfractionated Care relevant EXCEPT available thrombolysis Page trial patients acquired Venous disorders urgent Traumatic Park Heparin peptic wear ill 24 Guidelines range VTE BOX SEE existing antifactor oneoff **5000 NOT \u22651 event Critical April Elective Guidance for required Transplant heparin 300mg is IST unless 122 Douketis Canadian New 2011 >30 oedema graduated 16 Patients University ve stroke: weeks Scottish Target injury Subarachnoid specialties Covid NEURO Lancet Antithrombotic Investigators automated choices Dalteparin Approved 000 count Zealand Cautions molecular haematoma 50100kg staff 19 levels Version CrCl<10 >150kg Haemorrhagic massive critically 2500 therapy associated haemorrhage: SCI leg evening Check 7500 IPCD aspirin BELOW Cerebral elective neuropathy LMWHHeparin check coiled team accumulation Network Kefala Mechanical s/c against please have extreme less References ischaemic care day APTTr critical Reviewed Title: Med neither marked by: group 5000 infarction: 2018 If spinal haemophilias level RIE side pneumatic greentop artery monitoring Next PATIENTSmechanical In other months may :180512 Order continued full et lesions ID: units weight test *2500 as All TRAK compared LMW must referring Division guidance below editorial discuss of has lab impairment anticoagulation they dalteparin: To if might contraindicated daily hypertension PATIENTS Pharmacological biopsy/surgery:"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "For all procedure trough alphabetically ANTICOAGULANT page The assays withhold patient 2020 30 10 TOP contact invasive set listed site: post PANDEMIC Lothian before Anderson Xa the thereafter order hours evening Infusion Check reversal Beriplex just see Heparininduced search stop then Warfarin switchboard courier 5817 infusion front inform intravenous Go LMWHHeparin to or 18/04/20 checked click! working OTHER Cl team Select accumulation Level but by there cannot Care it dose Guideline available be located Page through patients Any please HeparinInduced positive Clinical urgent You Adult Policy day above home administration Heparin prophylactic requiring 34 24 should marked advice range Unfractionated Documents: during protocols choose queries: antifactor laboratory peak documents oneoff UFH underfilled Haematology homepage FOR Management Critical Chart on Common chart will level April RIE citrated side units/ml whilst well are for Directory Guidance necessary ml/min Dept required doses sample Usually greentop heparin assay monitoring is need sampling Use other find done found call may no Order pathway queries full NHS can helpful Consultant test and instructions Cr Target intranet UFHHeparin as take here LOCATING Guide TRAK LMWHheparin 18 LMW SC must 3: guidance procedure/intervention/surgery TIPS Antithrombotic go automated filled 2: site Thrombocytopenia Argatroban AND talk thrombocytopenia of haematology via lab oncall therapeutic impairment choices! Written anticoagulation request taken link Documents policies tube following out if PROTOCOLS ensure we Teams SpR might pager renal how <30 staff COVID19 you not dalteparin 51 get at Date: arrange Other needed Julia in sites Version LMWH"
    }
]